{"add": {"doc": {"field": [{"@name": "docid", "#text": "BR-TU.13327"}, {"@name": "filename", "#text": "19291_tese.pdf"}, {"@name": "filetype", "#text": "PDF"}, {"@name": "text", "#text": "Universidade de Aveiro \n2016  \n\nDepartamento de Eng\u00aa de Materiais e Cer\u00e2mica \n\nPaula Maria  \nda Costa Torres \n \n\nCimentos injet\u00e1veis \u00e0 base de fosfatos de c\u00e1lcio \npara vertebroplastia \n \n\n \n\n  \n \n\n   \n\n\n\n \nUniversidade de Aveiro \n2016  \n\nDepartamento de Eng\u00aa de Materiais e Cer\u00e2mica \n\nPaula Maria  \nda Costa Torres \n \n \n\nCimentos injet\u00e1veis \u00e0 base de fosfatos de c\u00e1lcio \npara vertebroplastia \n \n\n Tese apresentada \u00e0 Universidade de Aveiro para cumprimento dos requisitos \nnecess\u00e1rios \u00e0 obten\u00e7\u00e3o do grau de Doutor em Ci\u00eancia e Engenharia de \nMateriais, realizada sob a orienta\u00e7\u00e3o cient\u00edfica do Professor Doutor Jos\u00e9 Maria \nda Fonte Ferreira, Professor Associado com Agrega\u00e7\u00e3o do Departamento de \nEngenharia de Materiais e Cer\u00e2mica da Universidade de Aveiro e da Doutora \nSusana Maria Henriques Olhero, Investigadora Auxiliar do Departamento de \nEngenharia de Materiais e Cer\u00e2mica da Universidade de Aveiro. \n\n \n\n  \n \n\nApoio financeiro da FCT e do \nPOPH/FSE no \u00e2mbito do III Quadro \nComunit\u00e1rio de Apoio. \nSFRH/BD/62021/2009 \n \n \n \n\n\n\n \n\n  \n\n  \n \n\n \n \n\n \n                                         \n \n \n \n \n \n \n \n \n \n \n \n \n                                                   \n \n \n \n \n \n \n \n                                                 Aos meus amores Tom\u00e1s e Paulo\u2026 \n                                                                       \n                                                 Aos meus pais\u2026 \n                                             \n                                                 \u00c0 minha fam\u00edlia e amigos\u2026 \n \n\n \n\n\n\n \n\n  \n \n\n \n \n \n\n \n \n\no j\u00fari   \n \n\npresidente Prof. Doutor Carlos Fernandes da Silva \nprofessor catedr\u00e1tico do Departamento de Educa\u00e7\u00e3o da Universidade de Aveiro \n\n  \n \n\n Prof. Doutora Ana Francisca de Campos Sim\u00e3o Bettencourt \nprofessor auxiliar da Faculdade de Farm\u00e1cia da Universidade de Lisboa \n\n  \n \n\n Prof. Doutor Alberto Eduardo Mor\u00e3o Cabral Ferro \nprofessor auxiliar do Departamento de Engenharia Mec\u00e2nica do Instituto Superior T\u00e9cnico \n\n  \n \n\n Prof. Doutor Jo\u00e3o Carlos Tom\u00e1s Ramos \nprofessor auxiliar da Faculdade de Medicina da Universidade de Coimbra \n\n  \n \n\n Prof. Doutora Maria Elisabete Jorge Vieira da Costa \nprofessor auxiliar do Departamento de Engenharia de Materiais e Cer\u00e2mica da Universidade de \nAveiro \n\n  \n \n\n Prof. Doutor Jos\u00e9 Maria da Fonte Ferreira \nprofessor associado com agrega\u00e7\u00e3o do Departamento de Engenharia de Materiais e Cer\u00e2mica  \nda Universidade de Aveiro \n\n  \n \n\n  \n \n \n \n\n\n\n \n\n  \n\n  \n \n\nagradecimentos \n \n\nQuero agradecer ao Professor Doutor Jos\u00e9 Maria F. Ferreira pelo seu apoio \ncient\u00edfico, sagacidade dos seus coment\u00e1rios, paci\u00eancia e resili\u00eancia. As longas \nhoras de discuss\u00f5es e correc\u00e7\u00f5es, enriquecedoras, animadas, por vezes \ndif\u00edceis e cansativas, pontuadas por acesas trocas de argumentos e por temas \ndiversos como politica e livros, nunca ser\u00e3o esquecidas.  \n\n\u00c0 minha co-orientadora e amiga, Doutora Susana Olhero. A sua contribui\u00e7\u00e3o \nfoi fundamental para conseguir finalizar esta tese. Meu eterno bem-haja, Susie, \npor todo o apoio que me deste: cientifico, emocional, e pelo suporte financeiro \nnesta \u00faltima fase.  \n\n\u00c0 FCT, pela bolsa de doutoramento concedida. \n\n\u00c0 UA, ao DEMAC e ao CICECO, pelos meios colocados \u00e0 minha disposi\u00e7\u00e3o; \naos seus funcion\u00e1rios e t\u00e9cnicos. Um especial bem-haja aos Professores\nJoaquim Vieira, Augusto Lopes e Ana Barros, \u00e0 Sandra Magina, Ros\u00e1rio, \nMarta, Bruno, Maria Jo\u00e3o, Celeste, Dra. Alexandra, Lu\u00edsa, Paulo, Ana, C\u00e9lia, \nSr. Jacinto e Oct\u00e1vio. \n\n\u00c0 Sandra Pina, pela disponibilidade, pela amizade e por me ter encaminhado \npara este interessante mundo dos cimentos de fosfato de c\u00e1lcio inject\u00e1veis.  \n\n\u00c0 Ana Marote, Regina Cerqueira, Sandra Vieira, Ant\u00f3nio Calado e Odete Cruz, \npelo trabalho desenvolvido, apoio cient\u00edfico, gentileza e disponibilidade.  \n\nAo Jo\u00e3o Abrantes, pela sua preciosa contribui\u00e7\u00e3o nas numerosas an\u00e1lises de \nDRX por refinamento de Rietveld, pela sua simpatia, disponibilidade e \npaci\u00eancia.  \n\n\u00c0 S\u00f3nia Gouveia, pela sua fundamental contribui\u00e7\u00e3o no tratamento de dados, \npela sua calma, perspic\u00e1cia e boa disposi\u00e7\u00e3o. Mergulhada e quase afogada \nnos dados, fui salva por si! \n\nAo Marc Bohner e ao Nicola D\u00f6belin, pelos conhecimentos transmitidos, trocas \nde ideias e coment\u00e1rios pertinentes que levaram a uma melhoria do trabalho \ndesenvolvido.  \n\nAo Hospital Infante D. Pedro de Aveiro, especialmente \u00e0 equipa envolvida no \nprocesso de esteriliza\u00e7\u00e3o de amostras. Um bem-haja \u00e0s enfermeiras \u00c1urea\nSim\u00f5es e Margarida Vilarinho. \n\nAos meus amigos e colegas de trabalho Catarina, Avito, Hugo, Ajay e Anurag \ne tamb\u00e9m \u00e0 Marisa Costa, pela amizade, boa disposi\u00e7\u00e3o, apoio e pela partilha \nde momentos bons e menos bons que contribu\u00edram para um enriquecimento \npessoal e profissional.  \n\nA todos os meus colegas, amigos e familiares que, de alguma forma, \nprestaram o seu apoio. \n\nAos meus pais e \u00e0 minha irm\u00e3 T\u00e9 que sempre me apoiaram e animaram em \ntodos os momentos mais dif\u00edceis do meu trajecto.  \n\u00c0 Gl\u00f3ria, pela for\u00e7a, determina\u00e7\u00e3o, coragem, calma e carinho que me tem \ndado. \nAo Paulo e ao meu filho Tom\u00e1s, pelo seu amor, cumplicidade, ajuda e \npaci\u00eancia. \n\n\n\n \n\n  \n \n \n \n \n \n \n \n \n \n \n\n  \n\npalavras-chave \n \n\nCimentos de fosfatos c\u00e1lcio, brushite, p\u00f3s de ?? e ??TCP, i\u00f5es dopantes, \ndistribui\u00e7\u00e3o de tamanho de part\u00edcula, sucrose como agente retardador, \ninjectabilidade, presa, resist\u00eancia mec\u00e2nica, regenera\u00e7\u00e3o \u00f3ssea \n \n\nresumo \n \n \n\nO principal objectivo desta investiga\u00e7\u00e3o foi o desenvolvimento cimentos de \nfosfatos de c\u00e1lcio com injetabilidade melhorada e propriedades mec\u00e2nicas \nadequadas para aplica\u00e7\u00e3o em vertebroplastia. \n\nOs p\u00f3s de fosfato de tric\u00e1lcico (TCP) n\u00e3o dopados e dopados (Mg, Sr e Mn) \nusados neste estudo foram obtidos pelo processo de precipita\u00e7\u00e3o em meio \naquoso, seguidos de tratamento t\u00e9rmico de forma a obter as fases \npretendidas, ?? e ??TCP. A substitui\u00e7\u00e3o parcial de i\u00f5es Ca por i\u00f5es dopantes \nmostrou ter implica\u00e7\u00f5es em termos de estabilidade t\u00e9rmica da fase ??TCP. Os \nresultados demonstraram que as transforma\u00e7\u00f5es de fase alotr\u00f3picas \n????TCP s\u00e3o fortemente influenciadas por vari\u00e1veis experimentais como a \ntaxa de arrefecimento, a presen\u00e7a de impurezas de pirofosfato de c\u00e1lcio e a \nextens\u00e3o do grau de dopagem com Mg. \n\nOs cimentos foram preparados atrav\u00e9s da mistura de p\u00f3s, ??TCP (n\u00e3o \ndopados e dopados) e fosfato monoc\u00e1lcico monidratado (MCPM), com meios \nl\u00edquidos diferentes usando \u00e1cido c\u00edtrico e a\u00e7ucares (sucrose e frutose) como \nagentes retardadores de presa, e o polietilenoglicol, a\nhidroxipropilmetilcelulose e a polivinilpirrolidona como agentes gelificantes. \nEstes aditivos, principalmente o \u00e1cido c\u00edtrico, e o MCPM aumentam \nsignificativamente a for\u00e7a i\u00f3nica do meio, influenciando a injetabilidade das \npastas. Os resultados tamb\u00e9m mostraram que a distribui\u00e7\u00e3o de tamanho de \npart\u00edcula dos p\u00f3s \u00e9 um factor determinante na injetabilidade das pastas \nciment\u00edcias.  \n\nA combina\u00e7\u00e3o da co-dopagem de Mn e Sr com a adi\u00e7\u00e3o de sucrose no l\u00edquido \nde presa e com uma distribui\u00e7\u00e3o de tamanho de part\u00edcula dos p\u00f3s adequada \nresultou em cimentos de brushite com propriedades bastante melhoradas em \ntermos de manuseamento, microestrutura, comportamento mec\u00e2nico e \nbiol\u00f3gico: (i) o tempo inicial de presa passou de ~3 min to ~9 min; (ii) as pastas \nciment\u00edcias foram totalmente injectadas para uma raz\u00e3o liquido/p\u00f3 de 0.28 mL \ng?1 com aus\u00eancia do efeito de \u201cfilter-pressing\u201d (separa\u00e7\u00e3o de fases l\u00edquida e \ns\u00f3lida); (iii) ap\u00f3s imers\u00e3o numa solu\u00e7\u00e3o durante 48 h, as amostras de cimento \nmolhadas apresentam uma porosidade total de ~32% e uma resist\u00eancia a \ncompress\u00e3o de ~17 MPa, valor muito superior ao obtido para os cimentos sem \na\u00e7\u00facar n\u00e3o dopados (5 MPa) ou dopados s\u00f3 com Sr (10 MPa); e (iv) o \ndesempenho biol\u00f3gico, incluindo a ades\u00e3o e crescimento de c\u00e9lulas \nosteobl\u00e1sticas na superf\u00edcie do cimento, foi muito melhorado. Este conjunto de \npropriedades torna os cimentos excelentes para regenera\u00e7\u00e3o \u00f3ssea e \nengenharia de tecidos, e muito promissores para aplica\u00e7\u00e3o em vertebroplastia. \n\n \n \n\n\n\n \n\n \n \n \n \n \n \n \n \n\n \n \n \n \n \n \n \n \n \n \n \n\n  \n\nkeywords \n \n\nCalcium phosphates cements, brushite, ?? and ??TCP powders, dopant ions, \nparticle size distribution, sucrose as retardant, injectability, self-setting, \nmechanical strength, bone regeneration \n \n\nabstract \n \n\nThe main objective of this research was the development of cements based on \ncalcium phosphates with improved injectability and mechanical properties \nsuitable for being used in vertebroplasty. \n\nThe tricalcium phosphate powders (TCP) undoped and doped (Mg, Sr and Mn) \nused in this study were obtained through aqueous precipitation process, \nfollowed by heat treatment in order to obtain appropriate phases, ?? and \n??TCP. The partial substitution of Ca ions by doping ions shown to have \nimplications in terms of thermal stability of ??TCP phase. The results showed \nthat ????TCP allotropic phase transformations are strongly influenced by \nexperimental variables like cooling rate, the presence of calcium \npyrophosphate impurities and the Mg-doping extent. \n\nThe cements were prepared by mixing the ??TCP and monocalcium phosphate \nmonohydrate (MCPM) powders with different liquids, using citric acid and \nsugars (sucrose and fructose) as setting retarders, and polyethylene glycol, \nhydroxypropyl methylcellulose and polyvinylpyrrolidone as gelling agents. \nThese additives, especially the citric acid, and MCPM significantly increase the \nionic strength of the medium, affecting the injectability of cement pastes. The \nresults also showed that the particle size distribution of the powders used is a \ndeterminant factor in the injectability of cement pastes. \n\nThe combination of co-doping of Sr and Mn with the addition of sucrose in the \nsetting liquid and with a suitable particle size distribution of the powders \nresulted in brushite based cements with overall greatly improved properties in \nterms of handling, microstructure, mechanical and biological behaviours: (i) the \ninitial setting time increased from ~3 min to ~9 min; (ii) the cement pastes were \nfully injected for a liquid powder ratio of 0.28 mL g?1 with absence of filter \npressing effects; (iii) after immersion for 48 hours in a solution, wet cement \nsamples exhibit a total porosity of ~32% and a compressive strength of ~17 \nMPa, much higher than those registered for sugar-free CPCs derived from non-\ndoped ??TCP (5 MPa) or from Sr-doped ??TCP (10 MPa); and (iv) the \nbiological performance, including adhesion and growth of osteoblastic cells in \ncement surface, was much improved. This set of properties turns these \ncements excellent for bone regeneration and tissue engineering, and very \npromising for application in vertebroplasty.  \n\n \n\n \n\n\n\n \n\n i \n\n\u00cdndice \n\n \n\nIntrodu\u00e7\u00e3o Geral ..................................................................................................................... 1 \n\nRefer\u00eancias bibliogr\u00e1ficas .............................................................................................................. 6 \n\nCap\u00edtulo 1 \n\nComposi\u00e7\u00e3o, estrutura e metabolismo do osso, e a import\u00e2ncia dos cimentos de fosfato de \n\nc\u00e1lcio como material substituto do tecido \u00f3sseo: no\u00e7\u00f5es gerais e objetivos deste estudo .......... 9 \n\n1. Estrutura, composi\u00e7\u00e3o e propriedades do osso....................................................................... 11 \n\n1.1 Macroestrutura do osso ..................................................................................................... 12 \n\n1.2 Microestrutura do osso ...................................................................................................... 14 \n\n1.2.1 Composi\u00e7\u00e3o e propriedades do osso ......................................................................... 14 \n\n1.2.2 C\u00e9lulas \u00f3sseas............................................................................................................. 16 \n\n1.3 Remodela\u00e7\u00e3o e autorrepara\u00e7\u00e3o \u00f3ssea............................................................................... 18 \n\n2. Materiais de substitui\u00e7\u00e3o \u00f3ssea ............................................................................................... 19 \n\n3. Fosfatos de c\u00e1lcio como substitutos \u00f3sseos ............................................................................ 20 \n\n3.1 Fosfatos de c\u00e1lcio ............................................................................................................... 21 \n\n3.2 Substitui\u00e7\u00e3o i\u00f3nica em fosfatos de c\u00e1lcio .......................................................................... 26 \n\n4. Cimentos \u00f3sseos....................................................................................................................... 27 \n\n4.1 Cimentos \u00e0 base de PMMA ................................................................................................ 28 \n\n4.2 Cimentos de sulfato de c\u00e1lcio ............................................................................................ 28 \n\n4.3 Cimentos de fosfato de c\u00e1lcio ............................................................................................ 29 \n\n4.3.1 Processo de presa e endurecimento.......................................................................... 29 \n\n4.3.1.1 Tempo de presa e endurecimento ....................................................................... 30 \n\n4.3.2 Tipos de cimentos ...................................................................................................... 32 \n\n4.3.3 Reac\u00e7\u00f5es qu\u00edmicas envolvidas na presa dos cimentos .............................................. 33 \n\n4.3.4 Principais diferen\u00e7as entre cimentos de apatite e de brushite ................................. 35 \n\n4.3.5 Flexibilidade dos CPCs em termos de desenhos das suas propriedades ................... 39 \n\n4.3.5.1 Injetabilidade........................................................................................................ 40 \n\n4.3.5.2 Comportamento mec\u00e2nico .................................................................................. 44 \n\n4.3.5.3 Biocompatibilidade e ressor\u00e7\u00e3o ........................................................................... 46 \n\n4.3.5.4 Incorpora\u00e7\u00e3o de i\u00f5es presentes no osso.............................................................. 48 \n\n\n\n \n\n ii \n\n5. Metas e objetivos ..................................................................................................................... 48 \n\n6. Refer\u00eancias bibliogr\u00e1ficas ........................................................................................................ 51 \n\nCap\u00edtulo 2 \n\nInflu\u00eancia da dopagem de magn\u00e9sio, das impurezas de pirofosfato de c\u00e1lcio e da taxa de \n\narrefecimento sobre as transforma\u00e7\u00f5es de fase alotr\u00f3picas ???????????? do fosfato tric\u00e1lcico ............ 65 \n\nAbstract ........................................................................................................................................ 68 \n\n1. Introduction.............................................................................................................................. 69 \n\n2. Materials and methods ............................................................................................................ 71 \n\n2.1 Powder synthesis................................................................................................................ 71 \n\n2.2 Powders characterization................................................................................................... 73 \n\n3. Results ...................................................................................................................................... 77 \n\n3.1 Influence of Mg-doping on the characteristics of starting powders.................................. 77 \n\n3.2 Thermal behaviour of Mg0TCP........................................................................................... 80 \n\n3.3 Influence of Mg-doping on thermal behaviour.................................................................. 85 \n\n4. Discussion................................................................................................................................. 87 \n\n4.1 Influence of Mg-doping on the characteristics of the Mg0?5TCP powders ...................... 87 \n\n4.2 The thermal behaviour of Mg0TCP .................................................................................... 88 \n\n4.3 Influence of Mg-doping on thermal behaviour.................................................................. 93 \n\n5. Conclusions............................................................................................................................... 95 \n\nAcknowledgements...................................................................................................................... 97 \n\nReferences.................................................................................................................................... 97 \n\nCap\u00edtulo 3 \n\nInjectabilidade de pastas de fosfato de c\u00e1lcio: Efeitos do tamanho da part\u00edcula e estado de \n\nagrega\u00e7\u00e3o de p\u00f3s de ?-fosfato tric\u00e1lcico ................................................................................105 \n\nAbstract ...................................................................................................................................... 108 \n\n1. Introduction............................................................................................................................ 109 \n\n2. Materials and methods .......................................................................................................... 111 \n\n2.1 Powder preparation and characterisation ....................................................................... 111 \n\n2.2 Granule preparation and characterisation....................................................................... 112 \n\n2.3 Injectability evaluation ..................................................................................................... 113 \n\n2.3.1 Preparation of the pastes......................................................................................... 113 \n\n2.3.2 Injectability tests ...................................................................................................... 114 \n\n2.4 Zeta potential and electrical conductivity in different electrolyte solutions................... 115 \n\n\n\n \n\n iii \n\n2.5 Influence of preparation conditions on the flow behaviour of pastes ............................ 115 \n\n2.6 Statistical methods and data analysis .............................................................................. 116 \n\n3. Results .................................................................................................................................... 117 \n\n3.1 Characterisation of starting powders............................................................................... 117 \n\n3.2 Characterisation of the Sr?TCP granules .......................................................................... 121 \n\n3.3 Injectability and filter pressing effect of pastes ............................................................... 122 \n\n3.3.1 Non-reactive systems............................................................................................... 122 \n\n3.3.2 Reactive systems ...................................................................................................... 125 \n\n3.3.3 Powder blends in reactive systems .......................................................................... 129 \n\n3.4 Influence of dispersing/reactive liquids on zeta potential and rheology......................... 132 \n\n4. Discussion............................................................................................................................... 134 \n\n5. Conclusions............................................................................................................................. 139 \n\nAcknowledgments...................................................................................................................... 140 \n\nReferences.................................................................................................................................. 141 \n\nCap\u00edtulo 4 \n\nEfeitos da dopagem do mangan\u00eas na estrutura e nas propriedades biol\u00f3gicas do fosfato \n\n?????tric\u00e1lcico ...........................................................................................................................147 \n\nAbstract ...................................................................................................................................... 150 \n\n1. Introduction............................................................................................................................ 151 \n\n2. Materials and methods .......................................................................................................... 153 \n\n2.1 Powders preparation........................................................................................................ 153 \n\n2.2 Powders characterization................................................................................................. 155 \n\n2.3 MC3T3-E1 cell culture ...................................................................................................... 156 \n\n2.4 Cytotoxicity and cell proliferation assays in Mn-doped ?-TCP powders ......................... 156 \n\n2.5 Antibodies and Fluorescing Chemicals............................................................................. 157 \n\n2.6 Immunoblot analyses of Type-I collagen protein expression and media secretion ........ 157 \n\n2.7 Confocal microscopy analyses of Type-I collagen protein distribution ........................... 158 \n\n2.8 Statistical analysis............................................................................................................. 158 \n\n3. Results .................................................................................................................................... 159 \n\n3.1 Influence of Mn-doping on the structure of ?-TCP.......................................................... 159 \n\n3.2. Biological properties........................................................................................................ 164 \n\n3.2.1 Mn0.5-1TCP powders increase MC3T3 cellular proliferation .................................. 164 \n\n\n\n \n\n iv \n\n3.2.2 MnTCP powders greatly decrease intracellular procollagen (I) levels and increase its \n\nmaturation and secretion ................................................................................................. 166 \n\n3.2.3 Mn1TCP induces osteoblastic differentiation .......................................................... 168 \n\n4. Discussion............................................................................................................................... 170 \n\n4.1 Influence of Mn-doping on the structure of ?-TCP.......................................................... 170 \n\n4.2 Biological properties......................................................................................................... 172 \n\n5. Conclusions............................................................................................................................. 173 \n\nAcknowledgements.................................................................................................................... 174 \n\nReferences.................................................................................................................................. 175 \n\nCap\u00edtulo 5 \n\nCimentos \u00f3sseos formados por brushite ado\u00e7ados e dopados com estr\u00f4ncio e mangan\u00eas: a \n\nreceita para fomentar a injectabilidade e o desempenho biol\u00f3gico in vitro ............................181 \n\nAbstract ...................................................................................................................................... 184 \n\n1. Introduction............................................................................................................................ 185 \n\n2. Materials and Methods .......................................................................................................... 187 \n\n2.1 Preparation of starting powders and cements ................................................................ 187 \n\n2.1.1 Preparation and characterisation of the powders ................................................... 187 \n\n2.1.2 Preparation of cement pastes.................................................................................. 188 \n\n2.2 Characterisation of cement pastes .................................................................................. 189 \n\n2.2.1 Setting time .............................................................................................................. 189 \n\n2.2.2 Injectability............................................................................................................... 190 \n\n2.2.3 Mechanical properties and porosity ........................................................................ 190 \n\n2.2.4 X-ray diffraction and structural analysis by the Rietveld refinement method ........ 191 \n\n2.3 Characterisation of cement/osteoblastic-like cells interactions...................................... 191 \n\n2.3.1 Cultures of MG63 cells with cements ...................................................................... 191 \n\n2.3.2 Viability and proliferation assays ............................................................................. 192 \n\n2.3.3 Chemical and phase composition of cements after 28DIV with MG63 cells ........... 192 \n\n2.3.4 Immunoblot analyses of type-I collagen .................................................................. 193 \n\n2.3.5 Confocal microscopy and scanning electron microscopy analyses of cells ............. 193 \n\n2.4 Statistical analysis............................................................................................................. 194 \n\n3. Results .................................................................................................................................... 195 \n\n3.1 Characterisation of ?-TCP powders ................................................................................. 195 \n\n3.2 Characterisation of cement pastes .................................................................................. 197 \n\n\n\n \n\n v \n\n3.3 Characterisation of in vitro osteoconductive properties ................................................. 205 \n\n3.3.1 Effects of Mn- and Sr-doping on cell viability and type-I collagen secretion........... 205 \n\n3.3.2 Mn0.5Sr5CPC potential to be an osteoconductive scaffold .................................... 207 \n\n4. Discussion............................................................................................................................... 212 \n\n4.1. Effects of MnSr-doping and sugars addition on the properties of cements ................... 212 \n\n4.2 Effects of MnSr-doping and adding sucrose on the in vitro biological behaviour ........... 218 \n\n5. Conclusions............................................................................................................................. 220 \n\nAcknowledgments...................................................................................................................... 221 \n\nReferences.................................................................................................................................. 222 \n\nCap\u00edtulo 6 \n\nConclus\u00f5es gerais e perspetivas futuras ................................................................................233 \n\nPerspetivas futuras..................................................................................................................... 237 \n\nAnexos .................................................................................................................................239 \n\nAnexo 1. Diagrama de equil\u00edbrio de fases do sistema Mg3(PO4)2-Ca3(PO4)2 .............................. 241 \n\nAnexo 1.1 Segundo Enderle et al. .......................................................................................... 241 \n\nAnexo 1.2 Segundo Carrodeguas et al. .................................................................................. 242 \n\nAnexo 2. Diagrama de equil\u00edbrio de fases do sistema CaO-P2O5 ............................................... 243 \n\nAnexo 3. Diagrama de equil\u00edbrio de fases do sistema CaO-P2O5-H2O........................................ 244 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n vi \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n vii \n\nLista de Abreviaturas \n\n \n\nA L\u00edquido de presa A: solu\u00e7\u00e3o aquosa com 5 wt.% CA + 10 wt.% PEG + \n0.5% wt.% HPMC \n\nSetting liquid A \n\nAS L\u00edquido de presa contendo sacarose, AS: solu\u00e7\u00e3o aquosa com 5 wt.% CA \n+ 10 wt.% PEG) + 0.5% wt.% HPMC + 10wt.% S \n\nSetting liquid AS \n\nAF L\u00edquido de presa contendo frutose, AF: solu\u00e7\u00e3o aquosa com 5 wt.% CA + \n10 wt.% PEG + 0.5% wt.% HPMC + 10wt.% F \n\nSetting liquid AF \n\nAP Apatite \n\nApatite \n\nBET M\u00e9todo de Brunauer\u2013Emmett\u2013Teller  \n\nBrunauer\u2013Emmett\u2013Teller method \n\nBSA Albumina de soro bovino \n\nBovine serum albumin \n\nCA \u00c1cido c\u00edtrico \n\nCitric acid \n\nCaP Fosfato de c\u00e1lcio \n\nCalcium phosphate  \n\nCDHA Hidroxiapatite n\u00e3o-estequiom\u00e9trica deficiente em c\u00e1lcio \n\nCalcium deficient hydroxyapatite \n\nCP Pasta reativa ou pasta ciment\u00edcia  \n\nReactive paste \n\nCPC Cimento de fosfato de c\u00e1lcio \n\nCalcium phosphate cement \n\nCPP Pirofosfato de c\u00e1lcio \n\nCalcium pyrophosphate \n\n  \n\n\n\n \n\n viii \n\nDCPA Fosfato dic\u00e1lcico ou monetite CaHPO4 \n\nDicalcium phosphate anhydrous \n\nDCPD Fosfato dic\u00e1lcico dihidratado ou brushite CaHPO4\u00b72H2O \n\nDicalcium phosphate dihydrate \n\nDiv Dias in vitro \n\nDays in vitro  \n\nDSC Calorimetria diferencial de varrimento ou calorimetria explorat\u00f3ria \ndiferencial \n\nDifferential scanning calorimeter \n\nEBSS  Solu\u00e7\u00e3o salina equilibrada de Earl \n\nEarle\u2019s Balanced Salt Solution \n\nECL  Quimioluminesc\u00eancia aumentada \n\nEnhanced chemiluminescence \n\nECM  Matriz extracelular \n\nExtracellular matrix \n\nF Frutose  \n\nFructose \n\nFBS  Soro fetal bovino \n\nFetal bovine serum \n\nFITC Isotiocianato de fluoresce\u00edna \n\nFluorescein isothiocyanate \n\nFST Tempo final de presa  \n\nFinal setting time \n\nFT-IR Espectroscopia no infravermelho por transformada de Fourier \n\nFourier Transform Infrared Spectrometry \n\nG Gr\u00e2nulos \n\nGranules \n\nHA Hidroxiapatite \n\nHydroxyapatite \n\nHPMC Hidroxipropilmetilcelulose \n\nHydroxypropyl methylcellulose \n\n\n\n \n\n ix \n\nHT-XRD Difrac\u00e7\u00e3o de raios X de alta temperatura \n\nhigh-temperature X-ray powder diffraction \n\nICP-OES Espectrometria de emiss\u00e3o \u00f3ptica por plasma acoplado indutivamente \n\nInductively coupled plasma optical emission spectrometry \n\nIST Tempo inicial de presa  \n\nInitial setting time  \n\nLPR Raz\u00e3o l\u00edquido-p\u00f3 \n\nLiquid-to-powder ratio \n\nMCPM Fosfato monoc\u00e1lcico monidratado \n\nMonocalcium phosphate monohydrate \n\nMgTCP P\u00f3 de TCP dopados com Mg \n\nMg doped TCP powder \n\nMnCPC CPC dopado com Mn \n\nCPC doped with Mn \n\nMnTCP, \nMn-TCP \n\nP\u00f3 de TCP dopados com Mn \n\nMn doped TCP powder \n\nMnSrCPC CPC co-dopado com Mn e Sr \n\nCPC co-doped with Mn and Sr \n\nOCP Fosfato octac\u00e1lcico \n\nOctacalcium phosphate   \n\nO.D.  Densidade \u00f3ptica \n\nOptical density \n\nO.D.f  Densidade \u00f3ptica final. \n\nFinal optical density \n\nP Pasta n\u00e3o reativa \n\nNon-reactive paste \n\nPBS Tamp\u00e3o fosfato-salino \n\nPhosphate-buffered saline \n\nPEG Polietilenoglicol \n\nPolyethylene glycol \n\n\n\n \n\n x \n\nPMMA Polimetilmetacrilato \n\nPolymethylmethacrylate \n\nPS Tamanho de particular \n\nParticle size \n\nPSD Distribui\u00e7\u00e3o de tamanho de part\u00edcula \n\nParticle size distribution \n\nPVP polivinilpirrolidona \n\npolyvinylpyrrolidone \n\nRT Temperatura ambiente \n\nRoom Temperature \n\nS Sacarose \n\nSucrose \n\nSBS Dodecil sulfato de s\u00f3dio \n\nSodium dodecyl sulfate \n\nSEM \n\n \n\nMicroscopia electr\u00f3nica de varrimento \n\nScanning Electron Microscopy \n\nSrCPC CPC dopado com Sr \n\nCPC doped with Sr \n\nSr-TCP P\u00f3 de TCP dopados com Sr \n\nSr doped TCP powder \n\nSSA \u00c1rea superficial espec\u00edfica \n\nSpecific surface area \n\nTCP Fosfato tric\u00e1lcico \n\nTricalcium phosphate \n\nTTCP Fosfato tetrac\u00e1lcico \n\nTetracalcium phosphate \n\nXRD Difrac\u00e7\u00e3o de raios X \n\nX-ray powder diffraction \n\n \n\n\n\n \n\n 1 \n\nIntrodu\u00e7\u00e3o Geral \n\n \n\nO envelhecimento da popula\u00e7\u00e3o e o consequente aumento da incid\u00eancia de \n\ndoen\u00e7as \u00f3sseas, tais como a osteoporose, osteomielite e tumores malignos, e de \n\nacidentes traum\u00e1ticos, entre outros, t\u00eam gerado uma procura crescente de \n\nmateriais de preenchimento e de repara\u00e7\u00e3o \u00f3ssea [1, 2]. Para fazer face \u00e0 essa \n\nmultiplicidade de patologias e de traumatismos que necessitam de respostas \n\nadequadas, grandes t\u00eam sido os esfor\u00e7os de investiga\u00e7\u00e3o nesta \u00e1rea com vista \n\nao desenvolvimento de uma grande variedade de substitutos \u00f3sseos.  \n\nEm geral, existem 206 ossos no esqueleto humano adulto e cerca de 300 ossos \n\nno de uma crian\u00e7a. O osso, material comp\u00f3sito natural, \u00e9 um tecido din\u00e2mico em \n\ncont\u00ednua remodela\u00e7\u00e3o ao longo da vida por a\u00e7\u00e3o de uma importante atividade \n\nmetab\u00f3lica das c\u00e9lulas \u00f3sseas. A atividade conjunta destas c\u00e9lulas contribui para \n\na degrada\u00e7\u00e3o de \u00e1reas lesadas ou envelhecidas do osso (osteoclastos), a sua \n\nregenera\u00e7\u00e3o (osteoblastos) e sua manuten\u00e7\u00e3o (oste\u00f3citos) [3]. No entanto, este \n\nprocesso biol\u00f3gico pode ser demasiado longo ou n\u00e3o ser suficiente, \n\nespecialmente no caso de perda \u00f3ssea significativa de origem traum\u00e1tica ou \n\npatol\u00f3gica. A osteoporose, por exemplo, que afeta um n\u00famero crescente de \n\npacientes, muito devido ao aumento da esperan\u00e7a m\u00e9dia de vida, requer o \n\npreenchimento de les\u00f5es, por vezes, de dif\u00edcil acesso. Para superar os v\u00e1rios \n\nproblemas, diversos procedimentos cir\u00fargicos foram desenvolvidos para a \n\nimplanta\u00e7\u00e3o de enxertos \u00f3sseos de diferentes origens. Os enxertos aut\u00f3genos \n\n(utiliza\u00e7\u00e3o de osso do mesmo paciente) est\u00e3o entre os mais bem-sucedidos, mas \n\ndeparam-se com limita\u00e7\u00f5es \u00f3bvias no que respeita \u00e0 fraca disponibilidade de \n\ntecido recolhido, morbidez, e complica\u00e7\u00f5es no local da colheita. Os enxertos \n\nal\u00f3genos (osso de cad\u00e1ver de indiv\u00edduo da mesma esp\u00e9cie) e xen\u00f3genos (osso \n\nde esp\u00e9cie diferente da do recetor) apresentam tamb\u00e9m v\u00e1rios inconvenientes, \n\nentre as quais a grande probabilidade de rejei\u00e7\u00e3o e de transmiss\u00e3o de doen\u00e7as \n\ninfeciosas [4]. Tendo em conta os maiores riscos de infe\u00e7\u00e3o e de contamina\u00e7\u00e3o  \n\n\n\nIntrodu\u00e7\u00e3o Geral \n\n 2 \n\ndos materiais de origem biol\u00f3gica, o desenvolvimento de substitutos \u00f3sseos \n\nsint\u00e9ticos tem vindo a ganhar cada vez mais import\u00e2ncia nos \u00faltimos anos. Entre \n\nos \u00faltimos materiais desenvolvidos encontram-se os cimentos minerais \n\nhidr\u00e1ulicos, nomeadamente, os cimentos de fosfatos de c\u00e1lcio, usados para o \n\nenchimento de cavidades \u00f3sseas e dent\u00e1rias. Estes cimentos apresentam a \n\nvantagem de ser biocompat\u00edveis, bioativos e biomim\u00e9ticos permitindo uma \u00f3tima \n\nintegra\u00e7\u00e3o do material no local implantado [1, 5, 6]. De facto, o tecido \u00f3sseo \u00e9 \n\nconstitu\u00eddo por ~60% de fase mineral, sendo a hidroxiapatite deficiente em c\u00e1lcio, \n\na fase dominante. As propriedades osteocondutoras e potencialmente \n\nosteoindutoras destes cimentos, e a sua potencial biodegradabilidade s\u00e3o outras \n\ncaracter\u00edsticas atrativas para o seu uso. Al\u00e9m disso, apresentando-se sob a forma \n\nde uma pasta que endurece in situ, eles d\u00e3o estabilidade a defeitos com qualquer \n\ngeometria sendo particularmente adequados para t\u00e9cnicas cir\u00fargicas \n\nminimamente invasivas, desde que as suas propriedades de fluxo sejam \n\nadequadas [6]. Infelizmente esta condi\u00e7\u00e3o nem sempre \u00e9 alcan\u00e7ada com \n\nsucesso, devido principalmente a fen\u00f3menos de separa\u00e7\u00e3o de fases s\u00f3lida-l\u00edquida \n\ndurante a extrus\u00e3o da pasta e ao consequente entupimento das agulhas ou \n\nc\u00e2nulas de inje\u00e7\u00e3o [7-9]. Em termos de propriedades mec\u00e2nicas, eles \n\napresentam-se muitas vezes fr\u00e1geis e a sua cin\u00e9tica de ressor\u00e7\u00e3o ap\u00f3s \n\nimplanta\u00e7\u00e3o nem sempre \u00e9 ajustada ao da neoforma\u00e7\u00e3o \u00f3ssea. O desajuste \n\ni\u00f3nico dos cimentos em rela\u00e7\u00e3o \u00e0 composi\u00e7\u00e3o \u00f3ssea \u00e9 tamb\u00e9m um fator que \n\nlimita o seu desempenho biol\u00f3gico. Estas defici\u00eancias, consensualmente \n\nreconhecidas por m\u00e9dicos, justificam o cont\u00ednuo esfor\u00e7o de investiga\u00e7\u00e3o \n\nrecentemente dedicado aos cimentos de fosfato de c\u00e1lcio [2, 5, 6, 10-14]. \n\nO trabalho apresentado nesta tese visou o desenvolvimento de cimentos de \n\nfosfatos de c\u00e1lcio \u00e1cidos e reabsorv\u00edveis \u00e0 base de brushite, nos quais o c\u00e1lcio foi \n\nparcialmente substitu\u00eddo por outros elementos, tais como o estr\u00f4ncio (Sr) e o \n\nmangan\u00eas (Mn), com propriedades melhoradas em termos de injectabilidade e de \n\nresist\u00eancia mec\u00e2nica, desejavelmente adequadas para aplica\u00e7\u00f5es em \n\nvertebroplastia. Este \u00e9 um procedimento cir\u00fargico minimamente invasivo para \n\nreparar fraturas de vertebras osteopor\u00f3ticas que colapsam sob os esfor\u00e7os de \n\ncompress\u00e3o. Para esse fim, o cimento \u00f3sseo ter\u00e1 de apresentar um conjunto \n\n\n\nIntrodu\u00e7\u00e3o Geral \n\n 3 \n\nmuito exigente de propriedades: (i) um adequado comportamento ao fluxo atrav\u00e9s \n\nda agulha da seringa, incluindo viscosidade e coes\u00e3o apropriadas a um \n\nmanuseamento f\u00e1cil e a uma injectabilidade completa, a par de uma capacidade \n\nde endurecimento r\u00e1pido (em alguns minutos) em contacto com os fluidos e \n\ntecidos biol\u00f3gicos; (ii) atingir, depois de implantado, uma resist\u00eancia mec\u00e2nica \n\ncompar\u00e1vel \u00e0 do osso; (iii) r\u00e1pido crescimento de novo osso e remodela\u00e7\u00e3o do \n\ndefeito \u00f3sseo de modo a reduzir o risco de falha do implante. Com a incorpora\u00e7\u00e3o \n\nde pequenas quantidades de elementos dopantes nos p\u00f3s de partida, esperam-se \n\nefeitos positivos relacionados com os processos biol\u00f3gicos e de integra\u00e7\u00e3o do \n\ncimento \u00f3sseo nos tecidos circundantes. \n\nA obten\u00e7\u00e3o de um cimento com tais caracter\u00edsticas \u00e9 uma tarefa muito ambiciosa \n\numa vez que as vari\u00e1veis que as determinam exercem muitas vezes efeitos \n\nantag\u00f3nicos quer no que respeita ao manuseamento quer \u00e0s suas propriedades \n\nfuncionais. Se as propriedades mec\u00e2nicas do implante forem similares \u00e0s do \n\nosso, o risco de falha estrutural do implante \u00e9 mais reduzido. No entanto, uma \n\nresist\u00eancia mec\u00e2nica elevada \u00e9 frequentemente associada a uma fra\u00e7\u00e3o de \n\nporosidade baixa, a qual, por sua vez, condiciona o crescimento \u00f3sseo atrav\u00e9s do \n\nimplante. Al\u00e9m disso, neste procedimento cir\u00fargico a pasta ciment\u00edcia \u00e9 injetada e \n\na injectabilidade varia diretamente com a raz\u00e3o entre os componentes l\u00edquido e \n\ns\u00f3lido (p\u00f3) usados na sua prepara\u00e7\u00e3o. Assim, quanto maior for a raz\u00e3o l\u00edquido-p\u00f3 \n\nusada, menor ser\u00e1 a resist\u00eancia mec\u00e2nica dos cimentos. A solu\u00e7\u00e3o passar\u00e1 \n\nportanto por um compromisso entre estas caracter\u00edsticas.  \n\nEsta tese est\u00e1 estruturada em seis cap\u00edtulos. No Cap\u00edtulo 1 s\u00e3o apresentadas \n\nalgumas no\u00e7\u00f5es gerais e algumas refer\u00eancias bibliogr\u00e1ficas que permitem situar \n\neste trabalho no dom\u00ednio dos cimentos \u00f3sseos \u00e0 base de fosfatos de c\u00e1lcio. Este \n\ninclui portanto v\u00e1rias sec\u00e7\u00f5es que abordam, com algum detalhe, generalidades \n\nque v\u00e3o desde a composi\u00e7\u00e3o e estrutura do osso at\u00e9 ao uso dos cimentos de \n\nfosfatos de c\u00e1lcio como substitutos \u00f3sseos. As metas e os objetivos desta tese \n\nest\u00e3o apresentados no final deste cap\u00edtulo. \n\nNas introdu\u00e7\u00f5es dos cap\u00edtulos seguintes (cap\u00edtulos 2 a 5) encontram-se revis\u00f5es \n\nbibliogr\u00e1ficas mais orientadas para uma melhor compreens\u00e3o das motiva\u00e7\u00f5es que \n\n\n\nIntrodu\u00e7\u00e3o Geral \n\n 4 \n\nlevaram \u00e0 realiza\u00e7\u00e3o dos v\u00e1rios estudos que comp\u00f5em esta tese e dos \n\nrespectivos resultados que foram obtidos.  \n\nO Cap\u00edtulo 2 est\u00e1 relacionado com dois tipos de p\u00f3s precursores, ??fosfato \n\ntric\u00e1lcico e ??fosfato tric\u00e1lcico, usados em muitas composi\u00e7\u00f5es de cimentos de \n\nfosfatos de c\u00e1lcio. A obten\u00e7\u00e3o de p\u00f3s de ?? fosfato tric\u00e1lcico puros, n\u00e3o dopados \n\nou dopados em laborat\u00f3rio, continua a n\u00e3o ser f\u00e1cil e as influ\u00eancias de factores \n\nexperimentais na transforma\u00e7\u00e3o entre estes dois polimorfos ainda n\u00e3o est\u00e3o bem \n\nclarificadas. De facto ? e ?  s\u00e3o fases alotr\u00f3picas e o trabalho apresentado neste \n\ncap\u00edtulo traz um aporte de informa\u00e7\u00e3o complementar sobre a estabilidade t\u00e9rmica \n\ndestas fases, em presen\u00e7a de impurezas de pirofosfato de c\u00e1lcio e de magn\u00e9sio \n\ncomo dopante. Apesar das composi\u00e7\u00f5es dopadas com magn\u00e9sio n\u00e3o terem sido \n\nusadas nos estudos seguintes, esclarecer o papel deste i\u00e3o na estabilidade \n\nt\u00e9rmica da fase ?? fosfato tric\u00e1lcico foi considerado essencial para uma melhor \n\ncompreens\u00e3o dos efeitos dos outros i\u00f5es dopantes usados neste trabalho. Esta \n\nescolha ficou ainda a dever-se ao facto de existirem v\u00e1rios estudos na literatura \n\nreferentes \u00e0s transforma\u00e7\u00f5es de fase ? ? ?  de fosfato tric\u00e1lcico dopado com \n\nmagn\u00e9sio. Para isso foram sintetizados e caracterizados p\u00f3s de ?-fosfato \n\ntric\u00e1lcico dopados com teores diferentes de magn\u00e9sio e sujeitos a diferentes \n\ncondi\u00e7\u00f5es de tratamento t\u00e9rmico. \u00c9 de salientar que os resultados obtidos neste \n\nestudo influenciaram de certa forma o tipo de p\u00f3 usado no Cap\u00edtulo 3. \n\nNo Cap\u00edtulo 3 \u00e9 explorada a influ\u00eancia do tamanho e distribui\u00e7\u00e3o de tamanho de \n\npart\u00edculas de p\u00f3s de ?-fosfato tric\u00e1lcicos e do seu estado de agrega\u00e7\u00e3o na \n\ninjectabilidade de sistemas n\u00e3o reativos e reativos. Para o efeito foram \n\npreparados e usados p\u00f3s de ?-fosfato tric\u00e1lcicos dopados com Sr. Este elemento \n\nfoi introduzido para aumentar a estabilidade t\u00e9rmica do ?-fosfato tric\u00e1lcico e, pelas \n\nsuas propriedades de i\u00e3o biologicamente ativo e de agente r\u00e1dio opacificante.  \n\nO Cap\u00edtulo 4 descreve a s\u00edntese e a caracteriza\u00e7\u00e3o f\u00edsico-qu\u00edmica de p\u00f3s de \n\n?-fosfato tric\u00e1lcico dopados com v\u00e1rios teores de Mn e a sua resposta biol\u00f3gica \n\nin vitro. Assim, este estudo permitiu avaliar o interesse da incorpora\u00e7\u00e3o de Mn (e \n\n\n\nIntrodu\u00e7\u00e3o Geral \n\n 5 \n\nem que teores) no desempenho biol\u00f3gico de cimentos de fosfatos de c\u00e1lcio \n\npreparados no cap\u00edtulo 5.  \n\nO Cap\u00edtulo 5 reporta resultados de investiga\u00e7\u00e3o levados a cabo com base nos \n\nresultados obtidos nos dois cap\u00edtulos anteriores, nomeadamente, envolvendo a \n\nprepara\u00e7\u00e3o e caracteriza\u00e7\u00e3o diversos p\u00f3s ?-fosfato tric\u00e1lcico dopados com Sr e \n\nMn. Neste caso, para al\u00e9m do l\u00edquido reativo normal, foram tamb\u00e9m preparados \n\ncimentos com l\u00edquidos contendo a\u00e7\u00facares (sucrose, tamb\u00e9m denominada por \n\nsacarose, e frutose) e avaliados os seus efeitos em termos de manuseamento \n\n(tempo de in\u00edcio de presa e injectabilidade), propriedades f\u00edsicas (resist\u00eancia a \n\ncompress\u00e3o e porosidade) e do seu desempenho biol\u00f3gico in vitro. \n\nNo Cap\u00edtulo 6 est\u00e3o apresentadas as conclus\u00f5es gerais que puderam ser \n\nretiradas das discuss\u00f5es de todos os resultados apresentados ao longo da tese, \n\nbem como algumas perspetivas interessantes para trabalhos futuros. \n\nFinalmente, em Anexos est\u00e3o apresentados alguns diagramas de fases \n\nrefer\u00eanciados no cap\u00edtulo 2, com o intuito de auxiliar o leitor facultando-lhe uma \n\nconsulta r\u00e1pida. \n\n \n\n\u00c9 de referir que nos cap\u00edtulos de 2 a 5 est\u00e3o apresentados os artigos publicados \n\n(cap\u00edtulos 2 a 4) ou submetidos para publica\u00e7\u00e3o (cap\u00edtulo 5) em jornais do \n\nScience Citation Index, relativos aos estudos realizados. Estes cap\u00edtulos s\u00e3o \n\napresentados em ingl\u00eas, ao contr\u00e1rio das restantes partes da tese que est\u00e3o \n\nescritas em portugu\u00eas. No cap\u00edtulo 5, as informa\u00e7\u00f5es suplementares do artigo \n\nforam colocadas ao longo do texto, e n\u00e3o em anexo, para facilitar a sua leitura e \n\ncompreens\u00e3o. \u00c0 excep\u00e7\u00e3o do trabalho experimental envolvendo testes biol\u00f3gicos, \n\na autora deu os seguintes contributos relevantes para a elabora\u00e7\u00e3o experimental \n\ne escrita dos seguintes estudos: \n\nCapitulo 2 - Maior parte do planeamento e do trabalho experimental. Maior parte \n\nda escrita. \n\n\n\nIntrodu\u00e7\u00e3o Geral \n\n 6 \n\nCapitulo 3 - Parte do planeamento e maior parte do trabalho experimental. Maior \n\nparte da escrita. \n\nCapitulo 4 - Maior parte do planeamento, todo o trabalho experimental e \n\nprepara\u00e7\u00e3o dos materiais para os testes biol\u00f3gicos. Maior parte da escrita. \n\nCapitulo 5 - Maior parte do planeamento, todo o trabalho experimental e \n\nprepara\u00e7\u00e3o dos materiais para os testes biol\u00f3gicos. Parte da escrita. \n\n \n\nRefer\u00eancias bibliogr\u00e1ficas  \n\n[1] S.V. Dorozhkin, Calcium orthophosphates cements for biomedical application, \n\nJ. Mater. Sci: Mater. Med. 43 (2008) 3028-57. \n\n[2] M. Bohner, U. Gbureck, J.E. Barralet, Technological issues for the \n\ndevelopment of more efficient calcium phosphate bone cements: a critical \n\nassessment, Biomaterials. 26 (2005) 6423-9. \n\n[3] R.R. Seeley, T.D. Stephens, P. Tate, Anatomia e fisiologia, Lusodid\u00e1dica, \n\nAnatomia &amp; fisiologia, 2001. \n\n[4] A.R. Amini, C.T. Laurencin, S.P. Nukavarapu, Bone Tissue Engineering: \n\nRecent Advances and Challenges, Crit. Rev. Biomed. Eng. 40 (2012) 363-408. \n\n[5] M Bohner, Reactivity of calcium phosphate cements, J. Mater. Chem. 17 \n\n(2007) 3980-6. \n\n[6] S. Dorozhkin, Self-Setting Calcium Orthophosphate Formulations, J Funct. \n\nBiomater. 4 (2013) 209-311. \n\n[7] M. Habib, G. Baroud, F. Gitzhofer, M. Bohner, Mechanisms underlying the \n\nlimited injectability of hydraulic calcium phosphate paste, Acta Biomater. 4 (2008) \n\n1465-71. \n\n\n\nIntrodu\u00e7\u00e3o Geral \n\n 7 \n\n[8] M. Habib, G. Baroud, F. Gitzhofer, M. Bohner, Mechanisms underlying the \n\nlimited injectability of hydraulic calcium phosphate paste. Part II: Particle \n\nseparation study, Acta Biomater. 6 (2010) 250-6. \n\n[9] M. Bohner, G. Baroud, Injectability of calcium phosphate pastes, Biomaterials. \n\n26 (2005) 1553-63. \n\n[10] E.F. Burguera, H.H.K. Xu, L.M. Sun, Injectable calcium phosphate cement: \n\nEffects of powder-to-liquid ratio and needle size 9, J. Biomed. Mater. Res. B Appl. \n\nBiomater. 84B (2008) 493-502. \n\n[11] H.L. Alves, L.A. Dos Santos, C.P. Bergmann, Injectability evaluation of \n\ntricalcium phosphate bone cement, J. Mater. Sci. Mater. Med. 19 (2008) 2241-6. \n\n[12] S. Pina, S.M. Olhero, S. Gheduzzi, A.W. Miles, JM. Ferreira, Influence of \n\nsetting liquid composition and liquid-to-powder ratio on properties of a Mg-\n\nsubstituted calcium phosphate cement, Acta Biomater. 5 (2009) 1233-40. \n\n[13] S. Pina, P.M. Torres, J.M. Ferreira, Injectability of brushite-forming Mg-\n\nsubstituted and Sr-substituted alpha-TCP bone cements, J Mater Sci Mater \n\nmedicine. 21 (2010) 431-8. \n\n[14] S. Pina, Vieira SI, P.M. Torres, Goetz-Neunhoeffer F, J. Neubauer, O.A. da \n\nCruz e Silva, et al. In vitro performance assessment of new brushite-forming Zn- \n\nand ZnSr-substituted beta-TCP bone cements, J. Biomed. Mater. Res. B, Appl. \n\nBiomater. 94 (2010) 414-20. \n\n \n \n\n \n\n\n\n  \n\n 8 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n  \n\n 9 \n\n \n\n \n\nCap\u00edtulo 1 \n\n \n\nComposi\u00e7\u00e3o, estrutura e metabolismo do \n\nosso, e a import\u00e2ncia dos cimentos de \n\nfosfato de c\u00e1lcio como material substituto do \n\ntecido \u00f3sseo: no\u00e7\u00f5es gerais e objetivos deste \n\nestudo \n\n \n\n\n\n  \n\n 10 \n\n \n\n\n\nCap\u00edtulo 1 \n\n 11 \n\nO tecido \u00f3sseo \u00e9 um material vivo que tem uma fascinante habilidade de se auto \n\nremodelar. Altamente adapt\u00e1vel, ele remodela-se para atender a necessidades \n\nrelacionadas com suas fun\u00e7\u00f5es espec\u00edficas; por exemplo, ele reabsorve quando \n\npouca ou nenhuma for\u00e7a externa \u00e9 aplicada por um longo per\u00edodo de tempo, ou \n\nreconstr\u00f3i quando for necess\u00e1ria uma maior dureza ou resist\u00eancia. Essa \n\nfacilidade de renova\u00e7\u00e3o concede ao osso a capacidade de auto repara\u00e7\u00e3o \n\npermitindo a regenera\u00e7\u00e3o de um defeito \u00f3sseo (de pequena dimens\u00e3o) sem \n\ndeixar cicatriz. Mas em alguns casos, a remodela\u00e7\u00e3o s\u00f3 por si n\u00e3o \u00e9 suficiente e \u00e9 \n\nnecess\u00e1rio recorrer \u00e0 implanta\u00e7\u00e3o de um biomaterial de enchimento (natural ou \n\nsint\u00e9tico) para substituir o osso em falta e, se poss\u00edvel, servir de suporte a uma \n\nremodela\u00e7\u00e3o do pr\u00f3prio biomaterial com o objetivo de formar novo osso. Al\u00e9m de \n\napresentar algumas no\u00e7\u00f5es gerais sobre este tema, este cap\u00edtulo dar\u00e1 uma \n\naten\u00e7\u00e3o especial a uma classe de biomateriais, os cimentos de fosfato de c\u00e1lcio, \n\no foco do presente estudo. \n\n \n\n1. Estrutura, composi\u00e7\u00e3o e propriedades do osso \n\nO corpo humano adulto \u00e9 constitu\u00eddo por cerca de 206 ossos. De tamanho, forma, \n\ncomposi\u00e7\u00e3o e estrutura complexa e diversificada, estes materiais comp\u00f3sitos \n\ndesempenham diferentes fun\u00e7\u00f5es. Juntamente com os m\u00fasculos, eles constituem \n\nos alicerces do corpo humano tendo portanto uma fun\u00e7\u00e3o estrutural. O esqueleto \n\nserve de ponto de fixa\u00e7\u00e3o para tend\u00f5es e apoio aos tecidos moles entre os quais \n\nse encontram os m\u00fasculos e os ligamentos. Al\u00e9m disso, em algumas partes do \n\ncorpo, eles t\u00eam tamb\u00e9m a fun\u00e7\u00e3o de proteger \u00f3rg\u00e3os vitais, como por exemplo, o \n\nc\u00e9rebro atrav\u00e9s da caixa craniana, o cora\u00e7\u00e3o e os pulm\u00f5es atrav\u00e9s da caixa \n\ntor\u00e1cica, a bexiga e v\u00edsceras p\u00e9lvicas atrav\u00e9s da p\u00e9lvis e a espinal medula que \u00e9 \n\nprotegida pelas v\u00e9rtebras. A matriz \u00f3ssea representa tamb\u00e9m o maior reservat\u00f3rio \n\nde i\u00f5es minerais do organismo, particularmente de c\u00e1lcio e f\u00f3sforo. 99% do c\u00e1lcio \n\ne 90% do f\u00f3sforo no nosso corpo est\u00e3o armazenados nos ossos, cartilagem e \n\ndentes. Todos os ossos t\u00eam uma participa\u00e7\u00e3o ativa na manuten\u00e7\u00e3o da \n\nhomeostase do c\u00e1lcio mas somente alguns (essencialmente, osso esterno, ossos \n\nil\u00edacos, v\u00e9rtebras e costelas) mant\u00eam sua fun\u00e7\u00e3o hematopoi\u00e9tica no corpo adulto: \n\n\n\nCap\u00edtulo 1 \n\n 12 \n\neles participam no processo de forma\u00e7\u00e3o de c\u00e9lulas do sangue, nomeadamente \n\npela medula \u00f3ssea vermelha, que produz os gl\u00f3bulos vermelhos, os gl\u00f3bulos \n\nbrancos e as plaquetas do sangue. \n\n \n\n1.1 Macroestrutura do osso \n\nOs ossos podem ser classificados quanto \u00e0 sua forma em osso longos (como o \n\nf\u00e9mur, radio, \u00famero, t\u00edbia), curtos (como o carpo e o tarso), planos (como o \n\nesterno, frontal, parietais, omoplata) e irregulares (como as vertebras).  \n\nA Fig. 1 apresenta uma estrutura t\u00edpica de um osso longo. Ele \u00e9 composto por \n\nduas partes principais: a di\u00e1fise, parte central e cil\u00edndrica, e as ep\u00edfises proximal e \n\ndistal, suas extremidades.  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 1. Desenho representativo da estrutura de um osso longo (a) e amplia\u00e7\u00f5es da estrutura da \n\nep\u00edfise proximal (b) e de uma sec\u00e7\u00e3o da di\u00e1fise (c) (adaptado de [1]). \n\nDi\u00e1fise\n\nEp\u00edfise\ndistale\n\nEp\u00edfise\nproximale\n\nCavidade \nmedular\n\nOsso cortical\n\nCartilagem\narticular \n\nOsso\ntrabecular\n\nCartilagem\narticular \n\nOsso trabecular\n\nOsso cortical\n\nOsso cortical\n\n(a) (c)\n\n(b)\nmedula \u00f3ssea \n\namarela\n\nend\u00f3steo\n\nperi\u00f3steo\n\nperi\u00f3steo\n\nLinha \nepifisial\n\nArt\u00e9rias \nnutrientes\n\nperfurantes \n(fibras de \nSharpey).\n\nDi\u00e1fise\n\u00f3steons\n\nCanal \nde Havers\n\nDi\u00e1fise\n\nEp\u00edfise\ndistale\n\nEp\u00edfise\nproximale\n\nCavidade \nmedular\n\nOsso cortical\n\nCartilagem\narticular \n\nOsso\ntrabecular\n\nCartilagem\narticular \n\nOsso trabecular\n\nOsso cortical\n\nOsso cortical\n\n(a) (c)\n\n(b)\nmedula \u00f3ssea \n\namarela\n\nend\u00f3steo\n\nperi\u00f3steo\n\nperi\u00f3steo\n\nLinha \nepifisial\n\nArt\u00e9rias \nnutrientes\n\nperfurantes \n(fibras de \nSharpey).\n\nDi\u00e1fiseDi\u00e1fise\n\nEp\u00edfise\ndistale\n\nEp\u00edfise\nproximale\n\nCavidade \nmedular\n\nOsso cortical\n\nCartilagem\narticular \n\nOsso\ntrabecular\n\nCartilagem\narticular \n\nOsso trabecular\n\nOsso cortical\n\nOsso cortical\n\n(a) (c)\n\n(b)\nmedula \u00f3ssea \n\namarela\n\nend\u00f3steo\n\nperi\u00f3steo\n\nperi\u00f3steo\n\nLinha \nepifisial\n\nArt\u00e9rias \nnutrientes\n\nperfurantes \n(fibras de \nSharpey).\n\nDi\u00e1fise\n\u00f3steons\u00f3steons\n\nCanal \nde Havers\n\n\n\nCap\u00edtulo 1 \n\n 13 \n\nO tecido \u00f3sseo da di\u00e1fise \u00e9 composto por osso compacto tamb\u00e9m denominado \n\npor osso cortical ou lamelar. Este prolonga-se sobre toda a periferia do osso, \n\nprotegendo a sua parte interna. No interior da di\u00e1fise, dentro da cavidade \n\nmedular, encontra-se a medula \u00f3ssea amarela constitu\u00edda principalmente por \n\ntecido adiposo. No interior das extremidades existe outro tipo de tecido \u00f3sseo, \n\nosso esponjoso tamb\u00e9m conhecido como osso trabecular, de porosidade muito \n\nsuperior \u00e0 do osso cortical. A recobrir as ep\u00edfises est\u00e1 uma fina camada de \n\ncartilagem articular que permite reduzir a fric\u00e7\u00e3o e amortizar os choques.  \n\nO osso cortical \u00e9 composto por fibras de colag\u00e9nio sobre as quais se \n\ndesenvolvem cristais do mineral \u00f3sseo. Estas fibras est\u00e3o coladas paralelamente \n\numas \u00e0s outras e organizadas em lamelas conc\u00eantricas formando os \u00f3steons \n\n(Fig. 1c). Estes s\u00e3o atravessados por uma rede tridimensional de nervos e de \n\nvasos sangu\u00edneos. A organiza\u00e7\u00e3o compacta dos \u00f3steons permite ao osso cortical \n\ndesempenhar um papel predominante no suporte mec\u00e2nico (resist\u00eancia e rigidez) \n\ne na fun\u00e7\u00e3o de prote\u00e7\u00e3o do esqueleto. Enquanto o osso cortical tem uma \n\nestrutura densa e microporosa (~10% de porosidade de di\u00e2metro de poro de 1 a \n\n10 \u00b5m), o osso trabecular \u00e9 formado por uma estrutura macro porosa (~55-70% \n\nde porosidade interligada [2] de 200 a 400 \u00b5m [3]), originando uma importante \n\nsuperf\u00edcie de trocas com os fluidos biol\u00f3gicos que lhe confere propriedades \n\nfuncionais e estruturais diferentes, nomeadamente fun\u00e7\u00f5es metab\u00f3licas tais como \n\na homeostase do c\u00e1lcio. \n\nAs superf\u00edcies do osso s\u00e3o recobertas por membranas de tecidos conjuntivos, o \n\nperi\u00f3steo e o end\u00f3steo (Fig. 1c). Ambos possuem a fun\u00e7\u00e3o de nutri\u00e7\u00e3o e \n\nfornecimento de novos osteoblastos para o crescimento e regenera\u00e7\u00e3o do osso. \n\nO peri\u00f3steo reveste a superf\u00edcie externa n\u00e3o articulada do osso. Este \u00e9 \n\nconstitu\u00eddo por: (i) uma camada externa que consiste num tecido conjuntivo \n\nfibroso denso, rico em fibras de colag\u00e9nio e alguns fibroblastos, e (ii) uma camada \n\ninterna composta por c\u00e9lulas osteoprogenitoras com a capacidade de se dividir \n\npor mitose e se diferenciar em osteoblastos. O peri\u00f3steo fixa-se ao tecido \u00f3sseo \n\natrav\u00e9s das fibras de sharpney (fibras de colag\u00e9nio especialmente do tipo I) \n\n(Fig. 1c). O peri\u00f3steo possui vasos sangu\u00edneos e nervos que transportam sangue \n\n\n\nCap\u00edtulo 1 \n\n 14 \n\nat\u00e9 ao interior do osso para entrega de nutrientes, atrav\u00e9s dos canais de \n\nVolkmann. O end\u00f3steo consiste numa membrana que reveste interiormente a \n\nsuperf\u00edcie do tecido \u00f3sseo que forma a cavidade medular, formada por c\u00e9lulas \n\nosteoprogenitoras e osteoblastos, e por uma pequena quantidade de tecido \n\nconjuntivo.  \n\n \n\n1.2 Microestrutura do osso \n\n1.2.1 Composi\u00e7\u00e3o e propriedades do osso  \n\nO osso \u00e9 formado por c\u00e9lulas \u00f3sseas e por um material extracelular (~90% do \n\npeso \u00f3sseo total), chamado de matriz \u00f3ssea. Esta matriz extracelular \u00e9 constitu\u00edda \n\npor ~65% de uma matriz mineral \u00e0 base de fosfato de c\u00e1lcio, ~5% de \u00e1gua e \n\n~30% de uma matriz org\u00e2nica [4-6]. Esta \u00faltima, composta por cerca de 90% de \n\nfibras de colag\u00e9nio do tipo I e por uma subst\u00e2ncia basal contendo proteoglicanos \n\ne glicoprote\u00ednas, \u00e9 a primeira a ser sintetizada aquando da forma\u00e7\u00e3o do osso, \n\nsendo posteriormente mineralizada por minerais de fosfato de c\u00e1lcio. O car\u00e1cter \n\ncomp\u00f3sito do tecido \u00f3sseo confere-lhe propriedades excecionais, nomeadamente \n\nmec\u00e2nicas. A componente org\u00e2nica do osso d\u00e1 flexibilidade e resili\u00eancia ao osso, \n\nenquanto a matriz inorg\u00e2nica traz dureza e rigidez. \n\nDevido ao facto do osso ser um tecido altamente adapt\u00e1vel, as suas propriedades \n\nmec\u00e2nicas variam entre os indiv\u00edduos, com a idade, de acordo com o local no \n\ncorpo, devido a doen\u00e7as. Valores aproximados de algumas propriedades \n\nmec\u00e2nicas e porosidade do osso podem ser encontrados na Tabela 1, mostrando \n\nas diferen\u00e7as entre os dois tipos de tecidos \u00f3sseos. \n\nTabela 1. Propriedades mec\u00e2nicas e porosidade do osso \n\nResist\u00eancia mec\u00e2nica \u00e0 \ncompress\u00e3o  \n\nM\u00f3dulo de Young Porosidade \nTipo de osso \n\n(MPa) (GPa) (%) \n\nCortical [5-12] 130-300 0,5-40 5-13 \n\nTrabecular [7, 8, 13, 14] 0,6-12 0,05-0.9 30-90 \n\n \n\n\n\nCap\u00edtulo 1 \n\n 15 \n\nA parte mineral do osso \u00e9 composta por uma apatite. A apatite forma uma \n\nalargada fam\u00edlia de minerais do grupo dos fosfatos cuja f\u00f3rmula qu\u00edmica geral dos \n\ncompostos estequiom\u00e9tricos \u00e9: \n\nMe10(XO4)6Y2 \n\nem que Me \u00e9 um metal divalente (Ca2+, Sr2+, Ba2+); XO4 um ani\u00e3o trivalente \n\n(PO4\n3?, VO4\n\n3?, AsO4\n3?) e o Y um ani\u00e3o monovalente (OH?, F?, Cl?) [15]. As apatites \n\ncristalizam no sistema hexagonal (grupo espacial P63/m), e esta estrutura tem a \n\ncapacidade de aceitar muitas substitui\u00e7\u00f5es at\u00f3micas de diferentes val\u00eancias em \n\nMe, XO4 e Y, e, lacunas em Me e Y. Entre elas encontra-se a hidroxiapatite \n\nestequiom\u00e9trica (Ca10(PO4)6(OH)2, HA), um dos fosfatos de c\u00e1lcio mais est\u00e1veis \n\ndo ponto de vista termodin\u00e2mico. Mas a apatite que comp\u00f5e a parte mineral do \n\nosso, longe de ser estequiom\u00e9trica, \u00e9 muito mais complexa que a HA. \u00c9 uma \n\napatite deficiente em c\u00e1lcio, poli-substitu\u00edda, carbonatada, contendo i\u00f5es HPO4\n2?, \n\ne que pode ser muito pouco hidroxilizada (OH?). Ela pode ser descrita pela \n\nf\u00f3rmula geral [16] a seguir apresentada, mas tendo em aten\u00e7\u00e3o que a composi\u00e7\u00e3o \n\ndo osso varia entre indiv\u00edduos e consoante a localiza\u00e7\u00e3o, idade, sexo, a exist\u00eancia \n\nde doen\u00e7as e regime alimentar: \n\n \n\nCa8,3 ?1.7 (PO4)4,3 (CO3)1,0 (HPO4)0,7 (CO3,OH)0,3 ?1,7 \n\n         Me2+       XO4\n3?            Y? \n\nem que ? indica uma lacuna na estrutura . \n\n \n\nA carbonata\u00e7\u00e3o pode ser de dois tipos, A e B, que podem ocorrer em simult\u00e2neo. \n\nQuando os i\u00f5es carbonato (CO3\n2?) substituem os i\u00f5es hidroxilo (OH?), a \n\ncarbonata\u00e7\u00e3o diz-se do tipo A. Ela \u00e9 do tipo B quando eles substituem os i\u00f5es \n\nfosfato (PO4\n3?) e esta substitui\u00e7\u00e3o \u00e9 acompanhada pela cria\u00e7\u00e3o de uma lacuna de \n\nca2+ e de uma de OH? numa proximidade imediata a fim de manter a \n\neletroneutralidade de cargas. Al\u00e9m da carbonata\u00e7\u00e3o, a apatite \u00f3ssea apresenta \n\n\n\nCap\u00edtulo 1 \n\n 16 \n\ntamb\u00e9m substitui\u00e7\u00f5es de i\u00f5es PO4\n3? por i\u00f5es hidrogenofosfato HPO4\n\n2?. O conjunto \n\ndestas substitui\u00e7\u00f5es conduz a uma apatite deficiente em c\u00e1lcio e fracamente \n\nhidroxilizada [17] com um grau de cristalinidade baixo [18] (tamb\u00e9m devido ao \n\ntamanho nanom\u00e9trico dos cristais). A extens\u00e3o da carbonata\u00e7\u00e3o depende dos \n\nindiv\u00edduos, da localiza\u00e7\u00e3o do osso e da idade, havendo uma tend\u00eancia para \n\naumentar ao longo da vida [16].  \n\nAl\u00e9m disso, os nano cristais, que constituem a apatite biol\u00f3gica, apresentam \u00e0 \n\nsuperf\u00edcie uma camada hidratada, estruturada mas fr\u00e1gil, que contem i\u00f5es (Ca2+, \n\nHPO4\n2?, CO3\n\n2?) suscet\u00edveis de interagir com os fluidos circundantes [19]. Este \n\nfator \u00e9 um dos principais respons\u00e1veis pela reatividade excecional deste \n\ncomposto, nomeadamente no que respeita a trocas i\u00f3nicas e, absor\u00e7\u00e3o de i\u00f5es e \n\nde mol\u00e9culas biol\u00f3gicas (prote\u00ednas) [19, 20]. \n\n \n\n1.2.2 C\u00e9lulas \u00f3sseas  \n\nO tecido \u00f3sseo \u00e9 constitu\u00eddo por quatro tipos de c\u00e9lulas \u00f3sseas: c\u00e9lulas \n\nosteoprogenitoras, os osteoblastos, os oste\u00f3citos e os osteoclastos. As c\u00e9lulas \n\n\u00f3sseas t\u00eam origem nas c\u00e9lulas estaminais, mais especificamente nas c\u00e9lulas \n\nestaminais mesenquimatosas que se podem diferenciar em v\u00e1rios tipos de \n\nc\u00e9lulas. Dependendo das condi\u00e7\u00f5es de meio celular envolvente, estas podem ser \n\nc\u00e9lulas osteoprogenitoras, c\u00e9lulas indiferenciadas, que t\u00eam a capacidade de se \n\ndiferenciar em osteoblastos. Estas c\u00e9lulas est\u00e3o localizadas, como j\u00e1 referido na \n\nsec\u00e7\u00e3o 2.1.1, no peri\u00f3steo e no end\u00f3steo. No caso dos osteoclastos, elas derivam \n\ndas c\u00e9lulas estaminais hematopoi\u00e9ticas (provenientes da medula \u00f3ssea \n\nvermelha).  \n\nAs c\u00e9lulas osteoprogenitoras s\u00e3o c\u00e9lulas indiferenciadas. Elas permanecem \n\nnesse estado indiferenciado at\u00e9 receberem um est\u00edmulo adequado, \n\ndiferenciando-se ent\u00e3o em osteoblastos.  \n\nOs osteoblastos s\u00e3o c\u00e9lulas diferenciadas mononucleares respons\u00e1veis pela \n\nforma\u00e7\u00e3o de matriz \u00f3ssea. Situadas na periferia do osso em forma\u00e7\u00e3o, estas \n\n\n\nCap\u00edtulo 1 \n\n 17 \n\nc\u00e9lulas s\u00e3o respons\u00e1veis pela s\u00edntese e deposi\u00e7\u00e3o nas superf\u00edcies \u00f3sseas de uma \n\nmatriz proteica de novo material intercelular (incluindo colag\u00e9nio do tipo I) \n\ndenominada osteoide (matriz \u00f3ssea ainda n\u00e3o calcificada) que vai sendo \n\nmineralizada formando novo osso. A mineraliza\u00e7\u00e3o da matriz avan\u00e7a \n\ngradualmente em direc\u00e7\u00e3o \u00e0 \u00faltima camada de osteoide secretado. I\u00f5es c\u00e1lcio e \n\nfosfato e ainda algumas enzimas s\u00e3o acumuladas em ves\u00edculas que v\u00e3o sendo \n\nsecretadas pelas c\u00e9lulas contribu\u00eddo para a progressiva mineraliza\u00e7\u00e3o. A \n\nfosfatase alcalina, uma das enzimas produzidas, cliva o pirofosfato removendo a \n\nsua influ\u00eancia estabilizadora e, ao mesmo tempo, aumenta o fosfato local \n\ndispon\u00edvel para a cristaliza\u00e7\u00e3o. \n\nOs oste\u00f3citos (c\u00e9lulas maduras) s\u00e3o provenientes dos osteoblastos que ficaram \n\npresos e cercados por matriz \u00f3ssea produzida por eles pr\u00f3prios. Ocupando \n\nlacunas \u00f3sseas, estas c\u00e9lulas comunicam entre si e com as c\u00e9lulas da superf\u00edcie \n\n\u00f3ssea, atrav\u00e9s de uma rede de canal\u00edculos, que cont\u00eam os seus numerosos \n\nprolongamentos citoplasm\u00e1ticos permitindo a passagem de nutrientes e de muitas \n\noutras subst\u00e2ncias. Eles t\u00eam um papel fundamental na manuten\u00e7\u00e3o da \n\nintegridade da matriz \u00f3ssea. Estas c\u00e9lulas captam as altera\u00e7\u00f5es da matriz \u00f3ssea \n\ne os est\u00edmulos mec\u00e2nicos que atuam sobre o osso (mecanossensores) e \n\ntransmitem estas informa\u00e7\u00f5es \u00e0s c\u00e9lulas da superf\u00edcie para que estas possam \n\nativar os processos de remodela\u00e7\u00e3o \u00f3ssea, sempre que estes sejam necess\u00e1rios \n\nOs osteoclastos s\u00e3o c\u00e9lulas polinucleadas de grandes dimens\u00f5es e que se \n\nlocalizam nas superf\u00edcies \u00f3sseas, principalmente no end\u00f3steo e, ocasionalmente, \n\nna superf\u00edcie do peri\u00f3steo. Eles s\u00e3o respons\u00e1veis pela reabsor\u00e7\u00e3o \u00f3ssea atrav\u00e9s \n\nde um processo sequencial, qu\u00edmico e enzim\u00e1tico. A primeira fase consiste num \n\nprocesso de acidifica\u00e7\u00e3o (produ\u00e7\u00e3o de prot\u00f5es H+) que provoca a dissolu\u00e7\u00e3o da \n\nfase mineral da matriz \u00f3ssea. Numa segunda fase, tem lugar a degrada\u00e7\u00e3o \n\ncompleta da fase org\u00e2nica por a\u00e7\u00e3o de numerosas enzimas proteol\u00edticas, sendo a \n\ncolagenase uma das principais.  \n\n \n\n \n\n\n\nCap\u00edtulo 1 \n\n 18 \n\n1.3 Remodela\u00e7\u00e3o e autorrepara\u00e7\u00e3o \u00f3ssea  \n\nO osso \u00e9 um tecido em constante mudan\u00e7a pois ele tem a capacidade de se \n\nremodelar continuamente durante toda a vida. A remodela\u00e7\u00e3o \u00f3ssea \u00e9 um \n\nprocesso din\u00e2mico resultante de um equil\u00edbrio entre a reabsor\u00e7\u00e3o e neo-forma\u00e7\u00e3o \n\n\u00f3ssea. Ela envolve portanto a remo\u00e7\u00e3o de osso velho e a forma\u00e7\u00e3o de osso novo \n\natrav\u00e9s da a\u00e7\u00e3o dos osteoclastos e dos osteoblastos, respetivamente. Este \n\nprocesso permite ao tecido \u00f3sseo adaptar-se \u00e0s mudan\u00e7as nas tens\u00f5es e for\u00e7as \n\nmec\u00e2nicas a que est\u00e1 sujeito, prevenir a degenera\u00e7\u00e3o \u00f3ssea, regular a \n\nconcentra\u00e7\u00e3o de i\u00f5es (especialmente de c\u00e1lcio) nos fluidos biol\u00f3gicos, \n\nconferindo-lhe a capacidade de se autorreparar desde que o tamanho do defeito \n\nseja inferior a um certo valor cr\u00edtico [21].  \n\nEm geral, o processo, constitu\u00eddo por v\u00e1rias fases, inicia-se com a forma\u00e7\u00e3o de \n\num hematoma \u00e0 volta do local fraturado, acompanhado por uma rea\u00e7\u00e3o \n\ninflamat\u00f3ria. De seguida, o hematoma \u00e9 substitu\u00eddo gradualmente por uma \n\nsubst\u00e2ncia fibrosa (calo fibroso): os fibroblastos invadem o hematoma levando a \n\nforma\u00e7\u00e3o de um complexo de fibrina. Com o desenvolvimento de vasos \n\nsangu\u00edneos, a presen\u00e7a de osteoblastos, a forma\u00e7\u00e3o de colag\u00e9nio e a deposi\u00e7\u00e3o \n\nde c\u00e1lcio d\u00e1-se a forma\u00e7\u00e3o de cartilagem (calo fibrocartilag\u00edneo). Os osteoclastos \n\nv\u00e3o reabsorvendo o osso morto e promovendo a ossifica\u00e7\u00e3o do calo que sofre \n\nposterior remodela\u00e7\u00e3o. Os osteoblastos restabelecem o sistema \u00f3sseo original, \n\nque s\u00f3 \u00e9 poss\u00edvel se n\u00e3o houver mais tecido fibroso no espa\u00e7o [21].  \n\n\u00c9 de notar que a consolida\u00e7\u00e3o \u00f3ssea de uma fratura \u00e9 dependente de fatores \n\ndiretamente relacionados com o indiv\u00edduo (idade, sexo, fatores hormonais, \n\nnutricionais, mec\u00e2nicos, entre outros) e com as caracter\u00edsticas inerentes \u00e0 fratura \n\n(tamanho, capacidade de vasculariza\u00e7\u00e3o, o tipo de tecido \u00f3sseo) [21]. \n\nNormalmente, as c\u00e9lulas \u00f3sseas podem promover a repara\u00e7\u00e3o de osso danificado \n\nap\u00f3s fratura ou cirurgia. Mas, como mencionado na sec\u00e7\u00e3o anterior, se o defeito \n\nexceder um tamanho cr\u00edtico (~1 cm), a reconstru\u00e7\u00e3o \u00f3ssea n\u00e3o ocorre com \n\nrapidez suficiente, formando-se tecido fibroso em vez de osso dentro do defeito. \n\n\n\nCap\u00edtulo 1 \n\n 19 \n\nUma das formas de prevenir isso \u00e9 preenchendo o defeito com um substituto \n\n\u00f3sseo. \n\n \n\n2. Materiais de substitui\u00e7\u00e3o \u00f3ssea \n\nOs substitutos \u00f3sseos podem ser biodegrad\u00e1veis, desaparecem do local da \n\nimplanta\u00e7\u00e3o ap\u00f3s determinado per\u00edodo de tempo, ou n\u00e3o biodegrad\u00e1veis \n\n(inertes), que residem dentro do defeito por tempo indefinido. O uso de substitutos \n\nbiodegrad\u00e1veis \u00e9 muitas vezes vantajoso visto que o tecido \u00f3sseo pode substituir \n\no biomaterial implantado \u00e0 medida que este se degrada. A taxa de ressor\u00e7\u00e3o do \n\nbiomaterial deve ser adequada \u00e0 taxa de forma\u00e7\u00e3o do novo osso para assim \n\nassegurar uma transi\u00e7\u00e3o harmoniosa entre eles e evitar o risco de crescimento de \n\ntecido fibroso.  \n\nRelativamente aos implantes biodegrad\u00e1veis, existem v\u00e1rios aspetos importantes \n\na ter em conta tais como as propriedades de manuseamento, as capacidades \n\nosteocondutoras e osteoindutoras, a taxa de degrada\u00e7\u00e3o e, dependendo do local, \n\nas propriedades mec\u00e2nicas. A degrada\u00e7\u00e3o de um implante pode ocorrer atrav\u00e9s \n\nde mecanismos que envolvem um processo de dissolu\u00e7\u00e3o (processo f\u00edsico-\n\nqu\u00edmico e dependente da solubilidade do material) e/ou processos biol\u00f3gicos que \n\ns\u00e3o mediados por agentes biol\u00f3gicos (como enzimas e c\u00e9lulas) [22, 23].  \n\n\u00c9 importante referir que a taxa de degrada\u00e7\u00e3o est\u00e1 fortemente relacionada com a \n\nporosidade do material. De facto, o aumento da porosidade leva geralmente a um \n\naumento da \u00e1rea superficial exposta ao meio envolvente, onde a dissolu\u00e7\u00e3o e/ou \n\na degrada\u00e7\u00e3o mediada pelas c\u00e9lulas e enzimas podem ocorrer, levando assim a \n\num aumento da taxa de degrada\u00e7\u00e3o.  \n\nExistem muitos tipos de substitutos \u00f3sseos, que podem ser classificados em duas \n\ngrandes fam\u00edlias, os naturais e os sint\u00e9ticos. Como j\u00e1 referido na Introdu\u00e7\u00e3o \n\nGeral, as limita\u00e7\u00f5es dos naturais levaram a um aumento substancial da \n\ninvestiga\u00e7\u00e3o na \u00e1rea dos biomateriais sint\u00e9ticos. Estes permitem obter substitutos \n\n\u00f3sseos de forma reprodut\u00edvel, em quantidade praticamente ilimitada, com menos \n\n\n\nCap\u00edtulo 1 \n\n 20 \n\nriscos de contamina\u00e7\u00f5es. Estes podem ser constitu\u00eddos por diferentes tipos de \n\nmateriais (metais, ligas, pol\u00edmeros, cer\u00e2micos) podendo apresentarem-se sob \n\ndiversas formas (blocos maci\u00e7os ou porosos, gr\u00e2nulos porosos, p\u00f3s, g\u00e9is, \n\ncimentos, etc.). \n\nNas \u00faltimas d\u00e9cadas, muitos biomateriais quando implantados em locais \n\nheterot\u00f3picos demonstraram possuir aptid\u00e3o para induzir a forma\u00e7\u00e3o de osso, \n\ncapacidade que se designa de osteoindu\u00e7\u00e3o [24]. Espera-se portanto que a \n\nimplanta\u00e7\u00e3o de um biomaterial com propriedades osteoindutoras num defeito \n\n\u00f3sseo aumente a taxa de forma\u00e7\u00e3o de osso, permitindo uma degrada\u00e7\u00e3o e \n\nremodela\u00e7\u00e3o mais r\u00e1pida. Apesar de muitos estudos j\u00e1 terem mostrado a \n\ncapacidade osteoindutora de v\u00e1rios tipos de biomateriais (sobretudo biomateriais \n\n\u00e0 base de fosfato de c\u00e1lcio), o mecanismo biol\u00f3gico subjacente a este fen\u00f3meno \n\nainda n\u00e3o est\u00e1 bem compreendido [24]. Mas os substitutos de preenchimento \n\n\u00f3sseo \u00e0 base de fosfatos de c\u00e1lcio, conhecidos por serem bioativos em termos de \n\nosteocondutividade, mostram serem tamb\u00e9m potencialmente osteoindutivos [24]. \n\n \n\n3. Fosfatos de c\u00e1lcio como substitutos \u00f3sseos \n\nOs compostos de fosfato de c\u00e1lcio (CaP, calcium phosphate) t\u00eam sido estudados \n\ncomo substitutos \u00f3sseos j\u00e1 h\u00e1 cerca de 100 anos [25]. O interesse por estes \n\ncompostos qu\u00edmicos deve-se \u00e0 sua similaridade qu\u00edmica com a parte inorg\u00e2nica \n\nda maior parte dos tecidos duros (ossos, dentes, chifres de veados, etc.) normais \n\nou com patologia dos mam\u00edferos [26]. Estes compostos, como j\u00e1 referido \n\nanteriormente, podem ser naturais ou sint\u00e9ticos. O primeiro estudo sobre um \n\nfosfato de c\u00e1lcio sint\u00e9tico utilizado in vivo foi publicado em 1920 por Fred Albee e \n\nHarold Morrison para repara\u00e7\u00e3o de fratura \u00f3ssea em coelhos [27]. \n\nBiocompat\u00edveis, eles est\u00e3o dispon\u00edveis sob diversas formas como blocos densos \n\nou porosos, granulados, cimentos, revestimentos de pr\u00f3teses met\u00e1licas, entre \n\noutros [22].  \n\n \n\n\n\nCap\u00edtulo 1 \n\n 21 \n\n3.1 Fosfatos de c\u00e1lcio \n\nDerivados de neutraliza\u00e7\u00f5es sucessivas do \u00e1cido fosf\u00f3rico, estes compostos \n\npodem ser classificados em tr\u00eas principais grupos: os ortofosfatos baseados em \n\nPO4\n3?, os metafosfatos baseados em PO3\n\n? e os pirofosfatos P2O7\n4?.  \n\nOs ortofosfatos de c\u00e1lcio, comummente denominados por fosfatos de c\u00e1lcio \n\n(termo usado ao longo desta tese) s\u00e3o os mais usados nas composi\u00e7\u00f5es dos \n\ncimentos de fosfato de c\u00e1lcio, apesar dos pirofosfatos de c\u00e1lcio estarem a ter \n\ncada vez mais interesse [28, 29]. Encontram-se listados na Tabela 2 alguns dos \n\nmais relevantes fosfatos de c\u00e1lcio.  \n\nTabela 2. Fosfatos de c\u00e1lcio mais comuns [26]. \n\nComposto \nAbreviatura \n\n(termos  \nem ingl\u00eas) \n\nF\u00f3rmula Ca/P \n\nFosfato monoc\u00e1lcico monidratado \n(Monocalcium phosphate monohydrate) \n\nMCPM Ca(H2PO4)2.H2O 0,5 \n\nFosfato monoc\u00e1lcico anidro \n(Monocalcium phosphate anhydrous) \n\nMCPA Ca(H2PO4)2 0,5 \n\nFosfato dic\u00e1lcico diidratado ou brushite \n(Dicalcium phosphate dihydrate or \nbrushite) \n\nDCPD CaHPO4.2 H2O 1 \n\nFosfato dic\u00e1lcico anidro ou monetite \n(Dicalcium phosphate anhydrous or \nmonetite) \n\nDCPA CaHPO4 1 \n\nFosfato octac\u00e1lcico \n(Octacalcium phosphate) \n\nOCP Ca8(HPO4)2(PO4)4.5H2O 1,33 \n\nFosfato de c\u00e1lcio amorfo \n(Amorphous calcium phosphate) \n\nACP \nCaxHy(PO4)z.nH2O \n\nn=3 \u2013 4.5 \n1,2 \u2013 2,2 \n\nAlfa-fosfato tric\u00e1lcico \n(Alpha-tricalcium phosphate) \n\n?-TCP Ca3(PO4)2 1,5 \n\nBeta-fosfato tric\u00e1lcico \n(Beta-tricalcium phosphate) \n\n?-TCP Ca3(PO4)2 1,5 \n\nHidroxiapatite deficiente em c\u00e1lcio \n(Calcium deficient hydroxyapatite) \n\nCDHA \nCa10-x(HPO4)x(PO4)6-x(OH)2-x \n\n0 &lt;x ? 1 \n1,5 \u2013 1,67 \n\nHidroxiapatite \n(Hydroxyapatite) \n\nHA Ca10(PO4)6(OH)2 1,67 \n\nFosfato tetrac\u00e1lcico \n(Tetracalcium phosphate) \n\nTTCP Ca4(PO4)2O 2 \n\n \n\n\n\nCap\u00edtulo 1 \n\n 22 \n\nA sua solubilidade \u00e9 apresentada na Fig. 2, onde se pode observar que a \n\nhidroxiapatite (HA) \u00e9 o composto menos sol\u00favel em pH neutros a b\u00e1sicos, \n\nenquanto os fosfatos de dic\u00e1lcio (DCPA e DCPD) s\u00e3o os menos sol\u00faveis a pH \n\n\u00e1cidos [30].  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 2. Solubilidade do Ca (a) e do P (b) de v\u00e1rios compostos de fosfatos de c\u00e1lcio [30] (sendo \n\nHAP - hidroxiapatite). \n\n(a) \n\n(b) \n\n\n\nCap\u00edtulo 1 \n\n 23 \n\nDesta grande variedade de fosfatos de c\u00e1lcio, apenas ser\u00e3o destacados os \n\nenvolvidos neste estudo: \n\n???? O fosfato monoc\u00e1lcico monoidratado (MCPM) \u00e9 o fosfato de c\u00e1lcio mais \u00e1cido e \n\no mais sol\u00favel para quase todos os valores de pH (Fig. 2, [30]). Devido a esses \n\ndois fatores, este composto n\u00e3o \u00e9 biocompat\u00edvel, n\u00e3o podendo, portanto, ser \n\nutilizado sozinho como substituto \u00f3sseo. Combinado com outros compostos de \n\nfosfato de c\u00e1lcio, o MCPM entra na composi\u00e7\u00e3o de muitos CPCs [31].  \n\n???? O fosfato dic\u00e1lcico diidratado (DCPD, brushite) \u00e9 um cristal monocl\u00ednico com \n\numa estrutura muito semelhante ao do gesso do sulfato de c\u00e1lcio [32]. \u00c9 um \n\ncomposto de car\u00e1cter \u00e1cido que cristaliza geralmente sob a forma de plaquetas, \n\nmas tamb\u00e9m pode apresentar-se sob a forma de agulhas. Al\u00e9m disso, \u00e9 o \n\ncomposto menos sol\u00favel a pH \u00e1cido (Fig. 2, [30]). Os seus cristais de estrutura \n\nmonocl\u00ednica podem ser facilmente obtidos a partir de solu\u00e7\u00f5es aquosas. \n\nRelativamente \u00e0 sua forma desidratada (monetite), a brushite \u00e9 a principal fase \n\nque precipita \u00e0 temperatura ambiente, embora seja metast\u00e1vel nessas condi\u00e7\u00f5es. \n\nA menor energia superficial (energia livre interfacial) da brushite, comparada com \n\na da monetite [33], e a elevada energia necess\u00e1ria para desidrata\u00e7\u00e3o de i\u00f5es \n\nc\u00e1lcio em solu\u00e7\u00e3o [34], favorecem a forma\u00e7\u00e3o da forma hidratada em vez da \n\nanidra. DCPD foi detetada em calos \u00f3sseos e em algumas calcifica\u00e7\u00f5es \n\npatol\u00f3gicas (c\u00e1lculos renais, c\u00e1lculos dent\u00e1rios) [35]. Como material de \n\nsubstitui\u00e7\u00e3o \u00f3ssea, este composto tem sido usado na forma de cimento por ser \n\nbiocompat\u00edvel, biodegrad\u00e1vel e osteocondutor, sendo in vivo facilmente convertido \n\nem hidroxiapatite (HA) [31]. \u00c9 importante referir que a monetite (DCPA) raramente \n\n\u00e9 obtida por precipita\u00e7\u00e3o a partir de uma solu\u00e7\u00e3o aquosa \u00e0 temperatura ambiente \n\n[36]. Este composto \u00e9 geralmente obtido por aquecimento da brushite a \n\ntemperaturas entre 120\u00baC e 170\u00baC. Da mesma forma, os processos de hidrata\u00e7\u00e3o \n\ndestes compostos s\u00e3o geralmente eficazes a temperaturas superiores a 50\u00baC \n\n[36]. \n\n? O fosfato tric\u00e1lcico (TCP, Ca3(PO4)2) \u00e9 um dos compostos de fosfatos de c\u00e1lcio \n\nque tem sido cada vez mais utilizado, tanto na sua forma ? como ?, como \n\n\n\nCap\u00edtulo 1 \n\n 24 \n\nmat\u00e9ria-prima para materiais de repara\u00e7\u00e3o \u00f3ssea, estando dispon\u00edvel sob v\u00e1rias \n\nformas, tais como gr\u00e2nulos, blocos e cimento de fosfato de c\u00e1lcio [31, 37]: \n\n\u2022 O ?-fosfato tric\u00e1lcico (?-TCP), fase de baixa temperatura, \u00e9 est\u00e1vel desde a \n\ntemperatura ambiente at\u00e9 1125\u00baC. Dentro de uma gama de temperaturas \n\nentre 1125\u00baC a 1430\u00baC, ele transforma-se na fase ?-TCP que pode ser \n\nmantida \u00e0 temperatura ambiente como fase metast\u00e1vel. Por ser mais \n\nrapidamente degradado no organismo do que a HA, o ?-TCP tem sido \n\nextensivamente utilizado como substituto \u00f3sseo, quer na forma de \n\ngr\u00e2nulos, blocos ou mesmo como cimentos de fosfatos de c\u00e1lcio [22]. O \n\n?-TCP tamb\u00e9m tem sido usado com HA formando materiais de fosfato de \n\nc\u00e1lcio bif\u00e1sico HA + ?-TCP, sendo ambos amplamente utilizados como \n\nmateriais biocer\u00e2micos de substitui\u00e7\u00e3o \u00f3ssea [22]. O controlo da raz\u00e3o \n\nHA/?-TCP permite ajustar a velocidade de ressor\u00e7\u00e3o consoante o tipo de \n\naplica\u00e7\u00e3o no organismo  \n\n\u2022 O ?-fosfato tric\u00e1lcico (?-TCP), fase de alta temperatura, \u00e9 geralmente \n\npreparado a partir de fase ?-TCP tratado termicamente acima de 1125\u00baC \n\nseguida geralmente de uma t\u00eampera para impedir a transforma\u00e7\u00e3o inversa. \n\nAs transforma\u00e7\u00f5es de fase  ? ? ?-TCP ser\u00e3o tratadas em maior detalhe no \n\nCap\u00edtulo 2. As fases ? e ?-TCP t\u00eam exactamente a mesma composi\u00e7\u00e3o \n\nqu\u00edmica, mas possuem estruturas cristalogr\u00e1ficas (monocl\u00ednica e \n\nrombo\u00e9drica, respectivamente) e solubilidades distintas (Fig. 2). ?-TCP \u00e9 \n\nbiocompat\u00edvel e mais sol\u00favel e biodegrad\u00e1vel do que ?-TCP. Por essa \n\nraz\u00e3o, o ?-TCP \u00e9 mais reactivo em sistemas aquosos e pode ser \n\nhidrolisado com uma mistura de outros fosfatos de c\u00e1lcio, raz\u00e3o porque \n\nnunca ocorre em ossifica\u00e7\u00f5es biol\u00f3gicas e porque \u00e9 frequentemente usado \n\nem cimentos de fosfatos de c\u00e1lcio [25, 38-40].  \n\n???? O fosfato octac\u00e1lcico (Ca8(HPO4)2(PO4)4.5H2O, OCP) \u00e9 mais sol\u00favel (Fig. 2) e \n\nmenos est\u00e1vel em condi\u00e7\u00f5es fisiol\u00f3gicas do que a HA. A hidr\u00f3lise do OCP para \n\nHA \u00e9 termodinamicamente favorecida e procede espontaneamente e de forma \n\nirrevers\u00edvel [41, 42]. Resultados obtidos por Legeros [41] sugerem que essa \n\ntransforma\u00e7\u00e3o ocorre atrav\u00e9s de um processo de dissolu\u00e7\u00e3o do OCP e da \n\n\n\nCap\u00edtulo 1 \n\n 25 \n\nsubsequente precipita\u00e7\u00e3o na forma de apatite deficiente em c\u00e1lcio, incorporando \n\nesp\u00e9cies i\u00f3nicas presentes em solu\u00e7\u00e3o (CO3\n2?, HPO4\n\n2? or F?), e indicam que a \n\nestabilidade do OCP em calcifica\u00e7\u00f5es patol\u00f3gicas pode ser devida \u00e0 presen\u00e7a de \n\ni\u00f5es Mg2+, citratos e/ou P2O7\n4? e/ou baixas concentra\u00e7\u00f5es dos i\u00f5es CO3\n\n2?, F?, \n\nCa2+, HPO4\n2? nos fluidos biol\u00f3gicos. As caracter\u00edsticas de osteocondu\u00e7\u00e3o e \n\npossivelmente osteoindutoras do OCP [43-46] aumentaram o interesse na \n\nprepara\u00e7\u00e3o de substitutos \u00f3sseos que contenham OCP na sua composi\u00e7\u00e3o [47]. \n\nO OCP pode ser obtido como produto de reac\u00e7\u00e3o de cimentos de fosfatos de \n\nc\u00e1lcio obtidos com mistura de dois ou mais p\u00f3s (por exemplo, mistura de ??TCP e \n\nbrushite ou de ?-TCP e monetite [47]). A sua forma\u00e7\u00e3o a partir de p\u00f3s de brushite \n\nimersos em meio de Eagle modificado por Dulbecco (Dulbecco's modified Eagle \n\nm\u00e9dium, DMEM) \u00e0 temperatura de 36,6\u00baC foi tamb\u00e9m detectada por Mandel e \n\nTas [48] ao fim de cerca de uma semana. \n\n \n\nDe acordo com a solubilidade, os fosfatos de c\u00e1lcio podem ser classificados por \n\nordem crescente da taxa de degrada\u00e7\u00e3o, da seguinte forma:  \n\nMCPM > TTCP ? ?-TCP > DCPD > OCP > ?-TCP > HA \n\nAssim, dependendo da sua composi\u00e7\u00e3o qu\u00edmica e porosidade, estes podem ser \n\nmais ou menos degrad\u00e1veis in vivo. Materiais \u00e0 base de HA s\u00e3o considerados \n\npraticamente inertes se forem densos (com porosidade baixa). Os restantes \n\nfosfatos c\u00e1lcicos s\u00e3o geralmente considerados como sendo degrad\u00e1veis [35, 40]. \n\nConsiderados portanto, em geral, ressorv\u00edveis, eles s\u00e3o tamb\u00e9m bioativos. Um \n\nmaterial bioativo \u00e9 um material que tem a capacidade de reagir positivamente com \n\no corpo acelerando processos de repara\u00e7\u00e3o tecidual. E, de facto, os compostos \n\nde fosfato de c\u00e1lcio t\u00eam a propriedade especial de formar uma forte liga\u00e7\u00e3o \n\nqu\u00edmica com o osso defeituoso, estabelecendo uma uni\u00e3o entre o implante e o \n\ntecido \u00f3sseo circundante, assegurando assim a biointegra\u00e7\u00e3o do material. No \n\nentanto, as suas fracas propriedades mec\u00e2nicas n\u00e3o lhes permitem serem usados \n\nem zonas sujeitas a cargas mec\u00e2nicas. \n\n\n\nCap\u00edtulo 1 \n\n 26 \n\n3.2 Substitui\u00e7\u00e3o i\u00f3nica em fosfatos de c\u00e1lcio \n\nAs apatites biol\u00f3gicas (apatites carbonatadas) cont\u00eam uma quantidade \n\nsignificativa de outros i\u00f5es na sua composi\u00e7\u00e3o. As composi\u00e7\u00f5es minerais dos \n\ntecidos duros, osso, esmalte e dentina, est\u00e3o apresentadas na Tabela 3 [49]. \n\nTabela 3. Composi\u00e7\u00e3o inorg\u00e2nica do osso, esmalte e dentina humana [49]. \n\nElementos Osso Esmalte Dentina \n\n(wt.%)    \n\nCa 36,6 37,6 40,3 \n\nP 17,1 18,3 18,6 \n\nCO2 4,8 3,0 4,8 \n\nNa 1,0 0,70 0,1 \n\nK 0,07 0,05 0,07 \n\nMg 0,6 0,2 1,1 \n\nSr 0,05 0,03 0,04 \n\nCl 0,1 0,4 0,27 \n\nF 0,1 0,01 0,07 \n\n    \n\n(ppm)    \n\nZn 39 263 173 \n\nBa  125 129 \n\nFe  118 93 \n\nAl  86 69 \n\nAg  0,6 2 \n\nCr 0,33 1 2 \n\nCo&lt;0,025 0,1 1 \n\nSb  1 0,7 \n\nMn 0,17 0,6 0,6 \n\nAu  0,1 0,07 \n\nBr  34 114 \n\nSi 500   \n\n    \n\nCa/P 1,65 1,59 1,67 \n\n \n\n\n\nCap\u00edtulo 1 \n\n 27 \n\nCada um dos elementos acima mencionados desempenha uma parte essencial \n\nno processo biol\u00f3gico. Por exemplo, Mg desempenha um papel chave no \n\nmetabolismo \u00f3sseo, uma vez que influencia a actividade dos osteoblastos e \n\nosteoclastos, e, assim, o crescimento \u00f3sseo. Quanto ao Sr, ele tem efeitos \n\nben\u00e9ficos no tratamento da osteoporose devido \u00e0 preven\u00e7\u00e3o da perda \u00f3ssea, \n\natrav\u00e9s de um mecanismo de inibi\u00e7\u00e3o da ressor\u00e7\u00e3o \u00f3ssea e manuten\u00e7\u00e3o da \n\nforma\u00e7\u00e3o \u00f3ssea [50]. O Mn Influencia a regula\u00e7\u00e3o da remodela\u00e7\u00e3o \u00f3ssea e o seu \n\nd\u00e9fice causa redu\u00e7\u00e3o da s\u00edntese da matriz org\u00e2nica e atrasos da osteog\u00eanese \n\nendocondral, aumentando a possibilidade de anomalias \u00f3sseas como a \n\ndiminui\u00e7\u00e3o da espessura do osso ou comprimento [51]. O suplemento oral de Mn \n\nverificou-se ser um inibidor eficaz da perda de massa \u00f3ssea ap\u00f3s ovariectomia \n\n[52]. A Influ\u00eancia dos elementos Mn e do Sr como dopantes ser\u00e1 abordada de \n\nforma detalhada nos Cap\u00edtulos 4 (Mn) e 5 (Mn e Sr).  \n\nDevido ao seu interesse biol\u00f3gico, a incorpora\u00e7\u00e3o de i\u00f5es tem despertado muito \n\ninteresse. A sua presen\u00e7a na estrutura de apatites sint\u00e9ticas pode alterar uma \n\ns\u00e9rie de propriedades dos fosfatos de c\u00e1lcio tanto estruturais como \n\nf\u00edsico-qu\u00edmicas (como par\u00e2metros de rede, cristalinidade, solubilidade, dissolu\u00e7\u00e3o, \n\nressor\u00e7\u00e3o \u00f3ssea, bioatividade, entre outros) [50, 53-56]. Sob esta perspectiva, a \n\nincorpora\u00e7\u00e3o de i\u00f5es como Mg, Sr, Zn, Mn, Na, K, F entre outros, e carbonatos \n\ntem sido e continua a ser o alvo de muitos estudos de s\u00edntese de p\u00f3s de fosfatos \n\nde c\u00e1lcio. Contudo, o mesmo n\u00edvel de aten\u00e7\u00e3o relativamente aos efeitos causados \n\npelas diversas substitui\u00e7\u00f5es i\u00f3nicas na rede dos fosfatos de c\u00e1lcio n\u00e3o tem sido \n\ndispensado no caso de cimentos \u00f3sseos \u00e0 base destes materiais. Isso justifica a \n\n\u00eanfase dada no \u00e2mbito desta tese ao estudo dos efeitos de alguns dos dopantes \n\nmais relevantes em termos de desempenho biol\u00f3gico.  \n\n \n\n4. Cimentos \u00f3sseos  \n\nOs cimentos \u00f3sseos s\u00e3o biomateriais sint\u00e9ticos compostos por uma fase s\u00f3lida \n\nem p\u00f3 e uma fase l\u00edquida que, ap\u00f3s mistura nas propor\u00e7\u00f5es adequadas, fazem \n\npresa e endurecem. Excluindo os cimentos usados apenas para uso odontol\u00f3gico, \n\n\n\nCap\u00edtulo 1 \n\n 28 \n\nos cimentos \u00f3sseos mais usados s\u00e3o \u00e0 base de polimetilmetacrilato (PMMA) e os \n\ncimentos cer\u00e2micos \u00e0 base de sulfatos c\u00e1lcio, ou de fosfatos de c\u00e1lcio. \n\nContrariamente aos dois primeiros tipos de cimentos que ser\u00e3o abordados de \n\nseguida de forma muito superficial, os cimentos de fosfatos de c\u00e1lcio s\u00e3o o foco \n\ndesta tese, nomeadamente, os cimentos de brushite.  \n\n \n\n4.1 Cimentos \u00e0 base de PMMA \n\nOs cimentos \u00e0 base de PMMA t\u00eam maior resist\u00eancia mec\u00e2nica do que os seus \n\nhom\u00f3logos cer\u00e2micos, com valores de resist\u00eancia compress\u00e3o na gama dos \n\n70-120 MPa, e de resist\u00eancia \u00e0 trac\u00e7\u00e3o at\u00e9 50 MPa [57]. No entanto, estes \n\ncimentos n\u00e3o s\u00e3o biodegrad\u00e1veis e podem causar necrose extensa devido \u00e0 \n\nelevada exotermicidade da reac\u00e7\u00e3o de presa baseada na polimeriza\u00e7\u00e3o de \n\nradicais livres do mon\u00f3mero de metilmetacrilato (MMA). A incapacidade biol\u00f3gica \n\npara remodelar ou integrar o osso circundante, a excessiva rigidez, a contrac\u00e7\u00e3o \n\nvol\u00famica do cimento durante a polimeriza\u00e7\u00e3o, a fraca resist\u00eancia \u00e0 fadiga e a \n\ntoxicidade dos mon\u00f3meros, s\u00e3o outros dos inconvenientes deste tipo de cimentos \n\n[58]. Apesar disso, gra\u00e7as \u00e0s suas propriedades mec\u00e2nicas, ainda \u00e9 dos mais \n\nusados numa grande variedade de aplica\u00e7\u00f5es. Os cimentos de PMMA s\u00e3o \n\ncomummente utilizados na fixa\u00e7\u00e3o de pr\u00f3teses e como enchimento de defeitos \n\nem cirurgias envolvendo remo\u00e7\u00e3o \u00f3ssea como no caso de tumores, ou em \n\nprocedimentos minimamente invasivos como a vetebroplastia e a cifoplastia \n\n[25, 40]. \n\n \n\n4.2 Cimentos de sulfato de c\u00e1lcio \n\nOs cimentos de sulfato de c\u00e1lcio t\u00eam uma longa hist\u00f3ria cl\u00ednica como substituto \n\n\u00f3sseo. Pela primeira vez em 1892, o sulfato de c\u00e1lcio foi usado como enchimento \n\nde cavidade \u00f3ssea por Dreesman et al. [59, 60]. Este tipo de cimento degrada-se \n\natrav\u00e9s de um processo de dissolu\u00e7\u00e3o e n\u00e3o de ressor\u00e7\u00e3o mediada por c\u00e9lulas. \n\nAl\u00e9m disso, a taxa de degrada\u00e7\u00e3o \u00e9 muito maior do que a dos cimentos de fosfato \n\n\n\nCap\u00edtulo 1 \n\n 29 \n\nde c\u00e1lcio, e a maioria deste tipo de implantes \u00e9 completamente dissolvida em \n\npoucos meses [60]. Essa r\u00e1pida dissolu\u00e7\u00e3o pode ser problem\u00e1tica se a sua taxa \n\nde degrada\u00e7\u00e3o for superior \u00e0 taxa de crescimento do osso novo, ficando a \n\ncavidade \u00f3ssea ainda n\u00e3o preenchida por osso novo no final do processo de \n\ndissolu\u00e7\u00e3o do implante.  \n\n \n\n4.3 Cimentos de fosfato de c\u00e1lcio \n\nA possibilidade de obter um cer\u00e2mico monol\u00edtico de fosfato de c\u00e1lcio, \u00e0 \n\ntemperatura ambiente ou \u00e0 temperatura corporal, atrav\u00e9s de uma rea\u00e7\u00e3o de \n\ncimenta\u00e7\u00e3o, foi apresentada no in\u00edcio dos anos de 1980 [25, 40, 61, 62]. A \n\ndescoberta destes cimentos, conhecidos por cimentos de fosfato de c\u00e1lcio (CPC, \n\ncalcium phosphate cement), abriu uma nova era nos substitutos \u00f3sseos para \n\naplica\u00e7\u00f5es m\u00e9dicas.  \n\n \n\n4.3.1 Processo de presa e endurecimento \n\nOs CPCs s\u00e3o preparados a partir de um p\u00f3 (uma mistura de p\u00f3 amorfo e/ou \n\ncristalino de fosfato(s) de c\u00e1lcio) e de uma solu\u00e7\u00e3o aquosa. A presa ocorre \n\natrav\u00e9s de um processo de dissolu\u00e7\u00e3o-precipita\u00e7\u00e3o, em que um ou mais \n\ncompostos de fosfato de c\u00e1lcio sol\u00faveis s\u00e3o dissolvidos na solu\u00e7\u00e3o aquosa e \n\nprecipitados numa fase menos sol\u00favel, fazendo com que a pasta ciment\u00edcia v\u00e1 \n\nperdendo as suas propriedades viscoel\u00e1sticas e se transforme num corpo s\u00f3lido \n\n[63]. Num primeiro momento, a pasta ciment\u00edcia aparenta n\u00e3o evoluir fisicamente \n\ne permanece muito male\u00e1vel. Quimicamente, as part\u00edculas do p\u00f3 percursor \n\ncome\u00e7am a dissolver-se no l\u00edquido, e \u00e0 medida que este processo avan\u00e7a, a \n\nsolu\u00e7\u00e3o aquosa fica sobressaturada em esp\u00e9cies que tendem a precipitar como \n\nnova(s) fase(s), formando n\u00facleos que v\u00e3o crescendo e d\u00e3o origem \u00e0 forma\u00e7\u00e3o \n\nde cristais cada vez maiores. \u00c0 medida que os cristais se desenvolvem e mais \n\nn\u00facleos s\u00e3o formados, os cristais come\u00e7am a interagir e emaranhar-se entre eles, \n\nresultando num material s\u00f3lido [25]. A este segundo momento d\u00e1-se o nome de \n\n\n\nCap\u00edtulo 1 \n\n 30 \n\npresa do cimento, que \u00e9 caracterizada por um tempo inicial de presa (IST, inicial \n\nsetting time) e um tempo final de presa (FST, final setting time). Acompanhada \n\npor um aumento da viscosidade da pasta, a presa atinge o seu fim quando a \n\npasta j\u00e1 n\u00e3o \u00e9 deformav\u00e9l e se transforma num material r\u00edgido. Segue-se a \u00faltima \n\nfase que \u00e9 de endurecimento, onde as rea\u00e7\u00f5es qu\u00edmicas prosseguem \n\naumentando as propriedades mec\u00e2nicas dos cimentos. Dependendo da qu\u00edmica \n\ndo cimento, do tamanho de part\u00edcula do p\u00f3 precursor e das condi\u00e7\u00f5es de reac\u00e7\u00e3o, \n\neste processo poder\u00e1 levar desde alguns segundos a algumas semanas.  \n\n \n\n4.3.1.1 Tempo de presa e endurecimento \n\nO tempo de presa n\u00e3o deve ser demasiado curto, pois dever\u00e1 permitir ao cirurgi\u00e3o \n\nimplantar facilmente o cimento, por moldagem ou injec\u00e7\u00e3o, no local pretendido. \n\nTamb\u00e9m n\u00e3o deve ser demasiado longo de modo a que o cirurgi\u00e3o possa fechar \n\no defeito imediatamente ap\u00f3s a sua coloca\u00e7\u00e3o. Assim, os dois tempos de presa \n\nacima mencionados devem ser convenientemente ajustados, sendo contados a \n\npartir do in\u00edcio da mistura p\u00f3-l\u00edquido. O IST \u00e9 o tempo a partir do qual o material \n\nn\u00e3o deve continuar a ser manuseado de modo a evitar danos estruturais [64]; \n\nenquanto o FST define o tempo a partir do qual o material fica endurecido. Mas \n\ntipicamente, o endurecimento completo s\u00f3 \u00e9 alcan\u00e7ado ap\u00f3s v\u00e1rios dias [65]. \n\nTanto o IST como o FST s\u00e3o avaliados utilizando o mesmo princ\u00edpio: uma agulha, \n\ncom um determinado di\u00e2metro e com um peso associado, \u00e9 colocada sobre a \n\nsuperf\u00edcie da amostra em intervalos regulares de tempo, em ambiente h\u00famido e \u00e0 \n\ntemperatura de 37\u00baC. Mas o di\u00e2metro da extremidade da agulha e o peso \n\nassociado diferem. As agulhas utilizadas para medir o IST s\u00e3o mais leves e \n\npodem ter um di\u00e2metro de ponta maior do que as usadas para medir o FST. Estas \n\nmedi\u00e7\u00f5es podem ser feitas por dois m\u00e9todos tradicionais padronizados: o m\u00e9todo \n\nda agulha de Vicat (ASTM C191-92) [66] e o m\u00e9todo das agulhas de Gilmore \n\n(ASTM C266-89) [67]. Enquanto o instrumento de Vicat apresenta uma s\u00f3 agulha \n\nque pode ser adequada para determinar o IST ou o FST, o de Gilmore \u00e9 \n\nconstitu\u00eddo por duas agulhas possibilitando a obten\u00e7\u00e3o dos dois tempos de presa. \n\n\n\nCap\u00edtulo 1 \n\n 31 \n\nNeste estudo, tal como em alguns estudos anteriores [39, 68], usou-se o m\u00e9todo \n\nda agulha de Vicat para a determina\u00e7\u00e3o do IST (Cap\u00edtulo 5).  \n\nO significado cl\u00ednico destes tempos de presa (IST e FST) \u00e9 que a pasta \n\nciment\u00edcea deve ser implantada antes do IST e a ferida deve ser fechada ap\u00f3s o \n\nFST conforme est\u00e1 representado na Fig. 3, na qual ainda est\u00e3o referidos os v\u00e1rios \n\npar\u00e2metros de manuseamento sugeridos para os CPCs [69, 70]. \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 3. O diagrama dos par\u00e2metros de presa relevantes para os CPCs (adaptado de [64]). \n\n \n\nPara que o cirurgi\u00e3o tenha pelo menos 1 min para aplicar e moldar o material, o \n\ntempo de coes\u00e3o (CT, cohesion time), que \u00e9 o tempo a partir do qual j\u00e1 n\u00e3o se \n\nverifica desintegra\u00e7\u00e3o do cimento quando em contacto com algum fluido, deve ser \n\npelo menos 1 min antes do IST [70]. Como o tempo de mistura p\u00f3-l\u00edquido \u00e9 de \n\naproximadamente 1 min, o tempo de coes\u00e3o mais curto que \u00e9 permitido \u00e9 de \n\naproximadamente 2 min. Assim, o cirurgi\u00e3o tem pelo menos 1 min para recolher a \n\npasta e coloc\u00e1-la (ou inject\u00e1-la) no local da ferida depois do CT e antes do IST \n\n(Fig. 3) [64, 70]. Para aplica\u00e7\u00f5es dent\u00e1rias, o IST deve estar perto dos 3 min, \n\nenquanto para aplica\u00e7\u00f5es ortop\u00e9dicas dever\u00e1 estar pr\u00f3ximo de 8 min. Al\u00e9m disso, \n\n\u00e9 sugerido que FSTs superiores a 15 min n\u00e3o seriam bem aceites na pr\u00e1tica \n\ncl\u00ednica, uma vez que a ferida deve ser fechada ap\u00f3s o FST [64, 70]. Contudo, esta \n\nnecessidade de fechamento da ferida depois do FST n\u00e3o \u00e9 consensual. Sarda et \n\nal. [71] sugeriram que o cimento provavelmente atinge uma resist\u00eancia mec\u00e2nica \n\n0    CT 3    IST 8     FST 15\n\nPRESAPRESA\n\nTempo (min)\n\nFecho da ferida\n\nintervalo de \nimplanta\u00e7\u00e3o\n\nImplanta\u00e7\u00e3o n\u00e3o \npermitida\n\n3 min ? IST &lt;8 min\n\nCT \u2013 tempo de coes\u00e3o;\n\nIST \u2013 tempo de presa inicial;\n\nFST \u2013 tempo de presa final.\n\nIST- CT ? 1min (intervalo de implanta\u00e7\u00e3o)\n\nFST ? 15 min\n\n\n\nCap\u00edtulo 1 \n\n 32 \n\nsuficiente para resistir \u00e0 press\u00e3o exercida durante o fecho da ferida bem antes do \n\nFST. \n\nV\u00e1rios estudos sobre o efeito da distribui\u00e7\u00e3o de tamanho de part\u00edculas dos TCPs \n\nna cin\u00e9tica de rea\u00e7\u00e3o dos CPCs est\u00e3o dispon\u00edveis na literatura [72, 73]. Todos \n\neles relataram que a presen\u00e7a de aglomerados de part\u00edculas e/ou de fase amorfa \n\nmodificam a cin\u00e9tica da rea\u00e7\u00e3o. Sabe-se que a diminui\u00e7\u00e3o do tamanho de \n\npart\u00edcula do p\u00f3 precursor acelera as rea\u00e7\u00f5es de presa e reduz o IST e o FST, mas \n\nos efeitos nas propriedades mec\u00e2nicas n\u00e3o s\u00e3o claros [61]. O uso de agentes \n\ngelificantes tamb\u00e9m pode ser usado para controlar a rea\u00e7\u00e3o de presa. Por \n\nexemplo, a adi\u00e7\u00e3o de polietilenoglicol (PEG) e hidroxipropilmetilcelulose (HPMC), \n\nusados como agentes de gelifica\u00e7\u00e3o, mostraram provocar um aumento do tempo \n\nde presa, sendo menos pronunciada no caso do PEG, em compara\u00e7\u00e3o com \n\nHPMC [74]. Estes agentes s\u00e3o pol\u00edmeros hidrof\u00edlicos que formam uma estrutura \n\nde rede com as mol\u00e9culas de \u00e1gua, que se tornam menos livres para reagir com \n\nos CaPs. Por outro lado, as esp\u00e9cies polim\u00e9ricas podem ser adsorvidas na \n\nsuperf\u00edcie das part\u00edculas de CaPs, atrasando assim os processos de \n\ndissolu\u00e7\u00e3o/precipita\u00e7\u00e3o. Este fen\u00f3meno \u00e9 mais pronunciado para pol\u00edmeros de \n\nelevado peso molecular, tal como HPMC, o que poderia explicar a aumento mais \n\nacentuado do tempo de presa na presen\u00e7a deste aditivo, em compara\u00e7\u00e3o com as \n\npastas de cimento com adi\u00e7\u00e3o de PEG [74]. Alguns estudos mostraram que a \n\npresen\u00e7a de Sr, de Zr e Mg como i\u00f5es dopantes em p\u00f3s de ?? e ??TCP [68, 75], \n\nassim como a adi\u00e7\u00e3o de silicato tric\u00e1lcico [76], aumentou a tempo de presa dos \n\ncimentos. \n\n \n\n4.3.2 Tipos de cimentos \n\nAp\u00f3s mistura dos dois componentes, s\u00f3lido e l\u00edquido, e da obten\u00e7\u00e3o de uma pasta \n\nsuficientemente viscosa e mold\u00e1vel (com coes\u00e3o adequada), esta pode ser \n\ncolocada num defeito \u00f3sseo como substituto da parte danificada do osso, onde \n\nendurece in situ na sala de opera\u00e7\u00f5es ap\u00f3s alguns minutos. As fases \n\npredominantes formadas durante a presa destes cimentos podem ser a \n\n\n\nCap\u00edtulo 1 \n\n 33 \n\nhidroxiapatite (HA), a hidroxiapatite deficiente em c\u00e1lcio (CDHA), ou a brushite \n\n(DCPD), a par de outras eventuais fases minorit\u00e1rias. \n\nAssim, de acordo com a fase predominante que comp\u00f5e os CPCs endurecidos, a \n\nqual depende do pH das pastas ciment\u00edcias durante a presa, os cimentos podem \n\nser classificados em dois principais grupos [25, 40, 62]: (1) cimentos de apatite \n\n(HA ou CDHA) e (2) cimentos de brushite (DCPD) embora alguns cimentos \n\ntenham monetite como produto final. Os cimentos de apatite s\u00e3o formados acima \n\nde pH 4,2, enquanto que os cimentos de brushite s\u00e3o preferencialmente formados \n\na pH &lt;4,2, embora por raz\u00f5es cin\u00e9ticas este limite possa subir um pouco mais \n\npara pH 6,5 [40, 77]. \n\nOs primeiros estudos em cimentos apat\u00edticos foram publicados em 1982 por \n\nLeGeros et al. [78] e em 1983 por Brown e Chow [79]. S\u00f3 alguns anos mais tarde, \n\nem 1989, \u00e9 que Mirchi et al. [80] publicaram pela primeira vez um estudo com \n\ncimentos de brushite. \n\n \n\n4.3.3 Reac\u00e7\u00f5es qu\u00edmicas envolvidas na presa dos cimentos \n\nAs reac\u00e7\u00f5es qu\u00edmicas que ocorrem durante a presa dependem muito da \n\ncomposi\u00e7\u00e3o qu\u00edmica dos CPCs. No entanto, elas podem ser de dois tipos: \n\n1. Reac\u00e7\u00e3o de \u00e1cido-base, onde uma fonte de fosfato de c\u00e1lcio \u00e1cida e outra \n\nalcalina reagem formando um produto neutro. Dois exemplos muito comuns de \n\nreac\u00e7\u00e3o de \u00e1cido-base s\u00e3o: \n\ni. Fosfato tetrac\u00e1lcico (TTCP, b\u00e1sico) reage com monetite (DCPA, levemente \n\n\u00e1cida) numa solu\u00e7\u00e3o aquosa, precipitando hidroxiapatite pouco cristalizada \n\n(HA, levemente alcalina) [79] (equa\u00e7\u00e3o 1), resultando assim num cimento de \n\napatite: \n\n2Ca4 (PO4)2 O + 2CaHPO4 ? Ca10 (PO4)6 (OH)2  (1) \n\nV\u00e1rios desvios da equa\u00e7\u00e3o 1 foram estudados em detalhe [81]. Foi mostrado \n\nque apenas os primeiros n\u00facleos s\u00e3o constitu\u00eddos por HA quase \n\n\n\nCap\u00edtulo 1 \n\n 34 \n\nestequiom\u00e9trica e que o seu crescimento subsequente ocorre \n\nprefencialmente sob a forma de CDHA [82], e que a HA estequiom\u00e9trica \n\ninicialmente formada reage com o DCPD remanescente para formar CDHA \n\n[83]. \n\nii. ?-TCP (ligeiramente b\u00e1sico) reage com MCPM (\u00e1cido) formando brushite \n\n(levemente \u00e1cida) [75, 84] (equa\u00e7\u00e3o 2): \n\n? - Ca3 (PO4)2 + Ca (H2PO4)2 H2O + 7 H2O ? 4CaHPO4 2H2O  (2) \n\nNesta equa\u00e7\u00e3o, o MCMP pode ser substitu\u00eddo por \u00e1cido fosf\u00f3rico (H3PO4) ou \n\nMCPA, e o ?-TCP por ?-TCP, por CDHA ou ainda por Ca(OH)2 e CaO [85]. \n\nDe facto, os cimentos de brushite cont\u00eam sempre uma fonte de c\u00e1lcio \n\nalcalina e uma fonte de f\u00f3sforo \u00e1cida. O componente alcalino tem uma raz\u00e3o \n\nCa/P> 1 (por exemplo, hidr\u00f3xido de c\u00e1lcio (Ca(OH)2), TTCP, HA, ?-TCP, ou \n\n?-TCP). Mas devido \u00e0 elevada energia requerida para a produ\u00e7\u00e3o da maior \n\nparte dos fosfatos de c\u00e1lcio mencionados, o ?-TCP \u00e9 o mais frequentemente \n\nusado [36]. A fonte \u00e1cida de fosfato deve ter uma raz\u00e3o Ca/P&lt;1, e os \n\ncompostos mais utilizados s\u00e3o o \u00e1cido fosf\u00f3rico [86], o MCPM [75], ou o \n\nfosfato monoc\u00e1lcico anidro (MCPA) [87]. Nesta tese, todos os cimentos s\u00e3o \n\nbaseadas no sistema ?-TCP / MCPM (equa\u00e7\u00e3o 2).  \n\n2. O segundo tipo de reac\u00e7\u00e3o pode ser definido como a hidr\u00f3lise de CaPs \n\nmetast\u00e1veis em meio aquoso. \u00c9 uma simples reac\u00e7\u00e3o de dissolu\u00e7\u00e3o-precipita\u00e7\u00e3o \n\nonde o p\u00f3 percursor e a fase formada t\u00eam a mesma raz\u00e3o Ca/P, mas diferentes \n\nsolubilidades. Por exemplo, a pH neutro, o ?-TCP (solubilidade relativamente \n\nelevada) tende a formar CDHA [88] (Equa\u00e7\u00e3o 3): \n\n? - Ca3 (PO4)2 + H2O ? Ca9 (HPO4)2 (PO4)5 OH (3) \n\nCimentos formados por reac\u00e7\u00e3o entre uma solu\u00e7\u00e3o aquosa e os compostos ?-\n\nTCP, ACP, ou TTCP, que re-cristalizam na forma de CDHA quando em contacto \n\ncom a \u00e1gua ou flu\u00eddos fisiol\u00f3gicos s\u00e3o outros exemplos deste tipo de reac\u00e7\u00e3o [85].  \n\n\n\nCap\u00edtulo 1 \n\n 35 \n\nAo contr\u00e1rio dos cimentos de PMMA que endurecem atrav\u00e9s de reac\u00e7\u00f5es de \n\npolimeriza\u00e7\u00e3o altamente exot\u00e9rmica acompanhadas de uma certa retrac\u00e7\u00e3o \n\nvol\u00famica [89], os CPCs apresentam reac\u00e7\u00f5es de presa fracamente exot\u00e9rmicas \n\nlibertando uma pequena quantidade de calor, durante as quais o cimento \n\npraticamente n\u00e3o retrai, isto \u00e9, o volume do cimento permanece quase constante \n\nao longo do processo de presa [39, 85, 90, 91]. \n\n \n\n4.3.4 Principais diferen\u00e7as entre cimentos de apatite e de brushite \n\nDevido aos diferentes precursores e fases finais nos cimentos de apatite e de \n\nbrushite, existem algumas diferen\u00e7as entre estes dois tipos de cimentos que vale \n\na pena serem mencionadas. Os cimentos de apatite apresentam maior resist\u00eancia \n\nmec\u00e2nica, mas taxas mais lentas de ressor\u00e7\u00e3o in vivo que interferem com o \n\nprocesso de regenera\u00e7\u00e3o \u00f3ssea. Mas pelo facto de a CDHA ter uma composi\u00e7\u00e3o \n\nqu\u00edmica similar \u00e0 do osso, eles t\u00eam sido os mais extensivamente investigados e \n\nproduzidos comercialmente. De facto, a maioria dos cimentos de fosfato de c\u00e1lcio \n\ncomercialmente dispon\u00edveis s\u00e3o cimentos apat\u00edticos, como se mostra na Tabela 4.  \n\nNo entanto, estudos in vivo e in vitro revelaram que os cimentos de brushite \n\napresentam maiores taxas de degrada\u00e7\u00e3o passiva (dissolu\u00e7\u00e3o) e ativa (mediadas \n\npor c\u00e9lulas) do que os cementos de apatite [92, 93], facto que tem vindo a \n\ndespertar um interesse crescente neste tipo de cimentos. Segundo um estudo de \n\nOhura et al. [94], a taxa de degrada\u00e7\u00e3o do cimento de brushite endurecido \u00e9 de \n\ncerca de 0.25 mm/semana. Admite-se que esta r\u00e1pida e linear degrada\u00e7\u00e3o pode \n\nlevar \u00e0 forma\u00e7\u00e3o de osso imaturo, problema que poderia ser mitigado pela \n\nincorpora\u00e7\u00e3o de gr\u00e2nulos de ??TCP no cimento, pois estes podem agir como \n\npontos de ancoragem \u00f3ssea e promover a forma\u00e7\u00e3o de osso maduro [94, 95]. \n\n \n\n \n\n \n\n\n\nCap\u00edtulo 1 \n\n 36 \n\nTabela 4. Alguns cimentos de fosfato de c\u00e1lcio comercialmente dispon\u00edveis [31]  \n\nEmpresa \nNome \n\ncomercial do \nproduto \n\nComposi\u00e7\u00e3o \nTipo de \ncimento \n\naap Implantate \n(GER) \n\nOsteoCem\u00ae \nP\u00f3: fosfatos de c\u00e1lcio (detalhes n\u00e3o conhecidos); \n\nSolu\u00e7\u00e3o: n\u00e3o conhecida \nApatite \n\nCem-OsteticTM \nP\u00f3: fosfatos de c\u00e1lcio (detalhes n\u00e3o conhecidos); \n\nSolu\u00e7\u00e3o: \u00e1gua \nApatite Berkeley \n\nAdvanced \nBiomaterials \n\n(U.S.) Tri-Ostetic\nTM \n\nP\u00f3: fosfatos de c\u00e1lcio (detalhes n\u00e3o conhecidos); \n\nSolu\u00e7\u00e3o: \u00e1gua \nApatite \n\nBiomatlante \n(FR) \n\nMCPC \nP\u00f3: maioritariamente ?-TCP, ACP, BCP (HA + ?-\nTCP); \n\nSolu\u00e7\u00e3o: solu\u00e7\u00e3o tamp\u00e3o de fosfato \nApatite \n\nBiomet (U.S.) \nInterpore (U.S.) \n\nCalcibon\u00ae \nP\u00f3: ?-TCP (61%), DCPA (26%), CaCO3 (10%), \nCDHA (3%); \n\nSolu\u00e7\u00e3o: H2O, Na2HPO4 \nApatite \n\nWalter Lorenz \nSurgical (GER) \n\nMimixTM \nP\u00f3: TTCP, ?-TCP, citrato triss\u00f3dico; \n\nSolu\u00e7\u00e3o: solu\u00e7\u00e3o aquosa de acido c\u00edtrico \nApatite \n\nCalcitec (U.S.) Osteofix \nP\u00f3: p\u00f3s de fosfatos de c\u00e1lcio e \u00f3xido de c\u00e1lcio; \n\nSolu\u00e7\u00e3o: solu\u00e7\u00e3o tamp\u00e3o de fosfato \nApatite \n\n?-BSM\u00ae; \nEmbarc; \nBiobon \n\nP\u00f3: ACP (50%), DCPD (50%); \n\nSolu\u00e7\u00e3o: solu\u00e7\u00e3o salina n\u00e3o tamponada \nApatite \n\n?-BSM\u00ae \nComposi\u00e7\u00e3o n\u00e3o conhecida (resistencia a \ncompress\u00e3o e injectabilidade superior ao ?-BSM\u00ae) \n\nApatite \n\n?-BSM\u00ae Composi\u00e7\u00e3o n\u00e3o conhecida Apatite \n\nOssiPro \nComposi\u00e7\u00e3o n\u00e3o conhecida; cimento macroporoso \ndepois de endurecido \n\nApatite \n\nETEX (U.S.) \n\nCarriGen \nComposi\u00e7\u00e3o: fosfatos de c\u00e1lcio, carboximetilcelulose \nde s\u00f3dio, bicarbonato de s\u00f3dio e carbonato de s\u00f3dio \n\nApatite \n\nGraftys\u00ae HBS \nP\u00f3: ?-TCP (78%), DCPD (5%), MCPM (5%), CDHA \n(10%), hidroxipropilmetilcelulose (2%); \n\nSolu\u00e7\u00e3o: solu\u00e7\u00e3o aquosa 5% Na2HPO4 \nApatite \n\nGraftys (FR) \n\nGraftys\u00ae \nQuickset \n\nComposi\u00e7\u00e3o: fosfatos de c\u00e1lcio e solu\u00e7\u00e3o com \nhidroxipropilmetilcelulose e fosfatos de c\u00e1lcio \n\nApatite \n\nJectos \nEurobone\u00ae \n\nP\u00f3: ?-TCP (98%), Na2P2O7 (2%); \n\nSolu\u00e7\u00e3o: H2O, H3PO4 (3.0 M), H2SO4 (0.1 M) \nBrushite \n\nKasios (FR) \n\nJectos+ Composi\u00e7\u00e3o n\u00e3o conhecida Brushite \n\nKyphon (U.S.) KyphOsTM \nP\u00f3: ?-TCP (77%), Mg3(PO4)2 (14%), MgHPO4 \n(4.8%), SrCO3 (3.6%); \n\nSolu\u00e7\u00e3o: H2O, (NH4)2HPO4 (3.5 M) \nApatite \n\nMerck (GER) \nBiomet (U.S.) \n\nBiocement D \nP\u00f3: 58% ?-TCP, 24% DCPA, 8.5% CaCO3, 8.5% \nCDHA; \n\nSolu\u00e7\u00e3o: 4 wt% Na2HPO4 em \u00e1gua \nApatite \n\n \n\n\n\nCap\u00edtulo 1 \n\n 37 \n\nTabela 4. cont. \n\nEmpresa \nNome \n\ncommercial \ndo produto \n\nComposi\u00e7\u00e3o \nTipo de \ncimento \n\nBiopex\u00ae \n\nP\u00f3: ?-TCP (75%), TTCP (20%\u201318%), DCPD (5%),        \nHA (0%\u20132%) \n\nSolu\u00e7\u00e3o: H2O, succinato s\u00f3dico (12%\u201313%), Sulfato \ns\u00f3dico de condroitina (5%\u20135.4%) \n\nApatite \nMitsubishi \n\nMaterials (J) \n\nBiopex\u00ae-R \nP\u00f3: ?-TCP, TTCP, DCPD, HA, Mg3(PO4)2, NaHSO3; \n\nSolu\u00e7\u00e3o: H2O, Sulfato s\u00f3dico de condroitina \nApatite \n\nProduits \nDentaires SA \n\n(CH) CalciphOs \n(CH) \n\nVitalOs4 \n\nSolu\u00e7\u00e3o 1: ?-TCP (1.34 g), Na2H2P2O7 (0.025 g), \nH2O, sais (0.05 M PBS, pH 7.4); \n\nSolu\u00e7\u00e3o 2: MCPM (0.78 g), CaSO4\u00b72H2O (0.39 g), \nH2O, H3PO4 (0.05 M) \n\nBrushite \n\nShanghai \nRebone \n\nBiomaterials \nCo (CN) \n\nRebone \nP\u00f3: TTCP, DCPA; \n\nSolu\u00e7\u00e3o: H2O \nApatite \n\nCallosTM \nP\u00f3: ?-TCP, CaCO3, MCPM; \n\nSolu\u00e7\u00e3o: silicato de s\u00f3dio \nApatite \n\nCallos InjectTM P\u00f3: ?-TCP e compostos n\u00e3o conhecidos Apatite \nSkeletal \n\nKinetics (U.S.) \nOsteoVation \n\nEX Inject \nComposi\u00e7\u00e3o n\u00e3o conhecida Apatite \n\nStryker (U.S.) \nLeibinger \n\n(GER) \nBoneSourceTM \n\nP\u00f3: TTCP (73%), DCPD (27%); \n\nSolu\u00e7\u00e3o: H2O, mixture of Na2HPO4 and NaH2PO4 \nApatite \n\nStryker (U.S.) HydroSetTM \nP\u00f3: TTCP, DCPD, citrato; tris\u00f3dico \n\nSolu\u00e7\u00e3o: H2O, polivinilpirolidona, fosfato de s\u00f3dio \nApatite \n\nNorian\u00ae SRS \nNorian\u00ae CRS \n\nP\u00f3: ?-TCP (85%), CaCO3 (12%), MCPM (3%); \n\nSolu\u00e7\u00e3o: H2O, Na2HPO4 \nApatite \n\nNorian\u00ae SRS \nFast Set Putty \nNorian\u00ae CRS \nFast Set Putty \n\nComposi\u00e7\u00e3o n\u00e3o conhecida Apatite \n\nNorian \nDrillable \n\nComposi\u00e7\u00e3o: p\u00f3 de fosfato de c\u00e1lcio, fibras bio-\nressorv\u00edveis e solu\u00e7\u00e3o de hialuronato de s\u00f3dio \n\nApatite \n\nDePuy Synthes \n(U.S.) \n\nChronOSTM \n\nInject \n\nP\u00f3: ?-TCP (73%), MCPM (21%), MgHPO4\u00b73H2O \n(5%), MgSO4 (&lt;1%), Na2H2P2O7 (&lt;1%); \n\nSolu\u00e7\u00e3o: H2O, hialuronato de s\u00f3dio (0.5%) \nBrushite \n\nCementek\u00ae \nP\u00f3: ?-TCP, TTCP, glicerofosfato de s\u00f3dio;  \n\nSolu\u00e7\u00e3o: H2O, Ca(OH)2, H3PO4 \nApatite \n\nTeknimed (FR) \n\nCementek\u00ae LV \nP\u00f3: ?-TCP, TTCP, glicerofosfato de s\u00f3dio, \ndimetilsiloxane; \n\nSolu\u00e7\u00e3o: H2O, Ca(OH)2, H3PO4 \nApatite \n\n \n\n \n\n\n\nCap\u00edtulo 1 \n\n 38 \n\nAl\u00e9m disso, a brushite \u00e9 metast\u00e1vel em condi\u00e7\u00f5es fisiol\u00f3gicas e os cimentos \u00e0 \n\nbase de brushite possuem tempos de presa mais curtos [25, 40, 62]. De facto, o \n\ntempo de presa destes dois tipos de cimentos difere bastante. Os cimentos \n\napat\u00edticos (exemplos apresentados nas equa\u00e7\u00f5es 1 e 3) t\u00eam presa lenta e podem \n\ndemorar at\u00e9 algumas semanas para endurecer totalmente. Pelo contr\u00e1rio, os \n\ncimentos de brushite prendem rapidamente, com tempos de presa que v\u00e3o desde \n\nalguns segundos a alguns minutos, dependendo da composi\u00e7\u00e3o do p\u00f3 precursor \n\n(no caso da equa\u00e7\u00e3o 2, ele varia de 30 a 60 segundos). Para fins cl\u00ednicos, o \n\ntempo de presa \u00f3ptimo sugerido \u00e9 10?15 minutos [64]. \n\nAssim, v\u00e1rios m\u00e9todos com vista a alterar o tempo de presa dos cimentos t\u00eam \n\nsido testados com algum sucesso. \n\nNos cimentos de apatite, as v\u00e1rias abordagens testadas incluem:  \n\n(1) A adi\u00e7\u00e3o de um agente que acelere a dissolu\u00e7\u00e3o dos precursores (por \n\nexemplo, \u00e1cido fosf\u00f3rico, Na2HPO4) [88];  \n\n(2) A diminui\u00e7\u00e3o da raz\u00e3o l\u00edquido/p\u00f3 com o intuito de provocar uma satura\u00e7\u00e3o \n\nmais r\u00e1pida dos i\u00f5es precipitantes [96];  \n\n(3) A diminui\u00e7\u00e3o do tamanho de part\u00edcula dos precursores de modo a aumentar a \n\nvelocidade da sua dissolu\u00e7\u00e3o no l\u00edquido de rea\u00e7\u00e3o [61]. \n\nNos cimentos de brushite, a busca das solu\u00e7\u00f5es envolveu abordagens opostas:  \n\n(1) A redu\u00e7\u00e3o da solubilidade do precursor atrav\u00e9s, por exemplo, da substitui\u00e7\u00e3o \n\ndo ??TCP por HA. O precursor alcalino usado para cimentos brushite n\u00e3o tem de \n\nser t\u00e3o sol\u00favel como os precursores utilizados nos cimentos de apatite, uma vez \n\nque a elevada acidez durante a presa dos cimentos de brushite aumenta a \n\nsolubilidade do precursor;  \n\n(2) A diminui\u00e7\u00e3o da taxa de dissolu\u00e7\u00e3o atrav\u00e9s do aumento do tamanho de \n\npart\u00edculas do p\u00f3 percursor;  \n\n(3) A adi\u00e7\u00e3o de aditivos que formem quelatos com os i\u00f5es precipitantes em \n\nsolu\u00e7\u00e3o, ou com i\u00f5es da superf\u00edcie do cristal em crescimento, podendo assim \n\nprevenir a forma\u00e7\u00e3o de n\u00facleos, o crescimento r\u00e1pido dos cristais, ou agrega\u00e7\u00e3o \n\n\n\nCap\u00edtulo 1 \n\n 39 \n\nde cristais devido \u00e0 blindagem est\u00e9rica que \u00e9 criada. \u00c1cido c\u00edtrico, pirofosfatos, \n\nsulfatos, \u00e1cido glic\u00f3lico, entre outros, t\u00eam sido usados para aumentar o tempo de \n\npresa dos cimentos de brushite [86, 97-100]. Al\u00e9m de aumentar o tempo \n\ndispon\u00edvel para o manuseamento (tornando as pastas menos viscosas durante \n\nmais tempo), outra vantagem relacionada com a adi\u00e7\u00e3o destes retardadores \u00e9 a \n\nmelhor organiza\u00e7\u00e3o dos cristais devido ao seu crescimento mais lento, resultando \n\nnuma melhor compacta\u00e7\u00e3o do comento endurecido e numa maior resist\u00eancia \n\nmec\u00e2nica [80, 97, 101]. Assim, a adi\u00e7\u00e3o deste tipo de aditivos pode contribuir para \n\ncolmatar os aspectos menos positivos dos cimentos de brushite, que travam o seu \n\nuso cl\u00ednico (baixa resist\u00eancia mec\u00e2nica, tempo de presa demasiado curto e \n\nconsequente r\u00e1pido aumento da viscosidade limitando o sua injectabilidade \n\natrav\u00e9s de agulhas hipod\u00e9rmicas). Esta \u00e9 uma das abordagens perseguidas no \n\n\u00e2mbito desta tese, mais concretamente no Cap\u00edtulo 5. \n\n \n\n4.3.5 Flexibilidade dos CPCs em termos de desenhos das suas propriedades  \n\nTipicamente, os CPCs apresentam composi\u00e7\u00f5es qu\u00edmicas e padr\u00f5es de difra\u00e7\u00e3o \n\nde raios X semelhantes aos do osso, possuem biocompatibilidade, bioatividade, \n\nosteoconductividade e capacidade de serem bioressorvidos e de estabelecerem \n\nliga\u00e7\u00f5es qu\u00edmicas com os ossos hospedeiros; s\u00e3o potencialmente osteoindutores \n\ne podem ser inject\u00e1veis e usados em cirurgias minimamente invasivas [25, 38, 61, \n\n62, 90, 98, 102, 103]. Para al\u00e9m destas caracter\u00edsticas gerais, a possibilidade de \n\nmanipular outras mais espec\u00edficas em cada tipo de CPC, tais como os graus de \n\ncristalinidade e de carbonata\u00e7\u00e3o da(s) fase(s) obtidas no cimento endurecido, a \n\nquantidade de lacunas ou de substitui\u00e7\u00f5es dos i\u00f5es Ca ou dos i\u00f5es OH?, etc., \n\noferecem oportunidades de ajuste das suas propriedades caracter\u00edsticas f\u00edsico-\n\nqu\u00edmicas, incluindo a porosidade, a taxa de degrada\u00e7\u00e3o/solubilidade e o seu \n\ncomportamento in vivo. Esta elevada flexibilidade acrescenta outros benef\u00edcios \n\npotenciais ao seu uso na corre\u00e7\u00e3o de fraturas e defeitos \u00f3sseos n\u00e3o sujeitos a \n\ncargas. S\u00e3o tamb\u00e9m bons candidatos para a liberta\u00e7\u00e3o de principios activos [104] \n\ncomo antibi\u00f3ticos [105,106], anti-inflamat\u00f3rios [107], medicamentos \n\nanti-cancer\u00edgenos [108], anti-osteopor\u00f3ticos [109]. Por outro lado, a sua f\u00e1cil \n\n\n\nCap\u00edtulo 1 \n\n 40 \n\nmanipula\u00e7\u00e3o, a sua adapta\u00e7\u00e3o \u00e0s superf\u00edcies teciduais em defeitos \u00f3sseos \n\n(excelente capacidade de se moldar) e a presa in situ \u00e0 temperatura do corpo, s\u00e3o \n\noutras vantagens adicionais dos CPCs [40] que fazem destes cimentos \n\nsubstitutos \u00f3sseos muito mais vers\u00e1teis e atrativos. \n\nContudo, as formula\u00e7\u00f5es comercialmente dispon\u00edveis continuam a sofrer de \n\nv\u00e1rios problemas relacionados com o n\u00edvel insatisfat\u00f3rio de algumas propriedades \n\n[25, 38, 40, 62], tais como:  \n\n(i) Fraca coes\u00e3o e injetabilidade  \n\n(ii) Baixa resist\u00eancia mec\u00e2nica \u00f3ssea (priciplamente numa fase inicial ap\u00f3s \n\nimplanta\u00e7\u00e3o); \n\n(iii) Desajuste i\u00f3nico em rela\u00e7\u00e3o \u00e0 composi\u00e7\u00e3o \u00f3ssea; \n\n(iv) Ressors\u00e3o in vivo mais lenta que a forma\u00e7\u00e3o de osso novo; \n\n(v) Taxa de crescimento \u00f3sseo limitada pela falta de macroporosidade e de \n\nporosidade interligada. \n\n \n\nEstas defici\u00eancias, consensualmente reconhecidas pelos profissionais de sa\u00fade, \n\njustificam o continuado esfor\u00e7o de investiga\u00e7\u00e3o que tem vindo a ser dispensado \n\naos CPCs, em v\u00e1rios est\u00e1gios do seu desenvolvimento [85]. Este trabalho usa \n\numa bordagem hol\u00edstica visando a melhoria geral das propriedades mais \n\nrelevantes dos CPCs, nomeadamente, da injectabilidade, propriedades \n\nmec\u00e2nicas, ajuste i\u00f3nico, as quais t\u00eam reflexos no seu desempenho in vivo. \n\n \n\n4.3.5.1 Injetabilidade \n\nA injectabilidade \u00e9 uma das propriedades mais cr\u00edticas dos CPCs, sendo \n\ngeralmente fraca, independentemente do tipo de cimento. No caso dos cimentos \u00e0 \n\nbase de brushite, os tempos de presa precisam de ser alongados de modo a \n\n\n\nCap\u00edtulo 1 \n\n 41 \n\npermitir o seu manuseamento adequado at\u00e9 serem injetados. Em termos de \n\npr\u00e1tica cl\u00ednica, esta capacidade de ser injet\u00e1vel \u00e9 uma das principais vantagens \n\ndo uso de cimentos, em rela\u00e7\u00e3o aos cer\u00e2micos pr\u00e9-fabricados, uma vez que \n\npermite a sua introdu\u00e7\u00e3o na cavidade de um defeito atrav\u00e9s de uma agulha. A \n\ninjectabilidade torna-se de extrema import\u00e2ncia no preenchimento de: (i) defeitos \n\ncom acessibilidade limitada e/ou que n\u00e3o podem ser abertos, como \u00e9 o caso de \n\nossos com osteoporose; (ii) cavidades estreitas onde existe necessidade de \n\ncoloca\u00e7\u00e3o de cimento de forma precisa tais como, por exemplo, na repara\u00e7\u00e3o do \n\nosso peridontal.  \n\nUma boa injetabilidade, associada a uma boa coes\u00e3o, moldabilidade e presa \n\nin situ permitem aos CPCs serem injetados diretamente em fraturas e defeitos \n\n\u00f3sseos, adaptando-se intimamente \u00e0 cavidade \u00f3ssea independentemente da sua \n\nforma, o que faculta a possibilidade de cirurgias minimamente invasivas tal como \n\nna vertebroplastia percut\u00e2nea (Fig. 3). Neste caso, a v\u00e9rtebra \u00e9 consolidada por \n\nestabiliza\u00e7\u00e3o mec\u00e2nica, a qual pode ter um efeito analg\u00e9sico (alivio r\u00e1pido da \n\ndor).  \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 3. Tratamento de uma fratura por compress\u00e3o atrav\u00e9s do processo de vertebroplastia [110]. \n\n \n\nO preenchimento de fissuras e les\u00f5es \u00f3sseas provocados por osteoporose ou \n\ntumores tamb\u00e9m recorrem a procedimentos minimamente invasivos onde a \n\ninjectabilidade \u00e9 determinante do seu sucesso [38, 40, 102].  \n\nFratura vertebral  \n\nCimento \u00f3sseo injetado atrav\u00e9s de uma c\u00e2nula \n\n\n\nCap\u00edtulo 1 \n\n 42 \n\nO uso de t\u00e9cnicas cir\u00fargicas minimamente invasivas permite a redu\u00e7\u00e3o do tempo \n\nde internamento hospitalar, tempo de recupera\u00e7\u00e3o do paciente, procedimentos \n\nmenos dolorosos e um aumento global da efici\u00eancia do processo [38, 102]. Pelas \n\nraz\u00f5es acima mencionadas, o desenvolvimento dos CPCs inject\u00e1veis \u00e9 visto com \n\ncada vez mais interesse. Mas a obten\u00e7\u00e3o de pastas de CPCs com boa \n\ninjectabilidade ainda permanece um grande desafio pelo facto das propriedades \n\nde fluxo serem afetadas por v\u00e1rios fatores tais como: (i) tamanho m\u00e9dio de \n\npart\u00edcula e distribui\u00e7\u00e3o de tamanho de part\u00edcula dos p\u00f3s de partida; (ii) propor\u00e7\u00e3o \n\ne natureza das fases apresentadas; (iii) a presen\u00e7a de part\u00edculas fortemente \n\nligados (agregados); (iv) a forma das part\u00edculas; (v) a raz\u00e3o l\u00edquido/p\u00f3 \n\n(liquid/powder ratio, LPR); (vi) a presen\u00e7a de modificadores reol\u00f3gicos e/ou \n\naditivos com fun\u00e7\u00f5es espec\u00edficas [40, 61, 62, 88, 111-115]. A injectabilidade \u00e9 \n\ntratada de forma detalhada no Cap\u00edtulo 3. \n\nAparentemente, ainda n\u00e3o existe nenhuma norma que descreva o protocolo a \n\nseguir para quantificar a injectabilidade de uma pasta ciment\u00edcia. As defini\u00e7\u00f5es \n\nvariam entre grupos de investiga\u00e7\u00e3o e diferentes dispositivos e protocolos de \n\nmedida da injectabilidade t\u00eam sido propostos [102, 114]. V\u00e1rios autores seguiram \n\numa defini\u00e7\u00e3o que envolve a aus\u00eancia de segrega\u00e7\u00e3o l\u00edquido/s\u00f3lido durante a \n\nextrus\u00e3o de uma pasta [111, 114, 116]. Assim, a injectabilidade \u00e9 definida como \n\nsendo a percentagem de pasta que pode ser extrudida atrav\u00e9s de uma seringa, \n\nde uma forma homog\u00e9nea, sob uma for\u00e7a aplicada [111, 114, 117], equa\u00e7\u00e3o 4. \n\n \n\n( )\nseringanateinicialmeninseridapastadevolumeoumassa\n\nseringadaextrudidapastadevolumeoumassa\ndadeInjetabili\n\n)(\n(%) =      (4) \n\n \n\nA Fig. 4 mostra um esquema do aparato experimental usado em testes de \n\ninjectabilidade. \n\n \n\n\n\nCap\u00edtulo 1 \n\n 43 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 4. Esquema representativo da configura\u00e7\u00e3o experimental usada para medir a injectabilidade \n\ndos CPCs. \n\n \n\nA ocorr\u00eancia, durante a extrus\u00e3o, de uma eventual separa\u00e7\u00e3o de \n\nfases l\u00edquida/s\u00f3lida (tamb\u00e9m conhecida como filter pressing effect) piora, ou inibe, \n\na injectabilidade. Em tais circunst\u00e2ncias, a primeira por\u00e7\u00e3o de pasta extrudida \n\ncont\u00e9m mais l\u00edquido do que a mistura inicial. A heterogeneidade da pasta tende a \n\naumentar a for\u00e7a requerida para a extrus\u00e3o, podendo mesmo levar ao \n\nentupimento da c\u00e2nula e bloquear o processo de extrus\u00e3o. Nestas circunst\u00e2ncias, \n\na pasta retida na seringa cont\u00e9m um teor de l\u00edquido menor do que a mistura \n\ninicial.  \n\nA separa\u00e7\u00e3o de fases l\u00edquida/s\u00f3lida provocada pela press\u00e3o aplicada \u00e0 pasta \n\ndurante a inje\u00e7\u00e3o/extrus\u00e3o (filter pressing effect) [40, 61, 62, 111, 116] foi relatada \n\nem v\u00e1rios trabalhos. Habib et al. [111, 116] mostraram que uma elevada \n\nvelocidade de extrus\u00e3o, pequeno tamanho de seringa, c\u00e2nula curta e elevada \n\nLPR favorecem a injetabilidade. Gbureck et al. [99] obtiveram um resultado \n\nsemelhante para cimentos de brushite e apatite, observando tamb\u00e9m um aumento \n\nda injetabilidade com o aumento de LPR. Leroux et al. [112] observaram que o \n\npasta\n\nFor\u00e7a aplicada\n\nSeringa\n\nPasta \ninjetada\n\nc\u00e2nula\n\npasta\n\nFor\u00e7a aplicada\n\nSeringa\n\nPasta \ninjetada\n\nc\u00e2nula\n\npasta\n\nFor\u00e7a aplicada\n\nSeringa\n\nPasta \ninjetada\n\nc\u00e2nula\n\n\n\nCap\u00edtulo 1 \n\n 44 \n\nuso de aditivos como glicerofosfato de s\u00f3dio, \u00e1cido l\u00e1cteo, glicerol e quitosano \n\ndiminu\u00eda a for\u00e7a de extrus\u00e3o e melhorava a injetabilidade. A mesma tend\u00eancia foi \n\nobservada com o uso de \u00e1cido c\u00edtrico (CA, citric acid) tanto em pastas ciment\u00edcias \n\n(CP, cement pastes) baseadas em p\u00f3s de ?-TCP [118] como em CP baseada na \n\nmistura de p\u00f3s de ?-TCP com MCPM [119], mostrando ter um efeito retardador \n\nnas rea\u00e7\u00f5es de dissolu\u00e7\u00e3o-precipita\u00e7\u00e3o, com consequentes aumentos do IST das \n\npastas ciment\u00edcias e da resist\u00eancia \u00e0 compress\u00e3o dos cimentos endurecidos. \n\nParecendo contrariar essa tend\u00eancia, Pina et al. [74] mostraram que o aumento \n\nda concentra\u00e7\u00e3o de CA em CP baseada em p\u00f3s de ?-TCP reduz o IST. Os \n\nresultados apresentados nesse mesmo estudo mostraram que a adi\u00e7\u00e3o de \n\nagentes reol\u00f3gicos, como o polietilenoglicol ou o hidroxipropilmetilcelulose, \n\naumentaram o IST, permitindo adequar o tempo de presa, as propriedades \n\nreol\u00f3gicas e de manuseamento das CPs. Sabe-se tamb\u00e9m que a presen\u00e7a de \n\nagregados de part\u00edculas afeta negativamente a injetabilidade, mas ainda n\u00e3o \n\nforam estabelecidas correla\u00e7\u00f5es claras e consensuais entre o grau de agrega\u00e7\u00e3o \n\nde part\u00edculas e a injetabilidade [40, 61, 111, 116, 120]. Por todas estas raz\u00f5es, \n\nv\u00e1rios dos fatores que mais afetam a injectabilidade foram objeto de estudo ao \n\nlongo do Cap\u00edtulo 3. \n\n \n\n4.3.5.2 Comportamento mec\u00e2nico \n\nO comportamento mec\u00e2nico dos cimentos \u00f3sseos \u00e9 de uma import\u00e2ncia \n\nprimordial visto serem utilizados como substitutos \u00f3sseos e porque a principal \n\nfun\u00e7\u00e3o do osso \u00e9 a de suportar o peso corporal. Embora o seu uso tenha at\u00e9 \n\nagora sido restrito a locais n\u00e3o sujeitos a carga, devido ao fraco desempenho \n\nmec\u00e2nico dos cimentos \u00f3sseos comercialmente dispon\u00edveis, seria desej\u00e1vel \n\nestender o seu uso a outros locais, tais como v\u00e9rtebras osteopor\u00f3ticas com \n\nfraturas compressivas, desde que eles se qualificassem para tal. No m\u00ednimo, a \n\nresist\u00eancia mec\u00e2nica requerida para os cimentos \u00f3sseos deveria ser pelo menos \n\nt\u00e3o elevada como os valores m\u00e1ximos apresentados para o osso trabecular na \n\nTabela 1 da sec\u00e7\u00e3o 1.2.1 (10-12 MPa).  \n\n\n\nCap\u00edtulo 1 \n\n 45 \n\nAs propriedades mec\u00e2nicas dos CPCs endurecidos s\u00e3o comummente avaliadas \n\natrav\u00e9s da determina\u00e7\u00e3o da resist\u00eancia \u00e0 compress\u00e3o (compression strenght, \n\nCS), ou da resist\u00eancia \u00e0 tra\u00e7\u00e3o. Como os CPCs s\u00e3o fr\u00e1geis, a CS \u00e9 a propriedade \n\nmec\u00e2nica mais estudada. Esta \u00e9 a tens\u00e3o m\u00e1xima (?max) em MPa que uma \n\namostra do material com uma determinada \u00e1rea de sec\u00e7\u00e3o transversal (A0) pode \n\nsuportar sob esfor\u00e7os de compress\u00e3o antes de fraturar. Esta medi\u00e7\u00e3o \u00e9 \n\nnormalmente feita utilizando uma m\u00e1quina de ensaio universal, medindo a for\u00e7a \n\nm\u00e1xima (Fmax) que pode ser aplicada ao material. Os provetes, geralmente de \n\ngeometria cil\u00edndrica com uma propor\u00e7\u00e3o de 1:2 entre o seu di\u00e2metro (6 mm) e \n\naltura (12 mm) s\u00e3o colocados na posi\u00e7\u00e3o vertical de acordo com a norma \n\nASTM F 451-0891 para cimentos \u00f3sseos acr\u00edlicos [121]. A tens\u00e3o de compress\u00e3o \n\n\u00e9 calculada de acordo com a equa\u00e7\u00e3o 5. \n\n0\n\nmax\nmax\n\nA\n\nF\n=?   (5) \n\n \n\nComo em tais materiais fr\u00e1geis a resist\u00eancia \u00e0 trac\u00e7\u00e3o \u00e9 dif\u00edcil de medir \n\ndirectamente, a sua avalia\u00e7\u00e3o \u00e9 geralmente feita atrav\u00e9s de um m\u00e9todo \n\nalternativo, nomeadamente, por compress\u00e3o diametral (diametral tensile strengh, \n\nDTS), apesar de esta t\u00e9cnica dar resultados que subestimam a verdadeira \n\nresist\u00eancia \u00e0 trac\u00e7\u00e3o por um factor de 85% [122]. A DTS \u00e9 medida de forma \n\nsemelhante \u00e0 CS, mas colocando as amostras cil\u00edndricas na posi\u00e7\u00e3o horizontal, \n\ninduzindo for\u00e7as de trac\u00e7\u00e3o perpendicular \u00e0 carga de compress\u00e3o aplicada. \n\nGeralmente, o tamanho da amostra \u00e9 de 6 mm de di\u00e2metro e 3 mm de altura. A \n\nDTS \u00e9 calculada atrav\u00e9s da equa\u00e7\u00e3o 6, onde d \u00e9 o di\u00e2metro da amostra e h \u00e9 a \n\naltura da amostra. \n\ndh\n\nF\n\n?\n? maxmax\n\n2\n=  (6) \n\n \n\n\n\nCap\u00edtulo 1 \n\n 46 \n\nAs propriedades mec\u00e2nicas das diferentes formula\u00e7\u00f5es referidas na literatura s\u00e3o \n\nde muito dif\u00edcil compara\u00e7\u00e3o devido ao facto das medi\u00e7\u00f5es destas propriedades \n\nserem feitas com amostras preparadas em condi\u00e7\u00f5es variadas (amostras obtidas \n\ncom ou sem press\u00e3o exercida sobre elas, ensaios feitos com amostras secas ou \n\nh\u00famidas e ap\u00f3s tempos de presa e endurecimento diversos sob temperatura e \n\nhumidade diferentes, etc.). Estes fatores t\u00eam grande influ\u00eancia nos valores finais \n\nmedidos. Contudo, os valores mais frequentemente reportados s\u00e3o baixos, e as \n\nfracas propriedades mec\u00e2nicas dos CPCs restringem o campo das suas \n\npotenciais aplica\u00e7\u00e3o cl\u00ednicas. Os valores de resist\u00eancia \u00e0 compress\u00e3o e de tempo \n\nde presa de alguns CPCs comerciais referidos na Tabela 2 da sec\u00e7\u00e3o 3.1 s\u00e3o: (i) \n\nNorian SRS\u00ae (~50% porosidade): 33 \u00b1 5 MPa e 8.5 \u00b1 0.5 min; (ii) Cementek\u00ae: \n\n8 \u00b1 2 MPa and 17 \u00b1 1 min; (iii) Biocement D\u00ae (~40% porosidade): 83 \u00b1 4 MPa and \n\n6.5 \u00b1 0.5 min; (iv) ?-BSM\u00ae (~80% porosidade): 4 \u00b1 1 MPa and 19 \u00b1 1 min, \n\nrespectivamente [31].  \n\nPraticamente todos os fatores que influenciam a injectabilidade tamb\u00e9m \n\ninfluenciam a CS. Assim, a varia\u00e7\u00e3o das caracter\u00edsticas dos p\u00f3s de partida, tais \n\ncomo o tamanho das part\u00edculas, a propor\u00e7\u00e3o e a natureza das fases formadas, a \n\nLPR, a presen\u00e7a (e/ou varia\u00e7\u00e3o) de aditivos, pode alterar de forma not\u00f3ria a CS. \n\nSabe-se que o aumento da porosidade ou da LPR diminuem a CS dos \n\ncimentos [62].  \n\n \n\n4.3.5.3 Biocompatibilidade e ressor\u00e7\u00e3o  \n\nA biocompatibilidade expressa a habilidade do material de n\u00e3o causar dano, \n\nreac\u00e7\u00f5es t\u00f3xicas ou imunol\u00f3gicas aos tecidos vivos. A biocompatibilidade e a \n\ncapacidade do material estabelecer liga\u00e7\u00f5es com os tecidos vivos podem ser \n\navaliadas atrav\u00e9s de teste in vitro e in vivo. Os testes de biocompatibilidade \n\nin vitro incluem culturas de c\u00e9lulas dispon\u00edveis no mercado [123]. Al\u00e9m disso, \n\nexiste uma vasta gama de m\u00e9todos repet\u00edveis e reprodut\u00edveis, que s\u00e3o regulados \n\npor normas nacionais e internacionais para uso comercial e para o \n\ndesenvolvimento cient\u00edfico de novos materiais e produtos. A an\u00e1lise detalhada da \n\n\n\nCap\u00edtulo 1 \n\n 47 \n\nsuperf\u00edcie de apatite formada em SBF por t\u00e9cnicas como difrac\u00e7\u00e3o de raios-X \n\n(DRX), espectroscopia de infravermelho por transformada de Fourier (FTIR), \n\nmicroscopia electr\u00f3nica de varrimento (SEM) e microscopia electr\u00f3nica de \n\ntransmiss\u00e3o (TEM) revelou que era semelhante ao mineral do osso na sua \n\ncomposi\u00e7\u00e3o e estrutura [124]. Como resultado, foi especulado que os \n\nosteoblastos podem preferencialmente proliferar e diferenciarem-se para produzir \n\napatite e colag\u00e9nio na sua superf\u00edcie. A apatite secund\u00e1ria formada \u00e9 a \n\nrespons\u00e1vel pela liga\u00e7\u00e3o entre os cimentos e os tecidos circundantes. Embora os \n\nestudos in vitro d\u00eaem informa\u00e7\u00f5es sobre as interac\u00e7\u00f5es fundamentais importantes \n\ncom biomateriais, eles n\u00e3o podem substituir a avalia\u00e7\u00e3o in vivo. Um modelo \n\nanimal \u00e9 uma forma adequada para identificar um material com bioatividade \n\n\u00f3ssea in vivo, tendo sempre em aten\u00e7\u00e3o as semelhan\u00e7as e as diferen\u00e7as na \n\ncomposi\u00e7\u00e3o e arquitetura entre o osso trabecular do animal e dos seres humanos.  \n\nFen\u00f3menos de troca i\u00f3nica que ocorrem com os CPCs est\u00e3o associados a \n\nreactividade face a liga\u00e7\u00e3o \u00f3ssea. A import\u00e2ncia dos oligoelementos na sa\u00fade \n\n\u00f3ssea est\u00e1 bem documentada. I\u00f5es como o zinco, magn\u00e9sio, mangan\u00eas, sil\u00edcio, \n\nestr\u00f4ncio, etc. t\u00eam mostrado aumentar a osteog\u00eanese e a neovasculariza\u00e7\u00e3o \n\n[125]. A presen\u00e7a Sr na composi\u00e7\u00e3o dos CPCs tem vinda a despertar muito \n\ninteresse devido a sua contribui\u00e7\u00e3o no aumento do desempenho biol\u00f3gico in vivo \n\ndestes materiais [50, 126].  \n\nUma das caracter\u00edsticas mais atraentes de CPCs \u00e9 a sua capacidade de serem \n\nressorvidos in vivo. Ap\u00f3s a implanta\u00e7\u00e3o, estes materiais atuam como suportes \n\nosteocondutores, degradam-se com o tempo, sendo gradualmente substitu\u00eddos \n\npor osso durante o processo de remodela\u00e7\u00e3o [3]. A taxa de ressor\u00e7\u00e3o pode ser \n\ninfluenciada por fatores como a idade, o sexo e a sa\u00fade metab\u00f3lica geral do \n\nhospedeiro. A ressor\u00e7\u00e3o completa dos CPCs pode variar entre 3 a 36 meses \n\ndependendo da conjun\u00e7\u00e3o destes fatores e das caracter\u00edsticas dos cimentos \n\n(composi\u00e7\u00e3o qu\u00edmica [90], volume implantado, porosidade, grau de cristalinidade \n\ne tamanho do cristais) [85].  \n\nA incorpora\u00e7\u00e3o nos cimentos de apatite de compostos mais sol\u00faveis, tais como \n\nCaCO3 e CaSO4, tem vindo a ser explorada com o intuito de acelerar a sua taxa \n\n\n\nCap\u00edtulo 1 \n\n 48 \n\nde ressor\u00e7\u00e3o [62]. Nesse aspecto, os cimentos de brushite levam vantagem ao \n\nserem mais rapidamente reabsorvidos em compara\u00e7\u00e3o com os de apatite, embora \n\na tranforma\u00e7\u00e3o in vivo da brushite em apatite tenha sido vista como limitadora da \n\nressor\u00e7\u00e3o do cimento [62]. Por outro lado, a presen\u00e7a de certos i\u00f5es (tais como \n\npor exemplo o magn\u00e9sio [127] e o pirofosfato [128]) que tendem a inibir a \n\nforma\u00e7\u00e3o de apatite pode travar essa transforma\u00e7\u00e3o  \n\n  \n\n4.3.5.4 Incorpora\u00e7\u00e3o de i\u00f5es presentes no osso  \n\nA incorpora\u00e7\u00e3o de elementos vestigiais na estrutura dos cimentos com o intuito de \n\nobter uma maior correspond\u00eancia entre a composi\u00e7\u00e3o dos substitutos \u00f3sseos e a \n\ndos tecidos duros tem sido objeto de v\u00e1rios estudos de investiga\u00e7\u00e3o [39, 55, 75, \n\n126,129,130]. Nesta tese, as motiva\u00e7\u00f5es para o uso de fosfatos de c\u00e1lcio \n\ndopados foram ainda al\u00e9m daqueles objetivos, visando n\u00e3o s\u00f3 melhorias ao n\u00edvel \n\ndo desempenho biol\u00f3gico dos cimentos, mas tamb\u00e9m de outras das suas \n\npropriedades mais relevantes, incluindo a facilidade de manuseamento \n\n(injectabilidade) e das propriedades mec\u00e2nicas de CPCs [68, 131].  \n\n \n\n5. Metas e objetivos \n\nA pesquisa bibliogr\u00e1fica revelou que, apesar do esfor\u00e7o de investiga\u00e7\u00e3o crescente \n\ne de alguns progressos verificados nestes \u00faltimos anos nesta \u00e1rea, o campo de \n\naplica\u00e7\u00e3o dos cimentos \u00f3sseos \u00e0 base de fosfatos de c\u00e1lcio \u00e9 ainda bastante \n\nrestrito a locais n\u00e3o sujeitos a carga. Real\u00e7ou ainda que os cimentos comerciais \n\npossuem fraca habilidade para serem manuseados e injetados. Outra ideia clara \n\nque ressalta do atual estado da arte \u00e9 o fraco dom\u00ednio das caracter\u00edsticas dos p\u00f3s \n\nprecursores, e a aus\u00eancia de correla\u00e7\u00f5es claras entre essas caracter\u00edsticas e as \n\npropriedades mais relevantes dos cimentos, incluindo a injectabilidade, e as \n\npropriedades f\u00edsicas, qu\u00edmicas e biol\u00f3gicas. Estes aspectos precisam de ser \n\naprofundados de modo a trazer um melhor n\u00edvel de compreens\u00e3o para esta \u00e1rea \n\ndo conhecimento. \n\n\n\nCap\u00edtulo 1 \n\n 49 \n\nAssim, o objetivo central estabelecido para esta tese era o desenvolvimento de \n\num cimento \u00f3sseo \u00e0 base de fosfatos de c\u00e1lcio com injectabilidade e propriedades \n\nmec\u00e2nicas melhoradas para aplica\u00e7\u00f5es em procedimentos cir\u00fargicos \n\nminimamente invasivos. Sendo a vertebroplastia o procedimento cir\u00fargico \n\nminimamente invasivo mais exigente no que concerne a estas propriedades \n\nespec\u00edficas, esta eventual aplica\u00e7\u00e3o foi vista como o n\u00edvel m\u00e1ximo da fasquia que \n\nqualquer um gostaria de superar, n\u00e3o devendo ser encarada como um objetivo \n\nnecessariamente alcan\u00e7\u00e1vel, mas mais como uma motiva\u00e7\u00e3o inspiradora para \n\nesp\u00edritos insatisfeitos.  \n\nA minimiza\u00e7\u00e3o da raz\u00e3o l\u00edquido-p\u00f3 usada na prepara\u00e7\u00e3o dos cimentos e o \n\naumento da injectabilidade atrav\u00e9s de uma viscosidade controlada foram os \n\npontos-chave para alcan\u00e7ar este objetivo. A incorpora\u00e7\u00e3o de aditivos na solu\u00e7\u00e3o \n\naquosa reativa (espessantes reol\u00f3gicos, lubrificantes, entre outros) e o uso de p\u00f3s \n\nde partida com distribui\u00e7\u00f5es de tamanhos de part\u00edculas otimizadas de modo a \n\nmaximizar as concentra\u00e7\u00f5es de s\u00f3lidos nas pastas ciment\u00edcias foram as vias \n\nexploradas para atingir essas metas. A melhoria das propriedades mec\u00e2nicas \n\nseria, portanto, conseguida \u00e0s custas de uma diminui\u00e7\u00e3o da porosidade do \n\ncimento, a qual, por sua vez, dever\u00e1 abrandar a cin\u00e9tica de reabsor\u00e7\u00e3o. Nesta \n\nperspetiva, a op\u00e7\u00e3o por cimentos \u00e0 base de brushite que t\u00eam uma taxa de \n\nreabsor\u00e7\u00e3o mais r\u00e1pida que os cimentos \u00e0 base de apatite, apresentou-se como a \n\nforma mais racional para contornar esse problema.  \n\nComo referido na Introdu\u00e7\u00e3o Geral, os objetivos espec\u00edficos do estudo \n\napresentado no Cap\u00edtulo 2 eram contribuir para uma melhor compreens\u00e3o dos \n\nefeitos da dopagem com Mg e do tratamento t\u00e9rmico nas transforma\u00e7\u00f5es \n\nalotr\u00f3picas ? ? ??TCP, especialmente em presen\u00e7a de impurezas de pirofosfato \n\nde c\u00e1lcio. Os resultados deveriam servir de base para selecionar qual dos dois \n\ntipos de p\u00f3s precursores, ??TCP ou ??TCP, seriam usados em estudos \n\nposteriores de prepara\u00e7\u00e3o de cimentos de fosfatos de c\u00e1lcio \u00e0 base de brushite. \n\nFicou demonstrado que o Mg estabiliza a fase ??TCP, dificultando a obten\u00e7\u00e3o de \n\n??TCP puro, uma tend\u00eancia comummente observada com outros elementos \n\ndopantes. Isto justificou a sele\u00e7\u00e3o de p\u00f3s de ?-TCP para os estudos seguintes.  \n\n\n\nCap\u00edtulo 1 \n\n 50 \n\nNo estudo apresentado no Cap\u00edtulo 3, os objetivos a atingir eram v\u00e1rios: \n\n(i) entender a influ\u00eancia do tamanho e da distribui\u00e7\u00e3o de tamanho de part\u00edculas de \n\np\u00f3s de ?-TCP e do seu estado de agrega\u00e7\u00e3o na injectabilidade de sistemas n\u00e3o \n\nreativos (pastas n\u00e3o reativas) e reativos (pastas ciment\u00edcias); (ii) averiguar se os \n\nresultados obtidos com os sistemas n\u00e3o-reativos eram transpon\u00edveis para os \n\nsistemas reativos; (iii) investigar os efeitos de alguns aditivos presentes no l\u00edquido \n\nreativo nas pastas ciment\u00edcias; (iv) otimizar a distribui\u00e7\u00e3o de tamanho de \n\npart\u00edculas a fim de aumentar a injectabilidade das pastas ciment\u00edcias com uma \n\nraz\u00e3o l\u00edquido-p\u00f3 t\u00e3o baixa quanto poss\u00edvel. Para o efeito foram preparados e \n\nusados p\u00f3s de ?-fosfato tric\u00e1lcicos dopados com Sr. Al\u00e9m das suas propriedades \n\nde i\u00e3o biologicamente ativo e de agente radiopacificante, este elemento foi \n\nintroduzido sobretudo para aumentar a estabilidade t\u00e9rmica do ?-TCP permitindo \n\na obten\u00e7\u00e3o de gr\u00e2nulos de ?-TCP bem densificados usados tamb\u00e9m neste \n\nestudo.  \n\nCom o intuito de aumentar o desempenho biol\u00f3gico dos cimentos, foram \n\nsintetizados p\u00f3s de ?-TCP dopados com v\u00e1rios teores de Mn. A caracteriza\u00e7\u00e3o \n\nf\u00edsico-qu\u00edmica destes p\u00f3s, assim como a sua resposta biol\u00f3gica in vitro s\u00e3o \n\napresentados no Cap\u00edtulo 4. \n\nTendo em aten\u00e7\u00e3o os resultados obtidos nos dois cap\u00edtulos anteriores, no \n\nCap\u00edtulo 5 foram preparados e caracterizados diversos p\u00f3s de ?-TCP dopados \n\ncom Sr, com Mn e co-dopados com estes dois i\u00f5es. Por outro lado, \n\nadicionaram-se a\u00e7\u00facares (sucrose, tamb\u00e9m denominada por sacarose e frutose) \n\n\u00e0 composi\u00e7\u00e3o do l\u00edquido reativo. Os v\u00e1rios objetivos parciais estabelecidos para \n\neste trabalho eram avaliar os efeitos singulares e conjugados dos i\u00f5es dopantes e \n\nda presen\u00e7a de a\u00e7\u00facares nas seguintes propriedades dos cimentos: \n\n(i) manuseamento (tempo de in\u00edcio de presa e injectabilidade); (ii) f\u00edsicas \n\n(resist\u00eancia \u00e0 compress\u00e3o e porosidade); (iii) desempenho biol\u00f3gico in vitro; \n\n(iv) obter uma formula\u00e7\u00e3o que v\u00e1 ao encontro do objetivo central desta tese. \n\n \n\n \n\n\n\nCap\u00edtulo 1 \n\n 51 \n\n6. Refer\u00eancias bibliogr\u00e1ficas \n\n[1] E.N.Marieb, K. Hoehn, Human Anatomy &amp; Physiology, Pearson 2006. \n\n[2] J.R. Jones, L.L. Hench, Regeneration of trabecular bone using porous \n\nceramics, Curr Opin Solid St M. 7 (2003) 301-7. \n\n[3] R LeGeros, G Daculsi, J LeGeros. Bioactive Bioceramics. In: W Pietrzak, \n\neditor, Musculoskeletal Tissue Regeneration, Humana Press (2008)153-81. \n\n[4] Sommerfeldt DW, Rubin CT, Biology of bone and how it orchestrates the form \n\nand function of the skeleton, Eur Spine J. 10 Suppl 2 (2001) S86-95. \n\n[5] S.C. Cowin, Bone Mechanics Handbook, Second Edition: Taylor &amp; Francis \n\n2001. \n\n[6] J.D. Currey, Bones: Structure and Mechanics, Princeton University Press 2002. \n\n[7] A.J. Wagoner Johnson,, B.A. Herschler, A review of the mechanical behavior \n\nof CaP and CaP/polymer composites for applications in bone replacement and \n\nrepair, Acta Biomater. 7 (2011) 16-30. \n\n[8] D.R. Carter, WC Hayes, Bone compressive strength: the influence of density \n\nand strain rate, Science 194 (1976) 1174-6. \n\n[9] T.M. Wright, W.C. Hayes, Tensile testing of bone over a wide range of strain \n\nrates: effects of strain rate, microstructure and density, Med biol Eng. 14 (1976) \n\n671-80. \n\n[10] J.D. Currey, Tensile yield in compact bone is determined by strain, post-yield \n\nbehaviour by mineral content, J Biomech.;37 (2004) 549-56. \n\n[11] M. Wright, W.C. Hayes, Tensile testing of bone over a wide range of strain \n\nrates: effects of strain rate, microstructure and density, J biomech. 37 (2004) \n\n1281-7. \n\n\n\nCap\u00edtulo 1 \n\n 52 \n\n[12] J.-Y. Rho, L. Kuhn-Spearing, P. Zioupos, Mechanical properties and the \n\nhierarchical structure of bone, Med Eng Phys. 20 (1998) 92-102. \n\n[13] E.B.W. Giesen, M. Ding, M. Dalstra, T.M.G.J. van Eijden, Mechanical \n\nproperties of cancellous bone in the human mandibular condyle are anisotropic, J \n\nBiomech. 34 (2001) 799-803. \n\n[14] X. Banse, T.J. Sims, A.J. Bailey, Mechanical properties of adult vertebral \n\ncancellous bone: correlation with collagen intermolecular cross-links, J Bone \n\nMiner Res. 17 (2002) 1621-8. \n\n[15] A. Doat, F. Pell\u00e9, N. Gardant, A. Lebugle, Synthesis of luminescent bioapatite \n\nnanoparticles for utilization as a biological probe, J Solid State Chem. 177 (2004) \n\n1179-87. \n\n[16] R. Legros, N. Balmain, G. Bonel, Age-related changes in mineral of rat and \n\nbovine cortical bone, Calcified Tissue Int. 41 (1987) 137-44. \n\n[17] C. Rey, J.L. Miquel, L. Facchini, A.P. Legrand, M.J. Glimcher, \n\nHydroxyl-groups in bone mineral, Bone. 16 (1995) 583-6. \n\n[18] L.C. Bonar, A.H. Roufosse, W.K. Sabine, M.D. Grynpas, M.J. Glimcher, X-ray \n\ndiffraction studies of the crystallinity of bone mineral in newly synthesized and \n\ndensity fractionated bone, Calcif Tissue Int. 35 (1983) 202-9. \n\n [19] S. Cazalbou, D. Eichert, C. Drouet, C. Combes, C. Rey, Min\u00e9ralisations \n\nbiologiques \u00e0 base de phosphate de calcium. C R Palevol. 3 (2004) 563-72. \n\n[20] S. Cazalbou, D. Eichert, X. Ranz, C. Drouet, C. Combes, M.F. Harmand, et \n\nal., Ion exchanges in apatites for biomedical application, J Mater Sci-Mater M. 16 \n\n(2005) 405-9. \n\n[21] R.R. Seeley, T.D. Stephens, P. Tate, Anatomia e Fisiologia, Lusodid\u00e1tica, \n\nAnatomia &amp; fisiologia 2001. \n\n\n\nCap\u00edtulo 1 \n\n 53 \n\n[22] M. Bohner, Resorbable biomaterials as bone graft substitutes, Mater Today. \n\n13 (2010)24-30. \n\n[23] Y. Luo, G. Engelmayr, D.T. Auguste, Ld.S. Ferreira, J.M. Karp, R. Saigal, et \n\nal., Chapter Twenty-Five - Three-Dimensional Scaffolds. In: R. Lanza, R. Langer, \n\nJ. Vacanti editors, Principles of Tissue Engineering (Third Edition), Burlington, \n\nAcademic Press (2007) 359-73. \n\n[24] A.M. Barradas, H. Yuan, C.A. van Blitterswijk, P. Habibovic, Osteoinductive \n\nbiomaterials: current knowledge of properties, experimental models and biological \n\nmechanisms, Eur Cell Mater. 21 (2011) 407-29. \n\n[25] M. Bohner, Calcium orthophosphates in medicine: from ceramics to calcium \n\nphosphate cements, Injury. 31 (2000) 37-47. \n\n[26] S.V. Dorozhkin, Calcium orthophosphates. J Mater Sci. 42 (2007) 1061-95. \n\n[27] F.H. Albee, Studies in bone growth triple calcium phosphate as a stimulus to \n\nosteogenesis, Ann Surg. 71 (1920) 32-9. \n\n[28] L.M. Grover, A.J. Wright, U. Gbureck, A. Bolarinwa, J. Song, Y. Liu, et al., The \n\neffect of amorphous pyrophosphate on calcium phosphate cement resorption and \n\nbone generation, Biomaterials. 34 (2013) 6631-7. \n\n[29] M.H. Alkhralsat, F.T. Marino, C.R. Rodriguez, LB Jerez, E.L. Cabarcos. \n\nCombined effect of strontium and pyrophosphate on the properties of brushite \n\ncements, Acta Biomater. 4 (2008) 664-70. \n\n[30] K. Ishikawa, Bone substitute fabrication based on dissolution-precipitation \n\nreactions, Materials. 3 (2010) 1138-55. \n\n[31] S. Dorozhkin, Self-Setting calcium orthophosphate formulations, J Funct \n\nBiomater. 4 (2013) 209-311. \n\n\n\nCap\u00edtulo 1 \n\n 54 \n\n[32] N.A. Curry, D.W. Jones, Crystal structure of brushite, calcium hydrogen \n\northophosphate dihydrate: a neutron-diffraction investigation, J. Chem. Soc. A. \n\n(1971) 3725-3729. \n\n[33] H.E. Lundager Madsen, F. Christensson, Precipitation of calcium phosphate \n\nat 40\u00b0C from neutral solution, J Cryst Growth. 114 (1991) 613-8. \n\n[34] H.E. Lundager Madsen, G. Thorvardarson, Precipitation of calcium phosphate \n\nfrom moderately acid solution, J Cryst Growth. 66 (1984) 369-76. \n\n[35] R. LeGeros, Calcium phosphates in oral biology and medicine, Monogr Oral \n\nSci. 15 (1991) 1-201. \n\n[36] F Tamimi, Z Sheikh, J Barralet, Dicalcium phosphate cements: Brushite and \n\nmonetite, Acta Biomater. 8 (2012) 474-87. \n\n[37] M. Bohner, Design of ceramic-based cements and putties for bone graft \n\nsubstitution, Eur Cells Mater. 20 (2010) 1-12. \n\n[38] H.L. Alves, L.A. Dos Santos, C.P. Bergmann. Injectability evaluation of \n\ntricalcium phosphate bone cement, J Mater Sci-Mater M. 19 (2008) 2241-6. \n\n[39] S. Pina, P.M. Torres, F. Goetz-Neunhoeffer, J. Neubauer, J.M.F. Ferreira, \n\nNewly developed Sr-substituted alpha-TCP bone cements, Acta Biomater. 6 \n\n(2010) 928-35. \n\n[40] S.V. Dorozhkin, Calcium orthophosphates cements for biomedical application, \n\nJ Mater Sci-Mater M. 43 (2008) 3028-57. \n\n[41] R.Z. LeGeros, G. Daculsi, I. Orly, T. Abergas, W. Torres, Solution-mediated \n\ntransformation of octacalcium phosphate (OCP) to apatite, Scanning Microsc. 3 \n\n(1989) 129-37. \n\n[42] J.L. Meyer, E.D. Eanes, A thermodynamic analysis of the secondary transition \n\nin the spontaneous precipitation of calcium phosphate, Calc Tissue Res. 25 \n\n(1978) 209-16. \n\n\n\nCap\u00edtulo 1 \n\n 55 \n\n[43] O. Suzuki, S. Kamakura, T. Katagiri, M. Nakamura, B. Zhao, Y. Honda, et al., \n\nBone formation enhanced by implanted octacalcium phosphate involving \n\nconversion into Ca-deficient hydroxyapatite, Biomaterials. 27 (2006) 2671-81. \n\n[44] P. Habibovic, C.M. van der Valk, C.A. van Blitterswijk, K. De Groot, G. Meijer, \n\nInfluence of octacalcium phosphate coating on osteoinductive properties of \n\nbiomaterials, J Mater Sci-Mater M. 15 (2004) 373-80. \n\n[45] H Imaizumi, M Sakurai, O Kashimoto, T Kikawa, O Suzuki, Comparative study \n\non osteoconductivity by synthetic octacalcium phosphate and sintered \n\nhydroxyapatite in rabbit bone marrow, Calcif Tissue Int. 2006;78:45-54. \n\n[46] A. Bigi, B. Bracci, F. Cuisinier, R. Elkaim, M. Fini, I. Mayer, et al., Human \n\nosteoblast response to pulsed laser deposited calcium phosphate coatings, \n\nBiomaterials. 26 (2005) 2381-9. \n\n[47] M. Markovic, L.C. Chow, An Octacalcium Phosphate Forming Cement. \n\nJournal of research of the National Institute of Standards and Technology. 115 \n\n(2010) 257-65. \n\n[48] S. Mandel, A.C. Tas, Brushite (CaHPO4 2H2O) to octacalcium phosphate \n\n(Ca8(HPO4)2(PO4)4\u20225H2O) transformation in DMEM solutions at 36.5\u00baC, Mater Sci \n\nEng C. 30 (2010) 245-54. \n\n[49] E. Boanini, M. Gazzano, A Bigi, Ionic substitutions in calcium phosphates \n\nsynthesized at low temperature, Acta Biomater. 6 (2010) 1882-94. \n\n[50] M. Schumacher, M. Gelinsky, Strontium modified calcium phosphate \n\ncements - Approaches towards targeted stimulation of bone turnover, J. Mater. \n\nChem. B. 3 (2015) 4626-40. \n\n[51] T. Landete-Castillejos, I. Molina-Quilez, J.A. Estevez, F Ceacero, A.J. Garcia, \n\nL. Gallego, Alternative hypothesis for the origin of osteoporosis: The role of Mn, \n\nFront Biosci. E4 (2012) 1385-90. \n\n\n\nCap\u00edtulo 1 \n\n 56 \n\n[52] H. Rico, N. G\u00f3mez-Raso, M. Revilla, E.R. Hern\u00e1ndez, C. Seco, E. P\u00e1ez, et \n\nal., Effects on bone loss of manganese alone or with copper supplement in \n\novariectomized rats A morphometric and densitomeric study, Eur. J. Obstet. \n\nGynecol. Reprod. Biol. 2000;90:97-101. \n\n[53] S. Kannan, S.I. Vieira, S.M. Olhero, P.M.C. Torres, S Pina, O.A.B. Da Cruz e \n\nSilva, et al., Synthesis, mechanical and biological characterization of ionic doped \n\ncarbonated hydroxyapatite/?-tricalcium phosphate mixtures. Acta Biomater. \n\n7(2011) 1835-43. \n\n[54] S. Kannan, J.M. Ventura, J.M.F. Ferreira, Aqueous precipitation method for \n\nthe formation of Mg-stabilized ?-tricalcium phosphate: An X-ray diffraction study, \n\nCeram Int. 33 (2007) 637-41. \n\n[55] S. Kannan, S. Pina, J.M.F. Ferreira, Formation of strontium-stabilized \n\n?-tricalcium phosphate from calcium-deficient apatite, J. Am. Ceram. Soc. 89 \n\n(2006) 3277-80. \n\n[56] S. Kannan, F. Goetz-Neunhoeffer, J. Neubauer, S. Pina, P.M.C. Torres, \n\nJ.M.F. Ferreira, Synthesis and structural characterization of strontium- and \n\nmagnesium-co-substituted ?-tricalcium phosphate, Acta Biomater. 6 (2010) 571-6. \n\n[57] G. Lewis, Properties of acrylic bone cement: state of the art review, J. \n\nBiomed. Mater. Res. 38 (1997) 155-82. \n\n[58] M.K. Singh, T. Shokuhfar, J.J.A. Gracio, A.C.M. de Sousa, J.M.F. Ferreira, H. \n\nGarmestani, et al., Hydroxyapatite Modified with Carbon-Nanotube-Reinforced \n\nPoly(methyl methacrylate): A Nanocomposite Material for Biomedical Applications, \n\nAdv Funct Mater. 18 (2008) 694-700. \n\n[59] M. Nilsson, E. Fernandez, S. Sarda, L. Lidgren, J.A. Planell, Characterization \n\nof a novel calcium phosphate/sulphate bone cement, J. Biomed. Mater. Res. 61 \n\n(2002) 600-7. \n\n\n\nCap\u00edtulo 1 \n\n 57 \n\n[60] G. Lewis, Injectable bone cements for use in vertebroplasty and kyphoplasty: \n\nstate-of-the-art review, J. Biomed. Mater. Res. B Appl. Biomater. 76 (2006) \n\n456-68. \n\n[61] M. Bohner, Reactivity of calcium phosphate cements, J. Mater. Chem. 17 \n\n(2007) 3980-6. \n\n[62] M. Bohner, U. Gbureck, J.E. Barralet, Technological issues for the \n\ndevelopment of more efficient calcium phosphate bone cements: a critical \n\nassessment. Biomaterials. 26 (2005) 6423-9. \n\n[63] M.P. Ginebra, E. Fernandez, E.A.P. DeMaeyer, R.M.H. Verbeeck, M.G. \n\nBoltong, J. Ginebra, et al., Setting reaction and hardening of an apatitic calcium \n\nphosphate cement, J.Dent. Res.;76 (1997) 905-12. \n\n[64] F.C.M. Driessens, J.A. Planell, M.G. Boltong, I. Khairoun, M.P. Ginebra, \n\nOsteotransductive bone cements, Proc. Inst. Mech. Eng. Part. H \u2013 J. Eng. Med. \n\n212 (1998) 427-35. \n\n[65] E. Fernandez, M.P. Ginebra, M.G. Boltong, F.C.M. Driessens, J. Ginebra, \n\nE.A.P. DeMaeyer, et al., Kinetic study of the setting reaction of a calcium \n\nphosphate bone cement, J Biomed. Mater. Res. 32 (1996) 367-74. \n\n[66] ASTM, Standard Test Method for Time of Setting of Hydraulic Cement Paste \n\nby Vicat Needle; ASTM C191-92; American Society for Testing and Materials: \n\nPhiladelphia, PA, USA, (1993) 158-160. \n\n[67] ASTM, Standard Test Method for Time of Setting of Hydraulic Cement Paste \n\nby Gillmore Needles; ASTM C266-89; American Society for Testing and Materials: \n\nPhiladelphia, PA, USA, (1993) 189-191. \n\n[68] S. Pina, P.M. Torres, J.M. Ferreira, Injectability of brushite-forming Mg-\n\nsubstituted and Sr-substituted alpha-TCP bone cements, J. Mater. Sci. Mater. M. \n\n21 (2010) 431-8. \n\n\n\nCap\u00edtulo 1 \n\n 58 \n\n[69] M.P. Ginebra, E. Fern\u00e1ndez, F.C.M. Driessens, M.G. Boltong, J. Muntasell, J. \n\nFont, et al., The effects of temperature on the behaviour of an apatitic calcium \n\nphosphate cement. J. Mater. Sci. Mater. M. 6 (1995) 857-60. \n\n[70] I. Khairoun, M.G. Boltong, F.C. Driessens, J.A. Planell, Limited compliance of \n\nsome apatitic calcium phosphate bone cements with clinical requirements, J. \n\nMater. Sci. Mater. M. 9 (1998) 667-71. \n\n[71] S. Sarda, E. Fernandez, J. Llorens, S. Martinez, M. Nilsson, J.A. Planell, \n\nRheological properties of an apatitic bone cement during initial setting, J. Mater. \n\nSci. Mater. M. 12 (2001) 905-9. \n\n[72] M. Bohner, A.K. Malsy, C.L. Camir\u00e9, U. Gbureck, Combining particle size \n\ndistribution and isothermal calorimetry data to determine the reaction kinetics of \n\n?-tricalcium phosphate-water mixtures, Acta Biomater. 2 (2006) 343-8. \n\n[73] M.P. Ginebra, F.C.M. Driessens, J.A. Planell, Effect of the particle size on the \n\nmicro and nanostructural features of a calcium phosphate cement: a kinetic \n\nanalysis, Biomaterials. 25 (2004) 3453-62. \n\n[74] S. Pina, S.M. Olhero, S. Gheduzzi, A.W. Miles, J.M. Ferreira, Influence of \n\nsetting liquid composition and liquid-to-powder ratio on properties of a Mg-\n\nsubstituted calcium phosphate cement, Acta Biomater. 5 (2009) 1233-40. \n\n[75] S. Pina, S.I. Vieira, P.M. Torres, F. Goetz-Neunhoeffer, J. Neubauer, O.A. da \n\nCruz e Silva, et al. In vitro performance assessment of new brushite-forming Zn- \n\nand ZnSr-substituted beta-TCP bone cements, J. Biomed. Mater. Res. B. Appl. \n\nBiomater.;94 (2010)414-20. \n\n[76] Z.G. Huan, J. Chang. Novel, Bioactive composite bone cements based on the \n\nbeta-tricalcium phosphate-monocalcium phosphate monohydrate composite \n\ncement system, Acta Biomater. 5 (2009) 1253-64. \n\n[77] U. Gbureck, S. Dembski, R. Thull, J.E. Barralet, Factors influencing calcium \n\nphosphate cement shelf-life, Biomaterials. 26 (2005) 3691-7. \n\n\n\nCap\u00edtulo 1 \n\n 59 \n\n[78] R Legeros, A Chohayeb, A Shulman, Apatitic calcium phosphates:possible \n\ndental restorative materials, J. Dent. Res. 61 (1982) 343. \n\n[79] W.E. Brown, L.C. Chow, A new calcium-phosphate setting cement, J.Dent. \n\nRes. 62 (1983) 672-672. \n\n[80] A.A. Mirtchi, J. Lemaitre, N. Terao, Calcium phosphate cements: study of the \n\nbeta-tricalcium phosphate--monocalcium phosphate system, Biomaterials \n\n10 (1989) 475-80. \n\n[81] K. Ishikawa, S. Takagi, L.C. Chow, K. Suzuki, Reaction of calcium phosphate \n\ncements with different amounts of tetracalcium phosphate and dicalcium \n\nphosphate anhydrous, J. Biomed. Mater. Res. 46 (1999) 504-10. \n\n[82] P.W. Brown, M. Fulmer, Kinetics of Hydroxyapatite Formation at Low \n\nTemperature, J. Am. Ceram. Soc. 74 (1991) 934-40. \n\n[83] K.S. TenHuisen, P.W. Brown, The formation of hydroxyapatite-ionomer \n\ncements at 38 degrees C, J. Dent. Res. 73 (1994) 598-606. \n\n[84] J. Engstrand, C. Persson, H. Engqvist, The effect of composition on \n\nmechanical properties of brushite cements, J Mech Behav Biomed Mater. \n\n29 (2014) 81-90. \n\n[85] S. Dorozhkin, Self-Setting calcium orthophosphate formulations, J Funct \n\nBiomater. 4 (2013) 209-311. \n\n[86] M. Bohner, J. Lemaitre, T.A. Ring, Effects of Sulfate, Pyrophosphate, and \n\nCitrate Ions on the Physicochemical Properties of Cements Made of ?-Tricalcium \n\nPhosphate-Phosphoric Acid-Water Mixtures, J. Am. Ceram. Soc. 79 (1996) \n\n1427-34. \n\n[87] J. Engstrand, J. Aberg, H. Engqvist, Influence of water content on hardening \n\nand handling of a premixed calcium phosphate cement, Mater Sci Eng C. \n\n33 (2013) 527-31. \n\n\n\nCap\u00edtulo 1 \n\n 60 \n\n[88] E.B. Montufar, Y. Maazouz, M.P. Ginebra, Relevance of the setting reaction \n\nto the injectability of tricalcium phosphate pastes, Acta Biomater. 9 (2013) \n\n6188-98. \n\n[89] S. McMahon, G. Hawdon, J. Bare, Y. Sim, N. Bertollo, W.R. Walsh, Thermal \n\nnecrosis and PMMA \u2013 a cause for concern? J. Bone Joint. Surg. Br. 94-B (2012) \n\n64. \n\n[90] M. Bohner, U. Gbureck, Thermal reactions of brushite cements, J. Biomed. \n\nMater. Res. B. Appl. Biomater. 84 (2008) 375-85.  \n\n[91] C. Liu, Y. Huang, J. Chen, The physicochemical properties of the solidification \n\nof calcium phosphate cement, J Biomed Mater Res B Appl Biomater. 69 (2004) \n\n73-8. \n\n[92] C. Grossardt, A. Ewald, L.M. Grover, J.E. Barralet, U. Gbureck, Passive and \n\nactive in vitro resorption of calcium and magnesium phosphate cements by \n\nosteoclastic cells, Tissue Eng. Part. A. 16 (2010) 3687-95. \n\n[93] D. Apelt, F. Theiss, A.O. El-Warrak, K. Zlinszky, R. Bettschart-Wolfisberger, \n\nM. Bohner, et al., In vivo behavior of three different injectable hydraulic calcium \n\nphosphate cements, Biomaterials. 25 (2004) 1439-51. \n\n[94] K. Ohura, M. Bohner, P. Hardouin, J. Lema\u00eetre, G. Pasquier, B. Flautre, \n\nResorption of, and bone formation from, new ?-tricalcium phosphate-monocalcium \n\nphosphate cements: An in vivo study, J. Biomed. Mater. Res. 30 (1996) 193-200. \n\n[95] B. Flautre, C. Maynou, J. Lemaitre, P. Van Landuyt, P. Hardouin, Bone \n\ncolonization of beta-TCP granules incorporated in brushite cements, J. Biomed. \n\nMater. Res. 63 (2002) 413-7. \n\n[96] C.S. Liu, H.F. Shao, F.Y. Chen, H.Y. Zheng, Rheological properties of \n\nconcentrated aqueous injectable calcium phosphate cement slurry, Biomaterials. \n\n27 (2006) 5003-13. \n\n\n\nCap\u00edtulo 1 \n\n 61 \n\n[97] J.L. Giocondi, B.S. El-Dasher, G.H. Nancollas, C.A. Orme, Molecular \n\nmechanisms of crystallization impacting calcium phosphate cements, Philos. \n\nTrans. A Math. Phys. Eng. Sci. 368 (2010) 1937-61. \n\n[98] F.T. Marino, J. Torres, M. Hamdan, C.R. Rodriguez, E.L. Cabarcos, \n\nAdvantages of using glycolic acid as a retardant in a brushite forming cement, J. \n\nBiomed. Mater. Res. B. Appl. Biomater. 83B (2007) 571-9. \n\n[99] U. Gbureck, J.E. Barralet, K. Spatz, L.M. Grover, R. Thull, Ionic modification \n\nof calcium phosphate cement viscosity. Part I: hypodermic injection and strength \n\nimprovement of apatite cement, Biomaterials. 25 (2004) 2187-95. \n\n[100] L.M. Grover, U. Gbureck, A.J. Wright, J.E. Barralet, Cement formulations in \n\nthe calcium phosphate H2O\u2013H3PO4\u2013H4P2O7 system, J. Am. Ceram. Soc. 88 \n\n(2005) 3096-103. \n\n[101] M. Bohner, H.P. Merkle, P. Van Landuyt, G. Trophardy, J. Lemaitre, Effect of \n\nseveral additives and their admixtures on the physico-chemical properties of a \n\ncalcium phosphate cement, J. Mater. Sci. Mater. M. 11 (2000) 111-6. \n\n[102] E.F. Burguera, H.H.K. Xu, L.M. Sun, Injectable calcium phosphate cement: \n\nEffects of powder-to-liquid ratio and needle size 9, J. Biomed. Mater. Res. B. Appl. \n\nBiomater. 84B (2008) 493-502.  \n\n[103] M.P. Hofmann, A.M. Young, U. Gbureck, S.N. Nazhat, J.E. Barralet, FTIR-\n\nmonitoring of a fast setting brushite bone cement: effect of intermediate phases, J. \n\nMater. Chem. 16 (2006) 3199-206. \n\n[104] M.P. Ginebra, C. Canal, M. Espanol, D. Pastorino, E.B. Montufar, Calcium \n\nphosphate cements as drug delivery materials, Adv Drug Deliv Rev. 64 (2012) \n\n1090-110. \n\n[105] U. Joosten, A. Joist, T. Frebel, B. Brandt, S. Diederichs, C. von Eiff, \n\nEvaluation of an in situ setting injectable calcium phosphate as a new carrier \n\nmaterial for gentamicin in the treatment of chronic osteomyelitis: Studies in vitro \n\nand in vivo, Biomaterials. 25 (2004) 4287-95. \n\n\n\nCap\u00edtulo 1 \n\n 62 \n\n[106] S. Hesaraki, R. Nemati, Cephalexin-loaded injectable macroporous calcium \n\nphosphate bone cement, J. Biomed. Mater. Res. B. Appl. Biomater. 89B (2009) \n\n342-52. \n\n[107] S. Girod Fullana, H. Ternet, M. Freche, J.L. Lacout, F. Rodriguez, Controlled \n\nrelease properties and final macroporosity of a pectin microspheres-calcium \n\nphosphate composite bone cement, Acta Biomater. 6 (2010) 2294-300. \n\n[108] Y. Tahara, Y. Ishii, Apatite cement containing cis-diamminedichloroplatinum \n\nimplanted in rabbit femur for sustained release of the anticancer drug and bone \n\nformation, J. Orthop. Sci. 6 (2001) 556-65. \n\n[109] S. Panzavolta, P. Torricelli, B. Bracci, M. Fini, A. Bigi, Functionalization of \n\nbiomimetic calcium phosphate bone cements with alendronate, J. Inorg. Biochem. \n\n104 (2010) 1099-106. \n\n[110] http://www.bristolrad.com/vertebroplasty-radiology-bristol-farmington-ct.html, \n\nacesso em 18/11/ 2015. \n\n[111] M. Habib, G. Baroud, F. Gitzhofer, M. Bohner, Mechanisms underlying the \n\nlimited injectability of hydraulic calcium phosphate paste, Acta Biomater. 4 (2008) \n\n1465-71. \n\n[112] L. Leroux, Z. Hatim, M. Freche, J.L. Lacout, Effects of various adjuvants \n\n(lactic acid, glycerol, and chitosan) on the injectability of a calcium phosphate \n\ncement, Bone. 25 (1999) 31S-4S. \n\n[113] G. Baroud, E. Cayer, M. Bohner, Rheological characterization of \n\nconcentrated aqueous ?-tricalcium phosphate suspensions: The effect of liquid-to-\n\npowder ratio, milling time, and additives, Acta Biomater. 1 (2005) 357-63. \n\n[114] M. Bohner, G. Baroud, Injectability of calcium phosphate pastes, \n\nBiomaterials. 26 (2005) 1553-63. \n\n\n\nCap\u00edtulo 1 \n\n 63 \n\n[115] A. Fatimi, J.F. Tassin, J. Bosco, R. Deterre, M.A.V. Axelos, P. Weiss, \n\nInjection of calcium phosphate pastes: prediction of injection force and \n\ncomparison with experiments, J Mater Sci Mater Med. 23 (2012) 1593-603. \n\n[116] M Habib, G Baroud, F Gitzhofer, M Bohner, Mechanisms underlying the \n\nlimited injectability of hydraulic calcium phosphate paste. Part II: particle \n\nseparation study, Acta Biomater. 6 (2010) 250-6. \n\n[117] I. Khairoun, M.G. Boltong, F.C.M. Driessens, J.A. Planell, Some factors \n\ncontrolling the injectability of calcium phosphate bone cements, J Mater Sci Mater \n\nMed. 9 (1998) 425-8. \n\n[118] S. Sarda, E. Fernandez, M. Nilsson, M. Balcells, J.A. Planell, Kinetic study of \n\ncitric acid influence on calcium phosphate bone cements as water-reducing agent, \n\nJ Biomed Mater Res. 61 (2002) 653-9. \n\n[119] J.E. Barralet, L.M. Grover, U. Gbureck, Ionic modification of calcium \n\nphosphate cement viscosity. Part II: hypodermic injection and strength \n\nimprovement of brushite cement, Biomaterials. 25 (2004) 2197-203. \n\n[120] T.J. Brunner, R.N. Grass, M. Bohner, W.J. Stark, Effect of particle size, \n\ncrystal phase and crystallinity on the reactivity of tricalcium phosphate cements for \n\nbone reconstruction, J. Mater. Chem. 17 (2007) 4072-8. \n\n[121] ASTM, Standard Specification for Acrylic Bone Cement. ASTM F451: ASTM \n\nInternational, 2008. \n\n[122] C. Pittet, J. Lemaitre, Mechanical characterization of brushite cements: a \n\nMohr circles' approach, J. Biomed. Mater. Res. 53 (2000) 769-80. \n\n[123] A. Ueno, Y. Miwa, K. Miyoshi, T. Horiguchi, H. Inoue, I. Ruspita, et al., \n\nConstitutive expression of thrombospondin 1 in MC3T3-E1 osteoblastic cells \n\ninhibits mineralization, J. Cell. Physiol. 209 (2006) 322-32. \n\n[124] T. Kokubo, H. Takadama. How useful is SBF in predicting in vivo bone \n\nbioactivity? Biomaterials. 27 (2006) 2907-15. \n\n\n\nCap\u00edtulo 1 \n\n 64 \n\n[125] S. Bose, G. Fielding, S. Tarafder, A. Bandyopadhyay, Understanding of \n\ndopant-induced osteogenesis and angiogenesis in calcium phosphate ceramics, \n\nTrends Biotechnol. 31 (2013) 594-605. \n\n[126] S. Pina, S.I. Vieira, P. Rego, P.M.C. Torres, O.A.B. da Cruz e Silva, E.F. da \n\nCruz e Silva, et al., Biological responses of brushite\u2013forming Zn- and ZnSr- \n\nsubtituted beta-tricalcium phosphate bone cements, Eur Cell Mater. 20 (2010) \n\n162-77. \n\n[127] K.J. Lilley, U. Gbureck, J.C. Knowles, D.F. Farrar, J.E. Barralet, Cement \n\nfrom magnesium substituted hydroxyapatite. J Mater Sci Mater Med.;16 (2005) \n\n455-60. \n\n[128] L.M. Grover, U. Gbureck, A.J. Wright, M. Tremayne, J.E. Barralet, \n\nBiologically mediated resorption of brushite cement in vitro, Biomaterials. \n\n27 (2006) 2178-85. \n\n[129] M. Hamdan Alkhraisat, C. Moseke, L. Blanco, J.E. Barralet, E. Lopez-\n\nCarbacos, U. Gbureck, Strontium modified biocements with zero order release \n\nkinetics, Biomaterials. 29 (2008) 4691-7. \n\n[130] S. Kannan, F. Goetz-Neunhoeffer, J. Neubauer, J.M.F. Ferreira, Ionic \n\nsubstitutions in biphasic hydroxyapatite and beta-tricalcium phosphate mixtures: \n\nStructural analysis by rietveld refinement, J. Am. Ceram. Soc. 91 (2008) 1-12. \n\n[131] S. Saint-Jean, C. Camir\u00e9, P. Nevsten, S. Hansen, M. Ginebra, Study of the \n\nreactivity and in vitro bioactivity of Sr-substituted alpha-TCP cements, J Mater Sci \n\nMater Med. 16 (2005) 993-1001. \n\n \n\n\n\n  \n\n 65 \n\n \n\n \n\nCap\u00edtulo 2 \n\n \n\nInflu\u00eancia da dopagem de magn\u00e9sio, das \n\nimpurezas de pirofosfato de c\u00e1lcio e da taxa \n\nde arrefecimento sobre as transforma\u00e7\u00f5es de \n\nfase alotr\u00f3picas ???????????? do fosfato tric\u00e1lcico \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n  \n\n 66 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\nCap\u00edtulo 2 \n\n 67 \n\n \n\n \n\n \n\nInfluence of Mg-doping, calcium pyrophosphate impurities and \n\ncooling rate on the allotropic ???????????????? tricalcium phosphate phase \n\ntransformations \n\n \n\nP.M.C. Torres a,*, J.C.C. Abrantes a, b, Ajay Kaushal a, S. Pina \u00aa, N. D\u00f6belin c, \n\nM. Bohner c, J.M.F. Ferreira a \n\n \n\na Department of Materials and Ceramics Engineering, CICECO, University of Aveiro, \n\n3810-193 Aveiro, Portugal \n\nb UIDM, ESTG, Polytechnic Institute of Viana do Castelo, 4900 Viana do Castelo, Portugal \n\nc RMS Foundation, Bischmattstrasse 12, CH-2544 Bettlach, Switzerland \n\n \n\n \n\nJournal of the European Ceramic Society 36 (2016) 817-827 \n\ndoi: 10.1016/j.jeurceramsoc.2015.09.037 \n\n \n\n \n\n \n*Corresponding author. Tel.: +351 234 370261; fax: +351 234 370204. \n\n   E-mail address: ptorres@ua.pt (P.M.C. Torres). \n \n\n \n\n \n\n \n\n\n\nCap\u00edtulo 2 \n\n 68 \n\n \n\n \n\nAbstract \n\nAlpha and beta-tricalcium phosphates are allotropic phases which play a very \n\nimportant role as bone graft substitutes, namely in calcium phosphate cements. \n\nDespite extensive research efforts, contradictory reports exist on the importance of \n\nquenching for maintaining ?-TCP purity. The role of calcium pyrophosphate \n\nimpurities derived from a certain calcium-deficiency, hydroxyapatite impurities \n\nderived from calcium excess, and various ionic substitutions on thermal stability of \n\nthese phases was not yet fully disclosed. The present work reports on the kinetics \n\nof ???-TCP phase transformations of calcium-deficient TCP powders with \n\ndifferent Mg-doping extents (0?5 mol%) prepared by precipitation. Mg clearly \n\nenhanced the thermal stability of ?-TCP. The effect of cooling rate was more \n\ncomplex and interdependent on the Mg content and the heat treatment schedule. \n\nHigh ?-TCP contents were retained upon cooling at 5\u00baC min?1 for Mg ? 1 mol% or \n\nupon quenching from 1550\u00baC for Mg contents ? 2 mol%.  \n\n \n\nKeywords: Tricalcium phosphate; Calcium pyrophosphate; Mg substitution; \n\nPhase transition; Thermal stability  \n\n \n\n\n\nCap\u00edtulo 2 \n\n 69 \n\n1. Introduction \n\nCalcium phosphate (CaP) materials are among the most appropriate bone graft \n\nsubstitute materials due to their chemical similarity to the mineral part of bone [1]. \n\nSpecifically, these materials are biocompatible and osteoconductive [2, 3], being \n\nin most cases degraded by cells such as macrophages and osteoclasts [4, 5]. \n\nTricalcium phosphate (TCP, Ca3(PO4)2) is one of the CaP compounds significantly \n\nused for biomedical applications. It consists of three polymorphs, ?, ?, and ?\u2019 [6] \n\ndepending on the temperature. The low temperature ??TCP phase is stable from \n\nroom temperature (RT) up to 1125\u00baC and thereafter within the temperature range \n\nof 1125\u00baC to 1430\u00baC transforms reconstructively [7, 8] to stable ?-TCP phase that \n\ncan be maintained at RT as a metastable phase. At temperatures > 1430\u00baC until \n\n1765\u00baC, TCP shows stable ?\u2019-TCP phase that is unable to survive at RT [6, 9]. \n\nNowadays, ?-TCP and ?-TCP have received growing attention as raw materials \n\nfor bone repairing, being available in various forms such as granules, blocks and \n\nhydraulic calcium phosphate cements (CPCs) [10, 11]. Unlike ?-TCP, ?-TCP \n\npowder is much more soluble in water exhibiting hydraulic behaviour, explaining \n\nwhy it is often used in CPCs [12, 13]. \n\nLiterature survey reveals different methods to synthesize ??TCP in laboratory \n\n(using molar ratio Ca/P ? 1.5) including solid-state reaction method [14-20], or \n\nthermal transformation of a precursor [21-24]. The thermal ??TCP ? ??TCP phase \n\ntransformation is the most direct way to obtain ?-TCP [25] and is therefore also \n\napplied in this study. However, the synthesis of pure ??TCP is not easy and still \n\nnot fully understood [26]. Small fractions of other crystalline phases such as \n\n?-TCP [15, 17, 18, 21, 27] and/or hydroxyapatite (HA) [14, 18, 28] in the final \n\nproduct have been reported. The presence of ?-TCP was sometimes attributed to \n\na partial reversion during cooling of the already formed ?-TCP [15]. As the \n\npolymorphic ???-phase transformation is considered to be reconstructive \n\n[7, 8, 23], the reverse ????TCP transformation would require surpassing a \n\nconsiderable activation energy barrier to proceed [23]. Thus, reverting from \n\n????TCP should only be possible under a very slow cooling rate or a longue \n\n\n\nCap\u00edtulo 2 \n\n 70 \n\ndwell at temperature below the transformation temperature [29]. Even recognizing \n\nthe reconstructive character of this transformation, most researchers advocate the \n\nuse of quenching [16, 19, 20, 30] to produce ?-TCP and to avoid the ???-TCP \n\nreversion, whereas few reports suggest that a moderate cooling rate \n\n(5\u00baC min?1 [23, 31] and 10\u00baC min?1 [23, 32]) is sufficient to maintain ?-TCP purity. \n\nThe incorporation of some ions such as Sr, Zn and Mg in the TCP lattice alters the \n\nrelative stability of the ?- and ?-TCP polymorphs [9, 23, 31, 33-39]. Due to specific \n\nroles played by these elements in biological processes upon implantation [40-42], \n\ntheir presence in TCP is often intentional. The partial substitution of Mg for Ca in \n\nTCP increases the thermal stability of the ?-phase [9, 23, 31, 35, 39, 43]. \n\nRecently, Carrodeguas et al. [23, Anexo 1.1] presented a new phase diagram for \n\nMg3(PO4)2 ? Ca3(PO4)2 system, different from the previously reported one by \n\nEnderle et al. [31, Anexo 1.2] in which a single phase boundary line was drawn \n\nbetween pure ?-TCP and pure ?-TCP phases. According to this new phase \n\ndiagram [23], a biphasic field ? + ?-TCP exist during thermal transformation of ?-\n\nTCP to ?-TCP at TCP rich zone. Therefore, the presence of a ?-TCP fraction in ?-\n\nTCP sample can be due to a sintering temperature lying in the range of the solid \n\nsolution. The authors showed that for TCP containing up to 1 mol% Mg no \n\nquenching was required for retaining the pure ?-TCP [23]. However, the solidus \n\nboundary between ?-TCP and a mixture of ?-TCP and ?-TCP was raised from \n\n1115 \u00baC to 1400 \u00baC upon increasing the Mg content from 0 to 5 mol% [23]. \n\nTherefore, it is likely that the kinetics of the ?-TCP ? ?-TCP conversion is affected \n\nby the Mg content. In addition, ?-TCP phase purity has also been reported to be \n\naffected by small variations of Ca/P ratio during its synthesis. Several phase \n\nequilibrium diagrams of CaO\u2013P2O5 system have been proposed [44-47]. The most \n\nrecent ones include Kreidler and Hummel [45, Anexo 2] using anhydrous \n\nconditions and Riboud [46, Anexo 3] in presence of H2O. Accordingly, when \n\nprocessed in hydrous condition, a slight variation (positive or negative) in \n\nstoichiometric ratio (Ca/P = 1.50), involuntary or intentional, lead to formation of \n\nTCP with minor amounts of HA (positive variation) or calcium pyrophosphate \n\n(CPP) (negative variation). CPP impurity is known to strongly effect ???-TCP \n\n\n\nCap\u00edtulo 2 \n\n 71 \n\nphase transition. Bohner et al. [32] showed that small amounts of CPP reduced \n\nthe ?-TCP purity; Welch and Gutt [44] observed an acceleration on the ??? \n\nphase transition in the presence of CPP. In these studies, as well as in the \n\nremaining available literature, no reasonable hypothesis has been advanced to \n\nexplain the effects exerted by the presence of small amounts of CPP in ??? \n\nphase transition and in the composition of the final products. Therefore, one aim of \n\nthe present study was filling this gap and shedding further light on the influence \n\nexerted by small amounts of CPP (induced by a certain calcium-deficiency of the \n\nstarting powders [(Ca+Mg)/P ? 1.485?1.490] on the kinetics of the ?-TCP ? ?-\n\nTCP phase transformation. Investigating the effects of cooling rate and of Mg-\n\ndoping extent on the thermal stability of ???-TCP phases were other intended \n\ntargets.  \n\n \n\n2. Materials and methods \n\n2.1 Powder synthesis \n\nMg-substituted ?-Ca3(PO4)2 powders with different Mg contents (0?5 mol%), \n\nhereafter designated as Mg0?5TCP, were synthesized and investigated. The \n\npowders were prepared by an aqueous precipitation method described by Kannan \n\net al. [48] after some modifications reported elsewhere [49]. The significance of \n\nthe aqueous precipitation method relies on the homogeneous mixture of the final \n\nproduct, making this method reliable for the production of powders. Briefly, \n\ncalcium nitrate tetrahydrate [Ca(NO3)?4H2O, Sigma?Aldrich], diammonium \n\nhydrogen phosphate [(NH4)2HPO4, Sigma?Aldrich] and magnesium nitrate \n\nhexahydrate [Mg(NO3)2?6H2O, Sigma?Aldrich] were used as starting chemical \n\nprecursors, respectively for calcium, phosphorus and magnesium. The planned \n\nconcentrations of Mg are depicted in Table 1 and the precursors were selected in \n\nsuch a way to keep the total molar ratio (Ca+Mg)/P = 1.500 for all compositions.  \n\n\n\n \n\n \n\nC\na\np\n\u00edtu\n\nlo\n 2\n\n \n\n7\n2\n \n\n \n\n \n\n \n\nTable 1. The planned and experimentally obtained (from elemental ICP analysis) compositions, quantitative phase analysis, lattice parameters and \n\ncalculated cell volumes obtained by Rietveld refinement for ?-tricalcium phosphate (?-TCP). 95% repeatability limits of the phase quantification should \n\nbe considered to be close to \u00b1 1% [50]. \n\n \n\n \n\n \n\n  \n\n \n\nPlanned compositions \nExperimental compositions \n(from elemental analysis) \n\n(\u00b1 0.03) \n\nwt.% of phase \ncomposition \n\n(\u00b1 1) \n\nLattice parameters \n(\u00c5) \n\nSample \nCode Ca/P \n\nmolar \nratio \n\n(Ca+Mg)/P \nmolar \nratio \n\nConc. of \nMg \n\n(mol%) \n\nCa/P \nmolar \nratio \n\n(Ca+Mg)/P \nmolar  \nratio \n\nConc. \nof Mg \n(mol%) \n\n????-TCP ????-CPP \na-axis \n\n(\u00b1 0.0004) \nc-axis \n\n(\u00b1 0.0004) \n\nCell \nvolume \n\n(\u00c53) \n(\u00b1 0.04) \n\nMg0TCP 1.500 1.500 0.00 1.484 1.484 0.04 96.0 4.0 10.4422 37.3952 3531.25 \n\nMg1TCP 1.480 1.500 1.00 1.476 1.492 1.07 98.2 1.9 10.4300 37.3822 3521.78 \n\nMg2TCP 1.470 1.500 2.00 1.460 1.491 2.05 97.9 2.1 10.4159 37.3587 3510.04 \n\nMg5TCP 1.420 1.500 5.00 1.412 1.492 5.36 98.0 2.0 10.3804 37.2720 3478.08 \n\n\n\nCap\u00edtulo 2 \n\n 73 \n\nThe synthesis of the powders was performed at 30\u00baC and a target pH ~6.5 \n\n(adjusted by adding ammonium hydroxide, NH4OH). The experimental pH values \n\nranged within 6-7. The precipitated suspensions were kept under constant stirring \n\n(700 rpm) for 3 h and then ripened for further 15 h under resting conditions. These \n\nexperimental synthesis conditions (temperature, pH, stirring conditions, maturation \n\ntime) were adjusted to favour the formation of a small amount of CPP [51]. The \n\nresulting precipitates were vacuum-filtered (without washing) and then dried at \n\n100\u00baC during 48 h. The dried cakes were ground to fine powders and sieved \n\nthrough a mesh size of 200 \u00b5m.  \n\nThe as obtained powders were heat treated at 800\u00baC in a Thermolab furnace \n\n(Pt30%Rh/Pt6%Rh-thermocouple) with a heating rate of 5\u00baC min?1 and a dwelling \n\ntime for 2 h to obtain undoped and Mg-doped ?-TCP. This heating schedule was \n\nshown to be suitable for the intended purposes [48] and the resulting powders, \n\nhereafter referred to as starting Mg0?5TCP powders, were well ground and sieved \n\nthrough a mesh size of 40 \u00b5m and stored for further characterization studies. \n\n \n\n2.2 Powders characterization \n\nThe powders were submitted to a range of tests including inductively coupled \n\nplasma spectrometry (ICP-OES), Fourier Transform Infrared Spectrometry (FTIR), \n\ndifferential scanning calorimeter (DSC), high-temperature X-ray powder \n\ndiffractometer (HT-XRD), and room-temperature XRD. Table 2 summarises all the \n\ncharacterisation experiments performed. More details on the various investigations \n\nare given in the next paragraphs. \n\nICP-OES ? Elemental (Mg, Ca and P) analysis was performed using ICP-OES \n\n(Jobin Yvon Activa M., USA). For this purpose, the required amount of each \n\nstarting powder was dissolved in nitric acid (HNO3) prior to ICP analysis.  \n\n \n\n \n\n\n\n \n\n \n\nC\na\np\n\u00edtu\n\nlo\n 2\n\n \n\n7\n4\n \n\n \n\n \n\nTable 2. Overview of the heating and cooling experiments performed on the starting powders (heat treated at 800\u00baC). The powders were characterized \n\nby ICP and Rietveld refinement (Table 1), XRD (Fig. 1) and FTIR (Fig. 2). The heating rate was fixed at 10\u00baC min?1 for all samples. Some experiments \n\nwere conducted without dwell time (*). \n\nMethod Powder(s) Calcination Temperature \n(\u00baC) \n\nDwell \ntime \n(h) \n\nCooling \n(\u00b0C min-1) \n\nReplicates \nResults in \nFig/Table \n\nMg0TCP 1550  * 5, 10, 20  n = 1 Fig. 3 \n\nn = 3 \n(heating) DSC \n\nMg0?5TCP 1550  * 10  \nn = 1 \n\n(cooling) \n\nFig. 6 \n\nXRD on DSC \nsamples \n\n(after cooling) \nMg0?5TCP 1550  * 5, 10, 20  n = 1 Table 3 \n\nHT-XRD Mg0TCP 1350 * 5 n = 3 Fig. 4 \n\nMg0?5TCP 1550 2 and 24 \nQuenching in \nH2O \n\nn = 3 Fig. 6 \n\nMg0TCP 1250, 1350,1550 2 5, 13 n = 3 Fig. 5, Fig. 7 \nXRD \n\nMg0?5TCP 1550 2 5, 13 n = 3 Fig. 7 \n\n \n\n \n\n\n\nCap\u00edtulo 2 \n\n 75 \n\nFTIR ? Infrared spectra were obtained by FT-IR (model Mattson Galaxy S-7000, \n\nUSA). Each starting powder was mixed with KBr in the proportion of 1/150 (by \n\nweight) for 15 min and pressed into a pellet. Each infrared spectrum was the \n\naverage of 32 scans collected at 2 cm\u20131 resolution at room temperature (RT).  \n\nDSC ? The thermal behaviour of the starting Mg0?5TCP powders was \n\ninvestigated using DSC (Setsys Evolution 16, Setaram) in O2 atmosphere, using a \n\nsample mass within the range of 20.5\u201322.5 mg. The samples were tested in \n\ntriplicate on heating from RT up to 1550\u00baC at 10\u00baC min?1 to check for \n\nreproducibility of the results. Without dwell time at the maximum temperature, the \n\ncooling from 1550 \u00baC to 200 \u00baC was carried out at different rates of 5, 10 and 20\u00baC \n\nmin?1. Based on the good reproducibility of the measurements on heating and \n\nconsidering the limited access to the equipment, only one test per sample was \n\nmade on cooling. The as obtained results were complemented with other data \n\ngathered by other characterization techniques. After DSC experiments, the \n\nsamples were analysed by XRD and quantitative phase analyses. \n\nHT-XRD ? The Mg0TCP polymorphic transitions were examined by HT-XRD \n\n(Philips X'Pert, model MPD equipped with Ni-filtered CuK? radiation). The \n\ninstrument was used in the temperature-programmed heating mode within the \n\ntemperature range of 30 ? 1350\u00baC, at heating and cooling rates of 10\u00baC min?1 and \n\n5\u00baC min?1, respectively. X-ray diffraction patterns were acquired in the 2? range of \n\n10 ? 115o (step size 0.02o, time per step 1 s) at different temperatures: (1) at 30\u00baC; \n\n(2) temperatures in the ranges of 800 ? 1350\u00baC (heating) and of 1350 ? 600\u00baC \n\n(cooling), and at 30\u00baC after cooling.  \n\nXRD and Rietveld refinement ? Considering the temperature limitations of in situ \n\nhigh-temperature X-ray diffraction technique and in order to compare with the \n\nquantitative analysis of the samples submitted to DSC experiments under similar \n\ncooling rates, complementary heat treatment tests were carried out to assess the \n\nphase transformations. Batches of ~0.5 g of undoped (Mg0TCP) and doped \n\n(Mg1?5TCP) powders were subjected to different heat treatment schedules in a \n\nThermolab bottom loading furnace:  \n\n\n\nCap\u00edtulo 2 \n\n 76 \n\n(i) heating Mg0?5TCP powders at 10\u00baC min?1 up to 1550\u00baC, holding at this \n\ntemperature for 2 h and 24 h, and then quenching (putting the crucible containing \n\nthe powder in cold H2O without wetting the powder) to stabilize the phase(s) \n\nformed at high temperature. As will be later shown and discussed, a dwell time of \n\n2 h revealed to be enough to stabilize ??phase at 1550\u00baC. Accordingly, a dwell \n\ntime of 2 h was used in all the remaining heat treatments;  \n\n(ii) heating undoped (Mg0TCP) powder at 10\u00baC min?1 up to 1250\u00baC, 1350\u00baC and \n\n1550\u00baC, holding for 2 h at maximum temperatures and then cooling at different \n\nrates of 5 and 13\u00baC min?1 for phase quantification analysis. The aim was to \n\nquantitatively investigate the effects of the maximum temperature and cooling rate \n\non the contents of the phases. \n\n(iii) heating doped (Mg1?5TCP) powders at 10\u00baC min?1 up to 1550\u00baC, holding for \n\n2 h at this temperature, and then cooling under different rates of 5 and 13\u00baC min?1. \n\nThe aim was to quantitatively investigate the effects of the Mg-doping extent and \n\ncooling rate on the contents of the obtained phases.  \n\nQualitative and quantitative phase analyses - Qualitative and quantitative phase \n\nanalyses were performed for Mg0?5TCP powders submitted to different heat \n\ntreatment schedules by combining X-ray diffraction (XRD) with Rietveld \n\nrefinement. A conventional Bragg-Brentano diffractometer (Philips PW 3710, \n\nEindhoven, The Netherlands) with Ni-filtered Cu-Ka radiation was used to record \n\nthe X-ray diffraction data within the 2?  range = 4 ? 70o (step size 0.02o and 50 s \n\nof counting time for each step). The software TOPAS version 4.2 (Bruker AXS, \n\nKarlsruhe, Germany) with the fundamental parameters approach was used for \n\nRietveld refinements using the structural model of ICDD cards numbers of # \n\n04-014-2292 for ?-TCP, # 04-009-3876 for ?-CPP, # 04-009-2362 for ?-CPP and \n\n# 040-001-4348 for ?-TCP. The XRD data for Mg0TCP (without any added Mg) \n\nwas refined assuming the space group R3c and structural parameters reported by \n\nYashima et al. [52]. The calculated unit cell parameters were a = b = 10.442 \u00c5, \n\nc = 37.395 \u00c5, ? = ? = 90 \u00ba, and ? = 120 \u00ba. The refined values for Mg0TCP were \n\ntaken as starting values to refine Mg-substituted ?-TCP powders. Refined \n\n\n\nCap\u00edtulo 2 \n\n 77 \n\nparameters were scale factor, specimen displacement, and background as \n\nChebyshev polynomial of fifth grade and 1/x function, and lattice parameters. \n\nCorundum (NIST SRM 676a) was added to all heat treated samples (except the \n\nones used in the DSC experiments) as an internal standard for the purpose of \n\nevaluating the presence of amorphous phase and to quantify it. The mixtures were \n\nground in an agate mortar and sieved through a mesh of 40 \u00b5m in order to \n\nhomogenize the samples and minimise the problems due to non-random \n\norientations. The phase fractions extracted by Rietveld refinements were rescaled \n\non the basis of the absolute weight of corundum originally added to their mixtures \n\nas an internal standard, and therefore, internally renormalized. \n\nExcept for samples derived from DSC tests, the XRD and quantitative phase \n\nanalyses were repeated three times in three independent samples for all the \n\ninvestigated compositions. The results of Rietveld phase analysis are expressed \n\nas means \u00b1 standard deviations. \n\nStatistical analysis \u2013 the results were analysed as factorial design of experiments. \n\nThe investigated factors are the cooling rate and the Mg content. Results were \n\nconsidered to be significant at p<0.01. \n\n \n\n3. Results \n\n3.1 Influence of Mg-doping on the characteristics of starting powders  \n\nTable 1 presents the planned and experimentally obtained (from elemental ICP \n\nanalysis) (Ca+Mg)/P and Ca/P molar ratios, and the Mg contents of the \n\nMg0?5TCP powders. A relatively close match was observed between \n\nexperimental and planned (Ca+Mg)/P and Ca/P molar ratios, the former ones \n\ntending to be slightly smaller (Table 1). The XRD patterns of the Mg0?5TCP \n\npowders heat-treated at 800\u00baC are displayed in Fig. 1.  \n\n \n\n \n\n\n\nCap\u00edtulo 2 \n\n 78 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 1.  (a) X-ray diffraction patterns of undoped (Mg0TCP) and Mg-doped (Mg1?5 TCP) starting ?-\n\nTCP powders (heat treated at 800\u00baC); (b) Zoomed area of Fig. 1a within the 2? range from 26?32\u00ba \n\nto show the effect of Mg incorporation on shifting the XRD peaks to higher 2? angles. The standard \n\nJCDD PDF 04-008-8714 of pure ?-TCP is also presented for comparison.  \n\n \n\nOnly ?-TCP diffraction peaks were detected. However, the results of quantitative \n\nphase analysis presented in Table 1 show that all ?-TCP powders contain the \n\n\n\nCap\u00edtulo 2 \n\n 79 \n\nintended traces amounts of ?-CPP. These results are consistent with the FT-IR \n\nspectra presented in Fig. 2.  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 2. FT-IR spectra of undoped (Mg0TCP) and Mg-doped (Mg1?5 TCP) starting ?-TCP powders \n\n(heat treated at 800\u00baC). \n\n \n\nThe characteristic vibrational modes of PO4 tetrahedra confirm the formation of \n\n?-TCP phase as the predominant crystalline phase. Other very small absorption \n\nbands observed at 728 cm\u20131 at 1210 cm\u20131 can be attributed to the presence of \n\npyrophosphate groups (P2O7\n4\u2013) and in particular to P\u2013O\u2013P bonds. Rietveld \n\nrefinement of Mg0?5TCP powders revealed a clear decreasing trend of the lattice \n\nparameters a-axis and c-axis, and consequently, of the cell volume with increasing \n\nincorporated amounts of Mg (Table 1). This is consistent with the shift of XRD \n\npeaks to higher 2? angles with Mg-doping observed in Fig. 1b.  \n\n\n\nCap\u00edtulo 2 \n\n 80 \n\n3.2 Thermal behaviour of Mg0TCP  \n\nA detailed analysis of the thermal behaviour of non-doped (Mg0TCP) sample is \n\nessential to then understand the effects of Mg-doping on the \n\n?-TCP??-TCP??-TCP phase transformation in presence of small content of \n\nCPP. Table 2 summarizes the characterization techniques and the experimental \n\nconditions used to assess the thermally induced changes, indicating where data \n\nare reported. The results DSC analysis collected at a fixed heating rate of \n\n10\u00baC min?1 and different cooling rates of 5, 10 and 20\u00baC min?1 are shown in Fig. 3, \n\nwhile the quantitative phase analysis data obtained by XRD and Rietveld \n\nrefinement performed in the samples retrieved from DSC experiments are \n\nreported in Table 3.  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 3. Normalized thermograms of Mg0TCP obtained at a fixed heating rate of 10\u00baC min?1 and \n\ncooled under different rates of 5, 10 and 20\u00baC min?1. \n\n\n\nCap\u00edtulo 2 \n\n 81 \n\nTable 3. Quantitative phase analysis data (wt.%) obtained by Rietveld refinement of Mg0?5TCP \n\npowder samples collected after DSC experiments in O2 controlled atmosphere: heated up to \n\n1544\u00baC at 10\u00baC min?1 and cooled under different cooling rates (5, 10 and 20\u00baC min?1). 95% \n\nrepeatability limits of the phase quantification should be considered to be close to \u00b11% [50]. Values \n\nbelow 0.2% were considered as \u201cnon-detectable\u201d (n.d.). Amorphous phases were not quantified \n\n(n.q.). Per condition, three measurements were performed on heating and one on cooling. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nThe DSC thermograms show three main endothermic events within the \n\ntemperature range of 1150\u20131550\u00baC, namely centred at 1182.4 \u00b1 0.4 \u00baC, \n\n1286.1 \u00b1 0.3 \u00baC and 1476.2 \u00b1 0.4 \u00baC (Fig. 3). On cooling, the intense exothermic \n\npeak/band observed at ~1450\u00baC for the cooling rate of 20\u00baC min?1 seems to result \n\n  Cooling rate (\u00baC min????1) \nSamples \n\n \nphases \n\n 5 10 20 \n\n ????????TCP  3 9 31 \n\n ????????TCP  96 90 65 \n\n ????????CPP &lt;1% n.d. 4 \n\n ????????CPP  n.d. 1 n.d. \n\nMg0TCP \n\n Amorphous  n.q. n.q. n.q. \n\n ????????TCP  71 76 70 \n\n ????????TCP  27 20 29 \n\n ????????CPP  2 3 1 \n\n ????-CPP  n.d. n.d. n.d. \n\nMg1TCP \n\n Amorphous  n.q. n.q. n.q. \n\n ????????TCP  97 96 97 \n\n ????????TCP  1&lt;1%&lt;1% \n\n ????????CPP  2 2 2 \n\n ????????CPP &lt;1%&lt;1%&lt;1% \n\nMg2TCP \n\n Amorphous  n.q. n.q. n.q. \n\n ????????TCP  91 94 96 \n\n ????????TCP  2 4 2 \n\n ????????CPP  4 1&lt;1% \n\n ????????CPP  3 n.d. 1 \n\nMg5TCP \n\n Amorphous  n.q. n.q. n.q. \n\n\n\nCap\u00edtulo 2 \n\n 82 \n\nfrom two almost superimposed events. As the cooling rate decreased, these two \n\nevents tended to appear at slightly higher temperatures and with a decreasing \n\nintensity, features that can be more easily seen in the zooms inserted in Fig. 3. \n\nAnother exothermic broad effect centred at about 1395\u00baC was registered for the \n\ncooling rate of 20\u00baC min?1, which apparently shifted to 1201\u00baC under cooling at \n\n10\u00baC min?1. Only the high temperature peak remained with further decreasing the \n\ncooling rate to 5\u00baC min?1.  \n\nComplementary HT-XRD analysis performed within the range of 30?1350\u00baC \n\nconfirmed that up to 800\u00baC the Mg0TCP sample consists of ?-TCP (Fig. 4a).  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 4. In situ collected X-ray diffraction patterns of Mg0TCP at different temperatures up to \n\n1350\u00baC: (a) under a heating rate of 10\u00baC min?1; (b) Zoomed diffractograms obtained at 1200, 1300 \n\nand 1350\u00baC (dotted line box) to better reveal the low intensity peaks; (c) under a cooling rate of \n\n5\u00baC min?1. The standard files of pure ??TCP (JCDD PDF 04-008-8714) and pure  ??TCP (JCDD \n\nPDF 04-010-4348) are also presented for comparison purposes. \n\n\n\nCap\u00edtulo 2 \n\n 83 \n\nThis ?-TCP phase still predominates at 1150\u00baC, with ?-TCP appearing as \n\nsecondary phase. Further increasing the temperature to 1200\u00baC caused a drastic \n\nchange in the XRD spectrum due to the predominance of ?-TCP over the ?-TCP. \n\nBetween 1200 and 1350\u00baC the sample became enriched in ?-TCP and only a \n\nsmall amount of ?-TCP could be detected (Fig. 4b). The above referred phase \n\ntransformations tend to be partially reversed upon cooling as revealed in Fig. 4c. \n\nTo shed further light on the origin of the thermal events observed in Fig. 3 (around \n\n1200\u00baC, 1300\u00baC, and 1450\u00baC), the Mg0TCP was dwelled for 2 h at 1250\u00baC, \n\n1350\u00baC and 1550\u00baC and then cooled at either 5\u00baC min?1 or 13\u00baC min?1 and \n\nanalysed by XRD analysis (Fig. 5).  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 5. X-ray diffraction patterns of the starting Mg0TCP powder (800\u00baC), and after further heat \n\ntreatments at 1250\u00baC, 1350\u00baC and 1550\u00baC (heating rate = 10\u00baC min?1, dwell time of 2 h at \n\nmaximum temperatures followed by cooling under different rates of 5\u00baC min?1 and 13\u00baC min?1). The \n\nstandard files of pure ??TCP (JCDD PDF 04-008-8714) and pure ??TCP (JCDD PDF 040-001-\n\n4348) are also presented for comparison purposes. \n\n\n\nCap\u00edtulo 2 \n\n 84 \n\nThe results of quantitative phase analysis of these samples are displayed in Fig. 6.  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 6. Quantitative phase analysis data (wt.%) obtained by Rietveld refinement of Mg0TCP \n\npowder heat treated at 10\u00baC min?1 up to 1250\u00baC and 1350\u00baC, and of Mg0?5TCP powders heat \n\ntreated at 10\u00baC min?1 up to 1550\u00baC, hold at the maximum temperature for 2 h, followed by \n\ncontrolled cooling rates (5 and 13\u00baC min?1). Similar data were gathered for the same samples \n\nsubmitted to the same heating schedule but hold for 2 h and 24 h at the maximum temperature, \n\nfollowed by quenching.  \n\n \n\nIt can be seen that upon heat treating at 1250\u00baC and 1350\u00baC ?-TCP was partially \n\ntransformed into ?-TCP and an amorphous phase, while the sample heat treated \n\nat 1550\u00baC consisted mostly of ?-TCP. There were only remnants of ?-TCP (better \n\nnoticed under faster cooling, Figs. 5 &amp; 6) and small amounts ?-CPP, ?-CPP, and \n\namorphous phase (Fig. 6). Higher amount of ?-TCP seems to be retained under a \n\nfaster cooling rate from 1250\u00baC (p<0.01) while a surprisingly opposite result was \n\n\n\nCap\u00edtulo 2 \n\n 85 \n\nobtained upon cooling from 1350 and 1550 \u00baC (p<0.01), i.e. an increase of cooling \n\nrate led to a decrease of ?-TCP content. This is also consistent with data obtained \n\nfrom DSC experiments (no dwell time) in Table 3. Fig. 6 also displays the \n\nquantitative phase analyses performed after dwelling the Mg0TCP sample for 2 \n\nand 24 h at 1550\u00baC, and subsequent quenching. After 2 h at 1550\u00baC the sample \n\nconsisted of ?-TCP and ~29 % of amorphous phase. The amount of ?-TCP \n\ndecreased and the amorphous phase increased upon prolonging dwelling time to \n\n24 h.  \n\n \n\n3.3 Influence of Mg-doping on thermal behaviour \n\nThe DSC thermograms collected upon heating and cooling at 10\u00baC min?1 of the \n\nMg0?5TCP powders are presented in Fig. 7. All samples exhibit small \n\nendothermic peaks close to 1290\u00baC and 1480\u00baC during heating. The peak seen \n\nfor Mg0TCP at ~1182\u00baC was not observed in the other samples. Upon cooling, \n\ntwo exothermic peaks were detected. Their position varied as a function of Mg \n\ncontent. Specifically, the temperature of the lowest peak increased from 1201\u00baC to \n\n1384 \u00baC with increasing Mg content, whereas the opposite trend was observed for \n\nthe highest temperature peak, dropping from 1460\u00baC for Mg0TCP down to 1416\u00baC \n\nfor Mg5TCP.  \n\nFig. 6 shows that the phase compositions of the Mg0?2TCP samples quenched \n\nfrom 1550\u00baC after a dwell time of 2 h are very similar, consisting essentially of ?-\n\nTCP and ~26?27% of amorphous phase. After the longer dwelling time (24 h) the \n\namount of ?-TCP decreased while the amorphous phase increased. In contrast, \n\nafter a dwell time of 2 h at 1550\u00baC the Mg5TCP sample is mostly constituted by \n\n??TCP and amorphous phase, the content of the later further increased at the \n\nexpenses of ??TCP after 24 h dwell time. \n\n \n\n \n\n\n\nCap\u00edtulo 2 \n\n 86 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 7. Normalized complete thermograms of the studied powders gathered at a heating/cooling \n\nrate of 10 \u00baC min?1 in O2 atmosphere. Some parts of heating (black) and cooling (red) branches \n\n(dotted line boxes) were zoomed up to better illustrate the thermal effects. The peaks observed \n\nupon heating are also shown in insets (solid line boxes) for better illustrations. The curve of \n\nMg0TCP (Fig. 3) is presented again for comparison. \n\n \n\n\n\nCap\u00edtulo 2 \n\n 87 \n\nThe XRD Rietveld refinement analysis of the DSC samples after cooling at 5, 10 \n\nor 20\u00baC min?1 showed that the Mg-free sample (Mg0TCP) consisted mostly of \n\n?-TCP (Table 3). However, almost 100% ?-TCP was detected with as little as \n\n2 mol% Mg (Mg2TCP). In Fig. 6, an increase of cooling rate from 5 to 13\u00baC min?1 \n\nled to a decrease of ?-TCP and amorphous phase content (p<0.01) for the \n\nsamples treated at 1550\u00baC. Finally, the comparison of the results obtained upon \n\nquenching and under controlled cooling at 5\u00baC min?1 and 13\u00baC min?1 (Fig. 6) \n\nrevealed a very complex interplay between cooling rate and Mg content: at low \n\nand high Mg contents, the cooling rate hardly affected the outcome, i.e. almost \n\npure ?-TCP or ?-TCP were obtained. However, keeping high amount of ?-TCP in \n\nMg2TCP sample was only possible upon quenching. Furthermore, cooling \n\nMg1TCP sample at 13\u00baC min?1 minimized the ?-TCP content compared to a lower \n\n(5\u00baC min?1) and higher (quenching) cooling rate.  \n\n \n\n4. Discussion \n\n4.1 Influence of Mg-doping on the characteristics of the Mg0????5TCP powders  \n\nThe predominance of ?-TCP phase in the starting powders (Fig. 1) is in close \n\nagreement with findings reported in previous studies [48, 49, 53] for aqueous \n\nprecipitated powders. The presence of small amounts of CPP helps explaining the \n\nnon-apparent detection of CPP peaks in the XRD patterns (Fig. 1). Another \n\ncontributing factor is the superposition of its most intense diffraction line at \n\n2? = 29.6\u00ba with a peak of ?-TCP. The second most intense peak of CPP (relative \n\nintensity 45%) at 2? = 28.9\u00ba could no more be observed below 4 wt.% [51, 54]. \n\nThe elementary analysis data presented in Table 1 reveal that Mg was readily \n\nincorporated into the ?-TCP structure. This is confirmed by the decrease of Ca/P \n\nmolar ratio, while the (Ca+Mg)/P ratio was kept almost constant. Accordingly, \n\nthere is a good coincidence between the planned and the experimentally \n\ndetermined values. The small systematic deviation between the planned of \n\n(Ca+Mg)/P = 1.5 and the measured values near 1.49 can be attributed to slight \n\n\n\nCap\u00edtulo 2 \n\n 88 \n\nexperimental fluctuations of pH (within the range of 6?7) during the overall \n\npreparation period (~18 h) of powders at 30\u00baC. Destainville et al. [51] underlined \n\nthe need of an accurate control of the entire set of experimental parameters during \n\nTCP synthesis. According to them, at least 10 h maturing must be imposed to \n\nensure reproducible synthesis of apatitic precursors of pure TCP at 30\u00baC, pH = 7. \n\nDeviations of one pH unit from the ideal value (pH = 7) i.e., pH 6 or pH 8, resulted \n\nin Ca/P molar ratios of 1.48 or 1.51, respectively. The obtained (Ca+Mg)/P molar \n\nratios slightly below the planned stoichiometric value of 1.5 justify the formation of \n\nCPP traces [45, 46, 51, 54-56], as confirmed by the FT-IR absorption bands at \n\n728 cm\u20131 and 1210 cm\u20131 (Fig. 2) and by the quantitative phase analysis data \n\nreported in Table 1. The most and the least intense FT-IR bands observed for \n\nMg0TCP and Mg1TCP, respectively, are consistent with the calculated higher and \n\nthe smaller amounts of ?-CPP.  \n\nThe refinement of XRD data for Mg0TCP (Table 1) is in good agreement with the \n\nunit cell parameters reported by Yashima et al. [52]. The decreasing trends \n\nobserved for unit cell parameters in doped Mg1?5TCP powders (Table 1) \n\nconstitute further confirmation that Mg was incorporated in Ca sites in ?-TCP \n\nstructure [31, 49]. This can be understood considering the smaller ionic radii of \n\nMg2+ (0.72 \u00c5 for eightfold coordination with O) in comparison with Ca2+ (1.00 \u00c5 for \n\neightfold coordination with O) [31, 48, 53, 57].  \n\n \n\n4.2 The thermal behaviour of Mg0TCP \n\nThe first endothermic event recorded for Mg0TCP upon heating, centred at \n\n1182.4 \u00b1 0.4 \u00baC (Fig. 3) may be attributed to the ??? transitions of ?-TCP and ?-\n\nCPP. The ??? phase transition temperatures for CPP and TCP are still \n\ncontroversial and might depend on specific preparation conditions. For ?-CPP, the \n\ntransformation has been reported to occur at 1140\u00baC [44] or at 1181\u00baC [56], while \n\nthe ???-TCP polymorphic phase transition might occur within a wider range of \n\ntemperatures, 1115\u00baC [23], 1125\u00baC [44], 1135\u00baC [45], 1150\u00baC [31, 51], \n\n\n\nCap\u00edtulo 2 \n\n 89 \n\n1160\u00baC [58]. Moreover, the presence of CPP delays the ???-TCP phase \n\ntransition to higher temperatures: Ryu et al. [59] showed that 3 wt.% of CPP \n\ndelayed the transition by 50\u00baC. The existence of a single endothermic peak \n\ncentred at ~1182\u00baC suggests that the thermal effects of ???  transitions of ?-TCP \n\nand ?-CPP might be superimposed due to the delayed transformation of \n\n???-TCP. This is consistent with the presence of ~4% CPP (Table 1). The results \n\nshown in Fig. 4a demonstrate that most of the ???-TCP phase transformation \n\noccurred within the range of 1150?1200\u00baC confirming that the endothermic effect \n\nregistered at ~1182\u00baC (Fig. 3) is due to ???  transition.  \n\nThe second endothermic effect registered upon heating within the temperature \n\nrange of 1280\u20131300\u00baC (Fig. 3) consists of a main peak centred at 1286.1 \u00b1 0.3 \u00baC \n\nand a small one at 1297 \u00b1 0.6 \u00baC. The first one coincides with the eutectic \n\nreported for the TCP\u2013CPP system [45] or in the close neighbourhood (1280\u00baC \n\n[51, 56, 59], and 1300\u00baC [45]) and is likely to represent a melting event. The small \n\nendothermic peak at about 1297\u00baC might be due to the crossing of liquidus curve \n\nas referred to by Maciejewski et al. [56], being corroborated by the presence of \n\ntraces of CPP (Fig. 2 and Table 1). The third endothermic peak centred at \n\n1476.2 \u00b1 0.4 \u00baC was preceded by a small shoulder at ~1463.9 \u00b1 0.9 \u00baC, pointing \n\nout to two concomitant thermal events. One of them certainly involves the \n\nmonoclinic ?-TCP ? trigonal ?\u00b4-TCP polymorphic phase transition [23, 24, 44], \n\nwhich has been reported to occur above 1430\u00baC [44], at 1465\u00baC [23], at \n\n1475\u00baC [46] and between 1458\u00baC and 1508\u00baC [24]. The other can be related to \n\nthe formation of a liquid phase. In fact, in the presence of CPP, the peak centred \n\nat ~1476\u00baC and the small shoulder at ~1464\u00baC are most likely linked to the ?-TCP \n\n+ liquid ? ?\u00b4-TCP + liquid transformation reported to occur at 1472 \u00baC and \n\n1475\u00baC according to the TCP?CPP phase diagram published by Welch and \n\nGutt [44] and Riboud [46], respectively. \n\nUpon cooling at 20\u00baC min?1, two almost superimposed events at ~1450?1453\u00baC \n\nappear with a decreasing intensity and at slightly higher temperatures as the \n\ncooling rate decreases (Fig. 3). These are typical kinetic effects as longer time for \n\n\n\nCap\u00edtulo 2 \n\n 90 \n\ntemperature equalization between the sample and the standard material is \n\nallowed as cooling rate decreases. Accordingly, the phase transition occurs at \n\nhigher temperatures, while the signal from DSC is weaker due to a closer \n\nproximity of the equilibrium conditions. Oppositely, at a higher cooling rate, \n\nstructural rearrangement cannot follow the cooling kinetics and the thermal events \n\nare shifted to lower temperatures, while the higher deviation from equilibrium \n\nconditions translates into an enhanced intensity of the exothermic peaks/bands. \n\nThese two events are probably the ?\u00b4?? polymorphic phase transition and partial \n\ncrystallization of the liquid into ?-TCP (reversions of the last two events referred \n\nabove).  \n\nThe reversion of ?\u00b4??-TCP was reported by Carrodeguas et al. [23] to occur at \n\n~1465\u00baC in pure ?-TCP under a cooling rate of 5\u00baC min?1. The maximum intensity \n\nof the exothermic event observed for the Mg0TCP powder under this cooling rate \n\nwas registered at ~1462\u00baC (Fig. 3), a similar temperature value. Apparently, no \n\nother thermal events could be detected upon cooling at 5 \u00baC min?1, suggesting the \n\nnon-occurrence of phase transformations under these conditions. This is \n\nreasonably consistent with the small amount of ?-TCP in this sample (~3 wt.%, \n\nTable 3), meaning that under this cooling rate the structure of ?-TCP remains \n\nmetastable at RT as reported elsewhere [23, 31, 32]. This finding is consistent \n\nwith the reconstructive character of the ??? polymorphic transformation \n\n[23, 26, 31]. In other words, quenching from high temperature is not the unique \n\nway to prepare pure or almost pure ?-TCP.  \n\nThe broad exothermic effect registered at ~1395\u00baC under the cooling rate of \n\n20\u00baC min?1 was apparently shifted to 1201\u00baC upon cooling at 10\u00baC min?1 (Fig. 3). \n\nThis shift coincided with incremental amounts of ?-TCP in comparison to that in \n\nthe sample cooled at 5\u00baC min?1 (Table 3). Therefore, these peaks are likely due to \n\n???-TCP phase reversion. This hypothesis is supported by the increments of \n\n?-TCP from ~9% to ~31% with cooling rate increasing from 10 to 20\u00baC min?1 \n\n(Table 3) and by the higher amount (~15%) of ?-TCP obtained upon cooling from \n\n1550\u00baC under the rate of 13\u00baC min?1 in comparison to only ~4% at \n\n\n\nCap\u00edtulo 2 \n\n 91 \n\n5\u00baC min?1 (Fig. 6). This suggests that the liquid phase derived from the presence \n\nof CPP is favouring the ???-phase transformation. It seems reasonable to \n\nassume that when a given solid phase incongruently changes into a liquid and \n\nanother solid phase, the composition of the remaining solid phase is not the same \n\nas the starting material. Therefore, changes in chemical activity cannot be \n\nexcluded when moving from one phase to another. This assumption would help \n\nexplaining the present results. Being the ? to ??TCP phase transformation a \n\nreconstructive structural change as consensually accepted in literature [7,8,23,29], \n\nsome holding time (at a suitable temperature range) is required for it to take place.  \n\nAfter quenching the Mg0TCP samples from 1550\u00baC (quenching rate >> \n\n20\u00baC min?1) only ?-TCP and an amorphous phase were detected (Fig. 6), \n\nsuggesting that the ???-TCP phase reversion was hindered upon quenching \n\n(Table 3). Increasing the dwell time from 2 to 24 h, increased the fraction of \n\namorphous phase, confirming the formation of a liquid phase and the \n\ninterpretation given above for the higher temperature endothermic effect attributed \n\nto the ??TCP + liquid ? ?\u00b4?TCP + liquid transformation [44, 46].  \n\nThe results of XRD (Fig. 5) and phase quantification (Fig. 6) clearly show an \n\nenrichment in amorphous (from about 3% to ~15%) and in ?-TCP (from about \n\n~28% to ~44%) phases at expenses of ?-TCP in samples heat treated at 1250\u00baC \n\nwith cooling rate increasing from 5\u00baC min?1 to 13\u00baC min?1. Such significant amount \n\nof amorphous phase obtained upon cooling at 13\u00baC min?1 is not likely to derive \n\nfrom pre-existing liquid phase, as the eutectic point of CPP is close to 1290\u00baC. The \n\nfollowing considerations might shed some light on this surprising result. The \n\noverall thermal effect depends on the heat treatment schedule (time, temperature), \n\nmeaning that the same chronothermic effect can be obtained at a lower \n\ntemperature by extending the heat treatment time. After 2 h at 1250\u00baC, ?-TCP was \n\nthe predominant phase (Fig. 4, Fig. 5, and Fig. 6). We could speculate that its \n\nstructural arrangement is likely to be slow and the phase reversion to ?-TCP will \n\nbe incomplete accordingly.  \n\n\n\nCap\u00edtulo 2 \n\n 92 \n\nIn contrast to the above, a decreasing trends were observed for the contents of \n\namorphous and ?-TCP phases (and concomitant increasing contents of ?-TCP \n\nphase) for samples heat treated at higher temperatures and when the cooling rate \n\nwas increased from 5\u00baC min?1 to 13\u00baC min?1 (p &lt;0.01). These two distinctive \n\ntrends for the effects of cooling rate on phase composition are consistent with the \n\nmore abundant liquid phase at higher temperatures, catalysing the ???-TCP \n\nphase reversion.  \n\nThe HT-XRD results showed that although most of the ??? phase transformation \n\noccurred within the range of 1150?1200\u00baC (Fig. 4a), the remaining part continued \n\nto occur along a broad temperature range as indicated by the coexistence of \n\n?-TCP and ?-TCP phases (Fig. 4b). At 1350\u00baC ?-TCP was the main phase and \n\npartially transformed to ?-TCP on cooling (5\u00baC min?1) at temperatures ? 1200\u00baC \n\n(Fig. 4c). This means that heat treating at 10\u00baC min?1 up to 1350\u00baC did not confer \n\nto ?-TCP enough structural/thermal stability to hinder phase reversion on cooling \n\nat both rates tested (Fig. 6) as the RT product consists predominantly of ?-TCP \n\nphase, especially for the faster cooling rate of 13\u00baC min?1. \n\nThe results reported in Fig. 5 and Fig. 6 confirm that increasing the heat treatment \n\ntemperature noticeably enhanced the thermal stability of the high temperature \n\nphase under a slow cooling rate (5\u00baC min?1). However, such trends are altered for \n\nthe samples heat treated at 1250\u00baC when increasing the cooling rate to \n\n13\u00baC min?1, as mentioned above. This change in the kinetics of phase \n\ntransformation is consistent with the presence of a higher amount of liquid formed \n\nat temperature above the eutectic point of CPP is at ~1285?1290\u00baC. The amounts \n\nof ?-TCP after cooling from 1550\u00baC at 5\u00baC min?1 and at 13\u00baC min?1, were ~79% \n\nand ~70%, respectively. These changes involved essentially a ???-TCP phase \n\nreversion, corroborating the trend observed for quantitative crystalline phase \n\nanalysis results of samples derived from the DSC experiments (Table 3).  \n\n \n\n \n\n\n\nCap\u00edtulo 2 \n\n 93 \n\n4.3 Influence of Mg-doping on thermal behaviour \n\nThe thermal stability of Mg-doped powders was considerably enhanced as \n\ndeduced from the shift of the first endothermic peak corresponding to ???-TCP \n\nphase transition from 1182.4 \u00b1 0.4 \u00baC (Mg0TCP) to higher temperatures \n\n(Mg1?5TCP, Fig. 7). This observation corroborates the findings in other literature \n\nreports [23, 31, 35-37, 43]. In the Mg1TCP sample this phase transition \n\napproximately coincided with the eutectic temperature in the CPP??-TCP system \n\n[44-47, 56] detected for Mg0TCP and Mg2?5TCP samples. These observations \n\ncorroborated the presence of traces of CPP detected by FTIR (Fig. 2) and \n\nquantified by Rietveld refinement (Table 1), and suggest that Mg does not \n\ninterfere with this eutectic transformation. This also means that at the eutectic \n\ntemperature the Mg1TCP system changes from CPP??-TCP ? ?-TCP + ?-TCP + \n\nliquid. The presence of ?-TCP above the eutectic temperature is confirmed by the \n\nHT-XRD experiments (Fig. 4b) performed for Mg0TCP. These experiments \n\nshowed that complete phase transformation does not occur suddenly at a \n\nwell-defined temperature but along a temperature range. In other words, the \n\nobserved thermal effects are likely to reflect most of the reaction vigour but do not \n\naccount for the entire phase transformation process. In the Mg2?5TCP samples \n\nthe ???-TCP phase transition occurred above the eutectic, at 1359.8 \u00b1 1.5 \u00baC \n\nand at 1473.7 \u00b1 1.2 \u00baC, respectively (Fig. 7), which consist of ?-TCP + liquid + \n\n?-TCP relics.  \n\nThe last thermal effects observed in DSC thermograms of the Mg1?5TCP samples \n\nupon heating appear better discriminated than in the case of Mg0TCP and their \n\nrelative intensities changed with increasing amounts of Mg, being reasonably split \n\nin two peaks (centred at 1464.7 \u00b1 0.5 \u00baC and at 1485.1 \u00b1 1.0 \u00baC respectively) for \n\nthe Mg2TCP sample (Fig. 7). Considering that allotropic phase transformations \n\nrequire less energy to occur than solid/liquid ones, it seems reasonable to \n\nhypothesize that the highest thermal effect in each DSC curve might be related \n\nwith a melting event. According to this hypothesis, and considering the noticeable \n\namount of ?-TCP (~72%) determined for Mg2TCP quenched after 2 h at \n\n\n\nCap\u00edtulo 2 \n\n 94 \n\n1550\u00baC (Fig. 6), the stronger endothermic effect at 1464.7 \u00b1 0.5 \u00baC observed for \n\nthis sample is likely to be mostly due to the ???'-TCP phase transformation plus \n\nfurther formation of liquid phase. On the other hand, the broad endothermic band \n\nregistered for Mg5TCP, seemingly resulting from the overlap of three thermal \n\nevents, suggests that the enhanced thermal stability of the resulting ?-TCP \n\nenables this phase to coexist with ?-TCP and eventually ?'-TCP + liquid. This \n\nwould explain why the phase assemblage after quenching consists mostly of \n\n?-TCP + amorphous phase. Moreover, the kinetics of liquid phase formation \n\nseems to be relatively slow, explaining the higher amount of amorphous phase \n\nafter 24 h dwell time at the expenses of ?-TCP (Fig. 6). This suggests that at \n\n1550\u00baC for Mg5TCP, ?-TCP passes directly to liquid phase instead of being \n\ntransformed into ?-TCP.  \n\nThe two exothermic peaks registered on cooling at 10\u00baC min?1 (red zoomed \n\nbranches, Fig. 7) appear gradually closer to each other and their relative \n\nintensities changed with increasing added amounts of Mg (Mg1?5TCP). The first \n\npeak jumped from 1460\u00baC (Mg0TCP) to 1452\u00baC (Mg1TCP), 1439\u00baC (Mg2TCP), \n\nand 1416\u00baC (Mg5TCP). This suggests that the enhanced thermal stability of \n\n?-TCP in Mg5TCP hindered its extensive transformation into ?-TCP, as can be \n\ndeduced from the quenching experiments in Fig. 6. This might explain why the first \n\nexothermic peak on cooling Mg5TCP is less intense then the second one. \n\nAccordingly, the second exothermic peak might be partially due to ???-TCP and \n\nmostly to liquid??-TCP phase transformation and/or solidification of the liquid as \n\namorphous phase. This interpretation is supported by the data reported in Fig. 6, \n\nfor samples quenched and cooled under controlled conditions, respectively.  \n\nThe content of ?-TCP in Mg2TCP cooled at 10\u00baC min?1 (DSC experiments) is very \n\nhigh (~96%, Table 3). The shorter dwell time (2 h) and cooling at 13\u00baC min?1 (the \n\nheat treatment schedule that approaches more the DSC testing conditions) also \n\nresulted mostly in ?-TCP (~94 %) and small amounts of ?-TCP (~4 %) and \n\namorphous phase (~2 %), Fig. 6. This contrasts with the relatively high contents in \n\n?-TCP (~72%) and amorphous phase (~26%) obtained from the same Mg2TCP \n\n\n\nCap\u00edtulo 2 \n\n 95 \n\nsample upon quenching (Fig. 6). An obvious conclusion can be drawn: both \n\n??TCP and liquid phases transformed into ?-TCP under controlled cooling rate. \n\nTherefore, the two exothermic peaks registered for Mg2TCP (Fig. 7) are likely due \n\nto: (i) ?'-TCP + liquid ? ?-TCP and (ii) ???-TCP phase transformation, \n\nrespectively.  \n\nThe same arguments could be used to explain the two exothermic peaks \n\nregistered for Mg1TCP upon cooling and the temperatures at which they occur. \n\nFig. 6 shows that ?-TCP in Mg1TCP is more stable than in Mg2?5TCP samples. \n\nAccordingly, a significant high amount of ?-TCP has been retained upon cooling at \n\n5\u00baC min?1 (Fig. 6), being consistent with the findings of Carrodeguas et al. [23] in \n\nthe absence of CPP and the partial ???-TCP transformation occurred at a lower \n\ntemperature (exothermic peak centred at 1304\u00baC) than in the case of Mg2?5TCP \n\n(1353 and 1354\u00baC, respectively, Fig. 7). \n\nThe comparison of quantitative phase analysis after DSC experiments (Table 3 \u2013 \n\nabsence of dwell time) with the corresponding data after 2 h dwell time at 1550\u00baC \n\n(Fig. 6) reveals that: (i) ?-TCP can be retained for Mg0TCP without a dwell time; \n\n(ii) A significantly smaller fraction of ?-TCP was retained in Mg1TCP due to its \n\ndecreased thermal stability, meaning that a dwell time is necessary to stabilize the \n\nhigh temperature phases; (iii) The differences between the data reported in \n\nTable 3 and Fig. 6 become less evident with increasing Mg contents due to the \n\nenhanced thermal stability of ?-TCP phase.  \n\n \n\n5. Conclusions \n\nThe present study aimed at shedding some light on the controversial aspects \n\n???-TCP phase transformations and on the roles of the most relevant \n\nexperimental variables: cooling rate, the presence of CPP impurities and the \n\nextent of Mg-doping. The following main conclusions could be drawn:  \n\n\n\nCap\u00edtulo 2 \n\n 96 \n\n1. Different thermal treatment schedules led to variable fractions of retained \n\n??TCP. Amorphous phase was formed in all heat treated powders, \n\ntogether with small amounts of CPP (except in those quenched from \n\n1550\u00baC). \n\n2. Like in pure TCP systems, the thermal stability of ?-TCP phase was \n\nsignificantly enhanced with increasing Mg-doping extents. \n\n3. The presence of small amount of CPP gave rise to the formation of a \n\neutectic at 1286 \u00b1 0.8 \u00baC. The liquid phase lowered the considerably high \n\nactivation energy for polymorphic ???-TCP transformation to occur in solid \n\nstate reactions, facilitating the ???-TCP phase reversion upon cooling.  \n\n4. Relatively high amounts of ?-TCP phase were retained upon quenching the \n\nMg0?2TCP samples from 1550\u00baC, as well as upon cooling the Mg0?1TCP \n\nsamples at the lowest rate tested (5\u00baC min?1) from de same temperature.  \n\n5. Concomitant decreases of ?-TCP and amorphous contents for all the \n\npowders were the most salient effects of an increase of cooling rate from 5 \n\nto 13\u00baC min?1. The ???-TCP phase reversion was stimulated for the higher \n\ncooling rate. This apparently counterintuitive result, which was highly \n\nreproducible in the frame of the present work, has never been reported so \n\nfar. The formation of liquid phase from a starting solid implies a \n\ncorresponding chemical change in the composition of solid phase in contact \n\nwith the liquid and, especially, in chemical activity. These changes are likely \n\nto strongly interfere with the kinetics of phase transformation, explaining \n\nwhy the presence of liquid phase promotes the ???-TCP phase reversion. \n\nBeing the ? to ??TCP phase transformation a reconstructive structural \n\nchange, some holding time (at a suitable temperature range) is required for \n\nit to take place. Upon quenching, such time is not allowed and the \n\ntransformation is hindered. \n\n6. The presence of CPP expands the route of preparing ?-TCP-rich powders \n\nwith some contents of amorphous phases for applications in CPC.  \n\n\n\nCap\u00edtulo 2 \n\n 97 \n\nAcknowledgements \n\nThis work was supported by the European Regional Development Fund (FEDER) \n\nthrough the COMPETE, by the Portuguese Government through the Portuguese \n\nFoundation for Science and Technology (FCT), in the scope of the projects \n\nUID/CTM/50011/2013 (Aveiro Institute of Materials, CICECO, www.ciceco.ua.pt) \n\nand by Mathys Ltd Bettlach (Switzerland). P.M.C. Torres (SFRH/BD/62021/2009), \n\nAjay Kaushal (SFRH/BPD/77598/2011) and S. Pina (SFRH/BPD/64119/2009) \n\nacknowledge the respective fellowship Grant by FCT. \n\nThe authors would also like to acknowledge Professor J.J.C. Cruz Pinto A. Barros-\n\nTimmons and Sandra Magina for the Thermal Analysis. Thermal Analysis \n\nLaboratory was funded by FEDER Funds through Programa Operacional Factores \n\nde Competitividade \u2013 COMPETE and by National Funds through FCT under the \n\nproject REEQ/515/CTM/2005. The XRD facility was funded by FEDER funds \n\nthrough QREN-Aviso SAIECT-IEC/2/2010 and Opera\u00e7\u00e3o NORTE-07-0162-\n\nFEDER-000050. \n\n \n\nReferences \n\n[1] Legeros RZ. Calcium Phosphate Materials in Restorative Dentistry: a Review. \n\nAdv Dent Res 1988;2:164-80. \n\n[2] Hench LL. Bioceramics. J Am Ceram Soc 1998;81:1705-28. \n\n[3] Greenspan DC. Bioactive ceramic implant materials. Curr Opin Solid State \n\nMater Sci 1999;4:389-93. \n\n[4] Eggli PS, Muller W, Schenk RK. Porous hydroxyapatite and tricalcium \n\nphosphate cylinders with two different pore size ranges implanted in the \n\ncancellous bone of rabbits. A comparative histomorphometric and histologic study \n\nof bone ingrowth and implant substitution. Clin Orthop Relat Res 1988:127-38. \n\n\n\nCap\u00edtulo 2 \n\n 98 \n\n[5] Kondo N, Ogose A, Tokunaga K, Ito T, Arai K, Kudo N, et al. Bone formation \n\nand resorption of highly purified ?-tricalcium phosphate in the rat femoral condyle. \n\nBiomaterials 2005;26:5600-8. \n\n[6] Elliott JC. Structure and chemistry of the apatites and other calcium \n\northophosphates. London: Elsevier; 1994. \n\n[7] Buerger MJ. Phase determination with the aid of implication theory. Phys Rev \n\n1948;73:927-8. \n\n[8] Buerger MJ. Some new functions of interest in x-ray crystallography. Proc Natl \n\nAcad Sci U S A 1953;36:376-82. \n\n[9] Ando J. Phase Diagrams of Ca3(PO4)2-Mg3(PO4)2 and Ca3(PO4)2-CaNaPO4 \n\nSystems. Bull Chem Soc Jpn 1958;31:201-5. \n\n[10] Bohner M. Resorbable biomaterials as bone graft substitutes. Mater Today \n\n2010;13:24-30. \n\n[11] Bucholz RW. Nonallograft Osteoconductive Bone Graft Substitutes. Clin \n\nOrthop Relat Res 2002;395:44-52. \n\n[12] Bohner M. Calcium orthophosphates in medicine: from ceramics to calcium \n\nphosphate cements. Injury 2000;31:37-47. \n\n[13] Dorozhkin SV. Calcium orthophosphates cements for biomedical application. \n\nJ Mater Sci: Mater Med 2008;43:3028-57. \n\n[14] Camir\u00e9 CL, Gbureck U, Hirsiger W, Bohner M. Correlating crystallinity and \n\nreactivity in an ?-tricalcium phosphate. Biomaterials 2005;26:2787-94. \n\n[15] Ginebra MP, Fernandez E, Driessens FCM, Planell JA. Modeling of the \n\nhydrolysis of ?-tricalcium phosphate. J Am Ceram Soc 1999;82:2808-12. \n\n[16] Liu W, Zhang J, Rethore G, Khairoun K, Pilet P, Tancret F, et al. A novel \n\ninjectable, cohesive and toughened Si-HPMC (silanized-hydroxypropyl \n\n\n\nCap\u00edtulo 2 \n\n 99 \n\nmethylcellulose) composite calcium phosphate cement for bone substitution. Acta \n\nBiomater 2014;10:3335-45. \n\n[17] Hurle K, Neubauer J, Bohner M, Doebelin N, Goetz-Neunhoeffer F. Effect of \n\namorphous phases during the hydraulic conversion of ?-TCP into calcium-\n\ndeficient hydroxyapatite. Acta Biomater 2014;10:3931-41. \n\n[18] Bohner M, Luginb\u00fchl R, Reber C, Doebelin N, Baroud G, Conforto E. A \n\nphysical approach to modify the hydraulic reactivity of ?-tricalcium phosphate \n\npowder. Acta Biomater 2009;5:3524-35. \n\n[19] Gbureck U, Barralet JE, Radu L, Klinger HG, Thull R. Amorphous alpha-\n\ntricalcium phosphate: Preparation and aqueous setting reaction. J Am Ceram Soc \n\n2004;87:1126-32. \n\n[20] Zhang JT, Tancret F, Bouler JM. Fabrication and mechanical properties of \n\ncalcium phosphate cements (CPC) for bone substitution. Mater Sci Eng C \n\n2011;31:740-7. \n\n[21] Pina S, Olhero SM, Gheduzzi S, Miles AW, Ferreira JM. Influence of setting \n\nliquid composition and liquid-to-powder ratio on properties of a Mg-substituted \n\ncalcium phosphate cement. Acta Biomater 2009;5:1233-40. \n\n[22] D\u00f6belin N, Brunner TJ, Stark WJ, Fisch M, Conforto E, Bohner M. Thermal \n\ntreatment of flame-synthesized amorphous tricalcium phosphate nanoparticles. J \n\nAm Ceram Soc 2010;93:3455-63. \n\n[23] Carrodeguas RG, De Aza AH, Turrillas X, Pena P, De Aza S. New approach \n\nto the ? ? ? polymorphic transformation in magnesium-substituted tricalcium \n\nphosphate and its practical implications. J Am Ceram Soc 2008;91:1281-6. \n\n[24] Yashima M, Sakai A. High-temperature neutron powder diffraction study of \n\nthe structural phase transition between ? and ?' phases in tricalcium phosphate \n\nCa3(PO4)2. Chem Phys Lett 2003;372:779-83. \n\n\n\nCap\u00edtulo 2 \n\n 100 \n\n[25] Kitamura M, Ohtsuki C, Iwasaki H, Ogata S-i, Tanihara M, Miyazaki T. The \n\ncontrolled resorption of porous ?-tricalcium phosphate using a \n\nhydroxypropylcellulose coating. J Mater Sci Mater Med 2004;15:1153-8. \n\n[26] Carrodeguas RG, De Aza S. ?-Tricalcium phosphate: Synthesis, properties \n\nand biomedical applications. Acta Biomater 2011;7:3536-46. \n\n[27] Fernandez E, Ginebra MP, Boltong MG, Driessens FCM, Ginebra J, \n\nDeMaeyer EAP, et al. Kinetic study of the setting reaction of a calcium phosphate \n\nbone cement. J Biomed Mater Res 1996;32:367-74. \n\n[28] Camir\u00e9 CL, Nevsten P, Lidgren L, McCarthy I. The effect of crystallinity on \n\nstrength development of ?-TCP bone substitutes. J Biomed Mater Res B: Appl \n\nBiomater 2006;79B:159-65. \n\n[29] Monma H and Goto M. Behavior of the ??? phase transformation in tricalcium \n\nphosphate. J Ceram Soc Jpn, 1983;91:473-475. \n\n[30] Montufar EB, Maazouz Y, Ginebra MP. Relevance of the setting reaction to \n\nthe injectability of tricalcium phosphate pastes. Acta Biomater 2013;9:6188-98. \n\n[31] Enderle R, G\u00f6tz-Neunhoeffer F, G\u00f6bbels M, M\u00fcller FA, Greil P. Influence of \n\nmagnesium doping on the phase transformation temperature of ?-TCP ceramics \n\nexamined by Rietveld refinement. Biomaterials 2005;26:3379-84. \n\n[32] Bohner M, Lema\u00eetre J, Legrand AP, De la Caillerie JBD, Belgrand P. \n\nSynthesis, X-ray diffraction and solid-state 31P magic angle spinning NMR study \n\nof ?-tricalcium orthophosphate. J Mater Sci: Mater Med 1996;7:457-63. \n\n[33] Xue W, Dahlquist K, Banerjee A, Bandyopadhyay A, Bose S. Synthesis and \n\ncharacterization of tricalcium phosphate with Zn and Mg based dopants. J Mater \n\nSci Mater Med 2008;19:2669-77. \n\n[34] Cacciotti I, Bianco A. High thermally stable Mg-substituted tricalcium \n\nphosphate via precipitation. Ceram Int 2011;37:127-37. \n\n\n\nCap\u00edtulo 2 \n\n 101 \n\n[35] Famery R, Richard N, Boch P. Preparation of ?- and ?-tricalcium phosphate \n\nceramics, with and without magnesium addition. Ceram Int 1994;20:327-36. \n\n[36] Goetz-Neunhoeffer F, Neubauer J, G\u00f6bbels M, Enderle R. Effect of Mg 2+ \n\ncontent on lattice parameter and phase transformation temperature of ?-? TCP. \n\nEur Cells Mater 2006;11:38. \n\n[37] Marchi J, Dantas ACS, Greil P, Bressiani JC, Bressiani AHA, Muller FA. \n\nInfluence of Mg-substitution on the physicochemical properties of calcium \n\nphosphate powders. Mater Res Bull 2007;42:1040-50. \n\n[38] Matsumoto N, Yoshida K, Hashimoto K, Toda Y. Thermal stability of ?-\n\ntricalcium phosphate doped with monovalent metal ions. Mater Res Bull \n\n2009;44:1889-94. \n\n[39] Tardei C, Grigore F, Pasuk I, Stoleriu S. The study of Mg2+/Ca2+ substitution \n\nof ?-tricalcium phosphate. J Optoelectr Adv Mater 2006;8:568-71. \n\n[40] Pina S, Vieira SI, Rego P, Torres PMC, da Cruz e Silva OAB, da Cruz e Silva \n\nEF, et al. Biological responses of brushite-forming Zn- and ZnSr-substituted ?- \n\ntricalcium phosphate bone cements. Eur Cell Mater 2010;20:162-77. \n\n[41] Bracci B, Torricelli P, Panzavolta S, Boanini E, Giardino R, Bigi A. Effect of \n\nMg2+, Sr2+, and Mn2+ on the chemico-physical and in vitro biological properties of \n\ncalcium phosphate biomimetic coatings. J Inorg Biochem 2009;103:1666-74. \n\n[42] Boanini E, Gazzano M, Bigi A. Ionic substitutions in calcium phosphates \n\nsynthesized at low temperature. Acta Biomater 2010;6:1882-94. \n\n[43] Carrodeguas RG, De Aza AH, Garc\u00eda-P\u00e1ez I, De Aza S, Pena P. Revisiting \n\nthe phase-equilibrium diagram of the Ca3(PO4)2-CaMg(SiO3)2 system. J Am \n\nCeram Soc 2010;93:561-9. \n\n[44] Welch JH, Gutt W. High-temperature studies of the system calcium oxide-\n\nphosphorus pentoxide. J Chem Soc 1961:4442-4. \n\n\n\nCap\u00edtulo 2 \n\n 102 \n\n[45] Kreidler ER, Hummel FA. Phase relationships in the system SrO-P2O5 and \n\nthe influence of water vapor on the formation of Sr4P2O9. Inorg Chem 1967;6:884-\n\n91. \n\n[46] Riboud PV. Composition et stabilit\u00e9 des phases \u00e0 structure d\u00b4apatite dans le \n\nsyst\u00e8me CaO\u2013P2O5- de fer-H2O \u00e0 haute temperature. Ann Chim 1973;8:381\u201390. \n\n[47] Margot-Marette H, Riboud PV. Study of liquidus temperatures of CaO\u2013P2O5\u2013\n\nSiO2\u2013Iron Oxide System. I. 15% FeO. Mem Sci Rev Metall 1966;63(11):959\u201367. \n\n[48] Kannan S, Ventura JM, Ferreira JMF. Aqueous precipitation method for the \n\nformation of Mg-stabilized ?-tricalcium phosphate: An X-ray diffraction study. \n\nCeram Int 2007;33:637-41. \n\n[49] Torres PMC, Vieira SI, Cerqueira AR, Pina S, da Cruz Silva OAB, Abrantes \n\nJCC, et al. Effects of Mn-doping on the structure and biological properties of ?-\n\ntricalcium phosphate. J Inorg Biochem 2014;136:57-66. \n\n[50] D\u00f6belin N. Interlaboratory study on the quantification of calcium phosphate \n\nphases by Rietveld refinement. Powder Diffr 2015; 30(3):231-41. \n\n[51] Destainville A, Champion E, Bernache-Assollant D, Laborde E. Synthesis, \n\ncharacterization and thermal behavior of apatitic tricalcium phosphate. Mater \n\nChem Phys 2003;80:269-77. \n\n[52] Yashima M, Sakai A, Kamiyama T, Hoshikawa A. Crystal structure analysis of \n\n?-tricalcium phosphate Ca3(PO4)2 by neutron powder diffraction. J Solid State \n\nChem 2003;175:272-7. \n\n[53] Kannan S, Goetz-Neunhoeffer F, Neubauer J, Pina S, Torres PMC, Ferreira \n\nJMF. Synthesis and structural characterization of strontium- and magnesium-co-\n\nsubstituted ?-tricalcium phosphate. Acta Biomater 2010;6:571-6. \n\n[54] Raynaud S, Champion E, Bernache-Assollant D, Thomas P. Calcium \n\nphosphate apatites with variable Ca/P atomic ratio I. Synthesis, characterisation \n\nand thermal stability of powders. Biomaterials 2002;23:1065-72. \n\n\n\nCap\u00edtulo 2 \n\n 103 \n\n[55] Descamps M, Hornez JC, Leriche A. Effects of powder stoichiometry on the \n\nsintering of ?-tricalcium phosphate. J Eur Cera. Soc. 2007;27:2401-6. \n\n[56] Maciejewski M, Brunner TJ, Loher SF, Stark WJ, Baiker A. Phase transitions \n\nin amorphous calcium phosphates with different Ca/P ratios. Thermochim Acta \n\n2008;468:75-80. \n\n[57] Shannon RD. Revised effective ionic-radii and systematic studies of \n\ninteratomic distances in halides and chalcogenides. Acta Crystallogr A \n\n1976;32:751-67. \n\n[58] Gibson IR, Rehman I, Best SM, Bonfield W. Characterization of the \n\ntransformation from calcium-deficient apatite to ?-tricalcium phosphate. J Mater \n\nSci Mater Med 2000;11:799-804. \n\n[59] Ryu HS, Youn HJ, Hong KS, Chang BS, Lee CK, Chung SS. An improvement \n\nin sintering property of beta-tricalcium phosphate by addition of calcium \n\npyrophosphate. Biomaterials 2002;23:909-14. \n\n \n\n \n\n\n\n \n\n 104 \n\n \n\n \n\n \n\n\n\n \n\n 105 \n\n \n\n \n\nCap\u00edtulo 3 \n\n \n\nInjectabilidade de pastas de fosfato de c\u00e1lcio: \n\nEfeitos do tamanho da part\u00edcula e estado de \n\nagrega\u00e7\u00e3o de p\u00f3s de ?-fosfato tric\u00e1lcico \n \n\n \n\n \n\n\n\n \n\n 106 \n\n \n\n \n\n\n\nCap\u00edtulo 3 \n\n 107 \n\n \n\n \n\n \n\nInjectability of calcium phosphate pastes: Effects of particle size \n\nand state of aggregation of ?-tricalcium phosphate powders \n\n \n\nP. M. C. Torresa,* , S. Gouveiab, S. Olheroa, A. Kaushala, J.M.F. Ferreiraa \n\n \n\na Department of Materials and Ceramics Engineering, CICECO, University of Aveiro, \n\n3810-193, Portugal \n\nb Institute of Electronics and Telematics Engineering of Aveiro (IEETA) and Center for \n\nResearch &amp; Development in Mathematics and Applications (CIDMA), University of Aveiro, \n\n3810-193 Aveiro, Portugal  \n\n \n\n \n\nActa Biomaterialia 21 (2015) 204\u2013216, doi: 10.1016/j.actbio.2015.04.006 \n\n \n\n \n\n \n\n*Corresponding author. Tel.: +351 234 370261; fax: +351 234 370204. \n\n   E-mail address: ptorres@ua.pt (P.M.C. Torres). \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\nCap\u00edtulo 3 \n\n 108 \n\n \n\n \n\n \n\nAbstract \n\nThe present study discloses a systematic study about the influence of some \n\nrelevant experimental variables on injectability of calcium phosphate cements. \n\nNon-reactive and reactive pastes were prepared, based on tricalcium phosphate \n\ndoped with 5 mol% (Sr?TCP) that was synthesised by co-precipitation. The varied \n\nexperimental parameters included: (i) the heat treatment temperature within the \n\nrange of 800?1100 \u00baC; (ii) different milling extents of calcined powders; (iii) the \n\nliquid-to-powder ratio (LPR); (iv) the use of powder blends with different particle \n\nsizes (PS) and particle size distributions (PSD); (v) the partial replacement of fine \n\npowders by large spherical dense granules prepared via freeze granulation \n\nmethod to simulate coarse individual particles. The aim was contributing to better \n\nunderstanding of the effects of PS, PSD, morphology and state of aggregation of \n\nthe starting powders on injectability of pastes produced thereof. Powders heat \n\ntreated at 800 and 1000\u00baC with different morphologies but with similar apparent \n\nPSD curves obtained by milling/blending originated completely injectable reactive \n\ncement pastes at low LPR. This contrasted with non-reactive systems prepared \n\nthereof under the same conditions. Hypotheses were put forward to explain why \n\nthe injectability results collected upon extruding non-reactive pastes cannot be \n\ndirectly transposed to reactive systems. The results obtained underline the \n\ninterdependent roles of the different powder features and ionic strength in the \n\nliquid media on determining the flow and injectability behaviours. \n\n \n\nKeywords: Calcium phosphates; Bone cements; Injectability; Aggregation state; \n\nParticle size distribution \n\n \n\n \n\n \n\n\n\nCap\u00edtulo 3 \n\n 109 \n\n1. Introduction \n\nCalcium phosphate bone cements (CPC) have attracted much attention in recent \n\nyears opening up a new era in the medical applications since early 1980s [1, 2]. \n\nCPC offer numerous attractive advantages including resorbability, \n\nosteoconductivity, resemblance with chemical bone composition, capability to \n\nestablish chemical bonds with the hard tissues, fast setting time, excellent \n\nmouldability, outstanding biocompatibility, etc. [3-7]. CPC also provide the \n\nopportunity for bone grafting using alloplastic materials, which are unlimited in \n\nquantity and provide no risk for infectious diseases [7]. Injectability and the \n\npractically isothermal in situ setting offer great opportunities to decrease the \n\ninvasiveness and painfulness of surgeries, reduced recovery time and increase \n\nthe overall benefits for the patient and the medical system [8, 9]. However, the \n\ncommercially available CPC formulations are not completely satisfactory [10, 11]. \n\nThe main shortcomings include insufficient mechanical strength and poor \n\ninjectability. These properties are crucial for bone graft applications in surgical \n\nprocedures for the correction of vertebral compression fractures, usually caused \n\nby osteoporosis. The currently used polymethylmethacrylate (PMMA) based \n\ncements injected into the vertebra offer good compressive strength but \n\nunsatisfactory fatigue resistance [12] and the high exothermicity of the \n\npolymerisation reactions might cause extensive necrosis [4, 5, 7, 13]. The \n\nmonomer toxicity and the inability to participate in the biological processes of bone \n\nremodelling constitute other weak points of PMMA based cements [3, 6]. These \n\nconcerns drove the search for CPC with improved flow and mechanical properties \n\nin the recent years. But achieving CPC pastes with good injectability still remains a \n\nmajor challenge as flow properties are affected by several factors such as: (i) \n\naverage particle size (PS) and particle size distributions (PSD) of the starting \n\npowders; (ii) fraction and nature of the phases presented; (iii) the presence of \n\nstrongly bonded particles (aggregates); (iv) particles shape; (v) liquid-to-powder \n\nratio (LPR); (vi) the presence of rheological modifiers and/or additives with specific \n\nroles [4-6, 14-27].  \n\n\n\nCap\u00edtulo 3 \n\n 110 \n\nInjectability is expressed as the percentage of paste that can be extruded from a \n\nsyringe, ideally in a homogeneous way under an applied force [17]. The eventual \n\noccurrence of solid/liquid segregation (also known as filter pressing effect) during \n\ninjection worsens or even hinders injectability [14, 17, 24]. In such circumstances \n\nthe firstly extruded paste contains more liquid than the initial mixture. This paste \n\nheterogeneity increases extrusion load and might clog the cannula and block the \n\nprocess, leaving retained paste in the syringe that contains less amount of liquid \n\nthan the initial mixture. \n\nNarrow PSD and the presence of aggregates (strongly bonded particles) tend to \n\nconfer a shear thickening behaviour to the pastes and increase their tendency to \n\nsegregate upon extrusion. Increasing the viscosity of mixing liquid is a common \n\nstrategy to decrease the filter pressing effect and enhance injectability, but further \n\nwork is required to better understand how to control the flow behaviour \n\n[15, 17, 23, 24]. Therefore, drawing firm conclusions about the effects of each \n\nexperimental variable is difficult when several factors are concomitantly changed, \n\nas it happens in a complex reactive CPC paste made of ill characterised powders. \n\nSimplifications were attempted in studies carried out with non-reactive systems \n\n(aqueous suspensions of tricalcium phosphate, ??Ca3(PO4)2 ? ?-TCP) [14, 17, 28], \n\nbut no systematic efforts were made towards discriminating between the size of \n\nparticles and the size of aggregates. The main limitations towards evaluating the \n\nspecific effects of each experimental variable on injectability are: (i) the lack of well \n\ncharacterised powders in what concerns PS and PSD; (ii) the frequent confusion \n\nbetween PS and aggregates size; and (iii) the limited size range of the practically \n\nachievable non-aggregates particles.  \n\nTherefore, the main goal of this study is to contribute to a better clarification about \n\nthe effects of particle size and particle size distribution and state of aggregation on \n\nthe injectability and filter pressing effect of CPC pastes. For that, non-setting and \n\nsetting pastes from strontium-doped tricalcium phosphate (Sr-TCP) powders \n\ncalcined at different temperatures (800?1100\u00baC) and milled for different times (0, 6 \n\nand 12 min), as well as some powder blends, were considered. Furthermore, \n\nrelatively large individual particles (spherical granules) of the same material were \n\n\n\nCap\u00edtulo 3 \n\n 111 \n\nprepared and added in controlled amounts to the previous formulations to enlarge \n\nthe PS scope.  \n\n \n\n2. Materials and methods \n\n2.1 Powder preparation and characterisation \n\nThe powder selected for the present study was ??TCP doped with 5 mol% of \n\nstrontium (Sr?TCP). Improvements in thermal stability of ??TCP powders [29] as \n\nwell as high performance of CPC derived from Sr?doped TCP [30] were the \n\nreasons for selecting the strontium-doped powders. The Sr?TCP in the present \n\nwork was prepared by a precipitation method described by Kannan et al. [31] with \n\na few minor modifications reported recently [32]. The precipitated powder was \n\nvacuum filtered, dried, ground and sieved through a mesh size of 200 \u00b5m, divided \n\ninto four batches and each portion was then heat-treated at one of the following \n\ntemperatures (800, 900, 1000 and 1100\u00baC) in air (Thermolab furnace, \n\nPt30%Rh/Pt6%Rh-thermocouple). The heat treatment schedule included a heating \n\nrate of 5\u00baC min?1, a dwelling time for 2 h at the maximum temperature, followed by \n\nnatural cooling to room temperature [31]. Each of these powders was submitted to \n\ndry milling for different times (6 and 12 min) in a 250 mL planetary agate mill \n\n(weight ratio of balls to powder of 3:1). For each calcination temperature, the \n\nfollowing sub-lots of powders were obtained: (i) non-milled; (ii) milled for 6 min; \n\nand (iii) milled for 12 min. The codes for powder samples consist of two parts \n\nseparated by a hyphen, the first one relative to temperature (800, 900, 1000, \n\n1100\u00baC) and the other to milling time (0, 6, 12 min). For example, 800?0 refers to a \n\nnon-milled powder sample calcined at 800\u00baC, while and 1100?12 refers to a \n\npowder sample calcined at 1100\u00baC and milled for 12 min. All investigated powders \n\nwere passed through a 40 \u00b5m sieve. \n\nThe qualitative analyses of crystalline phases presented in the powders \n\nheat-treated at different temperatures were performed by X-ray powder diffraction \n\n(XRD) using a high-resolution Rigaku Geigerflex D/Mac, C Series, diffractometer \n\n\n\nCap\u00edtulo 3 \n\n 112 \n\nwith Cu K? radiation (? = 1.540596 \u00c5). Data sets were recorded in the 2? range \n\n20 ? 50\u00ba with a step size of 0.02\u00ba 2? s?1. Elemental analyses of the powders for \n\nCa, Sr and P were determined using inductively coupled plasma (ICP) \n\nspectrometry (ICP-OES Jobin Yvon Activa M., USA). Particle size distributions of \n\nthe Sr?TCP powders were measured in a laser scattering instrument (Coulter \n\nLS230, Buckinghamshire, UK, Fraunhofer optical model). Specific surface area \n\n(SSA) of powders were obtained according to the BET method using a \n\nMicromeritics Gemini 2370 V5.00 (Norcross, USA) through the gas adsorption \n\nmeasurements, after degassing the powders in a Micromeritics Flow Prep 060 \n\n(Norcross, USA). The morphology and microstructure of the powders heat-treated \n\nat different temperatures, before and after milling at different times, were observed \n\nby Scanning Electron Microscopy (SEM, Hitachi S-4100, Tokyo, Japan). \n\n \n\n2.2 Granule preparation and characterisation \n\nSpherical dense granules might be regarded as individual large particles, thus \n\nenabling enlarging the range of available particle sizes and extending the scope of \n\nthe studies aiming at assessing the effects of PS and PSD on the flow behaviour \n\nand injectability. With this purpose, a high concentrated (47 vol.% solids) aqueous \n\nsuspension was prepared from the Sr?TCP powder calcined at 800\u00baC in presence \n\nof 0.4 wt.% ammonium salt of polyacrylate dispersant (BK Ladenburg, Germany). \n\nThe suspension was ball milled for several days in order to obtain a well \n\ndeagglomerated system using a weight ratio of zirconia balls to powder of 3:1. The \n\nas deagglomerated powder exhibited a narrow particle size distribution with two \n\nparticle populations centred at 2.5 \u00b5m and 0.05 \u00b5m, and an overall D50 ? 0.51 \u00b5m. \n\nThe suspension was then sprayed into liquid nitrogen (Power Pro freeze \n\ngranulator LS?2, Gothenburg, Sweden) and the frozen granules were then \n\nlyophilised (Labconco, LYPH Lock 4.5, Kansas City, MO) [33]. The dried granules \n\nwere subsequently sintered at 1150\u00baC in air atmosphere for 2 h at 5\u00baC min?1 \n\nheating rate, and finally separated by size to obtain a size range between 20 and \n\n40 \u00b5m. Differential thermal analysis (DTA, Setaram Labsys, Setaram \n\n\n\nCap\u00edtulo 3 \n\n 113 \n\nInstrumentation, Caluire, France) was used to determine the maximum sintering \n\ntemperature in order to obtain Sr-TCP granules of ??TCP phase (without ??TCP \n\nphase). The evolution of powder morphology with milling time and the \n\nmicrostructure of the sintered granules were observed by Scanning Electron \n\nMicroscopy (SEM, Hitachi S-4100, Tokyo, Japan). The density of the granules was \n\ndetermined by helium gas pycnometry (Accupyc Quantachrome apparatus, \n\nFlorida, USA) and complemented by SEM observation.  \n\n \n\n2.3 Injectability evaluation \n\n2.3.1 Preparation of the pastes  \n\nNon-setting pastes (non-reactive systems that do not harden over time) were \n\nprepared by mixing 6 g of each Sr?TCP powder sample with an aqueous solution \n\nof 3 wt.% of polyvinylpyrrolidone (PVP, Sigma?Aldrich, Germany) using liquid to \n\npowder ratios (LPR) of 0.28, 0.34, 0.4 and 0.6 mL g?1. Setting pastes (reactive \n\nsystems) were also prepared by mixing in a 1:1 wt. ratio, Sr?TCP powders and \n\nmonocalcium phosphate monohydrate (MCPM, Sigma?Aldrich, Germany) in a \n\ntotal of 6 g, with an aqueous solution containing 3 wt.% PVP + 15 wt.% citric acid \n\n(CA, 400, Sigma?Aldrich, Germany) + 0.5 wt.% hydroxyl propyl methylcellulose \n\n(HPMC, 5 mPa?s at 2% by mass, Sigma?Aldrich, Germany) using different LPR of \n\n0.28, 0.34, 0.4 mL g?1. The influence of replacing 10 wt.% of Sr?TCP powders by \n\nlarge sintered granules on the injectability of both reactive and non-reactive pastes \n\nwas also evaluated. Table 1 summarises all the investigated pastes and their \n\nrespective sample codes. As an example, P?800?6?G denotes a non-reactive \n\npaste (P), prepared from the 800?6 powder, and containing 10 wt.% of granules \n\n(G). Sample codes for reactive pastes are similar, substituting P by CP, such as, \n\nCP?800?6?G.  \n\n \n\n \n\n\n\nCap\u00edtulo 3 \n\n 114 \n\nTable 1. Sample codes (X?T?t) of tested pastes were adopted to simplify their designation. \n\nAccordingly, X = P stands for non-reactive pastes; X = CP stands for reactive pastes, T stands for \n\ncalcination temperature (\u00baC), and t for milling time (min). The suffix G is added to the code \n\n(X?T?t?G) to designate pastes containing granules. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n2.3.2 Injectability tests \n\nInjectability tests were performed as described in earlier studies [14, 17, 28, 34-36] \n\nby using a 10 mL syringe (15 mm diameter and 80 mm in length) fitted with a \n\ncannula of 2.2 mm inner diameter and 91 mm in length. The paste (6 g powder + \n\nrequired amount of liquid) was hand-mixed for 1 min and then placed into the \n\nsyringe. The extrusion set was placed in a suitable homemade fixture device and \n\nput in a testing machine (Shimadzu Autograph, trapezium 2, Japan). The extrusion \n\nwas performed at room temperature (RT = 20\u00baC) being always initiated 2 min after \n\nstarting mixing the paste. The crosshead speed and the maximum load were fixed \n\nat 15 mm min?1 up [23, 24, 35, 36] and 500 N, respectively. This maximum load \n\nwas selected to cover the entire range of applied forces and include all types of \n\ninjection devices (manual, injector guns) and for enlarging the regime of filter \n\npressing effect.  \n\nMinimizing LPR values while keeping high injectability levels are the key points to \n\ndevelop high strength CPC cements. With this in mind, in the search for an \n\noptimised PSD, pastes prepared from blends of the most performing powders \n\nwere also tested at the lowest LPR (0.28 mL g?1).  \n\n Milling time of Sr?TCP powder \n(min) \n\nTemperature of \ncalcination of Sr?TCP \n\npowder \n(\u00baC)  0 6 12 \n\n800  X?800?0 X?800?6 X?800?12 \n\n900  X?900?0 X?900?6 X?900?12 \n\n1000  X?1000?0 X?1000?6 X?1000?12 \n\n1100  X?1100?0 X?1100?6 X?1100?12 \n\n\n\nCap\u00edtulo 3 \n\n 115 \n\nThe percentage of injectability was determined as the mass of the paste that could \n\nbe expelled from the syringe divided by the initial mass of the paste inside the \n\nsyringe [17, 35, 36]. Each injectability experiment was repeated three times and \n\nthe average values were calculated. Paste samples were collected every 30 \u00b1 2 s \n\ncounted from the beginning of the extrusion process for evaluating the filter \n\npressing effect. Any remaining paste in the syringe (when complete extrusion did \n\nnot occur) was also collected. These samples were weighed before and after \n\ncomplete drying at 120\u00baC for 24 h to determine their LPR values.  \n\n \n\n2.4 Zeta potential and electrical conductivity in different electrolyte solutions \n\nThe powder blend 800?(50:50) was selected to assess the specific effects of the \n\nadditives in the reacting liquid and ionic strength on zeta potential (ZP) and \n\nelectrical conductivity (EC). The measurements were carried out using a Zeta Sizer \n\n(Nano ZS, Malvern, Worcestershire, UK) at several pH values. For this, 13 mg of \n\npowder was ultrasonically dispersed for 15 min into 50 mL of each aqueous \n\nelectrolyte solution tested using 1 mM KCl as background electrolyte. Each dilute \n\nsuspension was divided into two equal parts, one for increasing and the other for \n\ndecreasing pH runs, and the pH values were adjusted by using 0.1 M solutions of \n\neither 0.1 M NaOH or 0.1 M HCl, respectively. \n\n \n\n2.5 Influence of preparation conditions on the flow behaviour of pastes \n\nTo evaluate the influence of the dispersing/reacting liquids on the flow behaviour \n\nand injectability, the powders 800?6, 800?12 and their 800?(50:50) blend were \n\nselected. Pastes at various LPR (0.45, 0.40, 0.35, and 0.28 mL g?1) were prepared \n\nwith deionised water, NaCl 3 M, in the complete reacting liquid, and in aqueous \n\nsolutions of each separate additive used in the reacting liquid (0.5 wt.% HPMC, 3 \n\nwt.% PVP, or 15 wt.% CA). Viscosity measurements were performed using a \n\nrotational Rheometer (Kinexus pro+, Malvern, UK) equipped with a cone and plate \n\n(2\u00ba, 25 mm, and gap of 70 \u00b5m) measuring configuration. The flow measurements \n\n\n\nCap\u00edtulo 3 \n\n 116 \n\nwere conducted between 0.1 and 100 s?1 at 20 \u00baC. For each test, 2 g of powder \n\nwas mixed with each testing liquid at various LPR for 1 min to form a \n\nhomogeneous paste. The rheological measurement was always initiated 2 min \n\nafter starting mixing the paste to ensure the same rheological history during the \n\npreparation of all the pastes. \n\n \n\n2.6 Statistical methods and data analysis \n\nTable 1 summarises the codes of pastes prepared from the different powder \n\nsamples. The corresponding PSD curves are displayed in Fig. 2, with distributional \n\nfeatures/percentiles reported in Table 2. The injectability of the pastes prepared \n\nfrom the different powder samples (without and with replacement of 10 wt.% of \n\nSr?TCP powder by 10% of granules) was evaluated for non-reactive and reactive \n\nsystems (Figs. 6 and 7, respectively, with data points representing average values \n\nof three independent experiments). Along the text, injectability data were \n\nexpressed as means \u00b1 standard deviations. The filter pressing effect was \n\nevaluated by the significance of the variations in LPR (three independent \n\nexperiments) undergone upon the extrusion of each paste (Tables 3, 4 and 5) and \n\nquantified from repeated measures ANOVA with Greenhouse?Geisser correction \n\nand statistical significance for p<0.05. The pairwise comparisons between the \n\nchosen/blend powder samples and the reference one (1000?12) considered: \n\n(i) differences in particle size distributions (Fig. 8, with the evaluation of the \n\ndiscrepancy between distributions, D, as the integral of the absolute differences \n\nbetween two cumulative distributions); (ii) differences in injectability (Fig. 9 with \n\nstatistical significance for p<0.05 assessed by t-test with Bonferroni correction for \n\nmultiple testing). The conclusions from parametric statistical analysis were \n\ncorroborated in all cases with the non-parametric counterparts, due to the small \n\nsample size (Friedman test for the repeated measures ANOVA and \n\nMann?Whitney U test for the t?test). All statistical analyses were conducted in \n\nIBM\u00ae SPSS\u00ae Statistics (Version 21.0) and graphical displays were developed in \n\nMatlab\u00ae (R2006a). ZP and EC were evaluated for the 800?(50:50) powder \n\n\n\nCap\u00edtulo 3 \n\n 117 \n\ndispersed in different electrolyte solutions (Fig. 10(a) and (b)). Three \n\nmeasurements were performed for each testing condition and the average values \n\nand standard deviations were calculated. \n\n \n\n3. Results \n\n3.1 Characterisation of starting powders \n\nThe results of ICP analysis revealed that a Sr content of 5.02 mol% was retained \n\nin the lattice of the Sr?TCP powder, in good agreement with the planned Ca2.85 \n\nSr0.15 (PO4)2 composition. The XRD patterns of Sr?TCP powder samples heat-\n\ntreated at 800 \u00baC, 900 \u00baC, 1000 \u00baC and 1100 \u00baC displayed in Fig. 1 reveal that all \n\nsamples consist of ??TCP, ??Ca3(PO4)2, ICDD PDF 04-001-7104, also coinciding \n\nwith the standard (Ca2.83Sr0.17)(PO4)2 phase containing 5.6(6) mol% Sr (ICDD PDF \n\n01-076-8438) [37]. This coincidence means that lattice distortions in ??TCP \n\ncaused by the atomic replacement [31, 38, 39] are too small to be noticed in \n\nagreement with previous studies [31, 37]. \n\nThe volume based differential PSD curves of the different powder samples are \n\ndisplayed in Fig. 2. The most salient features of 800?0 include a quite broad PSD \n\nwith D50 around 6.7 \u00b5m, comprising a small population of particles at ~2.4 \u00b5m and \n\na more intense population of coarser particles centred at ~18 \u00b5m. Milling caused \n\nnarrowing of PSD and the upsurge of two distinct populations with varying \n\nintensities in 800?6. The bimodal features accentuated with milling extent and D50 \n\ndecreased to 0.7 \u00b5m for sample 800?12, with the most intense population of fine \n\nparticles centred at 0.6 \u00b5m and a smaller population of coarser particles centred at \n\n2.4 \u00b5m. These coarser populations presented in 800?6 and 800?12 powders are \n\nlikely to consist more of small aggregates of primary particles than of coarse \n\nindividual ones. \n\n \n\n\n\nCap\u00edtulo 3 \n\n 118 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 1. X-ray diffraction patterns for the Sr?TCP powders heat treated at different temperatures. \n\nThe diffraction lines of the standard Sr?TCP and ??TCP are also presented for comparison. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 2. Particle size distributions of Sr?TCP powders calcined at 800\u00baC, 900\u00baC, 1000\u00baC and 1100\u00baC \n\nwithout milling (0 min) and after 6 and 12 min of milling time. \n\n\n\nCap\u00edtulo 3 \n\n 119 \n\nThe PSD parameters (including D10, D50, and D90, as well as BET SSA) of the \n\npowders are presented in Table 2. The data enable concluding about a clear \n\nincrease of PS and a concomitant decrease of SSA as calcination temperature \n\nincreased. Moreover, increasing the milling time resulted in a gradual size \n\nreduction, accompanied by an increase of SSA, confirming the effects expected \n\nfrom milling.   \n\n \n\nTable 2. The features of Sr?TCP powders (particle size, wideness of the distribution and specific \n\nsurface area (SSA)) were affected by calcination temperature and by milling time. Features of \n\npowders blends used in this work are presented too.  \n\nCalcination \ntemperature (\u00baC) \n\nmilling time \n(min) \n\nD10\na \n\n(\u00b5\u00b5\u00b5\u00b5m) \nD50\n\nb \n(\u00b5\u00b5\u00b5\u00b5m) \n\nD90\nc \n\n(\u00b5\u00b5\u00b5\u00b5m) \n\ndDmean \n(\u00b5\u00b5\u00b5\u00b5m) \n\nSSA \n(\u00b10.5) \n(m2g????1) \n\n0 0.8 6.7 24.7 9.9 3.8 \n\n6 0.4 1.3 5.3 2.2 4.5 800\u00baC \n\n12 0.4 0.7 2.3 1.0 5.0 \n\n0 0.7 9.8 31.5 13.5 1.3 \n\n6 0.4 1.4 6.8 2.6 2.2 900 \u00baC \n\n12 0.4 0.8 3.6 1.4 2.5 \n\n0 0.6 11.1 28.9 13.2 0.1 \n\n6 0.4 1.6 8.7 3.0 0.6 1000\u00baC \n\n12 0.4 1.0 2.9 1.4 1.1 \n\n0 1.1 15.6 32.8 16.8 0.1 \n\n6 0.3 4.6 23.6 8.4 0.1 1100\u00baC \n\n12 0.3 2.4 14.8 5.2 0.3 \n\n50:50 Blend e 0.4 0.8 2.5 1.1 - \n800\u00baC \n\n75:25 Blend f 0.4 0.9 3.0 1.4 - \n\na D50 \u2013 median particle size: particle size for which 50 vol.% of the particles are finer. \nb D10 \u2013 10 vol.% of the particles are smaller than this value. \nc D90 \u2013 90 vol.% of the particles are smaller than this value. \nd Dmean \u2013\u201caverage\u201d size of particles. \ne 50:50 Blend ? blend of 50 wt% 800?6 + 50 wt% 800?12. \nf 75:25 Blend ? blend of 75 wt% 800?6 + 25 wt% 800?12. \n \n\n \n\n\n\nCap\u00edtulo 3 \n\n 120 \n\nFig. 3 shows the morphological SEM features of non-milled powders heat-treated \n\nat all temperatures, while Fig. 4 depicts the influence of milling on the morphology \n\nfor the powders heat-treated at 800\u00baC and 1100\u00baC. The less magnified SEM \n\nmicrographs of Fig. 3 show overall views of dispersed particles/aggregates \n\ndeposited over the metallic supports, while the higher magnified inserts show clear \n\ndetails about the gradual sintering effects upon increasing the heat treatment \n\ntemperature. The micrographs shown in Fig. 4 confirm the strong aggregation \n\neffect of calcination temperature and the importance of the milling process in \n\ndestroying the aggregates.  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 3. Scanning electron micrographs of Sr?TCP powders heat-treated at different temperatures.  \n\n \n\n \n\n \n\n \n\n \n\n\n\nCap\u00edtulo 3 \n\n 121 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 4. Scanning electron micrographs of Sr?TCP powders heat-treated at 800\u00baC (a) and 1100\u00baC \n\n(b) without milling (a1 and b1), after milling for 6 min (a2 and b2) and 12 min (a3, b3). \n \n\n3.2 Characterisation of the Sr?TCP granules  \n\nThe starting suspension exhibited an appropriate shear thinning behaviour (not \n\nshown) for the preparation of the granules. The DTA curve (not shown) exhibited \n\nan exothermic peak centred at 1209 \u00baC, which was attributed to the ? ? ? phase \n\ntransformation. Based on this result, 1150\u00baC was selected as the sintering \n\ntemperature for the granules. \n\n\n\nCap\u00edtulo 3 \n\n 122 \n\nThe morphology of sintered granules can be observed in the SEM micrographs \n\npresented in Fig. 5, confirming the high degrees of sphericity and density. The \n\nSEM observation of the internal cross sections of some granules revealed only a \n\nfew small pores. The experimental density achieved upon sintering, was 3.055 \u00b1 \n\n0.06 g cm?3, corresponding to relative density of ~97%.  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 5. SEM micrographs of the Sr?TCP granules sintered at 1150\u00baC. \n\n \n\n3.3 Injectability and filter pressing effect of pastes \n\n3.3.1 Non-reactive systems  \n\nThe results of injectability of non-setting pastes without and with added 10 wt.% \n\ngranules are present in Fig. 6a and b, respectively. From non-milled powders, \n\ninjectability could be solely performed for LPR = 0.6 mL g?1. Fig. 6a reveals that \n\ninjectability was improved with increasing milling times and LPR. From non-milled \n\npowders, only the P?1100?0 paste could be partially extruded at the lower LPR \n\n\n\nCap\u00edtulo 3 \n\n 123 \n\nvalues (0.34 and 0.4 mL g?1), achieving 32.8 \u00b1 0.4 % and 48.1 \u00b1 0.2 % of \n\ninjectability, respectively. The increase of LPR to 0.6 mL g?1 allowed the extrusion \n\nof all the pastes derived from non-milled powders.  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 6. (a) Injectability of non-reactive pastes prepared at different LPR values from powders \n\ncalcined at different temperatures and submitted to different milling times (each data point is the \n\naverage of three independent experiments); non setting pastes (standard deviations ? 1.55); \n\n(b) the same pastes by replacing 10 wt.% of Sr?TCP powder by 10% of granules \n\n(standard deviations ? 1.24).  \n\n(a) \n\n(b) \n\n\n\nCap\u00edtulo 3 \n\n 124 \n\nThe highest value of injectability (95.8 \u00b1 0.8 %) was obtained for P?1100?0, while \n\nthe lowest one (46.4 \u00b1 1.5 %) was observed for P?800?0. All the pastes prepared \n\nfrom powder milled for 12 min could be more extensively extruded in comparison \n\nto the ones derived from powders non-milled or milled for 6 min. For example, at \n\nthe LPR = 0.34 mL g?1, the injectability values for P?1000?12 and P?1100?12 \n\nwere as high as 95.2 \u00b1 1.4 %, and 95.7 \u00b1 0.7 %, respectively. The results \n\ndisplayed in Fig. 6a and b also reveal that injectability was enhanced by replacing \n\n10 wt.% of Sr?TCP powder by the same amount of spherical dense granules that \n\nsimulate larger individual particles. The larger improvements were achieved for the \n\npowder samples calcinated at 800\u00baC and 900\u00baC. The results about the influence of \n\nthe same experimental variables (calcination temperature, milling time and LPR) \n\non the extent of filter pressing effect are reported in Table 3. \n\n \n\nTable 3. The features of Sr?TCP powders determined by the heat treatment temperature and \n\nmilling time or by adding spherical dense granules, and the liquid-to powder ratio (LPR) affected \n\nthe homogeneity of non-reactive pastes upon extrusion.  \n\nPastes \nInitial \nLPR \n\n(mL g-1) \n\nLPR of A1a \n(mL g????1) \n\nLPR of A2a \n(mL g????1) \n\nLPR of A3a \n(mL g????1) \n\nLPR of  \nremaining paste \n\nnot extruded \n(mL g????1) \n\np\u2013Value \n\nP????800????0 0.66 \u00b1 0.01 0.61 \u00b1 0.01 - 0.51 \u00b1 0.02 0.011b \n\nP????900????0 0.64 \u00b1 0.00 0.60 \u00b1 0.02 - 0.51 \u00b1 0.01 0.003 b \n\nP????1000????0 0.59 \u00b1 0.01 0.62 \u00b1 0.01 - 0.50 \u00b1 0.01 0.004 b \n\nP????1100????0 \n\n0.6 \n\n0.57 \u00b1 0.01 0.56 \u00b1 0.01 0.59 \u00b1 0.02 - 0.050 \n\n0.34 0.43 \u00b1 0.01 - - 0.27 \u00b1 0.01 0.002b \n\n0.4 0.47 \u00b1 0.02 0.39 \u00b1 0.01 - 0.30 \u00b1 0.01 0.002 b P????1100????0 \n\n0.6 0.57 \u00b1 0.01 0.56 \u00b1 0.01 0.59 \u00b1 0.02 - 0.050 \n\nP????800????0 0.66 \u00b1 0.01 0.61 \u00b1 0.01 - 0.51 \u00b1 0.02 0.011 b \n\nP????800????12 \n0.6 \n\n0.58 \u00b1 0.01 0.58 \u00b1 0.01 0.59 \u00b1 0.01 - 0.620 \n\nP????800????6 0.41 \u00b1 0.01 - - 0.36 \u00b1 0.01 0.014b \n\nP????900????6 0.38 \u00b1 0.01 0.34 \u00b1 0.01 - 0.31 \u00b1 0.01 0.014 b \n\nP????800????6????G 0.41 \u00b1 0.01 0.38 \u00b1 0.01 0.39 \u00b1 0.01 - 0.026 b \n\nP????900????6????G \n\n0.4 \n\n0.39 \u00b1 0.01 0.38 \u00b1 0.01 0.39 \u00b1 0.01 - 0.225 \n\na A1, A2 and A3 - paste samples collected along the extrusion process. \nb Presence of filter pressing effect (p<0.05). \n\n\n\nCap\u00edtulo 3 \n\n 125 \n\nStatistical analysis indicated the occurrence of this phenomenon for most of the \n\nnon-reactive pastes except for the P?1100?0, P?800?12 and P?900?6?G ones. At \n\nLPR = 0.6 mL g?1, the pastes P?800?0, P?900?0, P?1000?0 and P?1100?0 \n\nrevealed enhanced flowability and decreased trend for solid/liquid phase \n\nseparation with the heat treatment temperature increasing. Accordingly, no \n\nsegregation has apparently occurred in P?1100?0, contrarily to the quite visible \n\nfilter pressing effect in the cases of P?800?0, and P?900?0 pastes. The LPR \n\nvalues for these last pastes at the beginning of the extrusion (A1) were higher than \n\nthe starting value (0.6 mL g?1). This initial liquid enrichment is consistent with the \n\nlower LPR values measured for the remaining portion of the paste in the syringe. \n\nIn the case of paste P?1000?0, a less extended filter pressing effect was only \n\nnoticed for the A2 sample. For the pastes P?1100?0, the filter pressing effect \n\nabsent at 0.6 mL g?1, became clearly and gradually noticeable with decreasing \n\nLPR values. Table 3 also shows that milling for 12 min was enough to prevent the \n\nfilter pressing effect at 0.6 mL g?1 for the paste P?800?12, contrarily to the \n\nextensive solid/liquid phase separation observed for P?800?0. But milling for 6 min \n\nwas insufficient to eliminate the filter pressing effect at 0.4 mL g?1 for the pastes \n\nP?800?6 and P?900?6. On the other hand, the filter pressing effect was much \n\nmitigated for P?800?6?G and completely prevented for P?900?6?G. \n\n \n\n3.3.2 Reactive systems  \n\nThe injectability results of reactive cement pastes at various LPR values, without \n\nand with added 10 wt.% granules, are presented in Fig. 7(a) and (b), respectively. \n\nSome observable features (enhanced injectability by increasing LPR and \n\ndecreasing particle/agglomerate sizes) are common to non-reactive systems [14, \n\n17]. However, exceptions can also be noticed: (i) the injectability of CP?1100?0 > \n\nCP?1100?6 > CP?1100?12; (ii) increasing the LPR decreased the injectability of \n\nCP?1100?6 and CP?1100?12 systems; (iii) at LRP = 0.34 mL g?1, the injectability \n\nof CP?800?12 (84.5 \u00b1 0.8 %) was lower than that of CP?800?6 (96.9 \u00b1 0.5 %). \n\n\n\nCap\u00edtulo 3 \n\n 126 \n\nPastes from non-milled powders could not be extruded at LRP = 0.28 mL g?1 and \n\nonly partially extruded at LPR = 0.34 mL g?1.  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 7. (a) Injectability of reactive cement pastes prepared at different LPR values from powders \n\ncalcined at different temperatures and submitted to different milling times (each data point is the \n\naverage of three independent experiments); cement pastes; (standard deviations ? 4.49); \n\n(b) the same pastes by replacing 10 wt.% of Sr?TCP powder by 10% of granules \n\n(standard deviations ? 3.28). \n\n(a) \n\n(b) \n\n\n\nCap\u00edtulo 3 \n\n 127 \n\nThe higher values of injectability at 0.34 mL g?1 were obtained for CP?800?0 \n\n(24.7 \u00b1 2.0 %) and CP?1100?0 (24.7 \u00b1 2.3 %), and the lower ones were observed \n\nfor CP?900?0 (3.7 \u00b1 0.9 %) and CP?1000?0 (19.5 \u00b1 2.7 %). This tendency was \n\nmaintained at LPR = 0.4 mL g?1 with CP?800?0 and CP?1100?0 reaching \n\n95.6 \u00b1 2.1 and 97.3 \u00b1 0.2 %, respectively. The pastes derived from powder \n\nsamples milled for 6 min could be partially extruded at LPR = 0.28 mL g?1. The \n\nhighest injectability value (50.9 \u00b1 2.5 %) was obtained for CP?1100?6 while the \n\nlowest one (1.8 \u00b1 0.3 %) was registered for CP?900?6. Increasing LPR to \n\n0.40 mL g?1 enhanced the injectability of the systems CP?800?6 (95.6 \u00b1 2.0 %), \n\nCP?900?6 (97.4 \u00b1 0.7 %) and CP?1000?6 (97.4 \u00b1 0.5 %), while worsen that of \n\nCP?1100?6 (23.9 \u00b1 1.3 %). For the pastes derived from powder samples milled for \n\n12 min, the higher injectability values at LPR = 0.28 mL g?1 were obtained for \n\nCP?800?12 (79.7 \u00b1 4.1 %) and CP?1000?12 (96.0 \u00b1 0.6 %), while the less \n\nperforming systems were CP?900?12 (33.6 \u00b1 2.2 %) and CP?1100?12 \n\n(35.6 \u00b1 2.1 %). \n\nComparing the injectability results for the pastes without (Fig. 7a) and with added \n\n10 wt.% of granules (Fig. 7b), slight increases are observed in just some cases \n\nwhen granules are present. This small beneficial effect of granules was more \n\nevident for CP?900?0?G and CP?1000?0?G at LPR = 0.40 mL g?1. In the \n\nremaining cases, granules worsened the injectability (Fig. 7b and Table 4). For the \n\nCP?1100?0?G at LPR = 0.40 mL g?1, injectability decreased from 97.3 \u00b1 0.2 wt.% \n\nto 35.3 \u00b1 1.8 wt.%. At LPR = 0.28 mL g?1, the liquid was insufficient to wet the non-\n\nmilled powders + granules, thus preventing extrusion. \n\nFor reactive pastes, the dependence of filter pressing effect on calcination \n\ntemperature and milling time can be judged from the results presented in Table 4. \n\nThe first set of pastes aimed at evaluating the effect of heat treatment \n\ntemperature, reveals that: (i) at LPR = 0.40 mL g?1 segregation phenomena \n\napparently did not occur for CP?1100?0 (p > 0.05), being noticeable for CP?900?0 \n\nand CP?1000?0 ones (p &lt;0.05 for both cases); (ii) the CP?800?0 could be \n\ncompletely extruded, but a slight filter pressing effect has occurred.  \n\n\n\nCap\u00edtulo 3 \n\n 128 \n\nTable 4. The features of Sr?TCP powders determined by the heat treatment temperature and \n\nmilling time or by adding spherical dense granules, and the liquid-to powder ratio (LPR) affected \n\nthe homogeneity of reactive pastes upon extrusion. \n\nCement \nPastes \n\nInitial \nLPR \n\n(mL g????1) \n\nLPR of \nA1a \n\n(\u00b1 0.01) \n(mL g????1) \n\nLPR of \nA2a \n\n(\u00b1 0.01) \n(mL g????1) \n\nLPR of \nA3a \n\n(\u00b1 0.01) \n(mL g????1) \n\nLPR of \nremaining \npaste not \nextruded \n(\u00b1 0.01)  \n(mL g????1) \n\np\u2013\nValue \n\nCP????800????0 0.41  0.37 0.37 - 0.040c \n\nCP????900????0 0.34  0.53 - 0.19 0.000c \n\nCP????1000????0 0.33  0.62 - 0.14 0.000c \n\nCP????1100????0 \n\n0.40 \n\n0.38  0.37 0.37 - 1.000 \n\n0.28 b b b b - \n\n0.34 0.45 0.39 - 0.29 0.001c CP????1100????0 \n\n0.40 0.38 0.37 0.37 - 1.000 \n\nCP????800????0 0.43 - - 0.19 0.000 c \n\nCP????800????6 \n0.34 \n\n0.33 0.34 0.34 - 0.667 \n\nCP????800????6 0.33 0.34 0.34 - 0.667 \n\nCP????900????6 0.34 0.36 - 0.29 0.000c \n\nCP????800????6????G 0.34 0.33 0.34 - 0.220 \n\nCP????900????6????G \n\n0.34 \n\n0.42 0.31 - 0.26 0.001c \n\na A1, A2 e A3 - samples of paste injected during the extrusion. \nb The liquid amount was not enough to form a paste. \nc Presence of filter pressing effect (p<0.05). \n\n \n\nThe second set of experiments aimed at evaluating the effect of LPR in \n\nCP?1100?0 pastes. At LPR = 0.28 mL g?1 no extrudable pastes could be formed. \n\nAt LPR = 0.34 mL g?1, an evident solid/liquid phase separation occurred; but this \n\nphenomenon was no more apparent at LPR = 0.40 mL g?1. The third set of \n\nexperiments was aimed at evaluating the effect of milling for 6 min on the filter \n\npressing effect upon extruding the CP?800?0 and CP?800?6 pastes. The filter \n\npressing effect, clearly evident for the CP?800?0 paste at LPR = 0.34 mL g?1, \n\ndisappeared in the case of CP?800?6, reflecting the beneficial effect of milling. \n\n\n\nCap\u00edtulo 3 \n\n 129 \n\nThe last set of pastes, prepared from powders milled for 6 min, was intended to \n\ninvestigate the influence of heat treatment temperature (800\u00baC, 900\u00baC) and of \n\nadding 10 wt.% of granules on the filter pressing effect at a fixed LPR \n\n(0.34 mL g?1). Segregation did not occur for CP?800?6 and CP?800?6?G, but \n\nappeared in the cases of CP?900?6 and CP?900?6?G, being more evident in \n\nCP?900?6?G.  \n\n \n\n3.3.3 Powder blends in reactive systems \n\nConsidering that: (i) the high injectability values of CP?1000?12 (96.0 \u00b1 0.6 %) and \n\nCP?800?12 (79.7 \u00b1 4.1 %) pastes at the lowest LPR (0.28 mL g?1) (Fig. 7a); (ii) \n\nthe jump in injectability of CP?800?6 to 96.9 \u00b1 0.5 % when LPR was increased to \n\n0.34 mL g?1, it was hypothesised that blends of powders 800?6 and 800?12 could \n\nbe a viable option to mimic the PSD of the sample CP?1000?12 and thus to \n\nenhance the injectability of the pastes. Accordingly, attempts were made to \n\nreproduce as much as possible the target PSD of the 1000?12 powder by blending \n\ntwo different powder samples. The selection of this pair of powders was based on \n\nthe PSD features reported in Table 2 and in Fig. 2. The blend of powders \n\n800?6 + 800?12 was found to exhibit features similar to the target. The features of \n\nthe pair 900?6 + 900?12 were not far, except for D90 that was significantly higher \n\n(Table 2). Powders obtained at 1100\u00baC deviated from the desired target (Fig. 2) \n\nand were excluded. Therefore, 5 powders were selected to proceed with this \n\nstudy: 1000?12 (1); 800?6 (2); 800?12 (3); and the blends of the powders \n\n800?6 + 800?12 in the following weight ratios: 50:50 (4) and 75:25 (5). The \n\ncorresponding PSD curves are plotted in Fig. 8a and b. \n\nFig. 8b shows that curve 1 (1000?12) is located in between the curves 2 (800?6) \nand 3 (800?12), corroborating the suitability of the pair 800?6 + 800?12 for the \n\nintended purposes. As a matter of fact, small deviations relative to curve 1 are \n\nobserved for PSD curves 4 and 5, in good agreement with data reported in Table \n\n\n\nCap\u00edtulo 3 \n\n 130 \n\n2. The best fit was obtained for blend 75:25 (curve 5) showing only a residual \n\ndiscrepancy, D value, between distributions. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 8. (a) Particle size distributions of Sr?TCP powders: (1) 1000?12; (2) 800?6; (3) 800?12; (4) \n\n50:50 blend of 800?6 and 800?12; (5) 75:25 blend of 800?6 and 800?12. (b) Pairwise comparison \n\nof different cumulative distributions with the one obtained for the 1000?12 sample. \u201cD\u201d quantifies \n\nthe integral of the absolute differences between two cumulative distributions. \n\n(a) \n\n(b) \n\n\n\nCap\u00edtulo 3 \n\n 131 \n\n \n\nFig. 9 shows the injectability results of the reactive pastes derived from the 5 \n\npowders selected above at two LPR values. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 9. Injectability of the cement pastes at two LPR values (0.28 and 0.34 mL g?1): \n\n(1) CP?1000?12; (2) CP?800?6; (3) CP?800?12; (4) CP?50:50 blend of 800?6 and 800?12; \n\n(5) 75:25 blend of 800?6 and 800?12. The symbol \u2018+\u2019 denotes significant differences of average \n\ninjectability values with respect to the reference CP?1000?12 (p<0.05). \n\n \n\nIt can be seen that injectability of CP?800?6 was significantly enhanced with LPR \n\nincreasing from 0.28 to 0.34 mL g?1, while the effect was less pronounced for \n\nCP?1000?12 and CP?800?12 pastes. The pastes derived from powder blends \n\ncould be completely extruded even at the lower LPR = 0.28 mL g?1, confirming the \n\nwiseness of these selections. The evolution LPR values along the extrusion \n\nprocess of the pastes prepared from the 5 selected powders is reported in Table 5.  \n\n \n\n\n\nCap\u00edtulo 3 \n\n 132 \n\nTable 5. The features of individual Sr?TCP powders heat treated at 800\u00baC and milled for different \n\ntimes and of their blends affected the homogeneity of reactive cement pastes upon extrusion. \n\n(1) CP?1000?12, presented for comparison; (2) CP?800?6; (3) CP?800?12; (4) 50:50 \n\n(800?6 + 800?12) blend; and (5) 75:25 (800?6 + 800?12) blend. \n\nCement \npastes \n\nInitial \nLPR \n\n(mL g????1) \n\nLPR of \nA1a \n\n(\u00b1 0.01) \n(mL g????1) \n\nLPR of \nA2a \n\n(\u00b1 0.01) \n(mL g????1) \n\nLPR of \nA3a \n\n(\u00b1 0.01) \n(mL g????1) \n\nLPR of \nremaining \npaste not \nextruded  \n(\u00b1 0.01)  \n(mL g????1) \n\nP-\nValue \n\n1 0.27 0.29 0.30 - 0.074 \n\n2 0.31 - - 0.26 0.003b \n\n3 0.28 0.30 - 0.26 0.017b \n\n4 0.27 0.29 0.29  0.069 \n\n5  \n\n0.28 \n\n0.29 0.29 0.28  0.725 \n\na A1, A2 e A3 - samples of paste injected during the extrusion. \nb Presence of filter pressing effect (p<0.05). \n \n\nThe filter pressing effect, evident in CP?800?6 and CP?800?12 systems (p &lt;0.05 \n\nfor both systems), could not be detected neither in the reference paste \n\nCP?1000?12 nor in the cement pastes derived from powder blends (4 and 5). \n\n \n\n3.4 Influence of dispersing/reactive liquids on zeta potential and rheology \n\nSince the most significant differences between non-reactive and reactive systems \n\nwere observed for powders heat treated at 800\u00baC, they were selected to \n\ninvestigate the effects of liquids\u2019 composition on their dispersing ability. The plots \n\nof ZP and EC of dilute 800?(50:50) systems are displayed in Figs. 10a and b, \nrespectively. The results for 15 wt.% CA are not shown in Fig. 10a because fast \ndissolution of the particles hindered any reliable measurement, in agreement with \n\nobservations reported elsewhere [21]. The absolute ZP values are close to zero in \n\nNaCl 3 M, being relatively small in the presence of 3 wt.% PVP and presenting a \n\nminimum at ~pH 7.5. The other curves show an increasing trend with pH \n\nincreasing, especially in the case of KCl 10-3 M. The EC is highest (~20 S m-1) in \n\n\n\nCap\u00edtulo 3 \n\n 133 \n\nNaCl 3 M, followed by the measured for the 15 wt.% CA-containing systems \n\n(~0.7 S m-1) irrespective of the presence of other additives. The remaining EC \n\ncurves appear almost superimposed and exhibit minima within the neutral pH \n\nregion.  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 10. Influence of the different aqueous electrolyte solutions and pH on (a) Zeta potential, and \n\n(b) Electrical conductivity of P?800?(50:50). Except for molar concentrations (M), the other \n\nnumerical coefficients in the sample codes stand for the concentration (wt.%) of the electrolyte in \n\nthe liquid. The error bars of standard deviations are almost imperceptible in some cases, meaning \n\nexcellent reproducibility of the data. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 11. Flow curves of pastes prepared with different aqueous solutions: (a) non-reactive \n\nP?800?(50:50) pastes; (b) reactive CP?800?6, CP?800?12 and CP?800?(50:50). The pastes \n\nwere prepared at different LPR (mL g?1): 0.45 (Black); 0.40 (Blue); 0.35 (Red); and 0.28 (Green). \n\n\n\nCap\u00edtulo 3 \n\n 134 \n\nThe flow curves of non-reactive P?800?(50:50) pastes prepared with different \n\naqueous solutions at various LPR are displayed in Fig. 11a. All the systems exhibit \n\nshear thinning behaviours within the entire shear rate range tested. With CA alone, \n\nand with the complete reactive liquid (3wt.%PVP + 0.5wt.%HPMC + 15wt.%CA), \n\nthe minima LPR values required to wet the powder and form a paste were 0.35 \n\nand 0.4 mLg?1, respectively. All the other curves (in black) correspond to LPR = \n\n0.45 mLg?1. In comparison to deionized water: (i) the NaCl 3 M solution forms a \n\nnoticeable less viscous paste; (ii) 3 wt.% PVP solution gives significantly higher \n\nviscosity values; (iii) the viscosity curve of paste prepared with the less \n\nconcentrated 0.5 wt.% HPMC solution is closer to that of pure water system. The \n\nleast viscous system was obtained for 15 wt.% CA solution. Further adding PVP \n\nand HPMC binders to CA solution somewhat enhanced the viscosity of the \n\nresulting paste.  \n\nThe shear thinning behaviour is also observed for the reactive systems in Fig. 11b, \n\nwith even smoother flow curves. At LPR = 0.45 mLg?1 the viscosity curve appears \n\nabove those corresponding to non-reactive pastes. The remaining viscosity curves \n\nat LPR = 0.28 mLg?1 (green) show the following features: (i) CP?800?(50:50) is \n\nless viscous than CP?800?6 or CP?800?12; (ii) the paste prepared with CA alone \n\nis slightly more viscous that obtained from the complete reactive liquid (3 wt.%PVP \n\n+ 0.5 wt.%HPMC + 15 wt.%CA), contrarily to what was observed for non-reactive \n\nsystems.  \n\n \n\n4. Discussion \n\nThe results of ICP analysis revealed an excellent agreement between the planned \n\nand the experimentally obtained Sr?TCP compositions. The good match of the \n\nXRD patterns (Fig. 1) and the standard files of pure and Sr?doped ??TCP (ICDD \n\nPDF 04-001-7104, and ICDD PDF 01-076-8438, respectively) mean that the lattice \n\ndistortions [31, 38, 39] are too small to be noticed [31, 37].  \n\n\n\nCap\u00edtulo 3 \n\n 135 \n\nThe precipitated primary Sr?TCP particles brought together by capillary forces \n\nupon drying tend to agglomerate through weak chemical bonds by releasing OH \n\nsurface groups and establishing oxygen bridges. These bonds strengthen and \n\nnecks are gradually formed as the heat-treatment temperature increases, resulting \n\nin the formation of hard agglomerates or even sintered aggregates [40], as \n\nillustrated in the SEM micrographs of Figs. 3 and 4. This explains why PSD curves \n\ndisplayed in Fig. 2 became gradually broader with increasing the heat-treatment \n\ntemperatures. The as formed aggregates are likely to be at least partially \n\ndestroyed by milling. This process is easier for the powders heat-treated at lower \n\ntemperatures that promote less extended neck formation among the primary \n\nparticles [40]. The SEM micrographs presented in Fig. 4 confirm the strong \n\naggregation effect of calcination temperature and the importance of the milling \n\nprocess in destroying the aggregates, in good agreement with the results \n\ndisplayed in Fig. 2 and Table 2. The SEM micrograph of 800?12 powder \n\n(Fig. 4, a3) shows assemblages of small particles brought together by capillary \n\naction upon the evaporation of the dispersing water (soft agglomerates). A first \n\nglance comparison of these relatively large particle assemblages with the smaller \n\nones seen in the SEM micrograph of 1100?12 (Fig. 4, b3) might be misleading. \n\nMoreover, the coarser aggregates present in the powder calcined at 1100\u00baC are \n\nlikely to sediment before collecting the dilute suspension droplet onto the metallic \n\nsupport used for SEM analysis. The grain growth and the extensive neck formation \n\namong the primary particles heat treated at 1100\u00baC confer a more compact and \n\ncohesive structure to the aggregates (Fig. 3), explaining the smaller specific \n\nsurface area in comparison to the sample calcined at 800\u00baC (Table 2). These \n\npowder characteristics are expected to affect their reactivity when in contact with \n\nthe liquid medium.  \n\nThe micrographs presented in Fig. 5 reveal that freeze granulation from the \n\n47 vol.% suspension of 800?0 powder (D50 ? 0.51 \u00b5m) was effective for preparing \n\nspherical granules and sintering the granules at 1150\u00baC enabled achieving high \n\ndegree of density. The high relative density of ~97%, (3.055 \u00b1 0.06 g cm?3) is \n\nconsistent with the good dispersion of the Sr?TCP powder in the starting \n\n\n\nCap\u00edtulo 3 \n\n 136 \n\nsuspension. Sintering at a temperature that is 59\u00baC below the one corresponding \n\nto the ? ? ? phase transformation (1209\u00baC, as determined by DTA) also \n\naccounted for the high level of densification achieved. Considering that pure \n\n??TCP undergoes ? ? ? phase transformation at ~1125\u00baC [41-44], these results \n\nindicate that thermal stability was enhanced for ~84\u00baC by doping ??TCP with \n\n5 mol% Sr.  \n\nFor non-reactive systems, the pastes prepared from powders heat-treated at lower \n\ntemperatures (800 and 900\u00baC) required higher LPR to be injected and were more \n\nprone to undergo solid/liquid phase separation upon extrusion in comparison to \n\nthose derived from powders calcined at higher temperatures (1000 and 1100\u00baC) \n\n(Table 3). This is consistent with the higher densification degrees (Fig. 3 and 4) \n\nand the lower values of SSA (Table 2) of the last powders, which will trap less \n\nliquid in the intra-agglomerate pores, thus availing more liquid to enhance the flow \n\n(Fig. 6a). On the other hand, strongly bonded particles moving together will make \n\nthe flow more difficult because of their mutual collisions and risks of clogging the \n\ncannula. This tendency for hindering the flow and form a slow moving or stopped \n\nporous paste bed is the well-known filter pressing effect. Therefore, destroying \n\nrigid particle aggregates that might clog the cannulas is a fundamental step to \n\nimprove injectability of pastes and to mitigate the filter pressing effect. This is \n\nconfirmed by the highest injectability combined with the absence of filter pressing \n\neffect observed for the P?1100?12 system (Fig. 6a and Table 3). Injectability was \n\nalso significantly enhanced by partially replacing irregularly shaped aggregates by \n\nspherical granules (Fig. 6b and Table 3) that simulate uniform larger particles \n\n(Fig. 5). These improvements can be attributed to the regular shape of granules, \n\nthe change in size ratio, and packing ability, and to less liquid trapped in the \n\nintra-aggregate pore spaces [45]. Therefore, higher LPR will be required to enable \n\npastes made of aggregated powders to flow in a homogeneous way. Table 3 \n\nconfirms that liquid phase migration upon extrusion occurred preferentially in \n\nsystems with lower LPR. These results are in agreement with the existing \n\nconsensus that increasing LPR facilitates the injectability [16] as observed in \n\nFig. 6.  \n\n\n\nCap\u00edtulo 3 \n\n 137 \n\nIn general, increasing LPR and milling time facilitated injectability of both non-\n\nreactive (Fig. 6a and b) and reactive systems (Fig. 7a and b) [14, 17]. The \n\nextended filter pressing effect observed especially for non-reactive pastes derived \n\nfrom powders calcined at lower temperatures became less evident in the case of \n\nreactive systems (Table 4). Moreover, the noticeable improvements in injectability \n\nwith increasing calcination temperature observed for non-reactive pastes were not \n\nverified for reactive systems (Fig. 7a). These differences in flow properties \n\nbetween reactive and non-reactive systems suggest that the relevance of \n\nparticle/agglomerate size and size distribution is not the same in these different \n\nsystems, supporting the explanatory hypothesis suggested above. Other \n\ninfluencing factors come into play in the more complex reactive systems and, \n\namong the powders\u2019 features particle/aggregate size distribution seems the most \n\nrelevant one, especially at the lower LPR values. On the other hand, the relatively \n\nhigh ionic strength of the reacting liquid contributed to mitigate the occurrence of \n\nfilter pressing effect in comparison to non-reactive pastes prepared from powders \n\ncalcined at lower temperatures (Table 4). The overall results suggest that the \n\nparticle/aggregate size distribution is the key factor that mostly determines \n\ninjectability of cement pastes. In fact, powder blends with an overall PSD close to \n\nthat of the standard powder 1000?12 (Fig. 8) performed similarly upon extrusion \n\n(Fig. 9 and Table 5). Several models [48-52] have been proposed to explain the \n\nenhanced packing ability of binary, ternary or even multimodal particle size \n\nsystems by mixing in various proportions different sized particles. \n\nFurnas model [48] is particularly useful for predicting the optimal packing of \n\npowder blends, with the smaller particles occupying the interstitial spaces among \n\nthe larger ones. Farris [53] explain the viscosity reduction that follows from mixing \n\ndiscretely sized particles with sufficiently large size ratios, considering that the \n\nsuspension could be regarded as a coarse fraction suspended in a fluid containing \n\nthe finer particles, with all fractions behaving independently of each other. The \n\nlimited benefits in terms of injectability of reactive pastes containing coarse \n\nspherical granules (Fig. 7b) can be attributed to the excessively large size \n\ngranule/particle ratio, contrasting with the observations made for non-reactive \n\nsystems in which granules enhanced injectability.  \n\n\n\nCap\u00edtulo 3 \n\n 138 \n\nThe lower viscosity of CP?800?(50:50) in comparison to CP?800?6 or \n\nCP?800?12, Fig. 11b, reflects the enhanced packing ability of the powder blend in \n\nagreement with the Furnas [48] and Farris [53] models. Considering the small \n\ndifferences between the viscosity curves of CP?800?6 and CP?800?12, the lower \n\nviscosity of CP?800?(50:50), and the noticeable differences in injectability of these \n\nsystems (Fig. 9), it seems clear that injectability is much more sensitive to \n\nvariations in PSD than viscosity alone.  \n\nOne of the most salient differences of reactive systems is the lower amount of \n\nliquid required for injecting the pastes (Fig. 7) in comparison to non-reactive ones \n\n(Fig. 6). In fact, all cement pastes, except those prepared with non-milled powders, \n\ncould be partially or totally extruded at LPR = 0.28 mL g?1 (Fig. 7a). This seems \n\nstrange considering the expected increase in viscosity involved in hydraulic setting \n\nreactions. However, a number of reasons could be alleged to explain the \n\nenhanced flowing ability of reactive systems: (i) the presence of ionic species \n\nderived from CA and/or HPMC and PVP in the setting liquid may change the \n\ninterparticle forces and the packing ability. It is known that interparticle forces have \n\nsignificant effects on the ability of particles to pack in suspensions or pastes \n\n[20, 21, 46]; (ii) dissolution reactions that increase the ionic strength of the liquid, \n\nwhich in turn tends to collapse the electrical double layers around the particles \n\nenabling them to approach up to closer distances [47]. This explanatory \n\nhypothesis is supported by the almost null ZP in the presence of NaCl 3 M (Fig. \n\n10a), the correspondingly high EC (Fig. 10b), and the noticeably lower viscosity in \n\ncomparison to that of non-reactive paste made with deionised water (Fig. 11a). \n\nThis was further proved by comparing the feasibility of preparing non-reactive \n\npastes from 800?6 at LPR = 0.34 mL g?1 using pure water or NaCl 3 M solution. \n\nThe powder was not completely wetted by deionised water, contrasting with a \n\nflowable paste obtained with NaCl 3 M.  \n\nWith CA or (CA + PVP + HPMC) solutions, minima LPR values of 0.35 and \n\n0.4 mL g?1, respectively, were required for forming (non-necessarily extrudable) \n\nnon-reactive pastes (Fig. 11a). These values are noticeably higher than \n\n0.28 mL g?1 used to prepare extrudable reactive systems (Fig. 11b). On the other \n\n\n\nCap\u00edtulo 3 \n\n 139 \n\nhand, at LPR = 0.45 mL g?1 the non-reactive pastes prepared with 15 wt.% CA or \n\n(3wt.%PVP + 0.5wt.%HPMC + 15wt.%CA) solutions are noticeably less viscous in \n\ncomparison to the other systems at the same LPR (Fig. 11a). This enhanced \n\nfluidity of CA-containing pastes is likely to be due to two concomitant and \n\nconcurrent effects: (i) surface adsorption of citrate ions, accentuating the negative \n\nZP values [20, 21]; (ii) increase of ionic strength derived from dissolution of ?-TCP \n\nand the acidic environment. Such significant flow ability differences between non-\n\nreactive and reactive pastes are likely to derive mostly from the huge increase in \n\nionic strength derived from the acidic pH values of 15 wt.% CA and \n\n(3wt.%PVP + 0.5wt.%HPMC + 15wt.%CA) solutions and the partial dissolution of \n\nMCPM and ??TCP in reactive systems. This is supported by the impossibility of \n\nmeasuring any reliable ZP values in CA-containing solutions and by the noticeable \n\nEC values measured in the presence of 15 wt.% CA and \n\n(3wt.%PVP + 0.5wt.%HPMC + 15wt.%CA) (Fig. 10b).  \n\nIn summary, the most salient differences between reactive and non-reactive \n\nsystems can be explained by the significant increase in ionic strength in the case \n\nof reactive pastes, collapsing the electrical double layers around the particles. The \n\napparent size of the particles decreases and the interactions among them are \n\nmediated by short range lubricating forces [47]. Another important factor is the \n\nreplacement of 50% of ??TCP by MCPM in reactive systems. Further, real \n\ncomplex particle size variations that are hard to describe in detail, are also \n\nexpected from the dissolution/precipitation and setting reactions. Due to \n\nthermodynamic reasons, the sharpener corners of the particles will firstly undergo \n\ndissolution. This will favour the particles sliding over each other, also contribution \n\nto enhance the flowability and injectability of reactive pastes.  \n\n \n\n5. Conclusions  \n\nThis work demonstrates that knowledge acquired upon using non-reactive \n\nsystems regarding the effects of powder features (PS, PSD, state of aggregation) \n\ncannot be directly transposed to the setting cement pastes prepared from the \n\n\n\nCap\u00edtulo 3 \n\n 140 \n\nsame powders. The collapse of the electrical double layers around the particles \n\nand the surge of short range lubricating forces are consistent with injectability tests \n\nperformed under high ionic strength conditions (3 M NaCl), supporting the \n\nexplanatory hypothesis proposed. Accordingly, the overall injectability results for \n\nreactive systems revealed that under the set of fixed experimental conditions \n\nused, particle/aggregate size distribution is the most determining factor, as \n\nconfirmed by the excellent injectability of pastes derived from powders with \n\nsignificant differences in SSA (CP?1000?12 and CP?50:50 and CP?75:25). \n\nPartially aggregated particle might behave like individual particles and enhance \n\ninjectability, provided that they are integrated in an overall continuous and \n\nrelatively large PSD.  \n\nThe partial replacement of fine and/or insufficiently milled (aggregate) powders by \n\nregular shaped dense granules might be promising, provided that granules with \n\nsuitable sizes can be prepared to generate blends with proper PSD. Future \n\nresearch will be required towards optimising PS and PSD preferentially of \n\nnon-aggregate particles.  \n\n \n\nAcknowledgments \n\nThis work was supported by the European Regional Development Fund (FEDER) \n\nthrough the COMPETE and by the Portuguese Government through the \n\nPortuguese Foundation for Science and Technology (FCT), in the scope of the \n\nprojects UID/ CTM/50011/2013 (Aveiro Institute of Materials, CICECO, www. \n\nciceco.ua.pt), project PEst-OE/EEI/UI0127/2014 and UID/CEC/ 00127/2013 \n\n(Institute of Electronics and Informatics Engineering of Aveiro, IEETA, \n\nwww.ieeta.pt) and project UID/MAT/04106/2013 (Center for Research and \n\nDevelopment in Mathematics and Applications, CIDMA, www.cidma.mat.ua.pt). \n\nP.M.C. Torres (SFRH/BD/62021/2009), S. Gouveia (SFRH/BPD/87037/2012), \n\nS.M. Olhero (SFRH/BPD/87486/2012) and, Ajay Kaushal (SFRH/BPD/ \n\n77598/2011) acknowledge the respective fellowship Grant by FCT. \n\n\n\nCap\u00edtulo 3 \n\n 141 \n\nReferences \n\n[1] W.E. Brown, L.C. Chow, A new calcium phosphate setting cement, J. Dent. \n\nRes. 62 (1983) 672. \n\n[2] R.Z. LeGeros, A. Chohayeb, A. Shulman, Apatitic calcium phosphates: \n\nPossible dental restorative materials, J Dent Res. 61(1982) 343. \n\n[3] M. Bohner, Calcium orthophosphates in medicine: from ceramics to calcium \n\nphosphate cements, Injury. 31(2000) 37-47. \n\n[4] M. Bohner, Reactivity of calcium phosphate cements, J. Mater. \n\nChem.17 (2007) 3980-6. \n\n[5] M. Bohner, U. Gbureck, J.E. Barralet, Technological issues for the \n\ndevelopment of more efficient calcium phosphate bone cements: a critical \n\nassessment, Biomaterials 26 (2005) 6423-9. \n\n[6] S.V. Dorozhkin, Calcium orthophosphates cements for biomedical \n\napplication, J. Mater. Sci. Mater. Med. 43(2008) 3028-57. \n\n[7] E. Fernandez, Bioactive bone cements. In: Akay M, editor. Wiley \n\nencyclopedia of biomedical engineering. New York: John Wiley &amp; Sons, Inc.  2006. \n\n1\u20139. \n\n[8] H. Alves, L. Santos, C. Bergmann, Injectability evaluation of tricalcium \n\nphosphate bone cement, J. Mater. Sci. Mater. Med. 19 (2008) 2241-6. \n\n[9] E.F. Burguera Xu HHK, L.M. Sun, Injectable calcium phosphate cement: \n\nEffects of powder-to-liquid ratio and needle size 9, J. Biomed. Mater. Res. B. 84B \n\n(2008) 493-502. \n\n[10] M. Bohner, Design of ceramic-based cements and putties for bone graft \n\nsubstitution, Eur Cells Mater. 20 (2010) 1-12. \n\n[11] S. Dorozhkin, Self-Setting Calcium Orthophosphate Formulations, J. Funct. \n\nBiomater. 4 (2013) 209-311. \n\n\n\nCap\u00edtulo 3 \n\n 142 \n\n[12] MK Singh, T Shokuhfar, J.J.A. Gracio, A.C.M. de Sousa, J.M.F. Ferreira, H. \n\nGarmestani, S. Ahzi, Hydroxyapatite Modified with Carbon-Nanotube-Reinforced \n\nPoly(methyl methacrylate): A Nanocomposite Material for Biomedical Applications, \n\nAdv. Funct. Mater.18 (2008) 694. \n\n[13] S. Metallidis, D. Topsis, J. Nikolaidis, E. Alexiadou, G. Lazaraki, L. Grovaris, \n\nA. Theodoridou, P. Nikolaidis, Penetration of moxifloxacin and levofloxacin into \n\ncancellous and cortical bone in patients undergoing total hip arthroplasty, J \n\nChemotherapy. 19 (2007) 682-7. \n\n[14] M. Habib, G. Baroud, F. Gitzhofer, M. Bohner, Mechanisms underlying the \n\nlimited injectability of hydraulic calcium phosphate paste, Acta Biomater. 4 (2008) \n\n1465-71. \n\n[15] L. Leroux, Z. Hatim, M. Freche, J.L. Lacout, Effects of various adjuvants \n\n(lactic acid, glycerol, and chitosan) on the injectability of a calcium phosphate \n\ncement, Bone 25 (1999) 31S-34S. \n\n[16] G. Baroud, E. Cayer, M. Bohner, Rheological characterization of \n\nconcentrated aqueous ?-tricalcium phosphate suspensions: The effect of liquid-to-\n\npowder ratio, milling time, and additives, Acta Biomater. 1 (2005) 357-63. \n\n[17] M. Bohner, G. Baroud, Injectability of calcium phosphate pastes, \n\nBiomaterials 26 (2005) 1553-63.  \n\n[18] E.B. Montufar, Y. Maazouz, M.P. Ginebra, Relevance of the setting reaction \n\nto the injectability of tricalcium phosphate pastes, Acta Biomater. 9 (2013)6188-98. \n\n[19] A. Fatimi, J.F. Tassin, J. Bosco, R. Deterre, M.A.V. Axelos, P. Weiss, \n\nInjection of calcium phosphate pastes: prediction of injection force and comparison \n\nwith experiments, J Mater Sci Mater Med. 23 (2012) 1593-603. \n\n[20] J.E. Barralet, L.M. Grover, U. Gbureck, Ionic modification of calcium \n\nphosphate cement viscosity. Part II: hypodermic injection and strength \n\nimprovement of brushite cement, Biomaterials 25 (2004)2197-203. \n\n\n\nCap\u00edtulo 3 \n\n 143 \n\n[21] U. Gbureck, J.E. Barralet, K. Spatz, L.M. Grover, R. Thull, Ionic modification \n\nof calcium phosphate cement viscosity. Part I: hypodermic injection and strength \n\nimprovement of apatite cement, Biomaterials 25 (2004) 2187-95. \n\n[22] U. Gbureck, K. Spatz, R. Thull, J.E. Barralet, Rheological enhancement of \n\nmechanically activated ?-tricalcium phosphate cements, J. Biomed. Mater. Res. B \n\nAppl. Biomater. 73 (2005) 1-6. \n\n[23] M.P. Ginebra, A. Rilliard, E. Fernandez, C. Elvira, J. San Roman, J.A. \n\nPlanell, Mechanical and rheological improvement of a calcium phosphate cement \n\nby the addition of a polymeric drug, J Biomed Mater Res. 57 (2001) 113-8. \n\n[24] Khairoun I, Boltong MG, Driessens FCM, Planell JA. Some factors \n\ncontrolling the injectability of calcium phosphate bone cements, J Mater Sci Mater \n\nMed. 9 (1998) 425-8. \n\n[25] S. Pina, S.M. Olhero, S. Gheduzzi, A.W. Miles, J.M. Ferreira, Influence of \n\nsetting liquid composition and liquid-to-powder ratio on properties of a Mg-\n\nsubstituted calcium phosphate cement, Acta Biomater. 5 (2009) 1233-40. \n\n[26] S. Sarda, E. Fernandez, M. Nilsson, M. Balcells, J.A. Planell, Kinetic study \n\nof citric acid influence on calcium phosphate bone cements as water-reducing \n\nagent, J. Biomed. Mater. Res. 61 (2002) 653-9. \n\n[27] S. Tadier, L. Galea, B. Charbonnier, G. Baroud, M. Bohner, Phase and size \n\nseparations occurring during the injection of model pastes composed of \n\n?-tricalcium phosphate powder, glass beads and aqueous solutions, Acta \n\nBiomater. 10 (2014) 2259-68. \n\n[28] M. Habib, G. Baroud, F. Gitzhofer, M. Bohner, Mechanisms underlying the \n\nlimited injectability of hydraulic calcium phosphate paste. Part II: Particle \n\nseparation study, Acta Biomater. 6 (2010) 250-6. \n\n \n\n\n\nCap\u00edtulo 3 \n\n 144 \n\n[29] R.G. Carrodeguas, A.H. De Aza, X. Turrillas, P. Pena, S. De Aza, New \n\napproach to the beta ? alpha polymorphic transformation in magnesium-\n\nsubstituted tricalcium phosphate and its practical implications, J. Am. Ceram. Soc. \n\n91 (2008) 1281-86. \n\n[30] S. Pina, P.M. Torres, F. Goetz-Neunhoeffer, J. Neubauer, J.M.F. Ferreira, \n\nNewly developed Sr-substituted alpha-TCP bone cements, Acta Biomater. \n\n6 (2010) 928-35. \n\n[31] S. Kannan, S. Pina, J.M.F. Ferreira, Formation of strontium-stabilized \n\n?-tricalcium phosphate from calcium-deficient apatite, J. Am. Ceram. Soc. \n\n89 (2006) 3277-280. \n\n[32] P.M.C. Torres, S.I. Vieira, A.R. Cerqueira, S. Pina, O.A.B. da Cruz Silva, \n\nJ.C.C. Abrantes, J.M.F. Ferreira, Effects of Mn-doping on the structure and \n\nbiological properties of ?-tricalcium phosphate, J Inorg Biochem.136 (2014) 57-66. \n\n[33] S.M. Olhero, A. Kaushal, J.M.F. Ferreira, Fostering the properties of \n\nZr0.8Sn0.2TiO4 (ZST) ceramics via freeze granulation without sintering additives, \n\nRSC Adv. 4 (2014) 48734-48740. \n\n[34] X.P. Wang, J.D. Ye, H. Wang, Effects of additives on the rheological \n\nproperties and injectability of a calcium phosphate bone substitute material, J. \n\nBiomed. Mater. Res. B-Appl. Biomater. 78B (2006) 259-64. \n\n[35] H.H.K. Xu, M.D. Weir, E.F. Burguera, A.M. Frase, Injectable and \n\nmacroporous calcium phosphate cement scaffold, Biomaterials 27 (2006) 4279-\n\n287. \n\n[36] S. Pina, P.M. Torres, J.M. Ferreira, Injectability of brushite-forming Mg-\n\nsubstituted and Sr-substituted alpha-TCP bone cements, J. Mater. Sci. Mater. \n\nMed. 21 (2010) 431-8. \n\n[37] G. Renaudin, P. Laquerriere, Y. Filinchuk, E Jallot, J.M. Nedelec, Structural \n\ncharacterization of sol-gel derived Sr-substituted calcium phosphates with anti-\n\n\n\nCap\u00edtulo 3 \n\n 145 \n\nosteoporotic and anti-inflammatory properties, J. Mater. Chem. 18 (2008) 3593-\n\n600. \n\n[38] A. Bigi, E. Foresti, M. Gandolfi, M. Gazzano, N. Roveri, Isomorphous \n\nsubstitutions in ?-tricalcium phosphate: The different effects of zinc and strontium, \n\nJ. Inorg. Biochem. 66 (1997) 259-65. \n\n[39] S. Kannan, F. Goetz-Neunhoeffer, J. Neubauer, J.M.F. Ferreira, \n\nCosubstitution of zinc and strontium in ?-tricalcium phosphate: Synthesis and \n\ncharacterization, J. Am. Ceram. Soc. 94 (2011) 230-35. \n\n[40] S.J.L. Kang, Sintering - Densification, Grain Growth, and Microstructure, \n\nOxford, Elsevier Butterworth-Heinemann 2005. \n\n[41] A.A. Belik, F. Izumi, S.Y. Stefanovich, A.P. Malakho, B.I. Lazoryak, I.A. \n\nLeonidov, O.N. Leonidova, S.A. Davydov, Polar and centrosymmetric phases in \n\nsolid solutions Ca3-xSrx(PO4)2 (0 ? x ? 16/7), Chem. Mater. 14 (2002) 3197-205. \n\n[42] B. Dickens, L.W. Schroeder, W.E. Brown, Crystallographic studies of role of \n\nMg as a stabilizung impurity in ?-Ca3(PO4)2.1. Crystal struture of pure ?-Ca3(PO4)2, \n\nJ. Solid. State Chem. 10 (1974) 232-48. \n\n[43] J.C. Elliott, Structure and chemistry of the apatites and other calcium \n\northophosphates, London, Elsevier 1994. \n\n[44] M. Mathew, L.W. Schroeder, B. Dickens, W.E. Brown, Crystal structure of \n\nalpha-Ca3(PO4)2, Acta Crystallogr. Sect B: Struct. Sci. 33 (1977) 1325-33.  \n\n[45] K. Ishikawa, S. Matsuya, M. Nakagawa, K. Udoh, K. Suzuki, Basic \n\nproperties of apatite cement containing spherical tetracalcium phosphate made \n\nwith plasma melting method, J. Mater. Sci. Mater. Med. 15 (2004) 13-17. \n\n[46] B.V. Velamakanni, F.F. Lange, Effect of interparticle potentials and \n\nsedimentation on particle packing density of bimodal particle distributions during \n\npressure filtration, J. Am. Ceram. Soc. 74 (1991) 166-72. \n\n\n\nCap\u00edtulo 3 \n\n 146 \n\n[47] F.F. Lange, Shape forming of ceramic powders by manipulating the \n\ninterparticle pair potential, Chem. Eng. Sci. 56 (2001) 3011-20. \n\n[48] C.C. Furnas, Grading aggregates - I. - Mathematical relations for beds of \n\nbroken solids of maximum density, Ind. Eng. Chem. 23 (1931) 1052-58. \n\n[49] A.E.R. Westman, H.R. Hugil, The packing of particles, J. Am. Ceram. Soc. \n\n13 (1930) 767-79. \n\n[50] H.E. White, S.F. Walton, Particle packing and particle shape, J. Am. Ceram. \n\nSoc. 20 (1937) 155-66. \n\n[51] R.K. McGeary, Mechanical packing of spherical particles, J. Am. Ceram. \n\nSoc. 44 (1961) 513-22. \n\n[52] R.F. Fedors, R. F. Landel, An empirical method of estimating the void \n\nfraction in mixtures of uniform particles of different size, Powder Tech. 23 (1979) \n\n225-231. \n\n[53] R.J. Farris, Prediction of the Viscosity of Multimodal Suspensions from \n\nUnimodal Viscosity Data, Trans. Soc. Rheol. 12 (1968) 281-301. \n\n \n\n \n\n\n\n \n\n 147 \n\n \n\n \n\nCap\u00edtulo 4 \n\n \n\nEfeitos da dopagem do mangan\u00eas na \n\nestrutura e nas propriedades biol\u00f3gicas do \n\nfosfato ?????tric\u00e1lcico \n \n\n \n\n\n\n \n\n 148 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\nCap\u00edtulo 4 \n\n 149 \n\n \n\n \n\n \n\nEffects of Mn?doping on the structure and biological properties  \n\nof ?????tricalcium phosphate \n\n \n\nP. M. C. Torres a,*, S. I. Vieira b,c, A.R. Cerqueira b,c, S. Pina a, O.A.B. da Cruz e \n\nSilva b,c, J.C.C. Abrantes a,d and J.M.F. Ferreira a \n\n \n\na Department of Materials and Ceramic Engineering, University of Aveiro, CICECO, \n\n3810-193 Aveiro, Portugal. \n\nb Department of Biology, Centre for Cellular Biology, University of Aveiro, 3810-193 \n\nAveiro, Portugal  \n\nc Department of Health Sciences, Centre of Cellular Biology, University of Aveiro, \n\n3810-193 Aveiro, Portugal \n\nd UIDM, ESTG, Polytechnic Institute of Viana do Castelo, 4900 Viana do Castelo, Portugal \n\n \n\n \n\nJournal of Inorganic Biochemistry 136 (2014) 57\u201366, \n\ndoi:10.1016/j.jinorgbio.2014.03.013 \n\n \n\n \n \n*Corresponding author. Tel.: +351 234 370261; fax: +351 234 370204. \n\n   E-mail address: ptorres@ua.pt (P.M.C. Torres). \n \n\n \n\n \n\n\n\nCap\u00edtulo 4 \n\n 150 \n\n \n\n \n\n \n\nAbstract  \n\nDoping calcium phosphates with trace elements that exist in bone tissues is \n\nbeneficial in terms of cell-material interactions and in vivo performance of the bone \n\ngrafts made thereof. Manganese (Mn) is an essential element for normal growth \n\nand metabolism of bone tissues, but studies reporting the effects of Mn-doping \n\ncalcium phosphates are scarce. The present study investigated the influence of \n\nMn-doping on the structure, morphology and biological properties of ??tricalcium \n\nphosphate [??Ca3(PO4)2] (?-TCP). Mn?doped (MnTCP) powders, with Mn contents \n\nvarying from 0?10 mol%), were obtained through an aqueous precipitation method \n\nfollowed by heat treatment at 800\u00baC. The successful incorporation of Mn into \n\n??TCP structure was proved through quantitative X-ray diffraction (XRD) phase \n\nanalysis coupled with structural Rietveld refinement. Increasing Mn concentrations \n\nled to decreasing trends of a- and c-axis lattice parameters, and Mn-doping also \n\nsignificantly affected the morphology of ?-TCP powders. In vitro proliferation and \n\ndifferentiation assays of MC3T3-E1 osteoblastic-like cells, grown in the presence \n\nof the powders, revealed that the biological benefits of Mn?doped ??TCP are \n\nlimited to lower Mn incorporation levels and potentially related to their surface \n\nmicrostructure. The Mn1??TCP composition revealed the best set of bioactivity \n\nproperties, potentially a good candidate for future applications of ??TCP materials \n\nin osteoregeneration. \n\n \n\nKeywords: ??Tricalcium phosphate, Manganese, Osteoblastic proliferation, \n\nOsteoblastic differentiation, Extracellular matrix \n\n\n\nCap\u00edtulo 4 \n\n 151 \n\n1. Introduction \n\nThe increasing incidence of bone diseases such osteoporosis, osteomyelitis, \n\nmalignant tumours, or traumatic accidents has generated higher demands for \n\nbone grafting materials [1, 2]. Currently more than 200 million people worldwide \n\nare affected by osteoporosis, resulting in a high number of fractures such as hip, \n\nvertebral compression, and Colles\u2019 fractures. An almost fourfold increase in \n\nincidence of these kinds of fractures is expected to occur over the next 50 \n\nyears [3], placing pressure on the development of a versatile bone graft material, \n\navailable in large quantities and bearing no risk to the patient. Bioceramics based \n\non calcium phosphates (CaP) fit this need, due to their close chemical similarity to \n\nthe inorganic component of bone and teeth mineral [1, 2, 4]. Doping CaPs with \n\ntrace elements existing in bone composition has been the subject of recent \n\nwidespread investigation, due to specific roles played by these in biological \n\nprocesses upon implantation [5-12]. Such approaches aim to obtain a closer \n\nmatch between the composition of bone grafts and the composition of hard \n\ntissues. The doping elements influence the tissue response, including the \n\npromotion of bone apposition through mechanisms of which our understanding still \n\nremains limited. Calcium and some trace elements including Mn, detected as \n\nminor constituents of teeth and bone, are known to play essential roles in the \n\nnormal growth and metabolism of bone tissues [3, 6]. Mn is an important cofactor \n\nfor several enzymes such as the glycosyltransferases (or mucopolysaccharides) \n\ninvolved in extracellular matrix (ECM) remodelling, necessary for the synthesis of \n\nproteoglycans, which is an important constituent of both skeletal and cartilage \n\nstructural matrix [13].  Its deficit impairs the synthesis of cartilaginous organic \n\nmatrix and, in turn, retards endochondral osteogenesis, increasing the possibility \n\nof bone abnormalities [13, 14]. Mn increases the ligand-binding affinity of integrins, \n\na quite large family of receptors that mediate cellular interactions with the ECM, \n\nand active cell adhesion [15].  \n\nMn also regulates bone remodelling because its low content in body is connected \n\nwith the increase of the extracellular concentration of calcium, phosphates and \n\nphosphatase [16]. Reginster et al. [17] suggested a key involvement of Mn in the \n\n\n\nCap\u00edtulo 4 \n\n 152 \n\nmaintenance of bone mass, pointing out a Mn deficiency in human body as a \n\nprobable cause of osteoporosis. This was strengthened by Rico et al. [17] that \n\nshowed that a Mn supplement was effective in inhibiting the loss of bone mass \n\nafter ovariectomy in rats. Interestingly, in a recent study, Landete-Castillejos et al. \n\n[18] suggested that calcium loss could be a consequence and not the origin of \n\nosteoporosis. These authors further believe that a lack of manganese is at the \n\ngenesis of this disease, resulting in the low calcium bone absorption that ultimately \n\nresults in osteoporosis. In a previous study, these authors addressed the \n\noccurrence of fractures presented in deer antlers [19], and related these to Mn \n\nchanges in the diet. This suggests that a Mn deficiency may prevent the \n\nincorporation of Ca in bone tissue, thus resulting in antler bone material which is \n\nless tough and dense, and even more porous than normal [19]. The confirmation \n\nby the scientific community of this new hypothesis for osteoporosis pathogenesis \n\ncould be a clinical breakthrough.  \n\nGiven the role of Mn in osteogenesis and osteoporosis, its incorporation into CaP \n\nmaterials for bone repair/regeneration applications, is likely to improve their \n\nbiological performance in terms of bioactivity and acceleration of bone \n\nmineralization. Previous studies revealed that Mn incorporation in carbonated \n\nCaP [20] and in CaP coatings on Ti substrates [7] favoured osteoblast \n\nproliferation, differentiation and mineralization depending of the amount \n\nincorporated. The Mn incorporation in ceramic materials, including CaP, was also \n\nshown to affect their surface microstructure and morphology [7, 10, 20-24], which, \n\nin turn, can influence the resulting biological responses. However, the benefits \n\nfrom Mn-doping are likely to be limited to certain Mn incorporation levels. As a \n\nmatter of fact, chronic exposure to toxic levels of Mn leads to manganism, a \n\nneurodegenerative disorder similar to Parkinson\u2019s disease [25], while Mn \n\ndeficiency may also be associated with diseases of the central nervous system \n\nsuch as Alzheimer\u2019s or Parkinson\u2019s disease [18, 26, 27]. A report based on clinical \n\ndata [18] suggests that Mn released from the bone during the remodelling process \n\nmight be available for other prioritized functions, such as brain functions, leading \n\nto osteoporosis particularly in the elderly population. The lack of consensus \n\n\n\nCap\u00edtulo 4 \n\n 153 \n\nrelative to the ideal Mn levels in the body might help explain the scarcity of \n\npublished works on Mn-doping of CaP materials for biomedical applications. \n\nThe aim of the present study is to investigate the influence of different amounts of \n\nMn on the structure, morphological features and in vitro proliferation and \n\ndifferentiation responses of osteoblast-like cells (MC3T3-E1 cell line) to Mn-doped \n\n??TCP powders. Various biological responses to the biomaterials were assessed, \n\nincluding cell viability and Type-I collagen secretion, to evaluate the biological \n\npotential of the ??TCP materials for repair/regeneration of bone affected by \n\nosteoporosis or serious traumas. The results are expected to contribute to a better \n\nunderstanding of the potential key role of Mn in bone physiology and osteoporosis \n\npathogenesis. The resorbable features and excellent osteoconductive properties \n\nof ??TCP [28] justify the selection of this material.  \n\n \n\n2. Materials and methods \n\n2.1 Powders preparation \n\n??TCP powders doped with different Mn contents (0?10 mol%) were obtained via \n\naqueous precipitation. The significance of the aqueous precipitation method relies \n\non the homogeneity of the final product. The experimental procedure described by \n\nKannan et al. [29, 30] was followed with minor modifications. Briefly, calcium \n\nnitrate tetrahydrate [Ca(NO3).4H2O, Vaz Pereira-Portugal, Sintra, Portugal], \n\ndiammonium hydrogen phosphate [(NH4)2HPO4, Vaz Pereira-Portugal, Sintra, \n\nPortugal] and manganese(II) nitrate hydrate [Mn(NO3)2.xH2O, Sigma-Aldrich, \n\nDarmstadt, Germany], were used as starting chemical precursors, respectively for \n\ncalcium, phosphorus and manganese. The planned concentrations of the \n\nprecursors are depicted in Table 1 and were selected in order to have a total \n\n(Ca+Mn)/P molar ratio equal to 1.48 for all the compositions to ensure no \n\nformation of hydroxyapatite [31]. \n\n \n\n \n\n\n\nCap\u00edtulo 4 \n\n 154 \n\nTable 1. Concentrations of the precursors Ca, P and Mn used in the synthesis. \n\n \n\nThe synthesis temperature was decreased from 90\u00baC [29] to 30\u00baC [32], to reduce \n\nthe amount of toxic ammonia gas released during the removal of the precipitated \n\nsuspension from the reactor. The other experimental synthesis conditions (pH, \n\nmaturation time, stirring conditions) were adjusted accordingly. Synthesis was \n\ntargeted at pH 7, but the experimental values ranged between 6.3?7 by adding the \n\nrequired amounts of ammonium hydroxide (NH4OH) solution. Keeping the pH \n\nvalue ? 7 is of paramount importance because Mn2 + ions are stable in acidic \n\nsolutions but precipitate as Mn(OH)2 under alkaline conditions (white colour), \n\nwhich is then readily oxidized to form MnO(OH)2 (brown colour) [33]. The \n\nprecipitated suspensions were kept for 3 h under constant stirring conditions \n\n(700 rpm) and ripened for a further 15 h under resting conditions. The resulting \n\nprecipitates were vacuum filtered and then dried at 100\u00baC during 48 h. The dried \n\ncakes were ground to fine powders and sieved through a mesh size of 200 \u00b5m. \n\nThe resulting powders underwent heat treatment at 800\u00baC in air in a Thermolab \n\nfurnace (Pt30%Rh / Pt6%Rh-thermocouple) with a heating rate of 5\u00baC min?1 and a \n\ndwelling time for 2 h to obtain undoped and Mn?doped ??TCP powders. The \n\nheat-treated powders were well ground and sieved through a mesh size of 40 \u00b5m \n\nbefore characterization studies. \n\n \n\nPlanned compositions \n\nMolar concentrations \nof the precursors \n\nSample \nCode \n\n \n\nCa P Mn \n\nCa/P \n molar ratio \n\n(Ca+Mn)/P \nmolar ratio \n\nConc. of \nMn  \n\n(mol%) \n\nMn0TCP  0.888 0.600 0.000 1.480 1.480 0.0 \n\nMn0.5TCP  0.884 0.600 0.004 1.473 1.480 0.5 \n\nMn1TCP  0.879 0.600 0.009 1.465 1.480 1.0 \n\nMn5TCP  0.844 0.600 0.044 1.407 1.480 5.0 \n\nMn7TCP  0.826 0.600 0.062 1.377 1.480 7.0 \n\nMn10TCP  0.799 0.600 0.089 1.332 1.480 10.0 \n\n\n\nCap\u00edtulo 4 \n\n 155 \n\n2.2 Powders characterization  \n\nThe qualitative analyses of crystalline phases present on heat-treated powders \n\nwere performed by X-ray powder diffraction (XRD) using a high-resolution Bruker \n\nD8 Advance DaVinci diffractometer with Cu K? radiation (? = 1.5406 \u00c5) produced \n\nat 40 kV and 40 mA. Data sets were recorded in the 2? range of 20 ? 80\u00ba with a \n\nstep size of 0.015\u00ba 2? s-1. Collection of XRD pattern data for Rietveld refinement \n\nstudies was performed using a conventional Bragg-Brentano diffractometer \n\n(Bruker D8 Advance DaVinci, Karlsruhe, Germany) with Ni-filtered Cu-K? radiation \n\nby recording X-ray diffraction data within the 2? range = 20 ? 80o (step size 0.015o \n\nand 0.5 seconds for each step). The software TOPAS version 4.2 (Bruker AXS, \n\nKarlsruhe, Germany) with the fundamental parameters approach was used for \n\nRietveld refinements. Rietveld refinement was performed using the structural \n\nmodel of ICSD card numbers of #97500 for ??TCP and #73712 for calcium \n\npyrophosphate (Ca2P2O7, CPP). Refined parameters were, scale factor, specimen \n\ndisplacement, background as Chebyshev polynomial of fifth grade and 1/x \n\nfunction, and lattice parameters.  \n\nElemental analyses for Mn and Ca were determined for all powders using \n\ninductively coupled plasma (ICP) spectrometry (ICP-OES Jobin Yvon Activa M., \n\nUSA). For this purpose, required amounts of powders were dissolved in nitric acid \n\n(HNO3) prior to ICP analysis. Phosphorus contents were determined by \n\ncolorimetry (Single Beam Scanning UV/Visible Spectrophotometer model \n\nCamspec ?501, United Kingdom, ? = 880 nm) using the ascorbic acid method \n\n(4500-P E.). \n\nInfrared spectra of powders were obtained by Fourier Transform Infrared \n\nSpectrometry (FT-IR model Mattson Galaxy S-7000, USA). For this purpose each \n\npowder was mixed with KBr in the proportion of 1/150 (by weight) for 15 min and \n\npressed into a pellet. Each infrared spectrum was the average of 32 scans \n\ncollected at 2 cm?1 resolution at room temperature. Specific surface areas (SSA) \n\nof powders were obtained according to the BET method using a Micromeritics \n\nGemini 2370 V5.00 (Norcross, USA) through the gas adsorption measurements, \n\n\n\nCap\u00edtulo 4 \n\n 156 \n\nafter degassing the powders in a Micromeritics Flow Prep 060 (Norcross, USA). \n\nParticle size distributions of the powders were determined using a light scattering \n\ninstrument (Coulter LS 230, UK, Fraunhofer optical model). The influence of Mn on \n\nthe morphology and microstructure of the powders was observed by Scanning \n\nElectron Microscopy (SEM, Hitachi SU-70, Tokyo, Japan).  \n\n \n\n2.3 MC3T3-E1 cell culture  \n\nThe osteoblastic cell line MC3T3-E1 (ATCC CRL-2593) was maintained at 37\u00baC in \n\na humidified atmosphere of 5% CO2 in air, in 2 mM Glutamine-containing \n\nMinimum Essential ?-Medium in EBSS (Eagle\u2019s Balanced Salt Solution) \n\nsupplemented with 10% (v/v) foetal bovine serum (FBS), 1% (v/v) of a 100 U mL?1 \n\npenicillin and 100 mg mL?1 streptomycin solution (Gibco BRL, Invitrogen), and 3.7 \n\ng L?1 NaHCO3. Sub-confluent cultures (at 80?90% confluency) were split 1:5 using \n\na 0.25% trypsin/EDTA solution (Gibco BRL, Invitrogen) at 5% CO2, 37\u00baC.  \n\n \n\n2.4 Cytotoxicity and cell proliferation assays in Mn-doped ????-TCP powders \n\nThe resazurin metabolic assay [34, 35] was used to determine the powders \n\ncytotoxicity/biocompatibility to MC3T3-E1 cells. The linear range between \n\nresazurin reduction to resorufin and MC3T3-E1 viable cells density was previously \n\ndetermined by us [34]. Cells were seeded at 1x104 cells cm?2 in 24 well plates and \n\ncultured in cell media supplemented with 1 mg mL?1 for each powder composition \n\n(saturated solutions) kept at 37 \u00b0C in a humidified 5% CO2 and 95% air \n\natmosphere for various days in vitro (div). At the indicated div, cells were \n\nincubated for 4 h with fresh medium containing 10% of a resazurin solution [0.1 \n\nmg mL?1 resazurin (Sigma Aldrich) in phosphate buffer saline (PBS; Pierce, \n\nPerbio)]. Resazurin reduction was thereafter spectrophotometrically measured \n\n(Infinite M200 PRO, Tecan) at 570 and 600 nm. For each time period, a final \n\nresazurin value (O.D.f) was calculated as the O.D. 570/O.D. 600 nm ratio minus \n\n\n\nCap\u00edtulo 4 \n\n 157 \n\nthe O.D. 570/O.D. 600 nm ratio of a negative control (resazurin media incubated \n\nfor 4 h in the absence of cells), and the O.D.f plotted against time of incubation in \n\ndiv. All experiments were carried out in triplicate and data expressed as \n\nmean \u00b1 standard error of three independent experiments. Prior to cell experiments \n\nall powders were sterilized by ?-radiation.  \n\n \n\n2.5 Antibodies and Fluorescing Chemicals \n\nThe primary antibody anti-Type-I Collagen antibody was used (Novus Biologicals, \n\nGermany) that recognizes Type-I procollagen (monomeric ?1(I) and ?2(I) chains, ? \n\nchains corresponding to ?/? dimmers, and trimeric ? chains), and various collagen \n\nforms (tropocollagen, mature trimeric ? chains, microfibrils, and fibrils). Secondary \n\nantibodies used were fluorescein isothiocyanate (FITC)-conjugated anti-rabbit \n\nIgGs (Calbiochem) for immunocytochemistry analyses, and horseradish \n\nperoxidase-linked anti-rabbit IgGs (GE Healthcare, Chalfont St. Giles, UK) for \n\nenhanced chemiluminescence (ECL) detection for western blot assays. Alexa \n\nFluor 568 phalloidin (Molecular Probes, Life technologies) and DAPI [4',6-\n\ndiamidino-2-phenylindole, included in the Vectashield antifading reagent (Vector, \n\nBurlingame, CA, USA)] were two chemicals used to label F-actin and the nucleus, \n\nrespectively. \n\n \n\n2.6 Immunoblot analyses of Type-I collagen protein expression and media \n\nsecretion \n\nAt the indicated div, cells conditioned media were collected into 10% SDS-\n\ncontaining microtubes, and cells were washed with PBS and harvested with a 1% \n\nSDS boiling solution. Samples were boiled for 10 min and rapidly sonicated in ice. \n\n100 \u00b5L of each cell lysate and media were subjected to reducing 6.5% SDS-PAGE \n\nin Tris-Glycine buffer and electrophoretically transferred onto nitrocellulose \n\nmembranes. Precision Plus Dual Colour (10?250 kDa, Bio-Rad, Portugal) was \n\nused as protein standards mix. Immunoblotting of the transferred proteins was \n\n\n\nCap\u00edtulo 4 \n\n 158 \n\nperformed as previously described [36], where anti-Collagen primary antibody was \n\nincubated overnight. Detection was achieved using a horseradish peroxidase-\n\nlinked secondary antibody and an ECL kit (GE Healthcare, Chalfont St. Giles, UK). \n\nPonceau S detection of all proteins was performed as a loading control; briefly, \n\nprior to immunoblotting procedures, the nitrocellulose membranes were subjected \n\nto 5 min of reversible Ponceau S staining, washed 2x with water, scanned for \n\nimage acquisition and washed with TBS-T for Ponceau complete distaining.   \n\n \n\n2.7 Confocal microscopy analyses of Type-I collagen protein distribution  \n\nControl and MC3T3-E1 cells cultured in cell media supplemented with Mn0/ 0.5/ 1/ \n\n10TCP powders were grown on 35 mm plates-containing pre-treated coverslips. At \n\n30 div, cells were fixed with a 4% paraformaldehyde in PBS solution for 30 min, \n\nand permeabilized with a 0.2% Triton PBS solution. Non-specific sites were \n\nblocked by 1 h incubation with a 3% bovine serum albumin (BSA)-PBS solution, \n\nand coverslips submitted to immunocytochemistry procedures using the anti-\n\nCollagen antibody diluted in 3% BSA-PBS. Upon three washes with PBS, cells \n\nwere incubated with a solution of PBS 3% BSA containing red fluorescing \n\nPhalloidin (1:50) and FITC-conjugated secondary antibody (1:300). Coverslips \n\nwere mounted on microscope slides with DAPI-containing Vectashield antifading \n\nreagent (Vector, Burlingame, CA, USA). Images were acquired in a LSM 510 \n\nMETA confocal microscope (Zeiss, G\u00f6ttingen, Germany) with a 40x objective and \n\nusing an Argon laser line of 488 nm (FITC channel), a Diode 405-430 laser (DAPI \n\nchannel) and 561 nm DPSS laser (Alexa 568 channel). \n\n \n\n2.8 Statistical analysis \n\nStatistical significance analysis was conducted using the GraphPad InStat \n\nsoftware, by one way analysis of variance ANOVA, followed by the Dunnett\u2019s test, \n\nwith the level of statistical significance set at p<0.05. In vitro data are expressed as \n\nmeans \u00b1 standard error of the mean of three independent experiments.  \n\n\n\nCap\u00edtulo 4 \n\n 159 \n\n3. Results  \n\n3.1 Influence of Mn-doping on the structure of ? ? ? ?-TCP  \n\nThe heat-treated powders presented a colour gradient ranging from white for \n\nundoped (Mn0TCP) to gradually more intense pink with increasing Mn \n\nconcentrations. This is in agreement with the most stable oxidation state (II) for \n\nmanganese, which has a light pink colour [33]. \n\nTable 2 presents Ca/P and (Ca+Mn)/P molar ratios and Mn contents obtained from \n\nelementary analysis for synthesized and heat-treated Mn?doped TCP powders.  \n\n \n\nTable 2. Physical and chemical characteristics of pure and Mn?doped TCP powders heat-treated at \n\n800 \u00baC. (Ca+Mn)/P, Ca/P molar ratios and Mn contents were obtained from ICP (Ca and Mn) and \n\nfrom ascorbic acid method (P). \n\nParticle size distribution  Elemental analysis \n\nDx\na (\u00b5m)  \n\nSample \nCode \n\nSSA \n(\u00b10.5) \n(m2g-1) Mean \n\n(\u00b5m) D10 D50 D90 \n\nCa/P \nmolar \nratio \n\n(Ca+Mn)/P \nmolar \nratio \n\nConc. of \nMn \n\n(\u00b10.03) \n(mol%)  \n\nMn0TCP 3.6  2.990 0.436 1.551 7.855 1.490 1.490 0.00 \n\nMn0.5TCP 2.2 1.459 0.408 0.814 3.715 1.485 1.490 0.35 \n\nMn1TCP 3.6  1.454 0.384 0.781 3.723 1.482 1.494 0.76 \n\nMn5TCP 4.3  3.032  0.411 1.791 7.866 1.433 1.486 3.54 \n\nMn7TCP 3.2  2.875 0.414 1.668 7.418 1.397 1.485 5.95 \n\nMn10TCP 3.8  2.983  0.418 1.823 7.634 1.348 1.482 9.02 \n\na Dx is the particle diameter at or below which there is the amount x (vol.%) of particles in the \n\ncumulative (from 0 to 100%) particle size distribution curve. \n\n \n\nA good agreement in terms of molar ratios can be observed between the planned \n\ncompositions (Table 1) and the experimentally obtained values. Nonetheless, the \n\nmeasured concentrations of Mn varied within the range of 70 and 90% of the \n\nplanned contents.  \n\n\n\nCap\u00edtulo 4 \n\n 160 \n\nThe particle size distribution parameters measured by laser scattering, including \n\nD10, D50, D90, and the mean, and BET specific surface areas of all the powders are \n\nalso detailed in Table 2. The data show a clear decreasing trend of particle sizes \n\nwith increasing Mn contents up to Mn1TCP, followed by a reverse trend for higher \n\nadded amounts of Mn. In contrast, no clear variation trend is apparent in terms of \n\nSSA.  \n\nThe XRD patterns of the Mn0-10TCP powders heat-treated at 800\u00baC are displayed \n\nin Fig. 1a.  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 1. (a) X-ray diffraction patterns for the different Mn-doped ??tricalciumphosphate powders \n\n(Mn0-10TCP) obtained after heat treatment at 800\u00baC; (b) Zoomed area of Fig. 1a within the 2? \n\nrange from 28-30 to highlight the presence of  ?-CPP; showing a gradual shift of XRD peaks to \n\nhigher 2? angles with increasing incorporation of Mn; (c) Zoomed area of Fig. 1a within the 2? \n\nrange from 26-32 to show the effect of Mn incorporation on shifting the XRD peaks to higher 2? \n\nangles for  ?-TCP (also noticed in Fig. 1b). The standard ICDD PDF 04-014-2292 of pure ?-TCP \n\nand 04-009-3876 of ?-CPP are also presented for comparison. \n\n \n\n2 ? (degree) \n\n(c) \n\n2 ? (degree) \n26 27 28 29 30 31 32 \n\nMn0TCP Mn7TCP \n\nIn\nte\n\nn\nsi\n\nty\n (\n\na.\nu\n\n.)\n \n\nMn0.5TCP \n\nMn10TCP \n\n(a) \n\n  \n\nIn\nte\n\nn\nsi\n\nty\n (\n\na.\nu\n\n.)\n \n\n2 ? (degree) \n\n????-TCP \n\n????-CPP \n\nMn0TCP \n\nMn5TCP \n\n \n\nMn1TCP \n\nMn7TCP \n\n20 30 40 50 60 70 80 \n\n????-CPP \n\n(b) \n\n????-TCP \n\nMn0TCP \n\nMn0.5TCP \n\nMn5TCP \n\nMn10TCP \n\nMn1TCP \n\nMn7TCP \n\nIn\nte\n\nn\nsi\n\nty\n (\n\na.\nu\n\n.)\n \n\n28.0 28.5 29.0 29.5 30.0 \n\n????-CPP \n????-TCP \n\n\n\nCap\u00edtulo 4 \n\n 161 \n\nIt can be seen that all powders apparently consist of pure ?-TCP phase. However, \n\nwith increasing concentrations of Mn in the system (Mn5TCP, Mn7TCP and \n\nMn10TCP), the formation of trace amounts of CPP became gradually more \n\nevident as can be seen in the zoomed areas of the pattern shown in Fig. 1b. For \n\nlow Mn contents, the peaks of ?-CPP and ?-TCP appear more or less overlapped, \n\nmaking the discrimination of both phases difficult. The discrimination obtained for \n\nhigher Mn contents is a consequence of the shift of the ?-TCP peak at 2? = 29.63\u00ba \n\nto higher at 2? angles (Fig. 1b and c) [32, 38].  \n\nFT-IR patterns of all the Mn0-10TCP powders, presented in Fig. 2, show the \n\ncharacteristic vibrational modes of PO4 tetrahedra, confirming the formation of \n\n?-TCP as the predominant crystalline phase. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 2. FT-IR spectra of undoped powder of ?-TCP (Mn0TCP) and Mn2+ -substituted ?-TCP \n\npowders (Mn0.5-10 TCP) heat-treated at 800\u00baC. \n\n  \n\n  \n\n  \n\nT\nra\n\nn\nsm\n\nit\nta\n\nn\nce\n\n (\na.\n\nu\n.)\n\n \n\nMn1TC\nP \n\nMn10T\nCP \n\nMn7TC\nP \n\n500 1000 1500 \nP2O7\n\n4- \n \n\nWave number (cm-1) \n\nMn0TC\nP \n\nMn0.5T\nCP \n\n \n\n \n\nP2O7\n4- \n\nMn5TC\nP \n\n\n\nCap\u00edtulo 4 \n\n 162 \n\nWith the increasing Mn concentrations other absorption bands at 726 cm?1 and \n\n1208 cm?1 became gradually more evident, which can be ascribed to \n\npyrophosphate groups (P2O7\n4\u2013), particularly to P\u2013O\u2013P bonds. This is not \n\nsurprising, considering that CPP is likely formed for Ca/P values lower \n\nthan 1.500 [37, 38]. By the XRD technique, the presence of ?-CPP became more \n\neasily detected by the gradual shifting (zoomed areas of Fig. 1b-c) of the ??TCP \n\npeaks at 2? ? 29.57\u00ba to higher angles as the Mn content increases (Fig. 1b-c) \n\nmeaning that the lattice parameters of ??TCP tend to decrease with increasing \n\namounts of added Mn. The XRD data for Mn0TCP was refined assuming the \n\nspace group R3c and the unit cell and structural parameters reported by \n\nYashima et al. [39]. The quantitative phase analysis obtained by Rietveld \n\nrefinement (wt.%) for the studied powders summarized in Table 3 corroborate the \n\nformation of traces of ?-CPP in all the ?-TCP powders.  \n\nTable 3. Quantitative phase analysis obtained by Rietveld refinement of the studied powders. \n\nwt% of composition \ndetermined \n\nby Rietveld quantification \nSample \nCode \n\n?-TCP ?-CPP \n\nMn0TCP 97.6 2.4 \n\nMn0.5TCP 97.6 2.5 \n\nMn1TCP 98.3 1.7 \n\nMn5TCP 96.7 3.3 \n\nMn7TCP 96.4 3.6 \n\nMn10TCP 95.0 5.0 \n\n \n\nThe ?-TCP unit cell parameters were a = b =10.441(0) \u00c5, c = 37.390(2), \n\n? = ?= 90 \u00ba, and ? = 120 \u00ba in the hexagonal setting (space group R3c), in good \n\nagreement with other literature reports [5, 29]. The refined values for Mn0TCP \n\nwere then taken as the starting values to refine the data of Mn-doped ?-TCP \n\npowders. An example for Mn1TCP sample shown in Fig. 3 confirms that this \n\npowder almost consists of single ?-TCP phase. Similar observations were made \n\nfor the other samples and the results of quantitative phase analysis presented in \n\n\n\nCap\u00edtulo 4 \n\n 163 \n\nTable 3 confirm ?-TCP as the main crystalline phase together with 1.7?5% of ?-\n\nCPP. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 3. Rietveld analysis patterns of powder diffraction data for Mn1TCP powder. The blue line is \n\ncalculated intensities and the red one is observed intensities. The difference between the observed \n\nand calculated intensities is plotted below the profile. \n\n \n\nThe refined lattice parameters for all the compositions are represented graphically \n\nin Fig. 4. The plots show clear decreasing trends in both lattice parameters along \n\na-axis and c-axis with increasing incorporated amounts of Mn.  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 4. Influence of Mn content on lattice a- and c-axis parameters and on unit cell volume of ?-\n\ntricalciumphosphate (?-TCP) struture. Lattice parameters measured for Mn0TCP: a = 10.4492 \u00c5; \n\nc = 37.3709 \u00c5 and for Mn10TCP (with 9.02 mol% of Mn): a = 10.3925 \u00c5; c = 37.2892 \u00c5. \n\n\n\nCap\u00edtulo 4 \n\n 164 \n\nFig. 5 shows the morphological features of Mn0TCP, Mn1TCP, Mn5TCP and \n\nMn10TCP (Fig. 5a, b, c and d, respectively) as observed by SEM.  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 5. Scanning electron micrographs of Mn0TCP (a), Mn1TCP (b), Mn5TCP (c) and Mn10TCP \n\n(d) powders with 0 mol%, 0.76 mol%, 3.54 mol% and 9.02 mol% of Mn content respectively. \n\n \n\nThe micrographs clearly show that the added amounts of Mn exert a strong \n\ninfluence on the overall morphological aspects. The primary particles appear less \n\nagglomerated for Mn1TCP. The presence of porous agglomerates confirmed by \n\nSEM analysis (Fig. 5) are likely to account for the opposite trends observed in \n\nparticle size distribution for lower and higher Mn contents, and the apparently \n\nambiguous SSA results (Table 1). \n\n \n\n3.2. Biological properties \n\n3.2.1 Mn0.5-1TCP powders increase MC3T3 cellular proliferation \n\nCell viability and proliferation of 1 x 104 cells cm?2 MC3T3-E1 osteoblastic-like \n\ncells cultured on doped MnTCP powders for various days in culture (2, 7, 14, 21 \n\n\n\nCap\u00edtulo 4 \n\n 165 \n\nand 30), were evaluated by the non-destructive and non-toxic resazurin metabolic \n\nassay (Fig. 6).  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 6. Cell viability assays of MC3T3-E1 osteoblastic-like cells exposed to ?-TCP powders \n\nsubstituted with increasing amounts of Mn (Mn0-10TCP). The resazurin metabolic assay was used \n\nto determine the powders cytotoxic and proliferative effects in MC3T3-E1 cells. 1x104 cells were \n\nseeded in 24 well plates containing medium supplemented with 1 mg mL-1 of the respective \n\npowder. Upon 30 days of incubation (days in vitro), cellular viability was indirectly measured by \n\ntheir efficiency in reducing resazurin, expressed as O.D.f mean \u00b1 SE, of three independent \n\nexperiments. \n\n \n\nThis is a proved method to measure MC3T3-E1 cell proliferation and viability, with \n\na linear response between 1 and 4 x 104 cells cm?2 [12, 34]. During the normal \n\nproliferation period (first 14 div), no cytotoxic effects were observed for any of the \n\npowders used and the cells final O.D. (O.D.f) was not significantly decreased. Mn-\n\ndoping generally maintained or increased proliferation over Mn0TCP values, \n\nhaving the following positive effects: (i) for Mn0.5?1TCP, cells proliferation \n\nincreased over Mn0TCP values immediately at early time points (p<0.05 \n\nand&lt;0.01 vs Mn0TCP values, respectively, at 7 div); (ii) cellular proliferation also \n\nincreased for Mn5-10TCP powders, but only at 14 div, a period when all Mn-doped \n\npowders are significantly higher than control and Mn0TCP (with significance \n\n\n\nCap\u00edtulo 4 \n\n 166 \n\ndifferent of p<0.01 and&lt;0.05). Along the subsequent two weeks in \n\nculture (14-30 div), Mn5-10TCP powders greatly decreased the number of viable \n\ncells (O.D.f significantly lower than control or Mn0TCP, p<0.01), while \n\nMn0.5?1TCP powders behave similarly as control cells, with steady comparable \n\ndecreases (Fig. 6, 21 and 30 div).  \n\nIn summary, Mn0.5-1TCP powders did not decrease MC3T3 viability during 30 \n\ndays in culture, and were even able to significantly induce pre-osteoblastic \n\nproliferation at the proliferative period (1-14 div), or even longer (21 div) in the \n\ncase of Mn1TCP (p<0.05 vs Mn0TCP values). For Mn5-10TCP powders, \n\nsignificant increased proliferation was only observed at 14 div, and cell viability \n\nwas greatly decreased in the subsequent differentiation period (14-30 div). Further \n\nanalyses concerned the effects of the powders on pre-osteoblastic cells \n\ndifferentiation, namely their effects on procollagen protein synthesis, secretion and \n\ndeposition into collagen fibrils.  \n\n \n\n3.2.2 MnTCP powders greatly decrease intracellular procollagen (I) levels \n\nand increase its maturation and secretion  \n\nCells exposed to the powders for 30 days (and their corresponding conditioned \n\nmedia) were collected into 1% SDS solutions, and subjected to SDS-PAGE. In \n\nterms of immunoblot bands profile, monomeric Type-I procollagen consists of ?1 \n\n(~140 kDa); and ?2 (~130 kDa) chains, which are intracellularly \n\nprocessed/matured by post-translational modifications (as proline and lysine \n\nhydroxylation, lysine glycosylation). Alpha chains can intracellularly associate into \n\ndimers (?, ~270 kDa) and trimers (?, ~400 kDa), forms that are not breakable in \n\nSDS-PAGE denaturing conditions [12, 40]. All these cell-associated Type-I \n\nprocollagen forms were present in control and in Mn0-1TCP cell lysates, but barely \n\nvisible in the Mn5-10TCP lysates (Fig. 7a). This may relate to their lower cell \n\nproliferation at 30 div (Fig. 6) but only partially, since this decrease in intracellular \n\nprocollagen is even more pronounced. All MnTCP powders decreased intracellular \n\nprocollagen (I) levels, with Mn1TCP powder presenting a less pronounced \n\n\n\nCap\u00edtulo 4 \n\n 167 \n\ndecrease. Analyses of medium secreted procollagen (Fig. 7b) revealed that \n\nMn0-1TCP powders increased the total amounts of soluble ?1 and ?2 procollagen \n\n(immature, arrowheads; mature, arrows). Further, all MnTCP powders increased \n\nprocollagen maturation and/or the secretion of these processed procollagen \n\nforms (arrows), thus potentially inducing extracellular collagen fibrillar deposition \n\n[9, 12]. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 7. Immunoblot analysis of cell-associated (a) and medium secreted (b) Type-I collagen upon \n\n30 days in vitro. MC3T3 cells lysates (a) and conditioned media (b) were resolved under reducing \n\nconditions, and Type-I collagen was immunodetected. C, control cells; Mn TCP 0-10, cells grown in \n\nmedia with TCP substituted with various concentrations of Mn. ?1(I) and ?2(I), procollagen \n\nmonomeric chains; arrowheads, immature; arrows, matured. ?(I), procollagen dimeric forms. ?(I), \n\nprocollagen trimeric forms. Migration of molecular weight markers is indicated to the right. Below \n\neach immunoblot is a representative sample of the membrane Ponceau S staining, shown as a \n\nloading control. \n\n \n\nb) Secreted Type I Collagen\n\nMnTCP\n\n- 200\n\n- 150\n\nC        0         0.5        1           5         7      10\n\na) Intracellular Type I Collagen \n\nMnTCP\n\n?2(I)\n\n?(I)\n\n?2(I)\n\n?1(I)\n\n?1(I)\n\n?(I)\n\nponceau S\n\nponceau S\n\nC         0         0.5        1        5         7       10\n- 200 \n\n- 150\n\nb) Secreted Type I Collagen\n\nMnTCP\n\n- 200\n\n- 150\n\nC        0         0.5        1           5         7      10\n\na) Intracellular Type I Collagen \n\nMnTCP\n\n?2(I)\n\n?(I)\n\n?2(I)\n\n?1(I)\n\n?1(I)\n\n?(I)\n\nponceau S\n\nponceau S\n\nC         0         0.5        1        5         7       10\n- 200 \n\n- 150\n\n\n\nCap\u00edtulo 4 \n\n 168 \n\nIn essence, while the Mn5-10TCP powders greatly decrease procollagen (I) \n\nformation and process and secrete the few cellular procollagen they contain, the \n\nMn0-1TCP powders highly induce procollagen (I) maturation and further secretion, \n\nresulting in higher extracellular collagen and most probably in their lower \n\nintracellular contents. \n\n \n\n3.2.3 Mn1TCP induces osteoblastic differentiation  \n\nIntracellular procollagen is secreted into the media, after which it is enzymatically \n\nprocessed into tropocollagen, promoting their aggregation into cell layer-\n\nassociated collagen fibrils [12, 41]. To investigate if the observed higher amounts \n\nof secreted procollagen resulted in increased number of collagen fibrils, MnTCP \n\nexposed cells were fixed at 30 days in vitro and subject to immunocytochemistry \n\nanalysis of Type-I collagen cellular distribution (Fig. 8). Conditions chosen were: \n\ncontrol non-exposed cells, Mn0-1TCP (that induced higher procollagen secretion) \n\nand Mn10TCP, for comparison purposes. While for control cells procollagen \n\nmainly accumulated inside intracellular secretory granule-like densities (Fig. 8, \n\narrowheads), as expected [12], MnTCP-exposed cells presented less intracellular \n\nprocollagen and higher levels of extracellular forms. Further, in accordance with \n\nthe immunoblot results, cells incubated with Mn10TCP for 30 days had generally \n\nless procollagen type I. Extracellular secreted collagen levels were in the following \n\norder: Mn10TCP &lt;Mn0TCP &lt;Mn0.5TCP &lt;Mn1TCP. F-actin, stained with red \n\nfluorescing phalloidin, denoted that, in general, all Mn0-10TCP powders induce \n\nhigher osteoblastic elongation and even alignment (Mn0.5TCP and Mn1TCP), with \n\nthese being particular evident for the Mn1TCP powder.  \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\nCap\u00edtulo 4 \n\n 169 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig.8. Confocal microscopy analysis of Type-I collagen cellular distribution after cells in \n\nvitro incubation for 30 days in the absence (Ctrl) or presence of 1 mg mL-1 of the MnTCP \n\npowders. Cells were subjected to immunocytochemistry procedures in order to detect \n\nType-I collagen distribution (green fluorescence), F-actin (red labelled phalloidin), and the \n\nnuclei (DAPI blue fluorescence). Arrowheads, intracellular granule-like densities. Arrows, \n\nextracellular cell-associated collagen (I) fibrils. Bar, 20 \u00b5m. \n\n\n\nCap\u00edtulo 4 \n\n 170 \n\n4. Discussion \n\n4.1 Influence of Mn-doping on the structure of ? ? ? ?-TCP  \n\nThe gradual accentuation of the pink colour presented by the heat-treated \n\npowders, characteristic of the oxidation state (II) of manganese [33] indicates its \n\ngradual incorporation into the ?-TCP lattice. This hypothesis is supported by the \n\nshifting of ?-TCP reflection plane (0 0 8) at 2? = 29.57\u00ba to higher angles with \n\nincreasing Mn contents (Fig. 1b-c), and by the refinement of XRD data (Fig. 3) \n\n[32, 38]. The gradual incorporation of Mn into the ?-TCP lattice is also supported \n\nby the changes in the unit cell parameters reported in Fig. 4. The measured cell \n\nparameters for Mn0TCP are in good agreement with those reported by Yashima et \n\nal. [39] and other authors [5, 29]. The clear decreasing trends for both a-axis and \n\nc-axis refined lattice parameters with increasing Mn contents (Fig. 4) are \n\nconsistent with the lower ionic radii of Mn2+ (0.83 \u00c5 for sixfold coordination with O) \n\nin comparison to Ca2+ (1.00 \u00c5 for sixfold coordination with O) [46], and with the \n\nobserved contraction in the unit cell volume (Fig. 4) when compared with the \n\nMn0TCP, as expected from other literature reports [23].  \n\nThe elementary analysis data reported in Table 2 offer further support to this \n\ninterpretation. The Ca/P molar decreases as expected with increasing added \n\namounts of Mn, but the (Ca+Mn)/P ratio is kept almost constant, meaning that \n\nmost of the added Mn has been incorporated in Ca sites of the crystalline lattice. \n\nThis is confirmed by the measured Mn concentrations in the synthesized powders. \n\nThe amount of Mn concentration calculated from experimental data was found to \n\nbe 70 to 90 % of Mn concentration calculated from planned compositions (as \n\nshown in Table 1 &amp; 2). This variation in Mn concentrations reveals higher \n\nproneness of Mn to stay in solution. This is according to the solubility products of \n\nthe Ca and Mn precursor, clearly indicating manganese nitrate as the most soluble \n\nof them [42]. The experimental fluctuations of pH values (between 6.3 and 7) may \n\nalso account for the small deviations between the planned (Ca+Mn)/P = 1.48 and \n\nthe measured values equal, or near to 1.49 (Table 2) [32]. The planned Ca/P and \n\n(Ca+Mn)/P molar rations slightly below the stoichiometric value justify the \n\n\n\nCap\u00edtulo 4 \n\n 171 \n\nformation of calcium pyrophosphate as secondary phase [43] identified in Fig. \n\n1b-c. The small fluctuations in the synthesis conditions are likely bound to the \n\nvariations observed in the quantitative phase analysis (Table 3). The expected \n\npredominance of ?-TCP phase is in close agreement with findings reported \n\nelsewhere [30, 44] for powders prepared via aqueous precipitation. On the other \n\nhand, small amount of calcium pyrophosphate CPP up to 5% would be expected \n\nfor Ca/P values equal to that planned [37, 38].  \n\nThe increased degeneracy of the FT-IR absorption bands caused by partial \n\nreplacement of Ca by Mn in the ?-TCP lattice (Fig. 2) is similar to that reported for \n\nzinc-doped ?-TCP [5, 45]. This similarity can be understood considering that both \n\nMn and Zn ions are smaller that the Ca ion. On the other hand, the intensity of the \n\nFT-IR absorption bands at 726 cm?1 and 1208 cm?1 due to pyrophosphate (P2O7\n4-) \n\ngroups, particularly to the P\u2013O\u2013P bonding, showing a close agreement with the \n\nquantitative phase analysis data reported in Table 3. The more and less intense \n\nbands are observed for Mn10TCP and Mn1TCP powders, respectively, which \n\ncontain the higher and the smaller amounts of ?-CPP formed for \n\nCa/P ratios &lt;1.500 [37, 38]. \n\nTherefore, the results gathered by the different characterization techniques \n\nconverge toward confirming the formation of small amounts of ?-CPP together with \n\nthe main ?-TCP phase.  \n\nThe SEM micrographs of heat treated powders shown in Fig. 5 reveal a \n\ndecreasing trend of the size of primary particles with increasing levels of Mn-\n\ndoping, probably due to the size mismatch (0.17 \u00c5) between Ca and Mn ions. This \n\ndecrease is likely to enhance the tendency of primary particles to form \n\nagglomerates during the synthesis and heat treatment processes. Moreover, \n\nduring the precipitation (3 h) and maturation periods (15 h), \n\ndissolution/precipitations reactions will occur, driven by kinetics (stirring, or rest \n\nconditions) and thermodynamic reasons according to the well-known Ostwald \n\nripening effect [47]. This mechanism predicts that smaller particles with a higher \n\nsurface curvature will preferentially dissolve, contributing to supersaturation of the \n\n\n\nCap\u00edtulo 4 \n\n 172 \n\nliquid media. The excess concentration of ionic species in solution will then be \n\nresolved by deposition of these species at the surface of the larger particles, as \n\nwell as within the necks between them. All these phenomena will contribute to the \n\nfusion of the primary particles, a process that will be exacerbated with increasing \n\nMn contents. The SEM observations (Fig. 5) roughly corroborate this \n\ninterpretation, with the finest and less agglomerated powder being observed for \n\nthe Mn1TCP sample. This conclusion is well supported by the particle size \n\ndistributions data (Table 2). However, straightforward relationships the \n\nmorphological changes of the powders (Fig. 5) and BET results (Table 2) with \n\nvarying Mn contents are difficult to establish due to the complex phenomena \n\noccurring along maturation stage. \n\n \n\n4.2 Biological properties \n\nDoping ?-TCP powders with Mn had a dual effect on MC3T3 in vitro viability and \n\nproliferation (Fig. 6). Mn0.5TCP and Mn1TCP powders slightly but significantly \n\ninduced pre-osteoblastic proliferation at the second proliferative week (7-14 div), \n\nwhile Mn5-10TCP powders only increased proliferation at 14 div and greatly \n\ndecreased cell viability at the differentiation period (14-30 div). A decrease in pre-\n\nosteoblastic proliferation with increasing Mn concentration has already been \n\nreported [7]. \n\nA response duality was also observed in procollagen intracellular content and \n\nmedium secretion (Fig. 7), with Mn5-10TCP compositions ultimately leading to \n\nless procollagen (I) and Mn0-1TCP powders inducing higher matured \n\nprocollagen (I) secretion. Interestingly, this duality in behaviour of pre-osteoblasts \n\nviability/proliferation and procollagen(I) production and secretion, appears to \n\naccompany the trends observed for particle and agglomerates size denoted in \n\nTable 2 and in SEM micrographs (Fig. 5), with the Mn1TCP powder representing \n\nthe turning point. The subsequent observation that Mn1TCP induces the highest \n\ninduction of osteoblastic differentiation highlights its key properties. All MnTCP \n\npowders enhanced extracellular collagen (I), concordant with previous reports of \n\nenhanced osteoblast differentiation for Mn-doped carbonated CaP [20] and in CaP \n\n\n\nCap\u00edtulo 4 \n\n 173 \n\ncoatings on Ti substrates [7], but osteoblasts grown on Mn1TCP powders were \n\nlonger and more aligned, presenting longer intracellular F-actin fibres and \n\nincreased extracellular collagen (I) fibrilar structures (Fig. 8).  \n\nIn agreement with that previously postulated [7, 20, 22] our data indicates that the \n\nbiological benefits of Mn-doped ?-TCP are indeed limited to certain Mn \n\nincorporation levels, and potentially related to their surface microstructure and \n\nmorphology. One or both may be occurring: MC3T3 pre-osteoblasts prefer the \n\nMn1TCP finest and less agglomerated powder topology to grow on, and/or the \n\namounts of the Mn trace element being released into the solution by this powder \n\nare closer to the optima for its biological activities. Indeed, in either case, Mn1TCP \n\nappears to be able to positively influence the cells\u00b4 ECM remodelling, an important \n\nevent in organic matrix formation and osteoblasts differentiation. This is denoted \n\nby the high alignment and apparent tight coordination between the intracellular \n\ncytoskeleton of filamentous actin and the ECM collagen (I) fibrils. ECM is not only \n\na component of bone but also a key element in osteoblasts differentiation and \n\nosteoregeneration [48, 49] as it bridges the extracellular milieu to the cell, via cell \n\nsurface integrins and their binding to the intracellular F-actin. We believe that the \n\nMn released by, or at the surface of Mn1TCP powders, is at a key concentration or \n\nposition to function as cofactor of glycosyltransferases enzymes [13], so as to \n\nincrease integrins activation (via enhancing its ligand-binding [15]), ultimately \n\nfavoring ECM remodeling and osteoblasts differentiation.  \n\n \n\n5. Conclusions \n\nGiven the various studies suggesting that Mn positively affects bone growth and \n\nrepair and that its deficiencies may be at the genesis of osteoporosis, the aim of \n\nthe present study was develop and characterize Mn-doped ?-TCP compositions, \n\nincluding their biological effects. The results presented and discussed along this \n\nwork enable the following conclusions to be drawn:  \n\n\n\nCap\u00edtulo 4 \n\n 174 \n\n1. Well crystalline ?-TCP phase with trace amounts of ?-CPP could be \n\nobtained for all investigated compositions as detected from XRD and FT-IR \n\nanalysis. \n\n2. Elemental analyses showed a reasonable coincidence between the planned \n\nMn concentrations and the measured incorporation levels for all the \n\npowders. \n\n3. Rietveld refinement of the XRD data confirmed a decreasing trend of the \n\nlattice parameters a and c with the increasing concentrations of Mn into the \n\n?-TCP structure, providing a solid evidence about the successful \n\nincorporation of Mn in the ?-TCP lattice.  \n\n4. The varying concentrations of Mn caused significant morphological changes \n\nin the Mn-doped ?-TCP powders, with Mn1TCP presenting smaller primary \n\nparticles aggregated in finest agglomerates.  \n\n5. The Mn1TCP powder presented the best set of positive effects on \n\nMC3T3-E1 in vitro pre-osteoblastic proliferation and differentiation. The \n\nincorporation of small amount (0.76 mol%) of Mn into ?-TCP proved to be \n\neffective in accelerating of bone mineralization, making the sample \n\nMn1TCP a good candidate for future studies in bone repair applications. \n\n \n\nAcknowledgements \n\nThanks are due to the Portuguese Foundation for Science and Technology for the \n\nfellowship grants of P.M.C. Torres (SFRH/BD/62021/2009) and S. Pina \n\n(SFRH/BPD/64119/2009), and to the Centre for Cell Biology (PEst-\n\nOE/SAU/UI0482/2011, REEQ/1023/BIO/2005). The XRD facility was funded by \n\nFEDER Funds through QREN\u2013Aviso SAIECT-IEC/2/2010, Opera\u00e7\u00e3o NORTE-07\u2013\n\n0162-FEDER-000050. \n\n \n\n\n\nCap\u00edtulo 4 \n\n 175 \n\nReferences \n\n[1] S.V. Dorozhkin, Bioceramics of calcium orthophosphates, Biomaterials 31 \n\n(2010) 1465-1485. \n\n[2] M. Bohner, Resorbable biomaterials as bone graft substitutes, Mater. Today, \n\n13 (2010) 24-30. \n\n[3] J. Aaseth, G. Boivin, O. Andersen, Osteoporosis and trace elements \u2013 An \n\noverview, J. Trace Elem. Med. Biol. 26 (2012) 149-152. \n\n[4] J.C. Elliott, Structure and chemistry of the apatites and other calcium \n\northophosphates, Elsevier, London; 1994. \n\n[5] A. Bigi, E. Foresti, M. Gandolfi, M. Gazzano, N. Roveri, Isomorphous \n\nsubstitutions in beta-tricalcium phosphate: The different effects of zinc and \n\nstrontium, J. Inorg. Biochem. 66 (1997) 259-265. \n\n[6] E. Boanini, M. Gazzano, A. Bigi, Ionic substitutions in calcium phosphates \n\nsynthesized at low temperature, Acta Biomater. 6(2010)1882-1894. \n\n[7] B. Bracci, P. Torricelli, S. Panzavolta, E. Boanini, R. Giardino, A. Bigi, Effect of \n\nMg2+, Sr2+, and Mn2+ on the chemico-physical and in vitro biological properties of \n\ncalcium phosphate biomimetic coatings, J. Inorg. Biochem. 103 (2009) 1666-1674. \n\n[8] S. Kannan, F. Goetz-Neunhoeffer, J. Neubauer, S. Pina, P.M.C. Torres, J.M.F. \n\nFerreira, Synthesis and structural characterization of strontium- and magnesium-\n\nco-substituted ?-tricalcium phosphate, Acta Biomater. 6 (2010) 571-576. \n\n[9] S. Kannan, S.I. Vieira, S.M. Olhero, P.M.C. Torres, S. Pina, O.A.B. Da Cruz E \n\nSilva, J.M.F. Ferreira, Synthesis, mechanical and biological characterization of \n\nionic doped carbonated hydroxyapatite/?-tricalcium phosphate mixtures, Acta \n\nBiomater. 7 (2011) 1835-1843. \n\n\n\nCap\u00edtulo 4 \n\n 176 \n\n[10] I. Mayer, F.J.G. Cuisinier, S. Gdalya, I. Popov, TEM study of the morphology \n\nof Mn2+-doped calcium hydroxyapatite and ?-tricalcium phosphate, J. Inorg. \n\nBiochem. 102 (2008) 311-317. \n\n[11] S. Pina, P.M. Torres, J.M. Ferreira, Injectability of brushite-forming Mg-\n\nsubstituted and Sr-substituted alpha-TCP bone cements, J. Mater. Sci. Mater. \n\nMed. 21 (2010) 431-438. \n\n[12] S. Pina, S.I. Vieira, P. Rego, P.M.C. Torres, O.A.B. da Cruz e Silva, E.F. da \n\nCruz e Silva, J.M.F. Ferreira, Biological responses of brushite-forming Zn- and \n\nZnSr- substituted beta-tricalcium phosphate bone cements, Eur. Cell. Mater. 20 \n\n(2010) 162-177. \n\n[13] P.D. Saltman, L.G. Strause, The role of trace minerals in osteoporosis, J. Am. \n\nColl. Nutr. 12 (1993) 384-389. \n\n[14] K. Cashman, A. Flynn, Trace elements and bone metabolism, Bibl. Nutr Dieta \n\n(1998) 150-164. \n\n[15] A. Armulik, G. Svineng, K. Wennerberg, R. F\u00e4ssler, S. Johansson, Expression \n\nof Integrin Subunit ?1B in Integrin ?1-Deficient GD25 Cells Does Not Interfere with \n\n?V?3 Functions, Exp. Cell. Res. 254 (2000) 55-63. \n\n[16] B.J. Friedman, J.H. Freeland-Graves, C.W. Bales, F. Behmardi, R.L. Shorey-\n\nKutschke, R.A. Willis, J.B. Crosby, P.C. Trickett, S.D. Houston, Manganese \n\nbalance and clinical observations in young men fed a manganese-deficient diet, J. \n\nNutr. 117 (1987) 133-143. \n\n[17] H. Rico, N. G\u00f3mez-Raso, M. Revilla, E.R. Hern\u00e1ndez, C. Seco, E. P\u00e1ez, E. \n\nCrespo, Effects on bone loss of manganese alone or with copper supplement in \n\novariectomized rats A morphometric and densitomeric study, Eur. J. Obstet. \n\nGynecol. Reprod. Biol. 90 (2000) 97-101. \n\n[18] T. Landete-Castillejos, I. Molina-Quilez, J.A. Estevez, F. Ceacero, A.J. Garcia, \n\nL. Gallego, Alternative hypothesis for the origin of osteoporosis: The role of Mn, \n\nFront Biosci. E4 (2012) 1385-1390. \n\n\n\nCap\u00edtulo 4 \n\n 177 \n\n[19] T. Landete-Castillejos, J.D. Currey, J.A. Estevez, Y. Fierro, A. Calatayud, F. \n\nCeacero, A.J. Garcia, L. Gallego, Do drastic weather effects on diet influence \n\nchanges in chemical composition, mechanical properties and structure in deer \n\nantlers? Bone 47 (2010) 815-825. \n\n[20] A. Bigi, B. Bracci, F. Cuisinier, R. Elkaim, M. Fini, I. Mayer, I.N. Mihailescu, G. \n\nSocol, L. Sturba, P. Torricelli, Human osteoblast response to pulsed laser \n\ndeposited calcium phosphate coatings, Biomaterials 26 (2005) 2381-2389. \n\n[21] M. Jia, Y. Hong, S. Duan, Y. Liu, B. Yuan, F. Jiang, The influence of transition \n\nmetal ions on collagen mineralization,  Mater. Sci. Eng: C 33 (2013) 2399-2406. \n\n[22] M.B. Pabbruwe, O.C. Standard, C.C. Sorrell, C.R. Howlett, Bone formation \n\nwithin alumina tubes: effect of calcium, manganese, and chromium dopants, \n\nBiomaterials 25 (2004) 4901-4910. \n\n[23] I. Mayer, F.J.G. Cuisinier, I. Popov, Y. Schleich, S. Gdalya, O. Burghaus, D. \n\nReinen, Phase Relations Between ?-Tricalcium Phosphate and Hydroxyapatite \n\nwith Manganese(II): Structural and Spectroscopic Properties, Eur. J. Org. Chem. \n\n2006 (2006) 1460-1465. \n\n[24] I. Mayer, O. Jacobsohn, T. Niazov, J. Werckmann, M. Iliescu, M. Richard-\n\nPlouet, O. Burghaus, D. Reinen, Manganese in Precipitated Hydroxyapatites, Eur. \n\nJ. Org. Chem. 2003 (2003) 1445-1451. \n\n[25] E.-S.Y. Lee, M. Sidoryk, H. Jiang, Z. Yin, M. Aschner, Estrogen and tamoxifen \n\nreverse manganese-induced glutamate transporter impairment in astrocytes, J. \n\nNeurochem. 110 (2009) 530-544. \n\n[26] G.F. Carl, L.K. Blackwell, F.C. Barnett, L.A. Thompson, C.J. Kissinger, K.L. \n\nOlin, J.W. Critchfield, C.L. Keen, B.B. Gallagher, Manganese and Epilepsy: Brain \n\nGlutamine Synthetase and Liver Arginase Activities in Genetically Epilepsy Prone \n\nand Chronically Seizured Rats, Epilepsia 34 (1993) 441-446. \n\n\n\nCap\u00edtulo 4 \n\n 178 \n\n[27] D.J. S\u00e1nchez, M. G\u00f3mez, J.M. Llobet, J. Corbella, J.L. Domingo, Effects of \n\nAluminium on the Mineral Metabolism of Rats in Relation to Age, Pharmacol. \n\nToxicol. 80 (1997) 11-17. \n\n[28] M. Bohner, Reactivity of calcium phosphate cements, J. Mater. Chem. 17 \n\n(2007) 3980-3986. \n\n[29] S. Kannan, J.M. Ventura, J.M.F. Ferreira, Aqueous precipitation method for \n\nthe formation of Mg-stabilized ?-tricalcium phosphate: An X-ray diffraction study, \n\nCeram. Inter. 33 (2007) 637-641. \n\n[30] S. Kannan, S. Pina, J.M.F. Ferreira, Formation of strontium-stabilized \n\n?-tricalcium phosphate from calcium-deficient apatite, J. Am. Ceram. Soc. 89 \n\n(2006) 3277-3280. \n\n[31] M. Descamps, J.C. Hornez, A. Leriche, Effects of powder stoichiometry on the \n\nsintering of ?-tricalcium phosphate, J. Eur. Ceram. Soc. 27 (2007) 2401-2406. \n\n[32] A. Destainville, E. Champion, D. Bernache-Assollant, E. Laborde, Synthesis, \n\ncharacterization and thermal behavior of apatitic tricalcium phosphate, Mater. \n\nChem. Phys. 80 (2003) 269-277. \n\n[33] G. Rayner-Canham, Descriptive inorganic chemistry, Macmillan, 2009. \n\n[34] S. Pina, S.I. Vieira, P.M. Torres, F. Goetz-Neunhoeffer, J. Neubauer, E.S.O.A. \n\nda Cruz, E.S.E.F. da Cruz, J.M. Ferreira, In vitro performance assessment of new \n\nbrushite-forming Zn- and ZnSr-substituted beta-TCP bone cements, J. Biomed. \n\nMater. Res. Part B, Appl. Biomat. 94 (2010) 414-420. \n\n[35] A. Ueno, Y. Miwa, K. Miyoshi, T. Horiguchi, H. Inoue, I. Ruspita, K. Abe, K. \n\nYamashita, E. Hayashi, T. Noma, Constitutive expression of thrombospondin 1 in \n\nMC3T3-E1 osteoblastic cells inhibits mineralization, J. Cell. Physiol. 209 (2006) \n\n322-332. \n\n\n\nCap\u00edtulo 4 \n\n 179 \n\n[36] S. Vieira, S. Rebelo, S. Domingues, E. Cruz e Silva, O.B. Cruz e Silva, S655 \n\nphosphorylation enhances APP secretory traffic, Mol. Cell. Biochem. 328 (2009) \n\n145-154. \n\n[37] E.R. Kreidler, F.A. Hummel, Phase relationships in the system SrO-P2O5 and \n\nthe influence of water vapor on the formation of Sr4P2O9, Inorg. Chem. 6 (1967) \n\n884-891. \n\n[38] S. Raynaud, E. Champion, D. Bernache-Assollant, P. Thomas, Calcium \n\nphosphate apatites with variable Ca/P atomic ratio I. Synthesis, characterisation \n\nand thermal stability of powders, Biomaterials 23 (2002) 1065-1072. \n\n[39] M. Yashima, A. Sakai, T. Kamiyama, A. Hoshikawa, Crystal structure analysis \n\nof ?-tricalcium phosphate Ca3(PO4)2 by neutron powder diffraction, J. Solid. State \n\nChem. 175 (2003) 272-277. \n\n[40] R.R. Lareu, I. Arsianti, K.S. Harve, Y. Peng, M. Raghunath, in: F. Ibrahim, N. \n\nOsman, J. Usman, In Vitro Augmentation of Collagen Matrix Formation \u2014 \n\nApplications in Tissue Engineering, N. Kadri (Eds.), 3rd Kuala Lumpur \n\nInternational Conference on Biomedical Engineering 2006, 15, IFMBE \n\nProceedings, Springer Berlin Heidelberg, 2007, pp 696-699. \n\n[41] S.M. Sweeney, J.P. Orgel, A. Fertala, J.D. McAuliffe, K.R. Turner, G.A. Di \n\nLullo, S. Chen, O. Antipova, S. Perumal, L. Ala-Kokko, A. Forlino, W.A. Cabral, \n\nA.M. Barnes, J.C. Marini, J.D.S. Antonio, Candidate Cell and Matrix Interaction \n\nDomains on the Collagen Fibril, the Predominant Protein of Vertebrates, J. Biol. \n\nChem. 283 (2008) 21187-21197. \n\n[42] Perry DL. Handbook of inorganic compounds, Taylor &amp; Francis, Second ed., \n\n2011. \n\n[43] M. Maciejewski, T.J. Brunner, S.F. Loher, W.J. Stark, A. Baiker, Phase \n\ntransitions in amorphous calcium phosphates with different Ca/P ratios, \n\nThermochim. Acta 468 (2008) 75-80. \n\n\n\nCap\u00edtulo 4 \n\n 180 \n\n[44] S. Kannan, A.F. Lemos, J.H.G. Rocha, J.M.F. Ferreira, Characterization and \n\nMechanical Performance of the Mg-Stabilized ?-Ca3(PO4)2 Prepared from Mg-\n\nSubstituted Ca-Deficient Apatite, J. Am. Ceram. Soc. 89 (2006) 2757-2761. \n\n[45] S. Kannan, F. Goetz-Neunhoeffer, J. Neubauer, J.M.F. Ferreira, Synthesis \n\nand structure refinement of zinc-doped ?-tricalcium phosphate powders, J. Am. \n\nCeram. Soc. 92 (2009) 1592-1595. \n\n[46] R.D. Shannon, Revised effective ionic radii and systematic studies of \n\ninteratomic distances in halides and chalcogenides, Acta Crystallogr. Sect A 32 \n\n(1976) 751-767. \n\n[47] P. Dagtepe, V. Chikan, Quantized Ostwald Ripening of Colloidal \n\nNanoparticles, J. Phys. Chem. C 114 (2010) 16263-16269. \n\n[48] S.F. Badylak, D.O. Freytes, T.W. Gilbert, Extracellular matrix as a biological \n\nscaffold material: Structure and function, Acta Biomater. 5 (2009) 1-13. \n\n[49] N.R. Gandavarapu, P.D. Mariner, M.P. Schwartz, K.S. Anseth, Extracellular \n\nmatrix protein adsorption to phosphate-functionalized gels from serum promotes \n\nosteogenic differentiation of human mesenchymal stem cells, Acta Biomater. 9 \n\n(2013) 4525-4534. \n\n \n\n \n\n\n\n \n\n 181 \n\n \n\n \n\nCap\u00edtulo 5 \n\n \n\nCimentos \u00f3sseos formados por brushite \n\nado\u00e7ados e dopados com estr\u00f4ncio e \n\nmangan\u00eas: a receita para fomentar a \n\ninjectabilidade e o desempenho biol\u00f3gico in \n\nvitro \n \n\n \n\n \n\n\n\n \n\n 182 \n\n \n\n \n\n\n\nCap\u00edtulo 5 \n\n 183 \n\n \n\n \n\n \n\nSweetened and MnSr-doped brushite-forming bone cements: the \n\nrecipe for fostering injectability and in vitro biological \n\nperformance  \n\n \n\nP. M. C. Torres a,*, A. Marote b, R. Cerqueira b, A. Calado c, J. C. C. Abrantes a,d, \n\n S. Olhero a, O. A. B. Cruz e Silva, S. I. Vieira b,#, J. M. F. Ferreira a,# \n\n \n\na Department of Materials and Ceramic Engineering, CICECO, University of Aveiro, 3810-\n\n193 Aveiro, Portugal \n\nb Neurociences and Cellular Signaling Group, Institute for Biomedicine (iBiMED), SACS, \n\nUniversity of Aveiro, 3810-193 Aveiro, Portugal \n\nc Department of Biology, GeoBioTec, University of Aveiro, 3810-193 Aveiro, Portugal   \n\nd UIDM, ESTG, Polytechnic Institute of Viana do Castelo, 4900 Viana do Castelo, Portugal \n\n \n\n# Equally contributing authors \n\n \n\n \n\nSubmitted to Biomaterials \n\n \n\n \n\n \n\n*Corresponding authors.  \nE-mail addresses: ptorres@ua.pt (P.M.C. Torres) and sivieira@ua.pt (S. I. Vieira) \n\n\n\nCap\u00edtulo 5 \n\n 184 \n\n \n\n \n\n \n\nAbstract \n\nCalcium phosphate cements (CPCs) are widely used in osteoregeneration due to \n\ntheir biocompatibility and biomimicking compositions. The general weak \n\nperformance in terms of injectability and mechanical properties are the major \n\ndrawbacks preventing widerspread applications of CPCs, but enhancements in \n\ncell adhesion and osteoconductivity would also be advantageous. This study \n\npresents innovative solutions to improve the handling ability (setting time, \n\ninjectability), the mechanical strength and the biological performance of brushite \n\nCPCs. The improvements were achieved via: (i) doping the starting ?-tricalcium \n\nphosphate (?-TCP) powders with Sr and Mn; (ii) adding sugar (sucrose or \n\nfructose) to the setting-liquid solution. The combination of these two strategies \n\nenabled increasing the setting time from ~3 min to ~9 min, and to reach wet \n\ncompressive strengths of ~17 MPa at 48 h, much higher than those registered for \n\nsugar-free CPCs derived from non-doped ?-TCP (5 MPa) or from Sr-doped ?-TCP \n\n(10 MPa). Doping with Sr alone, or combined with low levels of Mn, also improved \n\nthe proliferative response of human osteoblastic-like MG63 cells to CPCs, and \n\nincreased their rate of type-I collagen secretion. The Sr/Mn co-doped CPCs, \n\nparticularly when kneaded with sucrose-containing setting liquid, allowed very \n\ngood levels of cell adhesion and growth on its surface, as observed by scanning \n\nelectron microscopy. The characteristics of co-doped CPCs with added sucrose \n\nwere greatly improved, including extended working times, excellent injectability, \n\nmechanical and biological performances, rendering them very promising materials \n\nfor bone regeneration and tissue engineering. \n\n \n\nKeywords: Strontium and manganese; Brushite cements; Sucrose as retardant; \n\nCompressive strength; Osteocompatible features \n\n \n\n\n\nCap\u00edtulo 5 \n\n 185 \n\n1. Introduction  \n\nCalcium phosphates (CaP) bioceramics are among the most appropriate bone \n\ngraft materials due to their close chemical similarity with the mineral bone \n\ncomposition [1-4]. These biocompatible, bioresorbable, bioactive and \n\nosteoconductive materials are commercially available in various forms, i.e. \n\ngranules, blocks, non-hardening pastes and hydraulic cements [5-9]. The \n\ninjectable forms of CPCs combine the optimal bone defect filling capacity via \n\nminimally invasive surgeries with the ability to harden in vivo at body temperature, \n\nand low exothermicity setting reactions [7, 10-14]. Based on their final hardened \n\ncompositions, calcium phosphate cements (CPCs) are usually grouped in two \n\ntypes: brushite (dicalcium phosphate dihydrate, or calcium monohydrogen \n\nphosphate dihydrate, CaHPO4\u00b72H2O; DCPD) or apatite, such as hydroxyapatite \n\n[Ca10 (PO4)6 (OH)2; HA] or calcium-deficient hydroxyapatite (CDHA) [15]. Brushite \n\nand its non-hydrated version, monetite (dicalcium phosphate anhydrous, CaHPO4; \n\nDCPA), are the most stable calcium orthophosphate phases at pH&lt;4.2, while \n\napatite is the most stable phase at pH ?4.2 (although brushite-based cements may \n\nsubsist up to pH 6.5) [16]. The better mechanical performance of apatite cements, \n\nin comparison to brushite-type ones, is counterbalanced by low resorption rates in \n\nvivo due to the superior stability of apatite under physiological conditions, \n\ninfluencing the bone regeneration process. The higher solubility of brushite-based \n\nCPCs brushite in vivo induces faster resorption rates, making them more attractive \n\nbiomaterials.  \n\nCalcium and some minor ion constituents of teeth and bone, including Sr and Mn, \n\nare known to play essential and specific roles in the normal growth and \n\nmetabolism of hard tissues [17, 18]. Thence, doping CaPs with trace elements \n\nexisting in bone composition has been a widespread research topic aiming for \n\ncloser matches between the compositions of bone grafts and hard tissues [18-25]. \n\nOne of the benefits of doping elements in CaPs after implantation consists on \n\nfostering bone apposition through mechanisms that are still not well understood. \n\nSr exerts beneficial effects in the treatment of osteoporosis, as it maintains bone \n\nformation. Sr increases osteoclast apoptosis, inhibiting bone resorption, and \n\n\n\nCap\u00edtulo 5 \n\n 186 \n\nenhances preosteoblastic cell proliferation and collagen synthesis [26]. While \n\ncertain levels of Mn exert positive effects on bone growth and repair, its deficiency \n\nmight be at the genesis of osteoporosis [27, 28]. Numerous literature reports are \n\navailable on the properties of Sr-substituted CPCs [29], but published works on \n\nMn-doping of CaP materials for biomedical applications are scarce, and none was \n\nfound on CPCs. Our previous in vitro study revealed that low Mn-doping levels in \n\n??tricalcium phosphate (?-TCP) powders exerted various positive effects on \n\nproliferation and differentiation of MC3T3-E1 osteoblastic-like cells, making the \n\nCPCs derived thereof attractive as osteoregenerative materials [30].  \n\nHowever, widespread clinical applications of CPCs require overcoming some \n\ncritical drawbacks: (i) poor injectability, characterized by the occurrence of phase \n\nseparation between the liquid and solid (filter pressing effect) [31, 32]; (ii) tendency \n\nto disintegrate upon early contact with blood or other physiological solutions, due \n\nto weak cohesion [33, 34]; and (iii) low mechanical properties after hardening that \n\nlimit its application to non-load-bearing locations [35, 36]. CPCs pastes should not \n\nmigrate to undesirable sites and must have adequate setting time and acceptable \n\nmechanical strength after hardening. Unfortunately, brushitic CPCs set faster and \n\nare more difficult to handle in comparison to apatitic ones. \n\nMany additives have been attempted aiming at improving the handling and/or \n\nmechanical properties of CPC pastes. Hydroxypropyl methylcellulose (HPMC) [37, \n\n38], citric acid (CA) [39-41], polyethylene glycol (PEG) [38, 42, 43] are a few \n\nexamples. Adding sugar to Portland mortars was found to significantly delay the \n\nhydration rate and induce microstructural changes in the hardened cements [44]. \n\nThis suggests sucrose (consisting of two monosaccharides, glucose and fructose) \n\nas an interesting candidate to extend the setting time for CPCs. The ubiquitous \n\npresence of sucrose in the human body, as fuel to generate heat and form \n\nadenosine triphosphate (ATP) [45], makes it a safe and innocuous additive.  \n\nThe main aim of this study was to evaluate the combined effects of doping the \n\nstarting ?-TCP powders with Sr and Mn and adding sucrose or fructose into the \n\nsetting liquid on the overall properties of brushite-forming Mn- and \n\n\n\nCap\u00edtulo 5 \n\n 187 \n\nMnSr-substituted CPCs. The relevant properties for biomedical applications \n\ninclude handling, injectability, setting time, mechanic, and biological in vitro \n\nperformance. \n\n \n\n2. Materials and Methods \n\n2.1 Preparation of starting powders and cements \n\n2.1.1 Preparation and characterisation of the powders \n\nThe synthesis of doped [?-Ca3-x-yMnxSry(PO4)2] powders with solely 0.5 and 1 \n\nmol% Mn (x=0.015 and x=0.030, respectively, and y=0), solely 5 mol% Sr (x=0 \n\nand y=0.150), or co-doped with all combinations of these elements (Table 1) was \n\ncarried out by the aqueous precipitation [30, 46]. The concentrations of precursors \n\nwere set to have a fixed total molar ratio (Ca+Sr+Mn)/P=1.48 to ensure no \n\nhydroxyapatite formation [47]. For comparison purposes, non-doped ?-TCP was \n\nalso prepared and used as reference (Ref?TCP). The precipitates were vacuum \n\nfiltrated, dried at 110\u00baC and finally heat treated for 2 h at 800\u00baC.  \n\n \n\nTable 1. Planned and experimentally obtained molar concentrations of Mn and Sr in the starting \n\n?-TCP powders. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nConcentrations of the Sr and Mn (mol%) \n\nExperimentally planned  \nICP elemental analysis  \n\n(\u00b10.03) \nSample code   \n\nMn Sr  Mn Sr \n\nSr5????TCP  0 5  0.00 5.02 \nMn0.5????TCP  0.5 0  0.33 0.04 \nMn1????TCP  1 0  0.69 0.03 \n\nMn0.5Sr5????TCP  0.5 5  0.32 5.03 \nMn1Sr5????TCP  1 5  0.70 5.02 \n\n\n\nCap\u00edtulo 5 \n\n 188 \n\nAll calcined formulations were ground under dry conditions for different time \n\nperiods in order to obtain powders with similar particle size distributions (PSDs) \n\n(Coulter LS 230, UK, Fraunhofer optical model) after being passed through a \n\n40 \u00b5m mesh sieve. Inductively coupled plasma spectrometry (ICP-OES Jobin \n\nYvon Activa M., USA) was used to determine the elemental concentrations of Ca, \n\nP, Mn and Sr by dissolving the required amounts of powders in 1 vol% of nitric \n\nacid (HNO3) in deionised water. Qualitative phase analysis was performed by X-\n\nray powder diffraction (XRD) using a high-resolution Bruker D8 Advance DaVinci \n\ndiffractometer with Cu K? radiation (? = 1.5406 \u00c5) produced at 40 kV and 40 mA. \n\nData sets were recorded in the 2? range of 20 ? 50\u00ba with a step size of 0.015\u00ba \n\n2? s\u20131. The XRD information was complemented by infrared spectra obtained by \n\nFourier Transform Infrared Spectrometry (FT-IR model Mattson Galaxy S-7000, \n\nUSA). For this purpose each powder was mixed with KBr in the proportion of 1/150 \n\n(by weight) for 15 min and pressed into a pellet. Each infrared spectrum is the \n\naverage of 32 scans collected at 2 cm?1 resolution at room temperature (RT). \n\n \n\n2.1.2 Preparation of cement pastes \n\nThe starting powders were firstly dry blended with equimolar amounts of \n\nmonocalcium phosphate monohydrate (MCPM, Sigma\u2013Aldrich, Germany) for 20 s, \n\nfollowed by hand mixing for 1 min with the reacting liquid at constant \n\nliquid-to-powder ratio (LPR=0.28 mL?g?1) to produce the CPC pastes. Three \n\ndifferent setting liquids were tested: A, AS and AF. Liquid A, an aqueous solution \n\ncontaining 15 wt.% citric acid (CA) (Sigma Aldrich, Germany) + 10 wt.% \n\npoly(ethylene glycol) (PEG) (400, Sigma) + 0.5% wt.% hydroxyl propyl \n\nmethylcellulose (HPMC) (3.5\u20135.6 mPa?s at 2 wt.% in water, Sigma Aldrich, \n\nGermany). The liquids AS and AF derived from liquid A by further adding 10 wt.% \n\nof sucrose (S, C12H22O11, MW=342.30 g?mol\n?1), or fructose (F, C6H12O6, \n\nMW=180.12 g?mol?1), respectively (Sigma Aldrich, Germany). Table 2 summarizes \n\nall the CPCs studied and their respective sample codes.  \n\n\n\nCap\u00edtulo 5 \n\n 189 \n\nTable 2. For simplification purposes, the sample codes of CPCs were built by affixing the liquid \n\ndesignation to the codes of starting ?-TCP powders. \n\n Setting liquids  ????????TCP powders  \n \n\n A AS AF \n\nRef????TCP  RefCPC?A RefCPC?AS RefCPC?AF \nSr5????TCP  Sr5CPC?A Sr5CPC?AS Sr5CPC?AF \n\nMn0.5????TCP  Mn0.5CPC?A Mn0.5CPC?AS Mn0.5CPC?AF \n\nMn1????TCP  Mn1CPC?A Mn1CPC?AS Mn1CPC?AF \n\nMn0.5Sr5????TCP  Mn0.5Sr5CPC?A Mn0.5Sr5CPC?AS Mn0.5Sr5CPC?AF \n\nMn1Sr5????TCP  Mn1Sr5CPC?A Mn1Sr5CPC?AS Mn1Sr5CPC?AF \n \n\nAs an example, RefCPC?A denotes a CPC prepared from the starting pure ?-TCP \n\npowder (Ref?TCP) and liquid A. \n\n \n\n2.2 Characterisation of cement pastes \n\n2.2.1 Setting time \n\nThe initial setting time (IST) of cement pastes was determined using the Vicat \n\nneedle technique as described elsewhere (n=3) [29]. One minute after placing the \n\ncement paste into a glass plate stored at 37\u00baC in 100% humidity box, the indenter \n\n(100 g in mass, 1 mm needle diameter) was lowered vertically and dropped onto \n\nthe cement surface. Indentations were repeated at ~30 s intervals until no more \n\npenetration was possible, taking this time point as IST. The CPC specimens were \n\nkept under controlled conditions (37\u00baC, 100% relative humidity) for a further 48 h \n\nand setting reaction was then stopped by crushing and mixing them with acetone. \n\nThe powdered samples were dried at 40\u00baC and used for qualitative and \n\nquantitative phase analyses by XRD.  \n\n \n\n \n\n\n\nCap\u00edtulo 5 \n\n 190 \n\n2.2.2 Injectability  \n\nA protocol described previously [46] was used to test the injectability of CPC \n\npastes. The cement pastes hand-mixed for 1 min were placed into a 6 ml syringe \n\n(12.50 mm inner diameter; 67 mm in length) fitted with a cannula (2.2 mm inner \n\ndiameter; 91 mm in length). The extrusion set consisted of a homemade fixture \n\ndevice adapted to a testing machine (Shimadzu Autograph, trapezium 2, Japan). \n\nThe tests were performed at 20\u00baC, 2.5 min after mixing the powders with liquid. \n\nThe crosshead speed and the maximum load were fixed at 15 mm min?1 up and \n\n300 N, respectively. The percentage of injectability was determined as the ratio \n\nbetween the mass of the paste that could be expelled from the syringe and the \n\ninitial mass of the paste inside the syringe (n=3) [24, 32, 46].   \n\n \n\n2.2.3 Mechanical properties and porosity  \n\nFor compressive strength (CS) and porosity measurements, cement pastes were \n\ncast into PTFE-moulds (? 6 \u00d7 12 mm3) and stored in 100% humidity at 37\u00baC for \n\n1 h. The CPC specimens were then removed from the moulds, the surfaces \n\npolished to obtain flat and parallel faces, and immersed in phosphate-buffered \n\nsaline (PBS) solution (Pierce, Perbio) at 37\u00baC for further 48 h. Following, the \n\ncements were immediately loaded to failure at a crosshead displacement rate of \n\n1 mm?min?1 using a universal materials testing machine (Shimadzu Autograph, \n\nTrapezium 2, Japan) equipped with a 10 kN load cell (n=7). The entire remaining \n\nspecimens were completely dried at 37\u00baC for several days, and used for total \n\nporosity and crystalline phase composition determinations. Total porosity (n=3-5) \n\nwas calculated as: Total porosity (vol%) = [(?calc? ?app)/?calc]*100, where ?calc is the \n\ndensity of fully dense CPCs (calculated from quantitative XRD phase analysis) and \n\n?app the sample\u2019s apparent density (determined through the Archimedes\u2019 method \n\nwith Hg-immersion). The specific surface areas (SSA) of the mechanically \n\nstrongest cements were determined by the BET method using a Micromeritics \n\nGemini 2370 V5.00 (Norcross, USA) after degassing the samples in a \n\nMicromeritics Flow Prep 060 (Norcross, USA). \n\n\n\nCap\u00edtulo 5 \n\n 191 \n\n2.2.4 X-ray diffraction and structural analysis by the Rietveld refinement \n\nmethod  \n\nThe crystalline phase composition of the powdered CPCs was assessed using a \n\nPanalytical X'Pert Diffractometer with Ni filtered Cu-K? radiation (voltage 45 kV \n\nand intensity 40 mA) in a continuous scanning mode with spinning by recording \n\nX-ray diffraction data within the 2? range = 4\u201370\u00ba (step size 0.013\u00ba, 198.645 s for \n\neach step). The software TOPAS version 4.2 (Bruker AXS, Karlsruhe, Germany) \n\nwith the fundamental parameter approach was used for Rietveld refinements, by \n\nusing the following structural model of ICDD cards numbers: #04-001-7104 for \n\n?-TCP, #04-011-5377 for MCPM, #04-013-3344 for brushite, #04-009-3755 for \n\nmonetite and #04-013-3883 for octacalcium phosphate  (Ca8H2(PO4)6.5H2O;  \n\nOCP). \n\n \n\n2.3 Characterisation of cement/osteoblastic-like cells interactions \n\n2.3.1 Cultures of MG63 cells with cements  \n\nThe osteosarcoma cell line MG-63 (ATCC CRL-1427) was maintained in 2 mM \n\nGlutamine-containing Minimum Essential ?-Medium in EBSS (Eagle's balanced \n\nsalt solution) supplemented with 10% (v/v) foetal bovine serum (FBS), 1% (v/v) of \n\na 100 U m?L?1 penicillin and 100 mg?mL?1 streptomycin solution (Gibco BRL, \n\nInvitrogen), and 2.2 g?L?1 NaHCO3, at 37 \u00baC/5% CO2, and passaged using a 0.05% \n\ntrypsin/EDTA solution (Gibco BRL, Invitrogen). Disc-shaped cements (10 mm \n\ndiameter and ~1 mm height), prepared in liquids A and AS, were stored in \n\n100% humidity/37\u00baC for 48 h, air dried, sterilized by low-temperature hydrogen \n\nperoxide gas plasma, washed [3-4 times in PBS (Pierce, Perbio) and twice in cell \n\nmedia at 37\u00baC], and finally placed in 24-well plates. 1x104 cells?cm?2 MG-63 cells \n\nwere seeded on the cement-containing wells and incubated at 37\u00baC/5% CO2 for \n\nspecified days. Control cells were seeded directly on the polystyrene well bottom \n\nor on glass coverslips placed on the well (microscopy assays).  \n\n \n\n\n\nCap\u00edtulo 5 \n\n 192 \n\n2.3.2 Viability and proliferation assays \n\nThe resazurin metabolic assay was used to determine the cements\u2019 effects on \n\nMG63 cells viability and proliferation [39]. Cells were grown on cement-containing \n\nwells for 28 days, and at 1, 4, 7, 14, 28 days in vitro (DIV) incubated for 4 h with \n\nfresh medium containing 10% of a resazurin solution [0.1 mg?mL?1 resazurin \n\n(Sigma Aldrich) in PBS]. Resazurin reduction was spectrophotometrically \n\nmeasured (Infinite M200 PRO, Tecan) at 570 and 600 nm, the ratio OD 570/OD \n\n600 nm calculated for each time point, and the OD 570/OD 600 nm ratio of the \n\nblank (cell-free resazurin medium) subtracted. The resulting final ODs (fOD) were \n\nconverted to fold increases over the fOD value of control cells at 1 DIV (taken \n\nas 1), and plotted against time of incubation. As another indirect measure of total \n\ncell number, at the final time point (28 DIV), cells were collected and their total \n\nprotein content analysed via the BCA protein assay kit (Pierce\u2019s, Thermo \n\nScientific), following the manufacturers\u2019 instructions.  \n\n \n\n2.3.3 Chemical and phase composition of cements after 28DIV with MG63 \n\ncells \n\nThe culture medium was substituted after the first 24 h and every 3 days \n\nthereafter. The pH values of the medium removed at 1, 7, 14 and 28 DIV were \n\nregistered. The chemical variations of CPCs (Sr5CPC?AS, Mn0.5Sr5CPC?AS and \n\nMn1Sr5CPC?AS) induced by the in vitro cell assay medium were assessed by ICP \n\ndetermination (section 2.1.1) of the Mn and Sr contents in the samples before and \n\nafter the 28 DIV in the presence of cells (n=3). Qualitative and quantitative phase \n\nanalyses were also performed by XRD for all cement samples prepared with \n\nliquids A and AS after 28 DIV. \n\n \n\n \n\n \n\n\n\nCap\u00edtulo 5 \n\n 193 \n\n2.3.4 Immunoblot analyses of type-I collagen  \n\nAt 4 DIV, cells\u2019 conditioned media were collected, centrifuged at 1000 g/5 min to \n\nclear from cell debris, the supernatant collected into 1% SDS solutions and boiled \n\nfor 10 min. Volume-normalized aliquots were subjected to 7.5% SDS-PAGE in \n\nTris-Glycine buffer, the proteins electrophoretically transferred onto nitrocellulose \n\nmembranes, and immunoblotted as previously described [48] using \n\nanti-type-I collagen (Novus Biologicals, Germany) and horseradish peroxidase-\n\nlinked anti-rabbit (GE Healthcare, Chalfont St. Giles, UK) antibodies for enhanced \n\nchemiluminescence detection. Previous to the immunoblotting, Ponceau S \n\ndetection of all proteins was performed as a loading control [49]. Ponceau-S \n\nstained membranes and immunoblot autoradiograms were scanned (GS-800 \n\nimaging densitometer, Bio-Rad) and protein bands quantified (Quantity One \n\ndensitometry software, Bio-Rad). Immunoblot data was corrected to the respective \n\nPonceau loading control. \n\n \n\n2.3.5 Confocal microscopy and scanning electron microscopy analyses of \n\ncells  \n\nMG63 cells were seeded at 1x104 cells?cm?2 onto 24-well plates containing \n\ncement discs of RefCPC?A, Sr5CPC?A, Mn0.5Sr5CPC?A and Mn0.5Sr5CPC?AS \n\nover glass coverslips. Control cells were seeded only on the coverslip. At 7 DIV, \n\nconfocal microscopy was used to analyse the cells grown in the vicinity of the \n\ncements, and scanning electron microscopy was used to visualize cells grown on \n\ncements. \n\nImmunocytochemistry (ICC) and confocal microscopy ? cells grown on coverslips \n\nwere fixed with a 4% paraformaldehyde/PBS solution for 30 min, and \n\npermeabilised with a 0.2% Triton/PBS solution. Non-specific sites were blocked \n\nwith a 3% bovine serum albumin (BSA)-PBS solution for 1 h, and coverslips \n\nsubmitted to ICC procedures as before [25] using the anti-type-I collagen I \n\nantibody (1:250 in 3% BSA-PBS), a FITC-conjugated secondary antibody (1:300 in \n\n\n\nCap\u00edtulo 5 \n\n 194 \n\n3% BSA-PBS) and red fluorescing Alexa 568-labelled Phalloidin (1:500) to stain \n\nfilamentous actin. Images were acquired with a LSM 510 META confocal \n\nmicroscope (Zeiss, Jena, Germany) through a Plan-Neofluor 40\u00d7/1.30 oil objective \n\nand using an Argon 488 nm laser line (FITC channel), a Diode 405-430 laser \n\n(DAPI channel) and a 561 nm DPSS laser (Alexa 568 channel). \n\nScanning electron microscopy (SEM) ? cells grown on cement disks were fixed by \n\nimmersing the discs in 2.5% glutaraldehyde in PBS for 40 min at RT. After three \n\nwashes in PBS the samples were dehydrated through a graded ethanol series \n\n(15%, 30%, 50%, 70%, 90%, 96%, 3\u00d7100%). The disks were critical-point-dried in \n\na BAL-TEC CDC 030 (Balzers, Liechtenstein) and glued onto stubs, \n\nsputter-coated with gold-palladium and examined with a Hitachi S-4100 scanning \n\nelectron microscope (Hitachi High-Technologies Corp., Tokyo, Japan) operated at \n\n15 kV. \n\n  \n\n2.4 Statistical analysis \n\nData relative to the characterization of the cements are expressed as mean\u00b1SD \n\n(standard deviation) of the mean; cellular in vitro data are expressed as mean\u00b1SE \n\n(standard error) of the mean. A minimum of three independent experiments was \n\nperformed for each quantitative analysis. Statistical significance analysis was \n\nconducted using one- (cements composition) and two-way (cements composition \n\nand type of setting liquid) analysis of variance (ANOVA), followed by the \n\nGreenhouse-Geisser test, with the level of statistical significance set at 0.05. \n\nSymbols used: (*) for comparison between different CPCs and the Ref-CPC data, \n\nin a given liquid; (+) for comparison between data from different setting liquids for \n\neach cement composition; cellular in vitro data: (\u00ba) for comparison between control \n\ncells data and data from different CPCs in a set liquid.  \n\n \n\n \n\n\n\nCap\u00edtulo 5 \n\n 195 \n\n3. Results  \n\n3.1 Characterisation of ????-TCP powders  \n\nTable 1 presents Sr and Mn contents of starting powders obtained by ICP \n\nanalysis. For Sr, a good agreement is observed between the planned and the \n\nexperimentally obtained contents, while the measured Mn concentrations were \n\n64?70% of the planned ones.  \n\nFrom the XRD patterns displayed in Fig. 1a, all starting powders apparently \n\nconsist of pure ??TCP phase (ICDD PDF 04-001-7104). This apparent close \n\nmatching suggests that lattice distortions in ??TCP caused by the atomic \n\nreplacement of Ca by Sr [21, 50, 51] or/and by Mn [30] are too small to be \n\ndetected. The (Ca+Mn+Sr)/P ratios (1.485?1.496) obtained from ICP analyses \n\nsuggest the formation of small amounts of calcium pyrophosphate (Ca2P2O7, CPP) \n\n[52, 53].  \n\nThe noticeable vibrational modes of PO4 tetrahedra in FT-IR patterns of Fig. 1b \n\nconfirm the formation of ??TCP as the predominant phase. The absorption bands \n\nat 726 cm?1 and 1208 cm?1, ascribed to pyrophosphate groups (P2O7\n4?), \n\nparticularly to P?O?P bonds, are almost imperceptible being slightly more evident \n\nfor Ref-TCP.  \n\nThe results of particle size analysis displayed in Fig. 1c reveal that all starting \n\npowders exhibit analogous bimodal PSD curves, including size parameters Dmean \n\n(1.02 \u00b1 0.05 \u00b5m) and D50 (0.67 \u00b1 0.03 \u00b5m). This feature is of crucial importance to \n\nensure comparability between the different cement formulations prepared thereof. \n\nThe most intense populations of fine particles appear centred at ~0.6 \u00b5m, while \n\nsmaller populations of coarser ones are centred at ~2 \u00b5m. \n\n \n\n \n\n \n\n\n\nCap\u00edtulo 5 \n\n 196 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 1. a) X-ray diffraction patterns, b) FT-IR spectra and c) particle size distributions (including \n\nDmean and D50 values) of non-doped (Ref-TCP) and doped ?-TCP starting powders (after heat-\n\ntreating at 800\u00baC for 2 h and dry-milling) used in CPC preparation. Dmean (mean diameter) is the \n\n\u2018\u2018average\u2019\u2019 size of particles and D50 (median diameter) the size for which 50 vol.% of the particles \n\nare finer. \n\n \n\n0\n\n4\n\n8\n\n12\n\n16\n\n0.01 0.1 1 10 100\nParticle size (\u00b5\u00b5\u00b5\u00b5m)\n\nV\nol\n\nu\nm\n\ne \n(%\n\n)\n\nMn1Sr5-TCP\n\nMn0.5Sr5-TCP \n\nMn1-TCP\n\nMn0.5-TCP\n\nSr5-TCP\n\nRef-TCP\n\n,\n\n(c) ????-TCP Dmean D50\npowders  (\u00b5 (\u00b5 (\u00b5 (\u00b5m)  (\u00b5\u00b5\u00b5\u00b5m)\n\nMn1Sr5-TCP 1.01 0.69\n\nMn0.5Sr5-TCP 1.07 0.71\n\nMn1-TCP 0.97 0.62\n\nMn0.5-TCP 1.09 0.67\n\nSr5????TCP 0.96 0.68\nRef????TCP 0.99 0.67\n\n0\n\n4\n\n8\n\n12\n\n16\n\n0.01 0.1 1 10 100\nParticle size (\u00b5\u00b5\u00b5\u00b5m)\n\nV\nol\n\nu\nm\n\ne \n(%\n\n)\n\nMn1Sr5-TCP\n\nMn0.5Sr5-TCP \n\nMn1-TCP\n\nMn0.5-TCP\n\nSr5-TCP\n\nRef-TCP\n\n,\n\n(c) ????-TCP Dmean D50\npowders  (\u00b5 (\u00b5 (\u00b5 (\u00b5m)  (\u00b5\u00b5\u00b5\u00b5m)\n\nMn1Sr5-TCP 1.01 0.69\n\nMn0.5Sr5-TCP 1.07 0.71\n\nMn1-TCP 0.97 0.62\n\nMn0.5-TCP 1.09 0.67\n\nSr5????TCP 0.96 0.68\nRef????TCP 0.99 0.67\n\n\n\nCap\u00edtulo 5 \n\n 197 \n\n3.2 Characterisation of cement pastes \n\nThe properties of CPCs pastes listed in Table 2 are displayed in Fig. 2, including \n\nthe initial setting time (IST, Fig. 2a), compressive strength (CS, Fig. 2b) and \n\nporosity (Fig. 2c).  \n\nThe combined effects of doping the starting powders and adding sugars to the \n\nsetting liquid induced interesting changes in IST and CS. In comparison to the \n\nreference system RefCPC?A, the IST of Mn0.5CPC?A did not change and only a \n\nslight increase was noticed for Mn1CPC?A (Fig. 2a), while higher values of IST \n\nwere registered for Sr5CPC?A. The higher values were measured for co-doped \n\ncements (Mn0.5Sr5CPC?A and Mn1Sr5CPC?A). Similar trends are observed for \n\nIST upon replacing setting liquid A by liquids AS and AF, but variation is greater \n\nirrespective of the type of sugar used. The same experimental variables induced \n\nsimilar synergetic effects on CS (Fig. 2b) and porosity (Fig. 2c) of hardened \n\ncements, with fructose being less effective in enhancing the mechanical \n\nproperties. Mn0.5Sr5CPC?AS proved to be the strongest (CS ~17 MPa) and \n\nconsistently the less porous cement. Liquid AS (and in a lesser extent liquid AF) \n\nfavours CS and decreases porosity in comparison to liquid A. Irrespective of the \n\nsetting liquid used, all doped cements were less porous than RefCPC, the lowest \n\nporosity values (~32%) being achieved for Mn0.5SrCPC-A and \u2013AS. Interestingly, \n\nMn0.5SrCPC cements prepared with sugars containing liquids exhibit higher \n\nspecific surface area (SSA), with the highest value obtained for Mn0.5Sr5CPC?AS \n\n(Fig. 2c).   \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\nCap\u00edtulo 5 \n\n 198 \n\nc)\n\n****\n\n**\n\n**\n\n***\n\n***\n\n++++\n\n++\n\n+ +++\n+\n\n+\n\n++\n++\n\na)\n\n*\n\n*\n\n*** **\n\n++\n++ ++\n\n++\n++\n\n++\n\n+\n+\n\n+ +\n++\n\n+\n\nb)\n\n****\n\n****\n\n****\n\n****\n\n**\n++++\n\n+\n\n+++\n+ ++\n\n+++\n\n++++\n\n+++\n\n++++\n\n+++\n\n++\n\n1.41.91.2\n\nAFASA\n\nSSA (m2 g????1)\n\n1.41.91.2\n\nAFASA\n\nSSA (m2 g????1)c)\n\n****\n\n**\n\n**\n\n***\n\n***\n\n++++\n\n++\n\n+ +++\n+\n\n+\n\n++\n++\n\na)\n\n*\n\n*\n\n*** **\n\n++\n++ ++\n\n++\n++\n\n++\n\n+\n+\n\n+ +\n++\n\n+\n\nb)\n\n****\n\n****\n\n****\n\n****\n\n**\n++++\n\n+\n\n+++\n+ ++\n\n+++\n\n++++\n\n+++\n\n++++\n\n+++\n\n++\n\n1.41.91.2\n\nAFASA\n\nSSA (m2 g????1)\n\n1.41.91.2\n\nAFASA\n\nSSA (m2 g????1)c)\n\n****\n\n**\n\n**\n\n***\n\n***\n\n++++\n\n++\n\n+ +++\n+\n\n+\n\n++\n++\n\na)a)\n\n*\n\n*\n\n*** **\n\n++\n++ ++\n\n++\n++\n\n++\n\n+\n+\n\n+ +\n++\n\n+\n\nb)\n\n****\n\n****\n\n****\n\n****\n\n**\n++++\n\n+\n\n+++\n+ ++\n\n+++\n\n++++\n\n+++\n\n++++\n\n+++\n\n++\n\nb)\n\n****\n\n****\n\n****\n\n****\n\n**\n++++\n\n+\n\n+++\n+ ++\n\n+++\n\n++++\n\n+++\n\n++++\n\n+++\n\n++\n\n1.41.91.2\n\nAFASA\n\nSSA (m2 g????1)\n\n1.41.91.2\n\nAFASA\n\nSSA (m2 g????1)\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 2. Effects Effects of doping-ions (Sr and/or Mn in TCP powders) and of adding sugars, sucrose or \n\nfructose to setting liquids (AS or AF, respectively) on: a) initial setting time; b) compressive strength of wet \n\nCPC samples after 48 h of immersion in PBS solution at 37\u00baC; c) total porosity on CPCs prepared with a LPR \n\nof 0.28 mL?g?1. The inset in (c) reports SSA values of Mn0.5Sr5CPC prepared with different setting liquids. \n\nSymbol (*) denotes significantly different data for the doped CPCs?A with respect to RefCPC?A; symbol (+) \n\ndenotes significant differences between data from CPCs in ?AS and ?AF liquids and CPCs?A data, for each \n\ncement composition. */+, p<0.05; **/++, p<0.01; ***/+++, p<0.001; ****/++++, p<0.0001). \n\n\n\nCap\u00edtulo 5 \n\n 199 \n\nThe results of quantitative phase analysis of cements immersed in PBS at 37\u00baC for \n\n48 h or stored at 37\u00baC and 100% humidity for the same period are displayed in \n\nFig. 3a and 3b, respectively. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 3. Quantitative phase analysis data (wt.%) obtained by Rietveld refinement of cement samples \n\nafter: a) 48 h of immersion in PBS solution at 37\u00baC; b) 48 h storage at 37\u00baC under 100% humidity. \n\nDCPD = brushite; DCPA = monetite; ?-TCP = ?-tricalcium phosphate; MCPM = monocalcium \n\nphosphate monohydrate. \n\n \n\nAll doped samples kept in PBS consisted predominantly of brushite (DCPD) \n\ntogether with small amounts of monetite (DCPA) and unreacted ??TCP, \n\n0\n\n20\n\n40\n\n60\n\n80\n\n100\n\nA AS AF A AS AF A AS AF A AS AF A AS AF A AS AF\n\nRef Sr5 Mn0.5 Mn1 Mn0.5Sr5 Mn1Sr5\n\nCPC\n\nX\nR\n\nD\n c\n\nom\np\n\nos\nit\n\nio\nn\n\n (\nw\n\nt.\n%\n\n)\n\nDCPD DCPA    -TCP????\na) \n\n0\n\n20\n\n40\n\n60\n\n80\n\n100\n\nA AS AF A AS AF A AS AF A AS AF A AS AF A AS AF\n\nRef Sr5 Mn0.5 Mn1 Mn0.5Sr5 Mn1Sr5\n\nCPC\n\nX\nR\n\nD\n c\n\nom\np\n\nos\nit\n\nio\nn\n\n (\nw\n\nt.\n%\n\n)\n\nMCPM DCPD DCPA\nb) \n\n\n\nCap\u00edtulo 5 \n\n 200 \n\nirrespective of the setting liquid used. In contrast, in non-doped cements unreacted \n\n??TCP was absent and much higher monetite amounts formed, being this the \n\nmain phase in RefCPC?A and RefCPC?AF samples (Fig. 3a). Under 100% \n\nhumidity (Fig. 3b), remains of unreacted MCPM appeared instead of ??TCP; \n\ndoped cements exhibited brushite as the main phase, together with very small \n\namounts of monetite, contrasting with non-doped cements, in which monetite \n\npredominates. \n\nThe effects of doping starting powders and adding sugars to setting liquid A on \n\ninjectability (Fig. 4a) and extrusion force versus syringe plunger displacement \n\ncurves (Fig. 4b) were studied for the higher CS cements (Sr5CPC, Mn0.5Sr5CPC, \n\nMn1Sr5CPC). Mn-doping noticeably increased injectability from ~4% (Sr5CPC) to \n\n~80% (Mn0.5Sr5CPC?A, Mn1Sr5CPC?A). Adding sugars to setting liquid A \n\ndrastically enhanced the injectability of the least performing paste (Sr5CPC) to \n\n~97.5% (AS) or ~96% (AF). Sugars also enabled co-doped Mn0.5Sr5CPC and \n\nMn1Sr5CPC pastes to be fully extruded. The combined benefits of co-doping and \n\nadding sugars are also evident from Fig. 4b. The fully injectable pastes exhibited \n\ntypical extrusion curves [31, 32, 54], characterized by an initial fast increase of the \n\napplied force, followed by a plateau and a marked increase up to the maximal \n\nextrusion force. Instead of plateau, the intermediate segments of the extrusion \n\ncurves of partially injectable pastes (Sr5CPC?A, Mn0.5Sr5CPC?A, Mn1Sr5CPC?A \n\nand Sr5CPC?AF) became gradually inclined as injectability worsened, being \n\naccompanied by an increasing filter pressing effect [32, 46] (Supplementary Table \n\nS1). The force required to extrude the Sr5CPC?A paste sharply increased and \n\nquickly reached the set maximum value of 300 N [32]. Co-doping noticeably \n\nreduced the extruding force (Fig. 4b), while adding sugars clearly enhanced the \n\nextrusion ability of Sr5CPC?A in the order Sr5CPC?AS >Sr5CPC?AF and further \n\nimproved the reasonable injectability of co-doped cements (Fig. 4a and 4b).  \n\n \n\n \n\n \n\n\n\nCap\u00edtulo 5 \n\n 201 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 4. a) Percentage of injectability and b) extrusion force curves versus syringe plunger \n\ndisplacement for Sr5CPC, Mn0.5Sr5CPC and Mn1Sr5CPC pastes prepared with sugar free liquid \n\n(A) and liquids containing sucrose (AS) and fructose (AF) with LPR = 0.28 mL?g?1, extruded 2.5 min \n\nafter mixing the powders with the setting liquid. Symbol (*) denotes significantly different \n\ninjectability values for the co-doped CPCs-A with respect to Sr5CPC-A; symbol (+) denotes \n\nsignificantly different injectability values for CPCs in ?AS and ?AF liquids with respect to CPCs?A, \n\nfor each cement composition. ++, p<0.01; ***/+++, p<0.001; ****/++++, p<0.0001). \n\n \n\n \n\n\n\nCap\u00edtulo 5 \n\n 202 \n\nTable S1. Evaluation of the homogeneity of the CPC pastes [initial liquid to powder ratio \n\n(LPR) = 0.28 mL?g?1] upon extrusion. To evaluate filter pressing effects, paste samples were \n\ncollected every 30 \u00b1 2 s counted from the beginning of the extrusion process. Any remaining paste \n\nin the syringe (when complete extrusion did not occur) was also collected. These samples were \n\nweighed before and after complete drying at 120\u00baC for 24 h, to determine their LPR values. The \n\nfilter pressing effect was evaluated by the significance of the variations in LPR (three independent \n\nexperiments) undergone upon the extrusion of each paste and quantified from repeated measures. \n\nANOVA with Greenhouse Geisser correction was used to determine statistical significance (p &lt;\n\n0.05). \n\nLPR of A1 a LPR of A2 a LPR of A3 a \n\nLPR of  \n\nRemaining paste \n\n not extruded \n\np-value b \n\nCement Pastes \n\n(\u00b1 0.01)  \n(mL g????1) \n\n(\u00b1 0.01)  \n(mL g????1) \n\n(\u00b1 0.01)  \n(mL g????1) \n\n(\u00b1 0.01)  \n(mL g????1) \n\n \n\nSr5CPC????A 0.3 - - 0.26 0.029b \n\nSr5CPC????AS 0.27 0.28 0.29 - 0.156 \n\nSr5CPC????AF 0.27 0.29 0.28 - 0.103 \n\nMn0.5Sr5CPC????A 0.28 0.3 - 0.25 0.011b \n\nMn0.5Sr5CPC????A 0.27 0.28 0.28 - 0.055 \n\nMn0.5Sr5CPC????A 0.28 0.29 0.29 - 0.100 \n\nMn1Sr5CPC????A 0.28 0.3 - 0.26 0.029b \n\nMn1Sr5CPC????A 0.28 0.28 0.29 - 0.065 \n\nMn1Sr5CPC????A 0.27 0.29 0.29 - 0.057 \n\na A1, A2 and A3 \u2013 samples of paste injected during the extrusion. \nb Presence of filter pressing effect (p &lt;0.05). \n \n\n \n\n \n\n \n\n \n\n\n\nCap\u00edtulo 5 \n\n 203 \n\nThe phase compositional changes derived from aging CPCs for 28 days in vitro \n\n(DIV) in the presence of the MG63 pre-osteoblastic cells are shown in Fig. 5.  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 5. Quantitative phase analysis data (wt.%) obtained by Rietveld refinement of cement samples \n\nafter immersion during 28 days in vitro (DIV) in the presence of MG63 pre-osteoblastic cells. \n\nDCPD = brushite; DCPA = monetite; OCP = octacalcium phosphate. \n\n \n\nThe predominant monetite phase in RefCPCs (Fig. 3b) transformed into brushite \n\nand octacalcium phosphate (OCP); brushite remained as one of the main phases \n\nin the other cements, (Figs. 3b vs 5). Monetite, formed only in doped CPCs, tends \n\nto disappear in the presence of sucrose. Interestingly, significant fractions of OCP \n\nwere formed in all the non-doped and doped cement formulations, except Sr5CPC \n\nthat consisted of brushite alone (Sr5CPC?AS) or accompanied with monetite \n\n(Sr5CPC?A). These results suggest that Sr tends to hinder the formation of OCP \n\nfrom brushite cements.  \n\n \n\n \n\n0\n\n20\n\n40\n\n60\n\n80\n\n100\n\nA AS A AS A AS A AS A AS A AS\n\nRef Sr5 Mn0.5 Mn1 Mn0.5Sr5 Mn1Sr5\n\nCPC\n\nX\nR\n\nD\n c\n\nom\np\n\nos\nit\n\nio\nin\n\n (\nw\n\nt.\n%\n\n)\n\nDCPD DCPA OCP\n\n\n\nCap\u00edtulo 5 \n\n 204 \n\nThe amounts of doping Sr and Mn ions released into the culture medium during \n\nincubation with MG63 cells for 28 DIV from Sr5CPC?AS, Mn0.5Sr5CPC?AS and \n\nMn1Sr5CPC?AS samples obtained by ICP analysis (section 2.3.3) are reported in \n\nFig. 6.  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 6. Total released amounts of Sr and Mn ions from Sr5CPC-AS, Mn0.5Sr5CPC?AS and \n\nMn1Sr5CPC?AS samples during 28 days in vitro (DIV) in the presence of MG63 pre-osteoblastic \n\ncells (mg per g of cement, grey bars), and percentages (wt.%, values in brackets) relative to their \n\ncontents in cement samples before starting the in vitro test (after washing in PBS and in cell media \n\nat 37\u00baC).  \n\n \n\nIt can be seen that (i) a higher Mn content (Mn1Sr5CPC) released a higher dose \n\n(~0.4 mg?g?1); (ii) co-doping decreased the Sr release (Sr5CPC?AS > \n\nMn0.5Sr5CPC?AS > Mn1Sr5CPC?AS); (iii) the released percentage of Mn was \n\nmuch higher than that of Sr, suggesting a preferential leaching of the smaller Mn \n\n(ionic radius = 0.83 \u00c5) in comparison to Sr (ionic radius = 1.13 \u00c5); (iv) ionic \n\nleaching from co-doped cements is likely to continue beyond the 28 days if longer \n\ntime periods are allowed. \n\n \n\n(44.6 %)\n\n(7.4 %)\n\n(47.0 %)\n\n( 9.9 %)\n\n(17.2 %)\n\n0\n\n1\n\n2\n\n3\n\nSr Mn Sr Mn Sr Mn\n\nSr5CPC Mn0.5Sr5CPC Mn1Sr5CPC\n\nR\nel\n\nea\nse\n\nd\n i\n\non\n c\n\non\nte\n\nn\nt \n\n(m\ng \n\ng-\n1 )\n\n\n\nCap\u00edtulo 5 \n\n 205 \n\n3.3 Characterisation of in vitro osteoconductive properties \n\n3.3.1 Effects of Mn- and Sr-doping on cell viability and type-I collagen \nsecretion \n\nThe reversible metabolic resazurin assay, an indirect measure of the number of \n\nviable cells and their proliferation, was used to assess MG63 pre-osteoblastic cell \n\nviability at various time points of incubation with the CPCs (1, 4, 7, 14 and 28 DIV) \n\n(Fig. 7).  \n\nResazurin data was expressed as fold increases of control cells\u2019 values at 1 DIV \n\n(taken as 1). The time-dependent resazurin profiles obtained varied as expected \n\nfor these pre-osteobastic cells, with control cells growing exponentially during the \n\nfirst week in culture and maintaining their number thereafter (Fig. 7; [25]). \n\nRegardless of the setting liquids tested (A, AS), cell numbers decreased in the \n\npresence of cements, except for Sr5CPC (A and AS) at the latest time point \n\n(Fig. 7a and 7b, 28 DIV). Non-doped and Mn-doped cements strongly inhibited \n\nMG63 proliferation (Fig. 7a and b), while Sr stimulated the number of viable cells, \n\ncontributing for the increased resazurin fOD levels observed in co-doped cements \n\n(Mn0.5Sr5CPC, Mn1Sr5CPC) over solely Mn-doped ones (Mn0.5CPC, Mn1CPC). \n\nThis is especially true for Mn0.5Sr5CPC, which presented metabolic levels more \n\nsimilar to the Sr5CPC ones, whilst Mn1Sr5CPC strongly induced growth arrest \n\n(and potentially some cell death) at the latest DIV (Fig. 7a and 7b). The cells \n\ntime-dependent growth profile was similar when liquid AS (CPCs?AS) was used, \n\nwith fOD fold-increases being generally higher than for CPCs?A although not \n\nalways significant (Fig. 7a and 7b). Quantification of the total protein content of \n\nMG63 cell lysates at 28 DIV in CPCs?A, another indirect measure of the final \n\nnumber of cells, revealed a similar profile of cell growth (Fig. 7c). While protein \n\ncontents of cell grown with Sr5CPC?A and Mn0.5Sr5CPC?A were less distant \n\nthan the one of control cells, the yielded protein content was very small \n\n(~0.1 \u00b5g?\u00b5L?1) for the non-doped (RefCPC?A) and Mn-doped (Mn0.5CPC?A, \n\nMn1CPC?A) cements. \n\n \n\n\n\nCap\u00edtulo 5 \n\n 206 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 7. Cell viability and secretion of type-I collagen in human MG63 osteoblast-like cells exposed \n\nto non-doped and doped CPC discs. a) and b) Resazurin assay of MG63 cells cultured for 28 days \n\nin vitro (DIV) without cement discs (control \u2018Ctrl\u2019 cells) and with non-doped (RefCPC) or doped \n\n(Mn0.5CPC, Mn1CPC, Sr5CPC, Mn0.5Sr5CPC, Mn1Sr5CPC) cement discs prepared with setting \n\nliquids A (a) and AS (b). c) Total protein concentration of the lysates of cells cultured for 28 days \n\nwith CPC-A cements. d) Medium secreted type-I collagen levels were detected by immunoblot and \n\nquantified in conditioned media collected at 4 DIV; type-I procollagen a(I) and a(II) bands were \n\nquantified, data normalized to loading control (Ponceau staining). Symbol (*) and (\u00ba) denote \n\nsignificant differences between doped CPC?A data, and RefCPC?A or Control cells (\u2018Ctrl\u2019) data, \n\nrespectively; symbol (+) denotes significant differences between CPCs?AS and CPCs?A data, for \n\neach cement composition. */\u00ba/+, p<0.05; **/\u00ba\u00ba/++, p<0.01; ***/\u00ba\u00ba\u00ba/+++, p<0.001; \u00ba\u00ba\u00ba\u00ba/++++, p<0.0001). \n\n \n\n\n\nCap\u00edtulo 5 \n\n 207 \n\nType-I collagen is the major protein constituent of the organic bone matrix, and its \n\nprecursor chains are secreted by osteoblasts to form extracellular collagen fibrils. \n\nCellular monomeric type-I pro-collagen consists of  ?1 (~140 kDa) and ?2 (~130 \n\nkDa) chains, which can suffer a high number of post-translational modifications, \n\nbefore aggregating into oligomers and fibres [25]. The effects of the cements on \n\nsecreted pro-collagen protein levels were analysed in cells conditioned media \n\ncollected at 4 DIV, a time point of high pro-collagen secretion by pre-osteoblastic \n\ncells in culture (Fig. 7d); [25]). The results obtained were similar using either liquid \n\nA or AS (Fig. 7d, upper and lower graphs, respectively). As expected from their \n\nvery low resazurin levels (Fig. 7a and 7b), RefCPC and Mn-doped cements had \n\nseverely decreased amounts of secreted pro-collagen. In contrast, Sr-containing \n\ncements (Sr5CPC, Mn0.5Sr5CPC, Mn1Sr5CPC) induced cells to secrete pro-\n\ncollagen at levels very similar to control cells (Fig. 7d; non-statistically significant \n\nfrom control cells), even though their viability levels at 4 DIV are only half of the \n\ncontrol (Fig. 7a and 7b). Therefore, cells grown in the presence of Sr-containing \n\nCPCs had increased rates of pro-collagen secretion (at 4 DIV). \n\n \n\n3.3.2 Mn0.5Sr5CPC potential to be an osteoconductive scaffold \n\nMetabolic activity and secreted pro-collagen are bulk biochemical evaluations of \n\nthe biological responses of MG63 cells grown with the CPC samples. Upon \n\nseeding, cells have either grown on top of the cements or in their surroundings. To \n\ndiscriminate between the two cell populations, the compositions that exhibited the \n\nbest proliferation and differentiation results (Sr5CPC and Mn0.5Sr5CPC), in \n\ncomparison with RefCPC and regardless of the setting liquid used, were further \n\nanalysed using imaging techniques. Confocal microscopy was first used to monitor \n\nthe cells that did not adhere to cement discs and instead grew on their \n\nsurroundings at 7 DIV (Fig. 8). Fluorescent staining of cellular nuclei, \n\ntype-I collagen and filamentous-actin (F-actin) allowed the analysis of the cellular \n\ndistribution and collagen content in the various conditions (Fig. 8).  \n\n \n\n\n\nCap\u00edtulo 5 \n\n 208 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 8. Confocal microscopy analysis of MG63 osteoblasts cultured for 7 days on the surroundings \n\nof RefCPC, Sr5CPC and Mn0.5Sr5CPC discs. MG63 cells were seeded on RefCPC, Sr5CPC or \n\nMn0.5Sr5CPC (prepared with setting liquid(s) A and/or AS) discs placed on glass coverslips; cells \n\nthat did not adhere to the surface of the discs but grew on the top of the coverslip (in the cement \n\ndisks\u2019 vicinity) were probed for type-I collagen (green fluorescence), DAPI (blue nuclear staining), \n\nand filamentous actin (F-actin, probed with red-labeled phalloidin). Control (Ctrl) cells were grown \n\non a glass coverslip in the absence of any cement disk. Arrowheads, intracellular granule-like \n\ndensities. Scale bar = 50 \u00b5m. \n\n\n\nCap\u00edtulo 5 \n\n 209 \n\nAs expected, control cells grown on a coverslip in the absence of cements had a \n\ntissue-like spreading (pervasive cell-to-cell contacts in the F-actin staining), and \n\npresented homogeneous pools of granular intracellular type-I collagen (Fig. 8, \n\nCtrl cells) [25]. Contrastingly, very few cells grew in the presence of  RefCPC?A \n\n(approximately one cell was visible per 20x imaged field) (Fig. 8, RefCPC?A). \n\nAgreeing with its high metabolic activity, the majority of the Sr5CPC coverslips \n\nshowed high cell density (higher number of DAPI-positive nuclei per imaged area) \n\nand cells were often smaller than control ones, a characteristic of high growth \n\nrates in a limited area (Fig. 8, Sr5CPC?A). Further, intracellular collagen staining \n\ndecreased in cells exposed to every doped cement, suggesting that collagen had \n\nbeen partially secreted in the earlier days. Particularly for Mn0.5Sr5CPCs, the \n\nintensity of intracellular collagen staining was not homogeneous throughout the \n\ncell population (Fig. 8, Mn0.5Sr5CPC?A and ?AS). The number of cells grown for \n\n7 DIV in the presence of the Mn0.5SrCPC cements was also smaller, in \n\ncomparison to Sr5CPC and control cell conditions (Fig. 8, Mn0.5Sr5CPC?A and \n\n?AS). Remarkably, cells cultured in the presence of cements often grew in more \n\ndisorganized overlapping layers, potentially due to dislocations of the cement disks \n\nover the coverslips during time in culture. At first glance, these data on cell \n\npopulation numbers do not agree with the metabolic activity data of Fig. 7, where \n\nSr5CPC and Mn0.5Sr5CPC have similar metabolic activity at 7 DIV, about half of \n\ncontrol cells levels. SEM analysis of the MG63 cells that have grown on the top of \n\nthe cement discs for 7 DIV shed further light on this apparent contradiction (Fig. 9, \n\nand supplementary Figs. S1 and S2). Low cell density is detected on the surface \n\nof RefCPC?A (Supplementary Fig. S1) and Sr5CPC?A discs (Fig. 9a). In contrast, \n\nhigh cell densities are clearly observed on the surface of Mn0.5Sr5CPC?A and \n\n?AS cements, with the latter presenting the highest cell density (Fig. 9d and 9g; \n\ncell scores in supplementary Fig. S1d). Moreover, cells grown on RefCPC?A and \n\nSr5CPC?A appeared less adherent to the substrate than cells grown on the \n\nMn0.5Sr5CPC (compare supplementary Fig. S1c and Fig. 9b-c with Fig. 9e-f and \n\n9h-i).  \n\n \n\n\n\nCap\u00edtulo 5 \n\n 210 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 9. Representative aspects of MG63 cells cultured for 7 days on the cement discs of Sr5CPC, \n\nMn0.5Sr5CPC-A and Mn0.5Sr5CPC-AS, SEM. An area of 0.5 mm2 is shown for each of the \n\ncompositions in a), d) and g), accompanied on the right column by a medium and a higher \n\nmagnification of the same material. a)-c) Low cell density on the surface of Sr5CPC disk. The \n\narrows in a) and b) indicate the cells. As shown in c), most cells on this material appeared less \n\nclosely appressed to the substrate than those shown in e), f) and h)-i). d)-i): Cell coverage on \n\nMn0.5Sr5CPC-A (d-f) and Mn0.5Sr5CPC-AS (g-i). In both cases, cell shape and distribution on the \n\nsurface of the material suggest great division and migratory activity. Most cells are rather flat on the \n\nsubstrate. \n\n\n\nCap\u00edtulo 5 \n\n 211 \n\nIndeed, cells grown on Mn0.5Sr5CPC are rather flat denoting good spreading and \n\nadhesion to the substrate, and exhibit numerous pseudopodia extensions (more \n\nevidenced in supplementary Fig. S2). Further, cell shape and distribution over \n\nMn0.5Sr5CPC-A and -AS surfaces suggest high cell division and migratory activity \n\n(Fig. 9d-i). \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. S1. SEM images of MG63 human osteoblasts on disc surface of RefCPC after 7 days of \n\nculturing (a-c). The area shown in a) is 0.5 mm2. a)-b) Surface texture at two magnifications. No \n\ncells are visible in the area displayed. c) Detail of one of the rare cells found on the disk surface, \n\nshowing numerous thin pseudopodia extending toward surface particles from a relatively thick, \n\nelongated cell body (compare with Fig. 8). d) Plot of cell densities obtained under each of the four \n\nexperimental conditions, estimated from cell counts over at least 3 mm2 of disk surface visualized \n\nas in a). Symbol (*) denotes significantly different values for co-doped CPCs?A and ?AS with \n\nrespect to RefCPC?A; **, p<0.01; ***, p<0.001; ****, p<0.0001). Statistic significances in-between \n\ndoped CPCs: Sr5CPC?A vs Mn0.5Sr5CPC?A p<0.0001; Sr5CPC?A vs Mn0.5Sr5CPC?AS \n\np<0.0002; Mn0.5Sr5CPC?A vs Mn0.5Sr5CPC?AS p = 0.0518. \n\n\n\nCap\u00edtulo 5 \n\n 212 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. S2. Details of MG63 cells colonizing the disc surface of Mn0.5Sr5CPC?A (a) and \n\nMn0.5Sr5CPC-AS (b), SEM. Both cell-to-cell and cell-to-substrate connections by thin \n\npseudopodia are abundant. The cells are rather flat and somewhat electron-translucent, allowing \n\nthe distinction of underlying substrate particles. \n\n \n\n4. Discussion \n\n4.1. Effects of MnSr-doping and sugars addition on the properties of \n\ncements \n\nThe beneficial effects of Sr on preventing bone resorption and enhancing bone \n\napposition in vivo are well known [55, 56], and Sr incorporation into CPCs became \n\na hot topic tackled in various recent studies [25, 29, 57-65]. In contrast, the \n\nosteogenic effects of Mn did not arise much interest so far, and only a few studies \n\ndisclosed benefits in terms of bone growth and repair when it is present at low \n\nlevels in metallic implants [20], while its deficiency in the body may lead to \n\nosteoporosis [27, 28]. This work aims at fulfilling this gap by incorporating Sr and \n\nMn in CPCs and assessing their roles in determining relevant handling, physical \n\nand in vitro biological properties. The results of XRD (Fig. 1a) and ICP analysis \n\n(Table 2) confirmed that Ca has been partially replaced by doping elements in the \n\ncrystalline lattice of the starting ?-TCP powders [21, 50, 51].  \n\n\n\nCap\u00edtulo 5 \n\n 213 \n\nThe incorporation of species with different ionic radii (0.83 \u00c5 for Mn and \n\n1.13 \u00c5 for Sr) is likely to affect the chemical stability of doped powders and induce \n\nchanges in dissolution/precipitation reactions with the setting liquid. According to \n\nthe results displayed in (Fig. 2a), one can conclude that: (i) doping ions have \n\nenhanced the chemical stability, as the setting reactions have been delayed; (ii) in \n\nthis regard, there was a clear synergetic effect when both ions were present \n\n(Mn0.5Sr5CPC and Mn1Sr5CPC). The IST increased more than 2.5 times upon \n\nchanging from RefCPC?A to Mn1Sr5CPC?A. These observations are in \n\nagreement with the Sr retarding effect reported for the setting of Sr-containing \n\nbrushite cements [24, 66, 67]. Slower setting reaction rates are likely to favour \n\nmore uniform spatial arrangements of crystals and lead to more packed and less \n\nporous structures. This would help explaining why doped cements exhibit higher \n\nwet CS, with the highest value being observed for Mn0.5Sr5CPC. While these \n\nresults agree with those reported by Pina et al. [24, 25, 29], they disagree with the \n\nones reported for Sr-doped cements by Alkhraisat et al. [63], who did not find any \n\ninfluence of doping on the mechanical properties.   \n\nNoticeable increases in IST were also obtained when sugars were added to the \n\nsetting liquid, confirming their well-known roles as setting retardants in cement \n\nbuilding materials [44, 68-70]. However, the retarding mechanism is not yet \n\ncompletely understood even for Portland type cements [44, 70] and the subject \n\ndeserves to be further investigated, particularly in the case of CPCs systems \n\n[71, 72]. Considering that more time is allowed for handling the cement pastes \n\nwhen IST is longer, the enhanced flowing ability of the Sr5CPC?AS, \n\nMn0.5Sr5CPC?AS and Mn1Sr5CPC?AS pastes demonstrated in Fig. 4a and 4b is \n\nnot surprising. The poor injectability of Sr5CPC?A can be partially understood as \n\nextrusion was initiated at about 50% of IST. The enhanced injectability of \n\nMn0.5Sr5CPC?A and Mn1Sr5CPC?A can also be partially attributed to the \n\nincrease of IST by ~2 min, in comparison to Sr5CPC?A. The significant \n\nimprovements in flowing ability of Sr-doped cements upon adding sugars \n\n(Sr5CPC?AS, Sr5CPC?AF) cannot be dissociated from the induced increments in \n\nIST (Fig. 2a). In comparison to sucrose, fructose shows slightly less performance \n\n\n\nCap\u00edtulo 5 \n\n 214 \n\nin terms of injectability, and its extrusion curve along the intermediate stage is \n\nalways above in comparison to that of paste with added sucrose. In both cases, \n\nextrusion stopped at ~3.9 min after beginning mixing the paste, not much after \n\nachieving ~50% of IST (6.3 \u00b1 0.2 min).  \n\nHowever, the overall effects of doping and adding sugars on injectability are more \n\ncomplex than conveyed by this simplistic appraisal. At least three other factors are \n\nlikely to shed further light and have an impact on this issue: (i) the composition and \n\nintrinsic viscosity of the setting liquid; (ii) the structural changes induced in the \n\nstarting powders upon doping; (iii) the effects of additives on the kinetics of setting \n\nreactions. Sugars are expected to enhance the intrinsic viscosity of the liquid \n\nbeyond that conferred by other additives (PEG, HPMC), which alone would favour \n\nthe flow by hindering particles from agglomeration under shear [37, 38]. On the \n\nother hand, the retarding effects of sugars can be exerted through their specific \n\ninteractions with the surface of the particles.  \n\nThe electrophoretic curves displayed in supplementary Fig. S3a reveal that adding \n\nsugars to the background electrolyte decreased the absolute values of zeta \n\npotential, with more evident changes in the case of sucrose. These results confirm \n\nthat the positively charged polyatomic species derived from sugars dissociation \n\n[73] have been specifically adsorbed onto the surface of the particles. It is likely \n\nthat the adsorbed polyatomic ions will exert a certain hindrance towards the setting \n\nliquid species, decreasing the dissolution rate of solid particles and delaying \n\nformation of supersaturated concentration levels of species necessary for the \n\nprecipitation of reaction products. The possible formation of complexes involving \n\nthe polyatomic ions from sugars and ionic species derived from dissolution of \n\nsolids would also contribute for the observed increases in IST [68], and cannot be \n\ndiscarded. In any case, the presence of sugar-derived species will also directly \n\ninterfere with the formation kinetics of phases in the hardened cements by \n\nadsorbing at the surfaces of nuclei and conditioning their growth. As hypothesised \n\nabove, slower growing kinetics is likely to favour a more uniform spatial \n\narrangement of crystals and lead to more packed and less porous structures. \n\n \n\n\n\nCap\u00edtulo 5 \n\n 215 \n\n(a) (b) \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. S3. Since Sr5CPC cements presented the most significant differences of injectability \n\npercentage when sugars were added to the setting liquids, the Sr5-TCP powder was selected to \n\ninvestigate the effects of liquids\u2019 composition on their dispersing ability. The influences of different \n\naqueous electrolyte solutions and pH on a) Zeta Potential (ZP) and b) Electrical conductivity (EC) \n\nwere therefore surveyed. Except for molar concentration in KCl (M), the other numerical \n\ncoefficients in the sample codes stand for weight percent concentration (wt.%) in the electrolyte in \n\nsolution. The error bars of standard deviations are almost imperceptible in some cases, meaning \n\nexcellent reproducibility of data.  \n\nThe measurements were carried out at several pH values using a Zeta Sizer (Nano ZS, Malvern, \n\nWorcestershire, UK). For this, 13 mg of powder was ultrasonically dispersed for 15 min into 50 mL \n\nof the background electrolyte solution (1 mM KCl) and adding the other additives. Each dilute \n\nsuspension was divided into two equal parts, one for increasing and the other for decreasing pH \n\nruns, and the pH values were adjusted using 0.1 M NaOH or 0.1 M HCl solutions, respectively. \n\nResults revealed that ZP is significantly affected by pH and the type of additive, while EC is mostly \n\ndependent on pH (except in the presence of PEG).  \n\nThe results for 15 wt.% CA in a) are not shown because fast dissolution of particles hindered any \n\nreliable measurement, in agreement with observations reported elsewhere [46]. The ZP curves for \n\nthe Sr5-TCP powders suspended in 0.5 wt.% HPMC, 10 wt.% of fructose and KCl 10?3 M as \n\nelectrolytes, showed a decreasing trend as pH increases, more pronounced for KCl 10?3 M. ZP \n\ncurves in the presence of 10 wt.% PEG or 10 wt.% sucrose present minima of ~12 mV at pH range \n\n5?6 and of ~17 mV at pH?8, respectively. In the presence of fructose, higher absolute ZP values \n\nwere registered in comparison to sucrose. High EC values b) were measured when particles are \n\ndispersed in the complete setting liquids, irrespective of their additive contents. When the same \n\nadditives were dissolved in the KCl 10?3 M used for electrophoretic measurements, EC decreased \n\nfor about 1.5 order of magnitude.  \n\n \n\n\n\nCap\u00edtulo 5 \n\n 216 \n\nThis is consistent with the lower values of porosity observed in Fig. 2c for \n\nco-doped cements containing sugars. The same reasoning helps explaining why \n\nthese cements are mechanically stronger (Fig. 2b). The superior performance of \n\nsucrose in comparison to fructose can be attributed to its stronger affinity to the \n\nsurface of solid particles (of reactants and reaction products) and more extensive \n\nadsorption as deduced from the lower zeta potential values (supplementary \n\nFig. S3a). Sucrose should exert a more effective initial retarding effect, while its \n\nhigher molecular weight (almost double than fructose) is expected to enhance \n\nmore the intrinsic viscosity of the liquid and facilitate extrusion. Oppositely, \n\nfructose being less effective in preventing hydrolysis reactions is likely to allow \n\nearlier nuclei formation of reaction products. This might explain why the \n\nintermediate stage of the extrusion curves appears inclined in the present of \n\nfructose (Fig. 4b, Sr5CPC?AF). In fact, although similar IST values were \n\nmeasured for sugar-containing pastes (Fig. 2a), the setting reactions seem to \n\noccur more gradually in the presence of fructose, with viscosity progressively \n\nincreasing, leading to slightly less packed and more porous structures than in \n\nsucrose-containing cements. This is consistent with the porosity data reported in \n\nFig. 2c and the lower CS values displayed in Fig. 2b for all cements containing \n\nfructose, in comparison to those with added sucrose.  \n\nAlthough the roles attributed to MnSr-doping and sugars bring a better \n\nunderstanding of their effects on the handling and physical properties of CPCs, \n\nsome apparent inconsistencies noticed in this work still need to be further clarified: \n\n(i) The expected relationship between porosity and CS [74] is not observed for \n\nMn0.5Sr5CPC and Mn1Sr5CPC samples in Fig. 2b and c. A significantly higher \n\nCS was obtained when liquid A was replaced by liquid AS, but the hardened \n\ncements exhibited similar porosities. This apparent inconsistency could be \n\nattributed to different pore size distributions. This hypothesis is supported by the \n\nhigher SSA of Mn0.5Sr5CPC?AS, the strongest cement among the most \n\nmechanically performing cements. The increase in SSA could result either from: \n\n(1) a volume increase of open porosity (not determined in this study) and/or (2) a \n\nlarge number of smaller pores formed in Mn0.5Sr5CPC?AS than in \n\n\n\nCap\u00edtulo 5 \n\n 217 \n\nMn0.5Sr5CPC?A, as hypothesised above. However, only the latter justifies the \n\nobserved increase in CS for Mn0.5Sr5CPC?AS (Fig. 2b). This hypothesis is also \n\nsupported by SEM observations of hardened cements (Fig. 9d and g).  \n\n(ii) Although Mn/Sr co-doping generally enhanced the IST (Fig. 2a), handling time, \n\ninjectability (Fig. 4a and b), and CS (Fig. 2b), the Mn1Sr5CPC deviates from this \n\ntrend. The lower injectability of Mn1Sr5CPC?A (78%) in comparison to that of \n\nMn0.5Sr5CPC?A (82%) is consistent with the lower CS of hardened \n\nMn1Sr5CPC?A cement (Fig. 2b), and with its highest porosity values (Fig. 2c). All \n\nthese differences between these two cements [which have similar IST values (Fig. \n\n2a)] might be related to the slight differences observed in PSDs of the powders \n\n(Fig. 1c) [46].  \n\nThere is abundant experimental evidence demonstrating the influence of doping \n\nions on the PSD of the synthesised powders. The lattice strains induced by doping \n\nwith ions of different radii are likely to determine different milling behaviours under \n\na given set of experimental conditions. A previous study [30] showed that the \n\nMn-doping and its content exert a strong effect on the starting ??TCP powders\u2019 PS \n\nand PSD. It was also shown that small variations in PS and PSD could strongly \n\naffected the injectability [46] and the kinetics of setting reaction of CPCs [75], with \n\nfine particles accelerating the setting, and shortening both initial and final setting \n\ntimes. Therefore, a perfect comparability among different samples is only possible \n\nwhen starting from exactly coincident PSDs. Strangely, little attention has been \n\ngiven to this cornstone factor [24, 60, 63, 76]. Thence, using fixed milling \n\nconditions for doped and non-doped powders is not the most suitable criterion for \n\nenhancing the comparability among different cement samples. In this work, an \n\nattempt was made to accomplish this condition, by using differentiated milling \n\nconditions for each starting ??TCP powder (illustrated in Fig. 1c). \n\n \n\n \n\n\n\nCap\u00edtulo 5 \n\n 218 \n\n4.2 Effects of MnSr-doping and adding sucrose on the in vitro biological \n\nbehaviour \n\nThe resazurin assay for metabolic active cells and the analyses of the rate of \n\ntype-I collagen secretion revealed that Sr-containing CPCs are the most \n\nosteoconductive. While RefCPC and only Mn-doped CPCs are not permissive to \n\npre-osteoblastic proliferation (Fig. 7a and b), Sr-containing CPCs maintain cell \n\nproliferation levels closer to control ones, during the first proliferative week (Fig. 7a \n\nand b, Sr5CPC, Mn0.5Sr5CPC and Mn1Sr5CPC at 1-7 DIV). These three CPCs \n\nmainly delayed proliferation, having performed in the following order: Mn1Sr5CPC \n\n&lt;Mn0.5Sr5CPC &lt;Sr5CPC, with the latter roughly equalling control levels at \n\n28 DIV. During the maturation period, the levels of active cells seriously decreased \n\nfor Mn1Sr5CPC, independently of the setting-liquid used (Fig. 7a and b, \n\nMn1Sr5CPC at 14-28 DIV). Mn0.5Sr5CPC?A only presented this decrease \n\npunctually, and adding sucrose to the setting liquid prevented it (Fig. 7a and b, \n\nMn0.5Sr5CPC?A and ?AS at 14 DIV). Indeed, and although only punctually \n\nsignificantly different, cements set in AS generally performed better in terms of \n\nosteoblastic proliferation (higher f.ODs in Fig. 7b than in Fig. 7a). Sr-containing \n\nCPCs were also able to maintain good levels of type-I pro-collagen secretion \n\n(Fig. 7d). Pro-collagen is secreted to further acquire the quaternary fibrillary \n\ncollagen conformation that is the most abundant proteic constituent of the \n\nextracellular bone matrix. Given that at 4 DIV these cements have roughly half of \n\nthe number of cells relative to control conditions (Fig. 7a and b), this clearly \n\nindicates that the Sr-containing CPCs increase the rate of cellular pro-collagen \n\nsecretion. Accordingly, the MG63 cells grown for 7 DIV in the vicinity of these \n\ncements generally presented less intracellular pro-collagen (Fig. 8), indicating that \n\npro-collagen secretion occurs earlier. Particularly, cells cultured in the presence of \n\nco-doped Mn/Sr-CPCs are even more depleted than when in the presence of only \n\nSr-doped CPCs (Fig. 8, Mn0.5Sr5CPC vs Sr5CPC), confirming that Mn \n\naccelerates osteoblastic differentiation, as previously reported [30]. Regarding the \n\neffects of the biological 28 DIV incubation on the A and AS cements, significant \n\nfractions of OCP were formed in the non-doped and Mn-doped cement \n\nformulations Fig. 5. Mandel and Tas [77] demonstrated that brushite powders \n\n\n\nCap\u00edtulo 5 \n\n 219 \n\nsoaked in commercial DMEM solutions, at 36.6 \u00baC for about 1 week, were able to \n\ncompletely transform into OCP. A consistent pH decrease in the cell culture \n\nmedium was observed at day 7 for all these cements except for SrCPCs \n\n(supplementary Fig. S4), presenting OCP phase in their composition after 28 DIV \n\n(Fig. 5, compare with Fig. 3b).  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. S4. pH evolution of the cell culture medium in the presence of cement samples at different \n\ntime points up to 28 days of immersion in vitro conditions (28 DIV) in presence of the MG63 pre-\n\nosteoblastic cells. Data for the cement-free control (Ctrl) are also presented for comparison. The \n\nculture medium was substituted after the first 24 h and every 3 days further on. The pH values of \n\nthe medium removed at 1, 7, 14 and 28 DIV were registered. \n\n \n\nIn fact, when brushite transforms into OCP (more basic), the reaction generates \n\nH2PO4\n? ions in solution, acidifying the medium [77]. The higher pH values for \n\nSr-doped only cements (Fig. S4) suggest that this transformation did not occur as \n\nshown in Fig. 5 and that Sr tends to hinder the formation of OCP. \n\nThe interactions between the MG63 cells and CPCs are mediated by a number of \n\ncomplex factors (e.g. surface chemistry and topography, porosity, SSA, \n\ncomposition of the culture medium, etc.); the role of each of these is not easy to \n\n0\n\n2\n\n4\n\n6\n\n8\n\n10\n\nA AS A AS A AS A AS A AS A AS\n\nCtrl Ref Sr5 Mn0.5 Mn1 Mn0.5Sr5 Mn1Sr5\n\nCPC \n\np\nH\n\n1d 7d 14d 28d \n\n\n\nCap\u00edtulo 5 \n\n 220 \n\ndiscriminate due to their interdependencies. The adsorption of proteins from the \n\ncell culture medium on the cement surface is likely affected by ionic composition of \n\nthe medium, namely by the concentration of Mn ions [78-81]. But surface \n\ntopography (roughness, porosity, pore sizes and pore size distribution) also \n\ninfluences the absorption of proteins that help regulate cement-cells interactions \n\n[82, 83]. The smoother surface topographies of Mn0.5Sr5CPC (?A and ?AS) \n\ncements (Fig. 9, supplementary Fig. S1a-c) after 7 DIV are consistent with the \n\nenhanced attachment of osteoblastic cells. The higher cell density observed on the \n\nsurface of Mn0.5Sr5CPC?AS, in comparison with Mn0.5Sr5CPC?A (Fig. 9d and g, \n\nsupplementary Fig. S1d), is also consistent with residual cell nutrition effects from \n\neventual remains of sucrose, although slight differences in porosity might also play \n\na role (Fig. 9d and g). However, surface topography effects can hardly be \n\nseparated from those of doping ions released to the culture medium during \n\nincubation with MG63 cells for 28 DIV (Fig. 6). It is known that Mn increases the \n\nligand binding affinity of integrins, increasing integrin activation. This essential \n\ntransmembrane protein is involved in osteoblastic adhesion, increasing the \n\ncell-extracellular matrix interaction, cell adhesion, and consequently cell \n\nspreading/flattening and migration on the substrate [78-81]. Therefore, the Mn \n\nrelease most likely promotes cell attachment to the surface of the Mn0.5Sr5CPC, \n\nas shown in Fig. 9d-i and supplementary Fig. S2, in which the cells appeared even \n\nmore flattened and better spread across the surface, in comparison to cells grown \n\non SrCPC?A (Fig. 9a-c) and RefCPC?A (supplementary Fig. S1c). Altogether, \n\nthese results indicate that the incorporation of Mn can be a promising approach to \n\nimprove the osteointegration of CPCs [79, 80]. \n\n \n\n5. Conclusions \n\nThe treatment of bone defects via minimally invasive surgical techniques such as \n\nvertebroplasty requires considerable overall improvements to be achieved in the \n\nproperties of injectable CPC, in terms of handling, mechanical and biological \n\nperformances. The results presented and discussed along this article clearly \n\nindicate that handling (setting time and injectability), microstructure, mechanical \n\n\n\nCap\u00edtulo 5 \n\n 221 \n\nand biological properties of brushite cements are strongly dependent on ionic \n\nsubstitutions in the starting powders and on setting liquid composition (without or \n\nwith added sugars). Both independent approaches caused retarding effects in \n\nsetting reactions and enhanced injectability. Mn and Sr co-doping produced more \n\nbenefits in comparison to single doping. Concerning the influence of sugars, \n\nsucrose was more effective than fructose. However, the combined effects of Mn \n\nand Sr co-doping with the presence of sucrose in the setting liquid led to cements \n\nwith overall greatly improved properties, including extended working times, \n\nexcellent injectability, mechanical and biological performances, therefore rendering \n\nthem very promising materials for bone regeneration and tissue engineering. \n\nMoreover, small amounts of Mn promoted the adhesion of MG63 cells and may be \n\na promising way to improve the integration of brushite cements in future in vivo \n\nexperiments. \n\n \n\nAcknowledgments \n\nThis work was developed in the scope of the CICECO-Aveiro Institute of Materials \n\n(Ref. UID/CTM/50011/2013) and the Institute for Biomedicine iBiMED (Ref. \n\nUID/BIM/04501/2013) projects, and funded by FEDER funds through the \n\nOperational Programme Competitiveness Factors (COMPETE 2020) and the \n\nPortuguese Foundation for Science and Technology (FCT). P.M.C. Torres also \n\nacknowledges the FCT for the doctoral grant (SFRH/BD/62021/2009). \n\nThe XRD facility was funded by FEDER funds through QREN-Aviso SAIECT-\n\nIEC/2/2010 and Opera\u00e7\u00e3o NORTE-07-0162-FEDER-000050. The authors are very \n\nthankful to the Hospital Infante D. Pedro of Aveiro, namely to the team involved in \n\nthe process of sterilization of samples, especially to the Chief Nurse Aurea Sim\u00f5es \n\nand to the responsible for sterilization service, Nurse Margarida Vilarinho. \n\n \n\n \n\n\n\nCap\u00edtulo 5 \n\n 222 \n\nReferences \n\n[1] LeGeros RZ, Calcium phosphate materials in restorative dentistry: a review, \n\nAdv. Dent. Res. 2 (1988) 164?80. \n\n[2] P.S. Eggli, W. Muller, R.K. Schenk, Porous hydroxyapatite and tricalcium \n\nphosphate cylinders with two different pore size ranges implanted in the \n\ncancellous bone of rabbits. A comparative histomorphometric and histologic study \n\nof bone ingrowth and implant substitution, Clin. Orthop. Relat. Res. 232 (1988) \n\n127?38. \n\n[3] N. Kondo, A. Ogose, K. Tokunaga, T. Ito, K. Arai, N. Kudo, H. Inoue, H. Irie, N.  \n\nEndo, Bone formation and resorption of highly purified ?-tricalcium phosphate in \n\nthe rat femoral condyle, Biomaterials 26 (2005) 5600?8. \n\n[4] S.V. Dorozhkin, Bioceramics of calcium orthophosphates, Biomaterials  \n\n31.(2010) 1465?85. \n\n[5] M. Bohner, Resorbable biomaterials as bone graft substitutes, Mater Today 13 \n\n(2010) 24?30. \n\n[6] R.W. Bucholz, Nonallograft osteoconductive bone graft substitutes, Clin. \n\nOrthop. 395 (2002) 44?52. \n\n[7] B. von Rechenberg, O.R. G\u00e9not, K. Nuss, L. Galuppo, M. Fulmer, E. Jacobson, \n\nP. Kronen, K. Zlinszky, J.A. Auer, Evaluation of four biodegradable, injectable \n\nbone cements in an experimental drill hole model in sheep, Eur. J. Pharm. \n\nBiopharm. 85 (2013) 130?8. \n\n[8] M.A. Lopez-Heredia, M. Bongio, M. Bohner, V. Cuijpers, L.A.J.A. Winnubst, N. \n\nVan Dijk, J.G.C.Wolke, J.J.J.P. Van Den Beucken, J.A. Jansen, Processing and in \n\nvivo evaluation of multiphasic calcium phosphate cements with dual tricalcium \n\nphosphate phases, Acta Biomater. 8 (2012) 3500?8. \n\n\n\nCap\u00edtulo 5 \n\n 223 \n\n[9] M.P. Ginebra, M. Espanol, E.B. Montufar, R.A. Perez, G. Mestres, New \n\nprocessing approaches in calcium phosphate cements and their applications in \n\nregenerative medicine, Acta Biomater. 6 (2010) 2863?73. \n\n[10] K.L. Low, S.H. Tan, S.H.S. Zein, J.A. Roether, V. Mourino, A.R. Boccaccini. \n\nCalcium phosphate-based composites as injectable bone substitute materials. J \n\nBiomed Mater Res B. 94B (2010) 273?86. \n\n[11] S. V. Dorozhkin. Calcium Orthophosphate Cements and Concretes. Mat Sci \n\nEng C-Mater. 2 (2009) 221?91. \n\n[12] F Tamimi, J Torres, E Lopez-Cabarcos, D Bassett, P Habibovic, E Luceron, J. \n\nE. Barralet, Minimally invasive maxillofacial vertical bone augmentation using \n\nbrushite based cements, Biomaterials 30 (2009) 208?16. \n\n[13] M. Bohner. Calcium orthophosphates in medicine: from ceramics to calcium \n\nphosphate cements. Injury. 31 (2000) 37?47. \n\n[14] M. Bohner, Design of ceramic-based cements and putties for bone graft \n\nsubstitution, Eur. Cell. Mater. 20 (2010) 1?12. \n\n[15] M. Bohner, Calcium phosphate emulsions: possible applications, Key Eng. \n\nMater. 192-195 (2001)765?8. \n\n[16] U. Gbureck, S. Dembski, R. Thull, J.E. Barralet, Factors influencing calcium \n\nphosphate cement shelf-life, Biomaterials 26( 2005) 3691?7. \n\n[17] J. Aaseth, G. Boivin, O. Andersen. Osteoporosis and trace elements \u2013 An \n\noverview, J. Trace Elem. Med. Bio. 26 (2012) 149?52. \n\n[18] E. Boanini, M. Gazzano, A. Bigi, Ionic substitutions in calcium phosphates \n\nsynthesized at low temperature, Acta Biomater. 6 (2010)1882?94. \n\n[19] A. Bigi, E. Foresti, M. Gandolfi, M. Gazzano, N. Roveri, Isomorphous \n\nsubstitutions in ?-tricalcium phosphate: The different effects of zinc and strontium, \n\nJ. Inorg. Biochem. 66 (1997) 259?65. \n\n\n\nCap\u00edtulo 5 \n\n 224 \n\n[20] B. Bracci, P. Torricelli, S. Panzavolta, E. Boanini, R. Giardino, A. Bigi, Effect \n\nof Mg2+, Sr2+, and Mn2+ on the chemico-physical and in vitro biological properties \n\nof calcium phosphate biomimetic coatings, J. Inorg. Biochem. 103 (2009) \n\n1666?74. \n\n[21] S. Kannan, F. Goetz-Neunhoeffer, J. Neubauer, S. Pina, P.M.C. Torres, \n\nJ.M.F. Ferreira, Synthesis and structural characterization of strontium- and \n\nmagnesium-co-substituted ?-tricalcium phosphate, Acta Biomater. 6 (2010) 571?6. \n\n[22] S. Kannan, S.I. Vieira, S.M. Olhero, P.M.C. Torres, S. Pina, O.A.B. Da Cruz e \n\nSilva, J.M. Ferreira, Synthesis, mechanical and biological characterization of ionic \n\ndoped carbonated hydroxyapatite/?-tricalcium phosphate mixtures, Acta Biomater. \n\n7 (2011) 1835?43. \n\n[23] I. Mayer, F.J.G. Cuisinier, S. Gdalya, I. Popov, TEM study of the morphology \n\nof Mn2+-doped calcium hydroxyapatite and ?-tricalcium phosphate, J. Inorg. \n\nBiochem. 102 (2008) 311?7. \n\n[24] S. Pina, P.M. Torres, J.M. Ferreira, Injectability of brushite-forming Mg-\n\nsubstituted and Sr-substituted alpha-TCP bone cements, J. Mater. Sci. Mater. \n\nMed. 21 (2010) 431?8. \n\n[25] S. Pina, S.I. Vieira, P. Rego, P.M.C. Torres, O.A.B. da Cruz e Silva, E.F. da \n\nCruz e Silva, J.M.F. Ferreira, Biological Responses of Brushite forming Zn- and \n\nZnSr- substituted beta-tricalcium phosphate bone Cements, Eur. Cells Mater. 20 \n\n(2010) 162?77. \n\n \n\n[26] E. Rokita, C. Hermes, H.F. Nolting, J. Ryczek, Substitution of Calcium by \n\nStrontium within Selected Calcium Phosphates, J Crystal Growth 130 (1993) \n\n543?52. \n\n[27] T. Landete-Castillejos, I. Molina-Quilez, J.A. Estevez, F. Ceacero, A.J. Garcia, \n\nL. Gallego, Alternative hypothesis for the origin of osteoporosis: The role of Mn, \n\nFront Biosci. E4 (2012) 1385?90. \n\n\n\nCap\u00edtulo 5 \n\n 225 \n\n[28] H. Rico, N. G\u00f3mez-Raso, M. Revilla, E.R. Hern\u00e1ndez, C. Seco, E. P\u00e1ez, E. \n\nCrespo, Effects on bone loss of manganese alone or with copper supplement in \n\novariectomized rats A morphometric and densitomeric study, Eur. J. Obstet. Gyn. \n\nR. B. 90 (2000) 97?101. \n\n[29] S. Pina, P.M. Torres, F. Goetz-Neunhoeffer, J. Neubauer, J.M.F. Ferreira, \n\nNewly developed Sr-substituted alpha-TCP bone cements, Acta Biomater. 6 \n\n(2010) 928?35. \n\n[30] P.M.C. Torres, S.I. Vieira, A.R. Cerqueira, S. Pina, O.A.B. da Cruz Silva, \n\nJ.C.C. Abrantes, J.M. Ferreira, Effects of Mn-doping on the structure and \n\nbiological properties of ?-tricalcium phosphate, J. Inorg. Biochem. 136 (2014) \n\n57?66. \n\n[31] G. Baroud, E. Cayer, M. Bohner. Rheological characterization of concentrated \n\naqueous ?-tricalcium phosphate suspensions: The effect of liquid-to-powder ratio, \n\nmilling time, and additives. Acta Biomater. 1(2005) 357?63. \n\n[32] M. Bohner, G. Baroud. Injectability of calcium phosphate pastes. Biomaterials. \n\n26 (2005) 1553?63. \n\n[33] G. Chen, W. Li, X. Yu, K. Sun, Study of the cohesion of TTCP/DCPA \n\nphosphate cement through evolution of cohesion time and remaining percentage, \n\nJ. Mater. Sci. 44 (2009) 828?34. \n\n[34] I. Khairoun, F.C.M. Driessens, M.G. Boltong, J.A. Planell, R. Wenz, Addition \n\nof cohesion promoters to calcium phosphate cements, Biomaterials. 20 (1999) \n\n393?8. \n\n[35] C. Canal, M.P. Ginebra, Fibre-reinforced calcium phosphate cements: A \n\nreview, J. Mech. Behav. Biomed. Mater. 4 (2011) 1658?71. \n\n[36] R. Kr\u00fcger, J. Groll, Fiber reinforced calcium phosphate cements \u2013 On the way \n\nto degradable load bearing bone substitutes? Biomaterials 33 (2012) 5887?900. \n\n\n\nCap\u00edtulo 5 \n\n 226 \n\n[37] W. Liu, J. Zhang, P. Weiss, F. Tancret, J.-M. Bouler, The influence of different \n\ncellulose ethers on both the handling and mechanical properties of calcium \n\nphosphate cements for bone substitution, Acta Biomater. 9 (2013) 5740?50. \n\n[38] S. Pina, S.M. Olhero, S. Gheduzzi, A.W. Miles, J.M. Ferreira, Influence of \n\nsetting liquid composition and liquid-to-powder ratio on properties of a Mg-\n\nsubstituted calcium phosphate cement, Acta Biomater. 5 (2009) 1233?40. \n\n[39] S. Pina, S.I. Vieira, P.M. Torres, F. Goetz-Neunhoeffer, J. Neubauer, O. A. da \n\nCruz e Silva, E. F. da Cruz e Silva. J. M. Ferreira, In vitro performance \n\nassessment of new brushite-forming Zn- and ZnSr-substituted beta-TCP bone \n\ncements, J. Biomed. Mater. Res B. Appl. Biomater. 94 (2010) 414?20. \n\n[40] S. Sarda, E. Fernandez, M. Nilsson, M. Balcells, J.A. Planell, Kinetic study of \n\ncitric acid influence on calcium phosphate bone cements as water-reducing agent, \n\nJ. Biomed. Mater. Res. 61(2002) 653?9. \n\n[41] J.E. Barralet, L.M. Grover, U. Gbureck, Ionic modification of calcium \n\nphosphate cement viscosity. Part II: hypodermic injection and strength \n\nimprovement of brushite cement, Biomaterials 25 (2004) 2197?203. \n\n[42] B. Han, P.-W. Ma, L.-L. Zhang, Y.-J. Yin, K.-D. Yao, F.-J. Zhang, Y.-D. Zhang, \n\nX.-L. Li, W. Nie, Beta-TCP/MCPM-based premixed calcium phosphate cements, \n\nActa Biomater. 5 (2009) 3165?77. \n\n[43] M. Roy, K. Devoe, A. Bandyopadhyay, S. Bose, Mechanical property and in \n\nvitro biocompatibility of brushite cement modified by polyethylene glycol, Mater. \n\nSci. Eng. C 32 (2012) 2145?52. \n\n[44] M.C. Garci Juenger, H.M. Jennings, New insights into the effects of sugar on \n\nthe hydration and microstructure of cement pastes, Cement Concrete Res.. \n\n32(2002) 393?9. \n\n\n\nCap\u00edtulo 5 \n\n 227 \n\n[45] G. Eggleston. Sucrose and Related OligosaccharidesOligosaccharides. In: B. \n\nFraser-Reid, K. Tatsuta, J. Thiem, (eds.), Glycoscience, Springer Berlin \n\nHeidelberg, 2008, pp. 1163?83. \n\n[46] P.M. Torres, S. Gouveia, S. Olhero, A. Kaushal, J.M. Ferreira, Injectability of \n\ncalcium phosphate pastes: Effects of particle size and state of aggregation of beta-\n\ntricalcium phosphate powders, Acta Biomater. 21 (2015) 204?216. \n\n[47] M. Descamps, J.C. Hornez, A. Leriche, Effects of powder stoichiometry on the \n\nsintering of ?-tricalcium phosphate, J. Eur. Ceram. Soc. 27 (2007) 2401?6. \n\n[48] A.G. Henriques, S.I. Vieira, S. Rebelo, S.C. Domingues, E.F. da Cruz e Silva, \n\nO.A. da Cruz e Silva. Isoform specific amyloid-beta protein precursor metabolism. \n\nJ Alzheimer's dis. 11 (2007) 85?95. \n\n[49] J.F. da Rocha, O.A. da Cruz e Silva, S.I. Vieira, Analysis of the amyloid \n\nprecursor protein role in neuritogenesis reveals a biphasic SH-SY5Y neuronal cell \n\ndifferentiation model, J. Neurochem. 134 (2015) 288?301. \n\n[50] S. Kannan, S. Pina, J.M.F. Ferreira, Formation of strontium-stabilized ?-\n\ntricalcium phosphate from calcium-deficient apatite, J. Am. Ceram. Soc. 89 (2006) \n\n3277?80. \n\n[51] S Kannan, F Goetz-Neunhoeffer, J Neubauer, J.M.F. Ferreira, Cosubstitution \n\nof zinc and strontium in ?-tricalcium phosphate: Synthesis and characterization, J. \n\nAm. Ceram. Soc. 94 (2011) 230?5. \n\n[52] S. Raynaud, E. Champion, D. Bernache-Assollant, P. Thomas, Calcium \n\nphosphate apatites with variable Ca/P atomic ratio I. Synthesis, characterisation \n\nand thermal stability of powders, Biomaterials 23(2002) 1065?72. \n\n[53] E.R. Kreidler, F.A. Hummel, Phase relationships in the system SrO-P2O5 and \n\nthe influence of water vapor on the formation of Sr4P2O9, Inorg. chem. 6 (1967) \n\n884?91. \n\n\n\nCap\u00edtulo 5 \n\n 228 \n\n[54] C. Liu, H. Shao, F. Chen, H. Zheng, Rheological properties of concentrated \n\naqueous injectable calcium phosphate cement slurry, Biomaterials 27 (2006) \n\n5003?13. \n\n[55] J.Y. Reginster, O. Bruy\u00e8re, A. Sawicki, A. Roces-Varela, P. Fardellone, A. \n\nRoberts J. P. Devogelaer, Long-term treatment of postmenopausal osteoporosis \n\nwith strontium ranelate: Results at 8 years, Bone 45 (2009) 1059?64. \n\n[56] P.J. Marie, Strontium ranelate: a novel mode of action optimizing bone \n\nformation and resorption, Osteoporosis international: a journal established as \n\nresult of cooperation between the European Foundation for Osteoporosis and the \n\nNational Osteoporosis Foundation of the USA.;16 Suppl 1 (2005) S7?10. \n\n[57] Schumacher M, Gelinsky M. Strontium modified calcium phosphate cements - \n\nApproaches towards targeted stimulation of bone turnover, J. Mat. Chem. B. 3 \n\n(2015) 4626?40. \n\n[58] U. Thormann, S. Ray, U. Sommer, T. ElKhassawna, T. Rehling, M. \n\nHundgeburth, A. Hen\u00df, M. Rohnke, J Janek, L. J\u00fcrgen, S. Katrin, C. Heiss, G. \n\nSchlewitz, G. Szalay, M. Schumacher, M. Gelinsky, R. Schnettler, V. Alt, Bone \n\nformation induced by strontium modified calcium phosphate cement in critical-size \n\nmetaphyseal fracture defects in ovariectomized rats, Biomaterials 34 (2013) \n\n8589?98. \n\n[59] M. Schumacher, A. Lode, A. Helth, M. Gelinsky, A novel strontium(II)-modified \n\ncalcium phosphate bone cement stimulates human-bone-marrow-derived \n\nmesenchymal stem cell proliferation and osteogenic differentiation in vitro, Acta \n\nBiomater. 9 (2013) 9547?57. \n\n[60] M. Schumacher, A. Hen\u00df, M. Rohnke, M. Gelinsky, A novel and easy-to-\n\nprepare strontium(II) modified calcium phosphate bone cement with enhanced \n\nmechanical properties, Acta Biomater. 9 (2013) 7536?44. \n\n[61] M. Baier, P. Staudt, R. Klein, U. Sommer, R. Wenz, I. Grafe, P.J. Meeder, \n\nP.P. Nawroth, C. Kasperk, Strontium enhances osseointegration of calcium \n\n\n\nCap\u00edtulo 5 \n\n 229 \n\nphosphate cement: a histomorphometric pilot study in ovariectomized rats, J. \n\nOrthop. Surg. Res. 8 (2013) 16. \n\n[62] M.H. Alkhraisat, C. Rueda, E. Lopez Cabarcos, Strontium ions substitution in \n\nbrushite crystals: the role of strontium chloride, J. Funct. Biomater. 2 (2011) 31?8. \n\n[63] M.H. Alkhraisat, C. Moseke, L. Blanco, J.E. Barralet, E. Lopez-Carbacos, U. \n\nGbureck, Strontium modified biocements with zero order release kinetics, \n\nBiomaterials 29 (2008) 4691?7. \n\n[64] E. Boanini, S. Panzavolta, K. Rubini, M. Gandolfi, A. Bigi, Effect of strontium \n\nand gelatin on the reactivity of alpha-tricalcium phosphate, Acta Biomater. 6 \n\n(2010) 936?42. \n\n[65] S. Tadier, R. Bareille, R. Siadous, O. Marsan, C. Charvillat, S. Cazalbou, J. \n\nAm\u00e9d\u00e9e, C. Rey, C. Combes, Strontium-loaded mineral bone cements as \n\nsustained release systems: Compositions, release properties, and effects on \n\nhuman osteoprogenitor cells, J. Biomed. Mater. Res. B \u2013 Appl. Biomater. 100 B \n\n(2012) 378?90. \n\n[66] S. Panzavolta, P. Torricelli, L. Sturba, B. Bracci, R. Giardino, A. Bigi, Setting \n\nproperties and in vitro bioactivity of strontium-enriched gelatin\u2013calcium phosphate \n\nbone cements, J. Biomed. Mater. Res. A 84A (2008) 965?72. \n\n[67] M.H. Alkhraisat, F.T. Mari\u00f1o, C.R. Rodr\u00edguez, LB Jerez, E.L. Cabarcos, \n\nCombined effect of strontium and pyrophosphate on the properties of brushite \n\ncements, Acta Biomater. 4 (2008) 664?70. \n\n[68] M. Bishop, A.R. Barron, Cement hydration inhibition with sucrose, tartaric \n\nacid, and lignosulfonate: Analytical and spectroscopic study, Ind. Eng. Chem. Res. \n\n45 (2006) 7042?9. \n\n[69] N.L. Thomas, J.D. Birchall, The retarding action of sugars on cement \n\nhydration, Cement Concrete Res. 13 (1983) 830?42. \n\n\n\nCap\u00edtulo 5 \n\n 230 \n\n[70] J. Cheung, A. Jeknavorian, L. Roberts, D. Silva, Impact of admixtures on the \n\nhydration kinetics of Portland cement, Cement Concrete Res. 41 (2011)1289?309. \n\n[71] G. Cama, B. Gharibi, J.C. Knowles, S. Romeed, L. DiSilvio, S. Deb, Structural \n\nchanges and biological responsiveness of an injectable and mouldable monetite \n\nbone graft generated by a facile synthetic method, J. Roy. Soc. Interface 11 ( \n\n2014) 07?27. \n\n[72] S. Takagi, L.C. Chow, Formation of macropores in calcium phosphate cement \n\nimplants, J. Mater. Sci. Mater. Med. 12 (2001) 135?9. \n\n[73] V.F. Taylor, R.E. March, H.P. Longerich, C.J. Stadey, A mass spectrometric \n\nstudy of glucose, sucrose, and fructose using an inductively coupled plasma and \n\nelectrospray ionization, Inter. J. Mass. Spectrom. 243 (2005) 71?84. \n\n[74] J. Zhang, W. Liu, V. Schnitzler, F. Tancret, J.M. Bouler, Calcium phosphate \n\ncements for bone substitution: Chemistry, handling and mechanical properties, \n\nActa Biomater. 10 (2014) 1035?49. \n\n[75] M.P. Ginebra, F.C.M. Driessens, J.A. Planell, Effect of the particle size on the \n\nmicro and nanostructural features of a calcium phosphate cement: a kinectic \n\nanalysis, Biomaterials 25 (2004) 3453?62. \n\n[76] X. Wang, J. Ye, Y. Wang, Influence of a novel radiopacifier on the properties \n\nof an injectable calcium phosphate cement, Acta Biomater. 3 (2007) 757?63. \n\n[77] S. Mandel, A.C. Tas, Brushite (CaHPO4\u20222H2O) to octacalcium phosphate \n\n(Ca8(HPO4)2(PO4)4\u20225H2O) transformation in DMEM solutions at 36.5\u00baC, Mater. Sci. \n\nEng. C 30 (2010) 245?54. \n\n[78] D.W. Hamilton, D.M. Brunette, The effect of substratum topography on \n\nosteoblast adhesion mediated signal transduction and phosphorylation, \n\nBiomaterials 28 (2007) 1806?19. \n\n\n\nCap\u00edtulo 5 \n\n 231 \n\n[79] Z. Zhang, B. Gu, W. Zhu, L. Zhu, Integrin-mediated osteoblastic adhesion on \n\na porous manganese-incorporated TiO coating prepared by plasma electrolytic \n\noxidation, Exper. Ther. med. 6 (2013) 707?14. \n\n[80] F. L\u00fcthen, U. Bulnheim, P.D. M\u00fcller, J. Rychly, H. Jesswein, J.G.B. Nebe, \n\nInfluence of manganese ions on cellular behavior of human osteoblasts in vitro, \n\nBiomol. Eng. 24(2007) 531?6. \n\n[81] D.T. Bridgen, C.L. Gilchrist, W.J. Richardson, R.E. Isaacs, C.R. Brown, K.L. \n\nYang, J. Chen, L.A. Setton, Integrin-mediated interactions with extracellular matrix \n\nproteins for nucleus pulposus cells of the human intervertebral disc, J. Orthopaed. \n\nRes. 31 (2013)1661?7. \n\n[82] K. Anselme, Osteoblast adhesion on biomaterials, Biomaterials 21 (2000) \n\n667-81. \n\n[83] X.D. Zhu, H.J. Zhang, H.S. Fan, W. Li, X.D. Zhang, Effect of phase \n\ncomposition and microstructure of calcium phosphate ceramic particles on protein \n\nadsorption, Acta Biomater.6 (2010) 1536?41. \n\n \n\n \n\n \n\n\n\n \n\n 232 \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n 233 \n\n \n\n \n\nCap\u00edtulo 6 \n\n \n\nConclus\u00f5es gerais e perspetivas futuras \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n 234 \n\n \n\n \n\n\n\nCap\u00edtulo 6 \n\n 235 \n\nO trabalho apresentado nesta tese tinha como objetivo principal desenvolver \n\ncimentos de fosfatos de c\u00e1lcio com injectabilidade e propriedades mec\u00e2nicas \n\nmelhoradas para aplica\u00e7\u00f5es em procedimentos cir\u00fargicos minimamente invasivos. \n\nA eventual aplica\u00e7\u00e3o dos cimentos em vertebroplastia, o procedimento cir\u00fargico \n\nminimamente invasivo mais exigente no que concerne a estas propriedades \n\nespec\u00edficas, foi encarada como um grande desafio n\u00e3o necessariamente \n\nalcan\u00e7\u00e1vel, mas mantido como uma motiva\u00e7\u00e3o inspiradora para maximizar \n\nresultados. Os resultados obtidos ao longo das v\u00e1rias fases do estudo \n\nculminaram na obten\u00e7\u00e3o de um cimento de brushite co-dopado com Mn e Sr com \n\npropriedades gerais muito promissoras. Com base nestes resultados, pode \n\nconcluir-se que os objetivos inicialmente estabelecidos foram alcan\u00e7ados com um \n\ngrau de satisfa\u00e7\u00e3o relativamente elevado. \n\nA combina\u00e7\u00e3o da co-dopagem de 0.5 mol% Mn e 5 mol% dos p\u00f3s de ?-TCP com \n\na adi\u00e7\u00e3o de sucrose no l\u00edquido de presa, como agente retardador, resultou em \n\ncimentos de brushite com propriedades de manuseamento (tempo inicial de \n\npresa, injectabilidade), de microestrutura (porosidade), mec\u00e2nicas e biol\u00f3gicas \n\nbastante melhoradas: Para uma LPR de 0.28 mL g?1, o tempo inicial de presa \n\npassou de ~3 min a ~9 min; a injectabilidade das pastas foi completa sem \n\napresentar efeito de separa\u00e7\u00e3o de fases; a resist\u00eancia \u00e0 compress\u00e3o de amostras \n\nde cimento molhadas (ap\u00f3s 48 h numa solu\u00e7\u00e3o de PBS) foi de ~17 MPa, valor \n\nmuito superior ao que foi obtido para os cimentos sem a\u00e7\u00facar n\u00e3o dopados \n\n(5 MPa) ou dopados s\u00f3 com Sr (10 MPa). Numerosos estudos est\u00e3o dispon\u00edveis \n\nna literatura acerca das propriedades dos cimentos de fosfato de c\u00e1lcio dopados \n\ncom Sr, mas trabalhos publicados sobre fosfatos de c\u00e1lcio dopados com Mn para \n\naplica\u00e7\u00f5es biom\u00e9dicas s\u00e3o escassos, e nenhum foi encontrado no caso de \n\ncimentos de fosfato de c\u00e1lcio. A presen\u00e7a de Mn (combinado com Sr) neste tipo \n\nde cimentos e a utiliza\u00e7\u00e3o de sucrose s\u00e3o, portanto, duas novidades que tornam \n\neste trabalho original. Seu uso combinado n\u00e3o s\u00f3 melhorou muito o desempenho \n\nbiol\u00f3gico, tais como a ades\u00e3o e crescimento de c\u00e9lulas osteobl\u00e1sticas na \n\nsuperf\u00edcie do cimento, como tamb\u00e9m aumentou o tempo de manuseamento, \n\npromoveu uma excelente injectabilidade e uma melhoria significativa das \n\npropriedades mec\u00e2nicas, tornando assim estes cimentos materiais muito \n\n\n\nCap\u00edtulo 6 \n\n 236 \n\npromissores para regenera\u00e7\u00e3o \u00f3ssea e engenharia de tecidos e, eventualmente, \n\npara aplica\u00e7\u00e3o em vertebroplastia. \n\nTodos os p\u00f3s de fosfatos tric\u00e1lcicos usados ao longo deste estudo foram obtidos \n\npelo processo de precipita\u00e7\u00e3o em meio aquoso. Esta t\u00e9cnica mostrou-se \n\nadequada para preparar p\u00f3s de ?-TCP dopados com Mg, Sr, Mn e co-dopados \n\ncom Mn e Sr, como j\u00e1 tinha sido demostrado em estudos anteriores para o caso \n\nda dopagem com Mg, Sr e outros elementos. Os precipitados obtidos \u00e0 \n\ntemperatura de 30\u00baC foram calcinados \u00e0 temperatura de 800\u00baC originando \n\ncomposi\u00e7\u00f5es apat\u00edticas ligeiramente deficientes em c\u00e1lcio. A incorpora\u00e7\u00e3o dos \n\nelementos dopantes na estrutura do ??TCP foi confirmada pelas altera\u00e7\u00f5es dos \n\nvalores dos par\u00e2metros de rede que podem ser relacionados com: (i) os \n\ntamanhos dos raios i\u00f3nicos dos elementos dopantes relativamente ao do c\u00e1lcio; \n\n(ii) o grau de dopagem (quantidades incorporadas). Al\u00e9m das altera\u00e7\u00f5es nos \n\npar\u00e2metros de rede, a incorpora\u00e7\u00e3o dos elementos dopantes t\u00eam implica\u00e7\u00f5es em \n\ntermos de estabilidade t\u00e9rmica da fase ?-TCP (deslocando a transforma\u00e7\u00e3o \n\n?-TCP ? ?-TCP para temperaturas superiores). Os resultados mostraram ainda \n\nque as transforma\u00e7\u00f5es de fase alotr\u00f3picas ???-TCP s\u00e3o fortemente \n\ninfluenciadas por vari\u00e1veis experimentais como a taxa de arrefecimento, a \n\npresen\u00e7a de impurezas de CPP e a extens\u00e3o do grau de dopagem com Mg. A \n\nobten\u00e7\u00e3o de um p\u00f3 de ?-fosfato tric\u00e1lcico puro (sem outras fases presentes) \u00e9 \n\ntanto mais dificultada quanto maior for o teor de i\u00f5es dopantes e a presen\u00e7a de \n\nimpurezas de CPP. A presen\u00e7a de CPP promove a forma\u00e7\u00e3o de fase amorfa, \n\naspeto que pode ser interessante explorar com vista a obter p\u00f3s reativos ricos em \n\n?-TCP com um certo grau de dopagem e com algum teor de fase amorfa para \n\naplica\u00e7\u00e3o em cimentos de fosfatos de c\u00e1lcio. \n\nOs conhecimentos adquiridos no estudo dos efeitos das caracter\u00edsticas dos p\u00f3s \n\n(PS, PSD, estado de agrega\u00e7\u00e3o) na injectabilidade de pastas n\u00e3o reativas, n\u00e3o \n\npodem ser diretamente transpostos para as pastas ciment\u00edcias preparadas a partir \n\ndos mesmos p\u00f3s. No caso destas pastas, o aumento significativo da for\u00e7a i\u00f3nica \n\n(causado pelos aditivos presentes no l\u00edquido de presa e pelo MCPM) leva ao \n\ncolapso da dupla camada el\u00e9trica em torno das part\u00edculas, diminuindo assim o \n\n\n\nCap\u00edtulo 6 \n\n 237 \n\ntamanho aparente das part\u00edculas e a sua maior aproxima\u00e7\u00e3o. Desta forma, as \n\nintera\u00e7\u00f5es entre as part\u00edculas s\u00e3o medidas pelas for\u00e7as de lubrifica\u00e7\u00e3o de curto \n\nalcance. Al\u00e9m disso, os resultados revelaram que a distribui\u00e7\u00e3o de tamanho de \n\npart\u00edcula/agregado \u00e9 um fator determinante na injectabilidade de pastas \n\nciment\u00edcias. De facto, a injectabilidade destas pastas mostrou ser muito mais \n\nsens\u00edvel a pequenas varia\u00e7\u00f5es da distribui\u00e7\u00e3o granulom\u00e9trica do que a mudan\u00e7as \n\nde viscosidade. Foi poss\u00edvel injetar completamente pastas reativas com LPR de \n\n0.28 mL g?1 preparadas com p\u00f3s com a mesma distribui\u00e7\u00e3o de tamanhos de \n\npart\u00edcula/agregado mas com part\u00edculas com morfologia distinta (significativamente \n\ndiferentes em \u00e1rea superficial espec\u00edfica) sem apresentar o filter pressing effect \n\ndurante a sua extrus\u00e3o. \n\n \nPerspetivas futuras \n\nA realiza\u00e7\u00e3o de testes in vivo com as formula\u00e7\u00f5es de cimentos mais promissoras \n\n\u00e9 fundamental para aquilatar acerca da necessidade de outras melhorias na sua \n\ncomposi\u00e7\u00e3o ou processo de prepara\u00e7\u00e3o. \n\nAs an\u00e1lises histol\u00f3gicas dos explantes ser\u00e3o de grande import\u00e2ncia na avalia\u00e7\u00e3o \n\ndas propriedades osteog\u00e9nicas do cimento implantado. Assim, a exist\u00eancia ou \n\nn\u00e3o de tecido inflamado dentro dos defeitos criados e preenchidos com o cimento, \n\na biocompatibilidade, a osteocondutividade, como tamb\u00e9m a taxa de reabsor\u00e7\u00e3o \n\ndo cimento e da forma\u00e7\u00e3o do novo osso poderiam ser avaliadas. \n\nAl\u00e9m disso, o estudo in vivo permitiria ainda: \n\n\u2022 Avaliar se a pasta tem tend\u00eancia a dispersar-se (falta de coes\u00e3o) em \n\ncontacto com o fluido biol\u00f3gico;  \n\n\u2022 Avaliar a permeabilidade \u00f3ssea visando otimizar os par\u00e2metros de \n\ninje\u00e7\u00e3o e de infiltra\u00e7\u00e3o do cimento no osso, condi\u00e7\u00e3o essencial quando se \n\ntrata de aplica\u00e7\u00f5es em vertebroplastia percut\u00e2nea. De facto, sendo \n\ndependente da porosidade \u00f3ssea e da viscosidade do cimento, esta \n\npropriedade afeta o processo de inje\u00e7\u00e3o; \n\n\n\nCap\u00edtulo 6 \n\n 238 \n\n\u2022 Verificar se os cimentos apresentam contraste suficiente (radiopacidade) \n\naos Raios X para assistir no processo de inje\u00e7\u00e3o e permitir acompanhar a \n\nsua evolu\u00e7\u00e3o depois de implantado;  \n\n\u2022 Confirmar se os resultados das an\u00e1lises f\u00edsicas e qu\u00edmicas feitas aos \n\nexplantes ap\u00f3s determinados per\u00edodos de implanta\u00e7\u00e3o (7 e 28 dias, e \n\ntempos mais longos) v\u00e3o ao encontro dos resultados medidos para as \n\namostras testadas in vitro neste trabalho; \n\n\u2022 Avaliar a capacidade do cimento para induzir forma\u00e7\u00e3o de osso quando \n\nimplantado num local heterot\u00f3pico (capacidade osteoindutora). \n\n \n\nOutros estudos complementares tamb\u00e9m poderiam ser feitos: \n\n? A implementa\u00e7\u00e3o de condi\u00e7\u00f5es de mistura diferentes das usadas neste \n\ntrabalho (manual e a press\u00e3o atmosf\u00e9rica), como uma mistura mec\u00e2nica \n\ne sob v\u00e1cuo, de modo a garantir graus superiores de homogeneidade e \n\nde desarejamento das pastas ciment\u00edcias, com o intuito de melhorar \n\nainda mais o manuseamento/injectabilidade e propriedades mec\u00e2nicas. \n\n? A adi\u00e7\u00e3o de um agente antibacteriano no cimento e/ou de um antibi\u00f3tico, \n\ncom o objetivo de limitar ou prevenir riscos de infe\u00e7\u00e3o p\u00f3s-operat\u00f3ria. \n\n? A adi\u00e7\u00e3o de outras esp\u00e9cies i\u00f3nicas, existentes como elementos \n\nvestigiais na composi\u00e7\u00e3o do osso, aos cimentos co-dopado de Mn e Sr \n\ntornando-os cimentos poli-dopados para posteriormente avaliar as suas \n\npropriedades. \n\n? A adi\u00e7\u00e3o de outros aditivos no l\u00edquido de presa e estudar a sua influ\u00eancia \n\nnas propriedades de manuseamento, mec\u00e2nicas e biol\u00f3gicas dos \n\ncimentos. \n\n \n \n \n \n\n\n\n \n\n 239 \n\n \n\n \n\nAnexos \n\n \n\n\n\n \n\n 240 \n\n \n\n \n\n\n\nAnexos \n\n 241 \n\n \n\nAnexo 1. Diagrama de equil\u00edbrio de fases do sistema Mg3(PO4)2-Ca3(PO4)2  \n\nAnexo 1.1 Segundo Enderle et al. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nDiagrama de equil\u00edbrio de fases do sistema Mg3(PO4)2-Ca3(PO4)2 (TCP = fosfato tric\u00e1lcico) \n\nsegundo Enderle et al. ([31] do Cap\u00edtulo 2). \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\nAnexos \n\n 242 \n\n \n\nAnexo 1.2 Segundo Carrodeguas et al. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nDiagrama de equil\u00edbrio de fases do sistema Mg3(PO4)2-Ca3(PO4)2 (TCP = fosfato tric\u00e1lcico) \n\nsegundo Carrodeguas et al.([23] do Cap\u00edtulo 2). \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\nAnexos \n\n 243 \n\n \n\nAnexo 2. Diagrama de equil\u00edbrio de fases do sistema CaO-P2O5  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nDiagrama de equil\u00edbrio de fases do sistema CaO-P2O5 (C = CaO; P = P2O5) segundo Kreidler e \n\nHummel ([45] do Cap\u00edtulo 2). \n\n \n\n \n\n \n\n \n\n \n\n\n\nAnexos \n\n 244 \n\n \n\nAnexo 3. Diagrama de equil\u00edbrio de fases do sistema CaO-P2O5-H2O  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nDiagrama de equil\u00edbrio de fases do sistema CaO-P2O5-H2O (C=CaO; P=P2O5; \n\nAp=apatite/hidroxiapatite) segundo Ribaud ([46] do Cap\u00edtulo 2). \n\n \n\n \n\n \n\nT\ne\n\nm\np\n\ne\nra\n\ntu\nre\n\n (\n\u00baC\n\n)"}]}}}